UID,Searchword,API,URL,Title,Summary,Article,Title_Sentiment,Title_Positive,Title_Neutral,Title_Negative,Article_Sentiment,Article_Positive,Article_Neutral,Article_Negative,Verified,Language,Topics,Date,Load_Date,Source
14331,Deutsche Boerse,Twitter API,Twitter,Deutsche BÃ¶rse backed 360X issues regulated security token for music royalties â€“ LedgerÂ Insights https://t.co/zdsD84lwZs,nan,Deutsche BÃ¶rse backed 360X issues regulated security token for music royalties â€“ LedgerÂ Insights https://t.co/zdsD84lwZs,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['Deutsche BÃ¶rse', '360X issues', 'security token', 'music royalties', 'Ledger\xa0Insights', 'Deutsche BÃ¶rse', '360X issues', 'security token', 'music royalties', 'Ledger\xa0Insights']",2022-12-07,2022-12-12,Unknown
14332,Deutsche Boerse,Twitter API,Twitter,Deutsche BÃ¶rse backed 360X issues regulated security token for music royalties â€“ LedgerÂ Insights https://t.co/GqfRKaRiLm,nan,Deutsche BÃ¶rse backed 360X issues regulated security token for music royalties â€“ LedgerÂ Insights https://t.co/GqfRKaRiLm,neutral,0.02,0.98,0.0,neutral,0.02,0.98,0.0,True,English,"['Deutsche BÃ¶rse', '360X issues', 'security token', 'music royalties', 'Ledger\xa0Insights', 'GqfRKaRiLm', 'Deutsche BÃ¶rse', '360X issues', 'security token', 'music royalties', 'Ledger\xa0Insights', 'GqfRKaRiLm']",2022-12-07,2022-12-12,Unknown
14414,Deutsche Boerse,Twitter API,Twitter,Read how Deutsche BÃ¶rse Group is using Microsoft Azure to manage its data and shape the future of the financial serâ€¦ https://t.co/sZpYMsc1jA,nan,Read how Deutsche BÃ¶rse Group is using Microsoft Azure to manage its data and shape the future of the financial serâ€¦ https://t.co/sZpYMsc1jA,neutral,0.08,0.91,0.01,neutral,0.08,0.91,0.01,True,English,"['Deutsche BÃ¶rse Group', 'Microsoft Azure', 'financial ser', 'data', 'future', 'Deutsche BÃ¶rse Group', 'Microsoft Azure', 'financial ser', 'data', 'future']",2022-12-08,2022-12-12,Unknown
14415,Deutsche Boerse,Twitter API,Twitter,CASE STUDY: Learn how Deutsche BÃ¶rse (@DeutscheBoerse) uses Dataminr to protect its 10 000+ employees and assets woâ€¦ https://t.co/HAu7zbbUNF,nan,CASE STUDY: Learn how Deutsche BÃ¶rse (@DeutscheBoerse) uses Dataminr to protect its 10 000+ employees and assets woâ€¦ https://t.co/HAu7zbbUNF,neutral,0.08,0.91,0.01,neutral,0.08,0.91,0.01,True,English,"['Deutsche BÃ¶rse', 'CASE STUDY', '10,000+ employees', 'DeutscheBoerse', 'Dataminr', 'assets', 'HAu7zbbUNF', 'Deutsche BÃ¶rse', 'CASE STUDY', '10,000+ employees', 'DeutscheBoerse', 'Dataminr', 'assets', 'HAu7zbbUNF']",2022-12-07,2022-12-12,Unknown
14487,Clearstream,Twitter API,Twitter,The team at Enserva congratulates Flint Corp. (formerly ClearStream Energy Services Inc.) and their entire team forâ€¦ https://t.co/T4RL987S7g,nan,The team at Enserva congratulates Flint Corp. (formerly ClearStream Energy Services Inc.) and their entire team forâ€¦ https://t.co/T4RL987S7g,neutral,0.27,0.72,0.02,neutral,0.27,0.72,0.02,True,English,"['ClearStream Energy Services Inc.', 'Flint Corp.', 'entire team', 'Enserva', 'T4RL987S7g', 'ClearStream Energy Services Inc.', 'Flint Corp.', 'entire team', 'Enserva', 'T4RL987S7g']",2022-12-09,2022-12-12,Unknown
14492,Deutsche Boerse,Twitter API,Twitter,âž¡ï¸ðŸ‡©ðŸ‡ª #Porsche enters the DAXðŸ”¸Deutsche BÃ¶rse announced at 22:00 CET on Monday  5 December  that Porsche AG will beâ€¦ https://t.co/Dm9WhebNYm,nan,âž¡ï¸ðŸ‡©ðŸ‡ª #Porsche enters the DAXðŸ”¸Deutsche BÃ¶rse announced at 22:00 CET on Monday  5 December  that Porsche AG will beâ€¦ https://t.co/Dm9WhebNYm,neutral,0.07,0.93,0.01,neutral,0.07,0.93,0.01,True,English,"['Deutsche BÃ¶rse', 'Porsche AG', 'DAX', '22:00 CET', 'Monday', 'December', 'Deutsche BÃ¶rse', 'Porsche AG', 'DAX', '22:00 CET', 'Monday', 'December']",2022-12-09,2022-12-12,Unknown
14493,Deutsche Boerse,Twitter API,Twitter,Deutsche BÃ¶rse backed 360X issues regulated security token for music royalties - Ledger Insights - blockchain forâ€¦ https://t.co/NelKaXHueI,nan,Deutsche BÃ¶rse backed 360X issues regulated security token for music royalties - Ledger Insights - blockchain forâ€¦ https://t.co/NelKaXHueI,neutral,0.06,0.93,0.01,neutral,0.06,0.93,0.01,True,English,"['Deutsche BÃ¶rse', '360X issues', 'security token', 'music royalties', 'Ledger Insights', 'blockchain', 'NelKaXHueI', 'Deutsche BÃ¶rse', '360X issues', 'security token', 'music royalties', 'Ledger Insights', 'blockchain', 'NelKaXHueI']",2022-12-09,2022-12-12,Unknown
14494,Deutsche Boerse,Twitter API,Twitter,ðŸ”´Newsflash #Crypto #Royalty Deutsche BÃ¶rse Backed 360X Issues Regulated Security Token for Music Royalties360X Mâ€¦ https://t.co/40yYXB9qNC,nan,ðŸ”´Newsflash #Crypto #Royalty Deutsche BÃ¶rse Backed 360X Issues Regulated Security Token for Music Royalties360X Mâ€¦ https://t.co/40yYXB9qNC,neutral,0.09,0.9,0.01,neutral,0.09,0.9,0.01,True,English,"['Music Royalties 360X M', 'Deutsche BÃ¶rse', '360X Issues', 'Security Token', 'Newsflash', 'Crypto', 'Royalty', 'Music Royalties 360X M', 'Deutsche BÃ¶rse', '360X Issues', 'Security Token', 'Newsflash', 'Crypto', 'Royalty']",2022-12-08,2022-12-12,Unknown
14580,Deutsche Boerse,Twitter API,Twitter,"â€¦ @Curaleaf_Inc is #1 worldwide but not listed at ""Deutsche BÃ¶rse AG"". Why @Boris_Jordan ?ðŸ¤”ðŸŒ± https://t.co/rzti8wls3F",nan,"â€¦ @Curaleaf_Inc is #1 worldwide but not listed at ""Deutsche BÃ¶rse AG"". Why @Boris_Jordan ?ðŸ¤”ðŸŒ± https://t.co/rzti8wls3F",neutral,0.08,0.89,0.02,neutral,0.08,0.89,0.02,True,English,"['Deutsche BÃ¶rse AG', 'Boris_Jordan', 'Deutsche BÃ¶rse AG', 'Boris_Jordan']",2022-12-11,2022-12-12,Unknown
14581,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221211005029/en/MaaT-Pharma-Presents-Promising-Detailed-Results-from-Completed-Phase-1b-Trial-with-MaaT033-at-the-64th-ASH-Annual-Meeting,MaaT Pharma Presents Promising Detailed Results from Completed Phase 1b Trial with MaaT033 at the 64th ASH Annual Meeting,LYON  France--(BUSINESS WIRE)---- $MAAT #ASH22--Regulatory News: MaaT Pharma (EURONEXT: MAAT â€“ the â€œCompanyâ€)  a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes â€¦,LYON  France--(BUSINESS WIRE)--Regulatory News:MaaT Pharma (EURONEXT: MAAT â€“ the â€œCompanyâ€)  a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer  today presented detailed results from the completed Phase 1b CIMON trial with MaaT033 at the Annual Society of Hematology (ASH) Annual Meeting in New Orleans  U.S. To access the abstract  please click here.â€œMaaT Pharmaâ€™s mission is to improve cancer patientsâ€™ lives by driving innovation in the microbiome therapeutics field â€ said HervÃ© Affagard  CEO and co-founder of MaaT Pharma. â€œThese positive Phase 1b results reinforces the strong potential for our MET oral formulation  MaaT033  and we plan to investigate it as an adjunctive and maintenance treatment in patients with hematological malignancies.â€Prof. Mohamad Mohty added  â€œAllo-HSCT is often the only curative approach for patients with hematological malignancies such as acute leukemia. Evidence of a significant reduction in the risk of infection and GvHD-related mortality following stem cell transplantation has been associated with a higher gut microbiome diversity. Our ability to maintain or induce a high richness  and a high diversity gut microbiome would be key to prevent or minimize these adverse effects and contribute to a better overall prognosis for these patients.â€Key clinical findings with MaaT033 in Phase 1b study CIMONIn the dose-finding Phase 1b CIMON trial  21 patients with acute myeloid leukemia (AML) were treated with MaaT033 and evaluated for safety  tolerability  and initial signs of microbial species engraftment.MaaT033 was shown to be safe and tolerable in 21 patients. 4 severe adverse events (SAEs) were reported in 4 patients  only one considered as possibly related by the investigator.Treatment with MaaT033 induced increased microbiota richness as well as strong and persistent engraftment in cohorts 3 and 4 of the dose escalation study  which consisted in the intake of 3 capsules of the drug candidate per day.Engraftment following MaaT033 treatment correlated with increased anti-inflammatory marker levels and reduced inflammatory marker levels.Detailed results from the Phase 1b CIMON trial were presented in a poster on December 11 at the ASH Annual Meeting by Prof. Mohamad Mohty  Head of the Clinical Hematology and Cellular Department at the Saint-Antoine Hospital and Sorbonne University.As previously announced  MaaT Pharma is currently preparing a pivotal Phase IIb randomized  double-blind  placebo-controlled to evaluate MaaT033â€™s safety  engraftment  and efficacy in improving overall survival at 12 months and preventing complications in patients with blood cancers receiving hematopoietic stem cell transplantation. Initiation should take place shortly and the Company will provide a detailed status update in January 2023.About MaaT033MaaT033 is an oral  full-ecosystem  off-the-shelf  standardized  pooled-donor  high-richness Microbiome Ecosystem TherapyTM. MaaT033 is designed to restore the gut ecosystem to full functionality to improve clinical outcomes as well as to control adverse events related to conventional treatments for liquid tumors. The capsule formulation facilitates administration while maintaining the high and consistent richness and diversity of microbial species  including anti-inflammatory ButycoreTM species.About MaaT PharmaMaaT Pharma  a clinical stage biotechnology company  has established a complete approach to restoring patient-microbiome symbiosis in oncology. Committed to treating cancer and graft-versus-host disease (GvHD)  a serious complication of allogeneic stem cell transplantation  MaaT Pharma has launched  in March 2022  a Phase 3 clinical trial for patients with acute GvHD  following the achievement of its proof of concept in a Phase 2 trial. Its powerful discovery and analysis platform  gutPrintÂ®  supports the development and expansion of its pipeline by determining novel disease targets  evaluating drug candidates  and identifying biomarkers for microbiome-related conditions. The companyâ€™s Microbiome Ecosystem Therapies are produced through a standardized cGMP manufacturing and quality control process to safely deliver the full diversity of the microbiome  in liquid and oral formulations. MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to support the integration of the use of microbiome therapies in clinical practice.MaaT Pharma is the first company developing microbiome-based therapies listed on Euronext Paris (ticker: MAAT).Forward-looking StatementsAll statements other than statements of historical fact included in this press release about future events are subject to (i) change without notice and (ii) factors beyond the Companyâ€™s control. These statements may include  without limitation  any statements preceded by  followed by or including words such as â€œtarget â€ â€œbelieve â€ â€œexpect â€ â€œaim â€ â€œintend â€ â€œmay â€ â€œanticipate â€ â€œestimate â€ â€œplan â€ â€œproject â€ â€œwill â€ â€œcan have â€ â€œlikely â€ â€œshould â€ â€œwould â€ â€œcouldâ€ and other words and terms of similar meaning or the negative thereof. Forward-looking statements are subject to inherent risks and uncertainties beyond the Companyâ€™s control that could cause the Companyâ€™s actual results or performance to be materially different from the expected results or performance expressed or implied by such forward-looking statements.,neutral,0.0,1.0,0.0,mixed,0.24,0.14,0.62,True,English,"['64th ASH Annual Meeting', 'Promising Detailed Results', 'Phase 1b Trial', 'MaaT Pharma', 'MaaT033', 'pivotal Phase IIb randomized, double-blind, placebo-controlled', 'dose-finding Phase 1b CIMON trial', 'hematopoietic stem cell transplantation', 'allogeneic stem cell transplantation', 'positive Phase 1b results', 'high-richness Microbiome Ecosystem TherapyTM', 'higher gut microbiome diversity', 'clinical stage biotechnology company', 'high diversity gut microbiome', 'Phase 1b study', 'Phase 3 clinical trial', 'French clinical-stage biotech', 'Microbiome Ecosystem TherapiesTM', 'microbiome therapeutics field', 'Prof. Mohamad Mohty', 'dose escalation study', 'novel disease targets', 'standardized cGMP manufacturing', 'ASH) Annual Meeting', 'Key clinical findings', 'ASH Annual Meeting', 'anti-inflammatory ButycoreTM species', 'detailed status update', 'anti-inflammatory marker levels', 'quality control process', 'acute myeloid leukemia', '4 severe adverse events', 'Phase 2 trial', 'microbial species engraftment', 'gut ecosystem', 'cancer patientsâ€™ lives', 'microbiome therapies', 'detailed results', 'acute leukemia', 'full diversity', 'Annual Society', 'clinical outcomes', 'clinical practice', 'high richness', 'adverse effects', 'microbiome-based therapies', 'future events', 'Clinical Hematology', 'BUSINESS WIRE', 'Regulatory News', 'survival outcomes', 'New Orleans', 'U.S.', 'HervÃ© Affagard', 'oral formulation', 'hematological malignancies', 'curative approach', 'significant reduction', 'GvHD-related mortality', 'overall prognosis', 'initial signs', 'microbiota richness', 'drug candidate', 'Cellular Department', 'Saint-Antoine Hospital', 'Sorbonne University', 'overall survival', 'blood cancers', 'oral, full-ecosystem', 'full functionality', 'conventional treatments', 'capsule formulation', 'consistent richness', 'complete approach', 'patient-microbiome symbiosis', 'serious complication', 'powerful discovery', 'analysis platform', 'microbiome-related conditions', 'world-leading scientists', 'historical fact', 'press release', 'acute GvHD', 'MaaT Pharma', 'persistent engraftment', 'maintenance treatment', 'first company', 'strong potential', 'liquid tumors', 'Euronext Paris', 'Forward-looking Statements', 'MaaT033 treatment', '21 patients', '4 patients', 'LYON', 'France', 'pioneer', 'development', 'MET', 'abstract', 'mission', 'innovation', 'CEO', 'founder', 'adjunctive', 'Allo-HSCT', 'Evidence', 'risk', 'infection', 'ability', 'AML', 'safety', 'SAEs', 'investigator', 'cohorts', 'intake', '3 capsules', 'day', 'poster', 'December', 'Head', 'efficacy', '12 months', 'complications', 'Initiation', 'January', 'shelf', 'administration', 'oncology', 'March', 'achievement', 'proof', 'concept', 'gutPrint', 'expansion', 'pipeline', 'biomarkers', 'commitment', 'relationships', 'regulators', 'integration', 'use', 'change', 'notice', 'factors', 'limitation', 'words', 'believe', 'aim', 'estimate', 'project']",2022-12-11,2022-12-12,businesswire.com
14583,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/MAAT-PHARMA-128358114/news/MaaT-Pharma-Inside-Information-Other-news-releases-42523281/?utm_medium=RSS&utm_content=20221211,MaaT Pharma : Inside Information / Other news releases,(marketscreener.com)   MaaT Pharma Presents Promising Detailed Results from   Completed Phase 1b Trial with MaaT033   at the 64th ASH Annual Meeting    Detailed results from completed Phase 1b CIMON trial in 21 acute myeloid leukemia patients treaâ€¦,"MaaT Pharma Presents Promising Detailed Results fromCompleted Phase 1b Trial with MaaT033at the 64th ASH Annual MeetingDetailed results from completed Phase 1b CIMON trial in 21 acute myeloid leukemia (AML) patients treated with the company's Microbiome Ecosystem Therapy TM (MET) oral capsule  MaaT033  demonstrating its safety and ability to increase gut microbiota richness.(MET) oral capsule  MaaT033  demonstrating its safety and ability to increase gut microbiota richness. Results of the study evaluating the tolerated dose of MaaT033 in patients with AML showed initial engraftment of beneficial bacterial species.Company presented topline results in June 2022 and confirms its intention to conduct a Phase IIb pivotal trial shortly in order to evaluate MaaT033 to prevent complication of allo- HSCT. Readiness activities have continued in Q4.22 destined to optimize the protocol in light of deeper data analysis.Company to host investor webcast on Monday  December 12 at 6:00 pm CET/12:00pm EST. To register and access the webcast  please click here. A replay will be made available shortly after the conclusion of the webcast and archived on MaaT Pharma'swebsite for at least 90 days.Lyon  France December 11th  2022 - 4:00pm CET - MaaT Pharma(EURONEXT: MAAT - the ""Company"")  a French clinical-stagebiotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer  today presented detailed results from the completed Phase 1b CIMON trial with MaaT033 at the Annual Society of Hematology (ASH) Annual Meeting in New Orleans  U.S. To access the abstract  please click here.""MaaT Pharma's mission is to improve cancer patients' lives by driving innovation in the microbiome therapeutics field "" said HervÃ© Affagard  CEO and co-founderof MaaT Pharma. ""These positive Phase 1b results reinforces the strong potential for our MET oral formulation  MaaT033  and we plan to investigate it as an adjunctive and maintenance treatment in patients with hematological malignancies.""Prof. Mohamad Mohty added  ""Allo-HSCT is often the only curative approach for patients with hematological malignancies such as acute leukemia. Evidence of a significant reduction in the risk of infection and GvHD-related mortality following stem cell transplantation has been associated with a higher gut microbiome diversity. Our ability to maintain or induce a high richness  and a high diversity gut microbiome would be key to prevent or minimize these adverse effects and contribute to a better overall prognosis for these patients.""1/3",neutral,0.0,0.99,0.0,mixed,0.47,0.14,0.39,True,English,"['Other news releases', 'MaaT Pharma', 'Inside Information', 'Phase IIb pivotal trial', 'Phase 1b CIMON trial', 'Microbiome Ecosystem Therapy TM', 'higher gut microbiome diversity', 'high diversity gut microbiome', '64th ASH Annual Meeting', 'positive Phase 1b results', 'Phase 1b Trial', 'Microbiome Ecosystem TherapiesTM', 'ASH) Annual Meeting', 'microbiome therapeutics field', 'gut microbiota richness', 'beneficial bacterial species', 'deeper data analysis', 'Prof. Mohamad Mohty', 'stem cell transplantation', '21 acute myeloid leukemia', 'Promising Detailed Results', 'MET) oral capsule', ""cancer patients' lives"", 'high richness', 'Annual Society', 'acute leukemia', 'oral formulation', 'topline results', 'initial engraftment', 'allo- HSCT', 'Readiness activities', 'French clinical-stagebiotech', 'survival outcomes', 'New Orleans', 'U.S.', 'HervÃ© Affagard', 'strong potential', 'maintenance treatment', 'hematological malignancies', 'curative approach', 'significant reduction', 'GvHD-related mortality', 'adverse effects', 'overall prognosis', 'MaaT Pharma', 'investor webcast', 'AML) patients', 'MaaT033', 'company', 'safety', 'ability', 'study', 'dose', 'June', 'intention', 'order', 'complication', 'Q4.22', 'protocol', 'light', 'Monday', 'December', '00pm', 'replay', 'conclusion', 'website', '90 days', 'Lyon', 'France', 'EURONEXT', 'pioneer', 'development', 'Hematology', 'abstract', 'mission', 'innovation', 'CEO', 'founderof', 'adjunctive', 'Allo-HSCT', 'Evidence', 'risk', 'infection', '1/3', '6:00', '4:00']",2022-12-11,2022-12-12,marketscreener.com
14590,Clearstream,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/12/2571560/0/en/Clearstream-Chooses-Proxymity-s-Digital-Proxy-Voting-Service-for-Nine-Markets-Across-Europe.html,Clearstream Chooses Proxymity's Digital Proxy Voting Service for Nine Markets Across Europe,Proxymity's Vote Connect solution to be deployed across nine European countries  fueling further expansion of digital proxy voting in the region. Proxymity's Vote Connect solution to be deployed across nine European countries  fueling further expansion of digâ€¦,"LONDON  Dec. 12  2022 (GLOBE NEWSWIRE) -- Proxymity  the leading digital investor communication platform  announced today that Clearstream has gone live with its digital proxy voting service  Vote Connect  across nine European markets. This digital proxy voting service connects issuers  intermediaries  and investors  ensuring that investor communications are delivered in real-time.Proxymity Vote Connect is the flagship digital proxy service powered by Proxymity's investor communications platform. The service includes ""issuer golden source"" meeting announcements published directly from issuers to investors. Many European markets benefit from the full end-to-end digital connectivity provided by the solution  enabling greater transparency  speed  and accuracy to the ecosystem.With Vote Connect  shareholders' votes are sent digitally to issuers or their agents in real-time and they receive digital confirmation that their votes have been cast and counted at the meeting. The inefficient and disjointed infrastructure of existing channels has seen a growing number of businesses reassess how they manage proxy voting  with Proxymity's platform increasingly seen as the solution of choice.Dean Little  CEO and Co-Founder  Proxymity  commented: ""We continue to develop our long-standing partnership with Clearstream and the Deutsche BÃ¶rse Group  following on from the rollout of our Shareholder ID solution earlier in the year. This is another fantastic milestone for Proxymity as we expand our market coverage  including the introduction of Vote Connect into the Baltic Markets and increasing our overall global footprint.""Sam Riley  Head of Clearstream Securities Services  added: ""At Clearstream  we always seek to optimise our clients' experience throughout the whole securities life cycle. Together with our partner Proxymity  we are seeking to provide the best in digital proxy voting solutions  driving transparency  and increasing efficiency in the European capital markets.""About SRD IISRD II aims to make it easier for issuers to engage with shareholders  especially across different countries  encouraging the use of modern technology to aid communication between companies  their shareholders  and the intermediaries between them.The European-wide legislation impacts  amongst others  companies with registered offices and shares trading in the EU and EEA. This suggests new platforms and technologies like Proxymity may not only help upgrade existing processes to meet SRD II demands but could also be the most efficient and effective means of complying with the legislation.-Notes to editors-About ProxymityProxymity connects the world's ecosystem of issuers  intermediaries  and investors digitally in real-time  bringing unprecedented transparency  efficiency  and accuracy to traditional paper-based processes. Trusted by the world's largest financial institutions  it is the leading digital investor communications platform  serving over 25 markets world-wide. Proxymity's ground-breaking technology has also been recognised industry-wide  with recent awards including FSTech's ""Most Disruptive Technology in the FinTech Sector"" and GC Magazine's ""FinTech of the Year 2022"".Our solutions give public companies confidence that their AGM/EGM agendas are transmitted as ""golden source"" and provide institutional investors with the time to research and vote on corporate decisions  as well as actual digital confirmation that their votes have been received. The digital-native platform  built on highly scalable technology  provides full compliance with the latest regulations  such as the Shareholder Rights Directive (SRD II).Proxymity promotes enhanced environmental  social  and governance (ESG) by improving communication between issuers and investors while making it easier for intermediaries to provide efficient  timely and compliant client service.The company is backed by a global consortium of the industry's most influential financial institutions  representing seven of the world's top ten Global Custodians managing over $200 trillion in assets under custody (BNP Paribas  BNY Mellon  Citi  Computershare  Deutsche Bank  Deutsche BÃ¶rse  HSBC  J.P. Morgan  Mediant  State Street).For more information  visit www.proxymity.ioProxymity media contacts:Tel: +44 (0) 20 3195 3240 /Lauren Fraser: lfraser@sapiencecomms.co.ukJamie Gittings: jgittings@sapiencecomms.co.ukSergio Cortes Allsopp: scortesallsop@sapiencecomms.co.ukContact Information:Lauren FraserPR Teamlfraser@sapiencecomms.co.uk+44 20 3195 3240James GittingsPR Teamjgittings@sapiencecomms.co.uk+442031953240Related ImagesImage 1This content was issued through the press release distribution service at Newswire.com.Attachment",neutral,0.0,1.0,0.0,mixed,0.67,0.08,0.25,True,English,"['Digital Proxy Voting Service', 'Nine Markets', 'Clearstream', 'Proxymity', 'Europe', 'issuer golden source"" meeting announcements', 'leading digital investor communications platform', 'leading digital investor communication platform', 'press release distribution service', 'top ten Global Custodians', 'James Gittings PR Team', 'flagship digital proxy service', 'digital proxy voting service', 'Deutsche BÃ¶rse Group', 'Lauren Fraser PR Team', 'digital proxy voting solutions', 'compliant client service', 'actual digital confirmation', 'overall global footprint', 'securities life cycle', 'largest financial institutions', 'Shareholder Rights Directive', 'influential financial institutions', 'J.P. Morgan', 'Sergio Cortes Allsopp', 'traditional paper-based processes', 'nine European markets', 'Many European markets', 'European capital markets', 'Most Disruptive Technology', 'Shareholder ID solution', 'public companies confidence', 'Clearstream Securities Services', 'SRD II demands', 'Proxymity media contacts', 'Proxymity Vote Connect', 'digital connectivity', 'digital-native platform', 'global consortium', 'Deutsche Bank', 'Jamie Gittings', 'existing processes', 'Baltic Markets', 'modern technology', 'ground-breaking technology', 'scalable technology', 'GLOBE NEWSWIRE', 'disjointed infrastructure', 'existing channels', 'growing number', 'Dean Little', 'long-standing partnership', 'fantastic milestone', 'market coverage', 'Sam Riley', ""clients' experience"", 'different countries', 'registered offices', 'new platforms', 'effective means', 'recent awards', 'GC Magazine', 'AGM/EGM agendas', 'corporate decisions', 'full compliance', 'latest regulations', 'BNP Paribas', 'BNY Mellon', 'State Street', 'Related Images', 'Newswire.com', 'full end', 'greater transparency', 'European-wide legislation', 'FinTech Sector', 'efficient, timely', 'Contact Information', 'partner Proxymity', 'institutional investors', ""shareholders' votes"", '25 markets', 'LONDON', 'Dec.', 'issuers', 'intermediaries', 'real-time', 'speed', 'accuracy', 'ecosystem', 'agents', 'inefficient', 'businesses', 'choice', 'CEO', 'Founder', 'rollout', 'year', 'introduction', 'Head', 'efficiency', 'use', 'The', 'shares', 'EEA', 'technologies', 'Notes', 'editors', 'world', 'FSTech', 'highly', 'governance', 'ESG', 'company', 'industry', 'assets', 'custody', 'Citi', 'Computershare', 'HSBC', 'Mediant', 'Tel', 'jgittings', 'content', 'Attachment', '44']",2022-12-12,2022-12-12,globenewswire.com
14591,Clearstream,Bing API,https://www.assetservicingtimes.com/assetservicesnews/technologyarticle.php?article_id=13788&navigationaction=home&page=1&newssection=technology,Clearstream onboards Proxymityâ€™s Vote Connect in Europe,Clearstream has gone live with Proxymityâ€™s digital proxy voting service Vote Connect across nine European markets. Vote Connect provides â€˜issuer golden sourceâ€™ meeting announcements and allows for real-time communication between issuers ,Clearstream onboards Proxymityâ€™s Vote Connect in EuropeClearstream has gone live with Proxymityâ€™s digital proxy voting service Vote Connect across nine European markets.Vote Connect provides â€˜issuer golden sourceâ€™ meeting announcements and allows for real-time communication between issuers  intermediaries and investors. This makes the entire ecosystem faster  more accurate and more transparent  Proxymity says.Through the solution  the company aims to resolve current issues around proxy voting  whereby shareholders are often unable to engage with companies  it says.Clearstreamâ€™s adoption of Vote Connect follows news earlier this year that both J.P. Morgan and Citi Securities Services have launched the solution in Denmark and Australasia  respectively.Sam Riley  head of Clearstream Securities Services  says: â€œAt Clearstream  we always seek to optimise our clientsâ€™ experience throughout the whole securities life cycle. With Proxymity  we are seeking to provide the best in digital proxy voting solutions  driving transparency and increasing efficiency in the European capital markets.â€Dean Little  CEO and co-founder of Proxymity  adds: â€œWe continue to develop our long-standing partnership with Clearstream and the Deutsche BÃ¶rse Group  following on from the rollout of our Shareholder ID solution earlier in the year.â€œThis is another milestone for Proxymity as we expand our market coverage  introducing of Vote Connect into the Baltic Markets and increasing our overall global footprint.â€,neutral,0.08,0.92,0.0,positive,0.53,0.46,0.0,True,English,"['Vote Connect', 'Clearstream', 'Proxymity', 'Europe', 'issuer golden sourceâ€™ meeting announcements', 'Deutsche BÃ¶rse Group', 'digital proxy voting service', 'digital proxy voting solutions', 'J.P. Morgan', 'Citi Securities Services', 'securities life cycle', 'overall global footprint', 'nine European markets', 'European capital markets', 'Shareholder ID solution', 'Clearstream Securities Services', 'Baltic Markets', 'real-time communication', 'entire ecosystem', 'current issues', 'Sam Riley', 'clientsâ€™ experience', 'Dean Little', 'long-standing partnership', 'market coverage', 'Vote Connect', 'Proxymity', 'issuers', 'intermediaries', 'investors', 'company', 'shareholders', 'companies', 'adoption', 'news', 'Denmark', 'Australasia', 'head', 'transparency', 'efficiency', 'CEO', 'founder', 'rollout', 'year', 'milestone']",2022-12-12,2022-12-12,assetservicingtimes.com
14592,Clearstream,Bing API,https://ca.sports.yahoo.com/news/clearstream-chooses-proxymitys-digital-proxy-090000296.html,Clearstream Chooses Proxymity's Digital Proxy Voting Service for Nine Markets Across Europe,Proxymity's Vote Connect solution to be deployed across nine European countries  fueling further expansion of digital proxy voting in the region. Featured Image for  Featured Image for  LONDON  Dec. 12 ,"Proxymity's Vote Connect solution to be deployed across nine European countries  fueling further expansion of digital proxy voting in the region.Featured Image for ProxymityFeatured Image for ProxymityLONDON  Dec. 12  2022 (GLOBE NEWSWIRE) -- Proxymity  the leading digital investor communication platform  announced today that Clearstream has gone live with its digital proxy voting service  Vote Connect  across nine European markets. This digital proxy voting service connects issuers  intermediaries  and investors  ensuring that investor communications are delivered in real-time.Proxymity Vote Connect is the flagship digital proxy service powered by Proxymity's investor communications platform. The service includes ""issuer golden source"" meeting announcements published directly from issuers to investors. Many European markets benefit from the full end-to-end digital connectivity provided by the solution  enabling greater transparency  speed  and accuracy to the ecosystem.With Vote Connect  shareholders' votes are sent digitally to issuers or their agents in real-time and they receive digital confirmation that their votes have been cast and counted at the meeting. The inefficient and disjointed infrastructure of existing channels has seen a growing number of businesses reassess how they manage proxy voting  with Proxymity's platform increasingly seen as the solution of choice.Dean Little  CEO and Co-Founder  Proxymity  commented: ""We continue to develop our long-standing partnership with Clearstream and the Deutsche BÃ¶rse Group  following on from the rollout of our Shareholder ID solution earlier in the year. This is another fantastic milestone for Proxymity as we expand our market coverage  including the introduction of Vote Connect into the Baltic Markets and increasing our overall global footprint.""Sam Riley  Head of Clearstream Securities Services  added: ""At Clearstream  we always seek to optimise our clients' experience throughout the whole securities life cycle. Together with our partner Proxymity  we are seeking to provide the best in digital proxy voting solutions  driving transparency  and increasing efficiency in the European capital markets.""Story continuesAbout SRD IISRD II aims to make it easier for issuers to engage with shareholders  especially across different countries  encouraging the use of modern technology to aid communication between companies  their shareholders  and the intermediaries between them.The European-wide legislation impacts  amongst others  companies with registered offices and shares trading in the EU and EEA. This suggests new platforms and technologies like Proxymity may not only help upgrade existing processes to meet SRD II demands but could also be the most efficient and effective means of complying with the legislation.-Notes to editors-About ProxymityProxymity connects the world's ecosystem of issuers  intermediaries  and investors digitally in real-time  bringing unprecedented transparency  efficiency  and accuracy to traditional paper-based processes. Trusted by the world's largest financial institutions  it is the leading digital investor communications platform  serving over 25 markets world-wide. Proxymity's ground-breaking technology has also been recognised industry-wide  with recent awards including FSTech's ""Most Disruptive Technology in the FinTech Sector"" and GC Magazine's ""FinTech of the Year 2022"".Our solutions give public companies confidence that their AGM/EGM agendas are transmitted as ""golden source"" and provide institutional investors with the time to research and vote on corporate decisions  as well as actual digital confirmation that their votes have been received. The digital-native platform  built on highly scalable technology  provides full compliance with the latest regulations  such as the Shareholder Rights Directive (SRD II).Proxymity promotes enhanced environmental  social  and governance (ESG) by improving communication between issuers and investors while making it easier for intermediaries to provide efficient  timely and compliant client service.The company is backed by a global consortium of the industry's most influential financial institutions  representing seven of the world's top ten Global Custodians managing over $200 trillion in assets under custody (BNP Paribas  BNY Mellon  Citi  Computershare  Deutsche Bank  Deutsche BÃ¶rse  HSBC  J.P. Morgan  Mediant  State Street).For more information  visit www.proxymity.ioProxymity media contacts:Tel: +44 (0) 20 3195 3240 /Lauren Fraser: lfraser@sapiencecomms.co.ukJamie Gittings: jgittings@sapiencecomms.co.ukSergio Cortes Allsopp: scortesallsop@sapiencecomms.co.ukContact Information:Lauren FraserPR Teamlfraser@sapiencecomms.co.uk+44 20 3195 3240James GittingsPR Teamjgittings@sapiencecomms.co.uk+442031953240Related ImagesImage 1This content was issued through the press release distribution service at Newswire.com.Attachment",neutral,0.0,1.0,0.0,mixed,0.77,0.06,0.17,True,English,"['Digital Proxy Voting Service', 'Nine Markets', 'Clearstream', 'Proxymity', 'Europe', 'issuer golden source"" meeting announcements', 'leading digital investor communications platform', 'leading digital investor communication platform', 'press release distribution service', 'top ten Global Custodians', 'James Gittings PR Team', 'flagship digital proxy service', 'Deutsche BÃ¶rse Group', 'Lauren Fraser PR Team', 'digital proxy voting service', 'digital proxy voting solutions', 'compliant client service', 'actual digital confirmation', 'overall global footprint', 'securities life cycle', 'largest financial institutions', 'Shareholder Rights Directive', 'influential financial institutions', 'J.P. Morgan', 'Sergio Cortes Allsopp', 'nine European countries', 'traditional paper-based processes', 'nine European markets', 'Many European markets', 'European capital markets', 'Most Disruptive Technology', 'Shareholder ID solution', 'public companies confidence', 'Clearstream Securities Services', 'SRD II demands', 'Proxymity media contacts', 'Vote Connect solution', 'Proxymity Vote Connect', 'Proxymity Featured Image', 'digital connectivity', 'digital-native platform', 'global consortium', 'Deutsche Bank', 'Jamie Gittings', 'different countries', 'existing processes', 'Baltic Markets', 'modern technology', 'ground-breaking technology', 'scalable technology', 'GLOBE NEWSWIRE', 'disjointed infrastructure', 'existing channels', 'growing number', 'Dean Little', 'long-standing partnership', 'fantastic milestone', 'market coverage', 'Sam Riley', ""clients' experience"", 'registered offices', 'new platforms', 'effective means', 'recent awards', 'GC Magazine', 'AGM/EGM agendas', 'corporate decisions', 'full compliance', 'latest regulations', 'BNP Paribas', 'BNY Mellon', 'State Street', 'Related Images', 'Newswire.com', 'full end', 'greater transparency', 'European-wide legislation', 'FinTech Sector', 'efficient, timely', 'Contact Information', 'partner Proxymity', 'institutional investors', ""shareholders' votes"", '25 markets', 'expansion', 'region', 'LONDON', 'Dec.', 'issuers', 'intermediaries', 'real-time', 'speed', 'accuracy', 'ecosystem', 'agents', 'inefficient', 'businesses', 'choice', 'CEO', 'Founder', 'rollout', 'year', 'introduction', 'Head', 'efficiency', 'Story', 'use', 'The', 'shares', 'EEA', 'technologies', 'Notes', 'editors', 'world', 'FSTech', 'highly', 'governance', 'ESG', 'company', 'industry', 'assets', 'custody', 'Citi', 'Computershare', 'HSBC', 'Mediant', 'Tel', 'jgittings', 'content', 'Attachment', '44']",2022-12-12,2022-12-12,ca.sports.yahoo.com
14593,Clearstream,Twitter API,Twitter,Clearstream goes live with Proxymity's digital proxy voting service - FinanceFeeds https://t.co/vJ8PBCyXn4,nan,Clearstream goes live with Proxymity's digital proxy voting service - FinanceFeeds https://t.co/vJ8PBCyXn4,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['digital proxy voting service', 'Clearstream', 'Proxymity', 'FinanceFeeds', 'digital proxy voting service', 'Clearstream', 'Proxymity', 'FinanceFeeds']",2022-12-12,2022-12-12,Unknown
14594,Clearstream,Twitter API,Twitter,â€œWe continue to develop our long-standing partnership with Clearstream and the Deutsche Borse Group  following on fâ€¦ https://t.co/pSQBmy5VbU,nan,â€œWe continue to develop our long-standing partnership with Clearstream and the Deutsche Borse Group  following on fâ€¦ https://t.co/pSQBmy5VbU,neutral,0.07,0.92,0.01,neutral,0.07,0.92,0.01,True,English,"['Deutsche Borse Group', 'long-standing partnership', 'Clearstream', 'Deutsche Borse Group', 'long-standing partnership', 'Clearstream']",2022-12-12,2022-12-12,Unknown
14595,Clearstream,Twitter API,Twitter,New Post :Asset Maintenance Technology News |  Clearstream joins Proxymity's Vote Connect in Europe -- Read it at : https://t.co/jhHaIhpO1X,nan,New Post :Asset Maintenance Technology News |  Clearstream joins Proxymity's Vote Connect in Europe -- Read it at : https://t.co/jhHaIhpO1X,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['Asset Maintenance Technology News', 'New Post', 'Clearstream', 'Proxymity', 'Vote', 'Europe', 'jhHaIhpO1X', 'Asset Maintenance Technology News', 'New Post', 'Clearstream', 'Proxymity', 'Vote', 'Europe', 'jhHaIhpO1X']",2022-12-12,2022-12-12,Unknown
14596,Clearstream,Twitter API,Twitter,Post Edited: Clearstream Chooses Proxymity's Digital Proxy Voting Service for Nine Markets Across Europeâ€¦ https://t.co/vwHLSCzimH,nan,Post Edited: Clearstream Chooses Proxymity's Digital Proxy Voting Service for Nine Markets Across Europeâ€¦ https://t.co/vwHLSCzimH,neutral,0.05,0.93,0.02,neutral,0.05,0.93,0.02,True,English,"['Digital Proxy Voting Service', 'Nine Markets', 'Clearstream', 'Proxymity', 'Europe', 'Digital Proxy Voting Service', 'Nine Markets', 'Clearstream', 'Proxymity', 'Europe']",2022-12-12,2022-12-12,Unknown
14597,Clearstream,Twitter API,Twitter,Clearstream onboards Proxymityâ€™s Vote Connect in Europe https://t.co/WrNx8QEjp6 #breakingnews,nan,Clearstream onboards Proxymityâ€™s Vote Connect in Europe https://t.co/WrNx8QEjp6 #breakingnews,neutral,0.03,0.97,0.0,neutral,0.03,0.97,0.0,True,English,"['Vote Connect', 'Clearstream', 'Proxymity', 'Europe', 'WrNx8QEjp6', 'Vote Connect', 'Clearstream', 'Proxymity', 'Europe', 'WrNx8QEjp6']",2022-12-12,2022-12-12,Unknown
14598,Clearstream,Twitter API,Twitter,Clearstream onboards Proxymityâ€™s Vote Connect in Europe. Clearstream is the latest to go live with Vote Connect  laâ€¦ https://t.co/WPJd5dEYDb,nan,Clearstream onboards Proxymityâ€™s Vote Connect in Europe. Clearstream is the latest to go live with Vote Connect  laâ€¦ https://t.co/WPJd5dEYDb,neutral,0.08,0.9,0.01,neutral,0.08,0.9,0.01,True,English,"['Vote Connect', 'Clearstream', 'Proxymity', 'Europe', 'WPJd5dEYDb', 'Vote Connect', 'Clearstream', 'Proxymity', 'Europe', 'WPJd5dEYDb']",2022-12-12,2022-12-12,Unknown
14599,Clearstream,Twitter API,Twitter,KNEIP and Clearstream Christmas parties ðŸŽ„ðŸŽ…ðŸ»ðŸŒ¸ðŸŒ¼ðŸŽ…ðŸ»ðŸŽ„ @ Luxembourg  Luxembourg https://t.co/ngiN2eGWqR,nan,KNEIP and Clearstream Christmas parties ðŸŽ„ðŸŽ…ðŸ»ðŸŒ¸ðŸŒ¼ðŸŽ…ðŸ»ðŸŽ„ @ Luxembourg  Luxembourg https://t.co/ngiN2eGWqR,neutral,0.09,0.9,0.0,neutral,0.09,0.9,0.0,True,English,"['Clearstream Christmas parties', 'KNEIP', 'Luxembourg', 'ngiN2eGWqR', 'Clearstream Christmas parties', 'KNEIP', 'Luxembourg', 'ngiN2eGWqR']",2022-12-12,2022-12-12,Unknown
14600,Clearstream,Twitter API,Twitter,@Clearstream is now live with #Proxymity Vote Connect across nine #European markets. Proxymityâ€™s #VoteConnect solâ€¦ https://t.co/NYqCC8FFhm,nan,@Clearstream is now live with #Proxymity Vote Connect across nine #European markets. Proxymityâ€™s #VoteConnect solâ€¦ https://t.co/NYqCC8FFhm,neutral,0.06,0.93,0.01,neutral,0.06,0.93,0.01,True,English,"['nine #European markets', 'Proxymity', 'NYqCC8FFhm', 'nine #European markets', 'Proxymity', 'NYqCC8FFhm']",2022-12-12,2022-12-12,Unknown
14601,Clearstream,Twitter API,Twitter,Clearstream Chooses Proxymity's Digital Proxy Voting Service for Nine Markets Across Europe https://t.co/Ot4ZPm1J3J,nan,Clearstream Chooses Proxymity's Digital Proxy Voting Service for Nine Markets Across Europe https://t.co/Ot4ZPm1J3J,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['Digital Proxy Voting Service', 'Nine Markets', 'Clearstream', 'Proxymity', 'Europe', 'Ot4ZPm1J3J', 'Digital Proxy Voting Service', 'Nine Markets', 'Clearstream', 'Proxymity', 'Europe', 'Ot4ZPm1J3J']",2022-12-12,2022-12-12,Unknown
14602,Clearstream,Twitter API,Twitter,#clearstream#é€ãé€šã‚‹å°å·å±±P | videographer | camera |https://t.co/FFEqtThkpQ#GoPro hero9#ã‚«ãƒ¡ãƒ©ãƒžãƒ³#æ˜ åƒ#æ’®å½±#å‹•ç”»,nan,#clearstream#é€ãé€šã‚‹å°å·å±±P | videographer | camera |https://t.co/FFEqtThkpQ#GoPro hero9#ã‚«ãƒ¡ãƒ©ãƒžãƒ³#æ˜ åƒ#æ’®å½±#å‹•ç”»,neutral,0.04,0.95,0.0,neutral,0.04,0.95,0.0,True,(Unknown),"['å±±P', 'videographer', 'camera', 'ãé€šã‚‹', 'å·', 'ã‚«ãƒ¡ãƒ©ãƒžãƒ³', 'æ’®', 'å±±P', 'videographer', 'camera', 'ãé€šã‚‹', 'å·', 'ã‚«ãƒ¡ãƒ©ãƒžãƒ³', 'æ’®']",2022-12-11,2022-12-12,Unknown
14603,Deutsche Boerse,NewsApi.org,https://thefly.com/permalinks/entry.php/id3631005/DBOEY-Deutsche-Boerse-downgraded-to-Neutral-from-Overweight-at-JPMorgan,Deutsche Boerse downgraded to Neutral from Overweight at JPMorgan,See the rest of the story here.thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence  The Fly's real-time  streaming news feed keeps individual investors  professional money managers  active traders  and corporâ€¦,"Conference/Events Cullen/Frost to participate in a conference call with Truist Â» Cullen/Frost $137.26 / +0.31 (+0.23%) CFR Financial Analyst Dembaâ€¦ Story temporarily locked.To read stories as they happen please subscribe  Login above  or return tomorrow Get Free Trial Show Hide Related Items >> << Street ResearchEarningsOn The FlyEvents CFR Cullen/Frost $137.26 / +0.31 (+0.23%) 12/09/22 Truist Cullen/Frost price target lowered to $148 from $160 at Truist 12/05/22 Morgan Stanley Cullen/Frost initiated with an Overweight at Morgan Stanley 11/03/22 Wolfe Research Wolfe downgrades Zions  Cullen/Frost to neutral after outperformance 11/02/22 Wolfe Research Cullen/Frost downgraded to Peer Perform from Outperform at Wolfe Research CFR Cullen/Frost $137.26 / +0.31 (+0.23%) 10/27/22 Cullen/Frost says Wall Street estimates for Q4 EPS 'too low' 10/27/22 Cullen/Frost reports Q3 EPS $2.59  consensus $2.23 07/28/22 Cullen/Frost reports Q2 EPS $1.81  consensus $1.77 CFR Cullen/Frost $137.26 / +0.31 (+0.23%) 08/01/22 Street Wrap: Today's Top 15 Upgrades  Downgrades  Initiations 06/15/22 Street Wrap: Today's Top 15 Upgrades  Downgrades  InitiationsHot Stocks Raytheon Technologies board authorizes $6B share buyback Â» Raytheon Technologies $99.56 / +1.28 (+1.30%) RTX Raytheonâ€¦ Story temporarily locked.To read stories as they happen please subscribe  Login above  or return tomorrow Get Free Trial Show Hide Related Items >> << Company NewsStreet ResearchEarningsPeriodicalsOn The FlyOptions RTX Raytheon Technologies $99.56 / +1.28 (+1.30%) 12/08/22 Collins Aerospace to deliver new spacesuits to NASA 12/06/22 Raytheon TTM Technologies in pact to to purchase SPY-6 radar components 11/30/22 Raytheon Technologies awarded $1.22B Army contract 11/30/22 CPI Aerostructures receives multi-year agreement  $7.5M firm order from Collins RTX Raytheon Technologies $99.56 / +1.28 (+1.30%) 12/08/22 Citi Raytheon Technologies initiated with a Neutral at Citi 11/28/22 Cowen Raytheon Technologies a Best Idea for 2023  says Cowen 10/26/22 Morgan Stanley Raytheon Technologies price target lowered to $119 from $124 at Morgan Stanley 10/26/22 Baird Raytheon Technologies price target lowered to $106 from $117 at Baird RTX Raytheon Technologies $99.56 / +1.28 (+1.30%) 10/25/22 Raytheon Technologies ups FY22 adjusted EPS view to $4.70-$4.80 from $4.60-$4.80 10/25/22 Raytheon Technologies reports Q3 adjusted EPS $1.21  consensus $1.14 10/24/22 Notable companies reporting before tomorrow's open 10/24/22 Notable companies reporting before tomorrow's open RTX Raytheon Technologies $99.56 / +1.28 (+1.30%) 11/08/22 State Department approves potential $380M missile sale to Belgium  Reuters says 09/23/22 Airbus  Raytheon clash over aircraft output  Reuters reports 09/19/22 Defense companies urged to limit use of Chinese supplies  WSJ reports 09/17/22 IBM  CVS among cheap stocks not deserving to be in bargain bin  Barron's says RTX Raytheon Technologies $99.56 / +1.28 (+1.30%) 12/08/22 Street Wrap: Today's Top 15 Upgrades  Downgrades  Initiations 11/15/22 What You Missed On Wall Street On Tuesday 10/25/22 Fly Intel: Pre-market Movers 09/21/22 Fly Intel: Pre-market Movers RTX Raytheon Technologies $99.56 / +1.28 (+1.30%) 10/25/22 Unusually active option classes on open October 25th 10/24/22 Unusually active option classes on open October 24th 10/10/22 Raytheon Technologies call volume above normal and directionally bullish 08/22/22 Raytheon Technologies call volume above normal and directionally bullishSyndicate Cardio Diagnostics files to sell 11.9M shares of common stock for holders Cardio Diagnostics $1.70 / +0.03 (+1.80%) CDIO Show Hide Related Items >> << Company NewsStreet Research CDIO Cardio Diagnostics $1.70 / +0.03 (+1.80%) 10/26/22 Cardio Diagnostics commences trading on Nasdaq CDIO Cardio Diagnostics $1.70 / +0.03 (+1.80%) 09/02/22 Benchmark Mana Capital Acquisition initiated with a Speculative Buy at BenchmarkUpgrade U.S. Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette Â» U.S. Bancorp $43.46 / +0.345 (+0.80%) USB Keefe Bruyette analystâ€¦ Keefe Bruyette analyst David Konrad upgraded U.S. Bancorp to Outperform from Market Perform with a price target of $58  up from $52. The shares are trading at a ""deep discount to historical valuations"" with the market underestimating the earnings power of Union Bank given higher rates since the deal was announced  Konrad tells investors in a research note. The analyst says U.S. Bancorp has historically widened its valuation to the group in recessionary periods. U.S. Bancorp is trading at 3% discount on 2024 estimates  compared to its historical 10% premium  and this gap should ""collapse with improved visibility of earnings power and capital generation "" contends Konrad. Show Hide Related Items >> << Company NewsStreet ResearchEarningsPeriodicalsOn The FlyEventsOptions USB U.S. Bancorp $43.46 / +0.345 (+0.80%) 11/14/22 Berkshire Hathaway adds TSMC  exits STORE Capital in Q3 11/02/22 U.S. Bancorp raises prime lending rate to 7% from 6.25%  effective November 3 10/30/22 Fly Intel: Top five weekend stock stories 10/24/22 Adobe to aid U.S. Bancorp enhance online and in-branch customer experience USB U.S. Bancorp $43.46 / +0.345 (+0.80%) 12/01/22 Wolfe Research U.S. Bancorp downgraded to Peer Perform from Outperform at Wolfe Research 12/01/22 Wolfe Research Regions Financial upgraded to Outperform from Peer Perform at Wolfe Research 11/02/22 JPMorgan U.S. Bancorp price target raised to $47 from $46 at JPMorgan 10/11/22 JPMorgan U.S. Bancorp price target lowered to $46 from $56.50 at JPMorgan USB U.S. Bancorp $43.46 / +0.345 (+0.80%) 10/14/22 U.S. Bancorp sees FY22 revenue up 5%-6% vs. FY21  consensus $24.41B 10/14/22 U.S. Bancorp sees Q4 revenue up roughly 2% vs. Q3  consensus $6.59B 10/14/22 U.S. Bancorp reports Q3 adjusted EPS $1.18  consensus $1.17 10/13/22 Notable companies reporting before tomorrow's open USB U.S. Bancorp $43.46 / +0.345 (+0.80%) 10/29/22 Truist among dividend-paying stocks to help battle inflation  Barron's says 09/18/22 Big regional banks might face new crisis rules  WJS reports 07/20/22 CFPB to prod banks to cover more payment services scams  WSJ reports USB U.S. Bancorp $43.46 / +0.345 (+0.80%) 12/01/22 Street Wrap: Today's Top 15 Upgrades  Downgrades  Initiations 10/14/22 What You Missed On Wall Street On Friday 10/14/22 What You Missed On Wall Street This Morning 09/19/22 What You Missed On Wall Street On Monday USB U.S. Bancorp $43.46 / +0.345 (+0.80%) 10/14/22 Early notable gainers among liquid option names on October 14th 10/06/22 US Bancorp call volume above normal and directionally bullish 07/28/22 US Bancorp put volume heavy and directionally bearishUpgrade Haitian upgraded to Overweight from Equal Weight at Morgan Stanley Â» Haitian $2.40 / + (+0.00%) HAIIF Morgan Stanley analystâ€¦ Story temporarily locked.To read stories as they happen please subscribe  Login above  or return in 9 minutes Get Free Trial Show Hide Related Items >> << Street Research HAIIF Haitian $2.40 / + (+0.00%) 12/08/22 Goldman Sachs Haitian upgraded to Neutral from Sell at Goldman Sachs 03/24/22 Citi Haitian downgraded to Sell from Buy at CitiHot Stocks Piedmont Lithium announces North American Lithium to restart mining operations Â» Piedmont Lithium $56.50 / +0.52 (+0.93%) PLL Piedmont Lithiumâ€¦ Story temporarily locked.To read stories as they happen please subscribe  Login above  or return tomorrow Get Free Trial Show Hide Related Items >> << Company NewsStreet ResearchSyndicatePeriodicalsOn The FlyOptions PLL Piedmont Lithium $56.50 / +0.52 (+0.93%) 11/15/22 Piedmont Lithium: Sayona Quebec enters acquisition  earn-in pact with Jourdan 10/24/22 Piedmont Lithium: Atlantic Lithium completes drilling for Ewoyaa project 10/19/22 Piedmont Lithium selected for $141.7M grant by U.S. DOE 10/19/22 Microvast  Albemarle among infrastructure law funding recipients PLL Piedmont Lithium $56.50 / +0.52 (+0.93%) 12/02/22 DA Davidson Piedmont Lithium price target raised to $90 from $85 at DA Davidson 10/27/22 B. Riley Piedmont Lithium assumed with a Buy at B. Riley 06/22/22 Cowen Piedmont Lithium a catalyst rich North American growth story  says Cowen 05/23/22 Cowen Piedmont Lithium initiated with an Outperform at Cowen PLL Piedmont Lithium $56.50 / +0.52 (+0.93%) 06/14/22 Culper short Piedmont Lithium  sees 'little hope' for battery-grade lithium PLL Piedmont Lithium $56.50 / +0.52 (+0.93%) 06/14/22 What You Missed On Wall Street On Tuesday 06/14/22 What You Missed On Wall Street This Morning PLL Piedmont Lithium $56.50 / +0.52 (+0.93%) 09/14/22 Largest borrow rate increases among liquid namesSyndicate Bank of Montreal announces C$3.15B common share offering Â» Bank of Montreal $91.80 / -0.61 (-0.66%) BMO Bank of Montrealâ€¦ Story temporarily locked.To read stories as they happen please subscribe  Login above  or return in 9 minutes Get Free Trial Show Hide Related Items >> << Company NewsStreet ResearchEarningsPeriodicals BMO Bank of Montreal $91.80 / -0.61 (-0.66%) 12/01/22 Bank of Montreal raises quarterly dividend 3% to C$1.43 per share 11/08/22 BMO Harris to appeal verdict in Petters litigation 11/02/22 BMO Financial increases U.S. dollar prime lending rate to 7% 09/21/22 Bank of Montreal raises U.S. prime lending rate to 6.25% BMO Bank of Montreal $91.80 / -0.61 (-0.66%) 09:45 Today BofA Bank of Montreal downgraded to Neutral from Buy at BofA 12/02/22 TD Securities Bank of Montreal price target raised to C$150 from C$145 at TD Securities 12/02/22 Canaccord Bank of Montreal price target raised to C$151 from C$148 at Canaccord 11/22/22 Scotiabank Bank of Montreal price target lowered to C$156 from C$159 at Scotiabank BMO Bank of Montreal $91.80 / -0.61 (-0.66%) 12/01/22 Bank of Montreal reports Q4 adjusted EPS C$3.04 vs. C$3.33 a year ago 08/30/22 Bank of Montreal reports Q3 adjusted EPS C$3.09 vs. C$3.44 last year BMO Bank of Montreal $91.80 / -0.61 (-0.66%) 11/10/22 Bank of Canada's Macklem says low unemployment rate unsustainable ' WSJ says 09/15/22 BMO Capital cutting jobs amid weakening market  Bloomberg says 07/26/22 BMO Harris suffers 'setback' in Ponzi scheme suit  American Banker says 07/08/22 Rogers experiencing broad network failure in Canada  Bloomberg reportsDowngrade Horizon Therapeutics downgraded to Equal Weight from Overweight at Wells Fargpo Â» Horizon Therapeutics $112.34 / +14.995 (+15.40%) HZNP Amgen $276.76 / -1.825 (-0.66%) AMGN Wells Fargo analyst Derekâ€¦ Story temporarily locked.To read stories as they happen please subscribe  Login above  or return tomorrow Get Free Trial Show Hide Related Items >> << Company NewsStreet ResearchEarningsPeriodicalsOn The FlyOptions HZNPAMGN HZNP Horizon Therapeutics $112.34 / +14.995 (+15.40%) 06:06 Today Amgen to acquire Horizon Therapeutics for $116.50 per share in cash 06:02 Today Amgen to acquire Horizon Therapeutics for $116.50 per share in cash 12/11/22 Fly Intel: Top five weekend stock stories 12/11/22 Sanofi does not intend to make offer for Horizon Therapeutics AMGN Amgen $276.76 / -1.825 (-0.66%) 06:06 Today Amgen to acquire Horizon Therapeutics for $116.50 per share in cash 06:02 Today Amgen to acquire Horizon Therapeutics for $116.50 per share in cash 12/11/22 Fly Intel: Top five weekend stock stories 12/07/22 Cytokinetics initiates Phase 1 clinical study of CK-3828136 HZNPAMGN HZNP Horizon Therapeutics $112.34 / +14.995 (+15.40%) 12:44 Today Piper Sandler Horizon Therapeutics downgraded to Neutral from Overweight at Piper Sandler 10:02 Today Stifel Horizon Therapeutics downgraded to Hold from Buy at Stifel 12/07/22 Piper Sandler Horizon Therapeutics price target raised to $110 from $90 at Piper Sandler 12/01/22 Jefferies Horizon Therapeutics price target raised to $125 from $101 at Jefferies AMGN Amgen $276.76 / -1.825 (-0.66%) 10:02 Today Stifel Horizon Therapeutics downgraded to Hold from Buy at Stifel 12/07/22 Piper Sandler Horizon Therapeutics price target raised to $110 from $90 at Piper Sandler 12/06/22 Oppenheimer Amgen price target raised to $310 from $300 at Oppenheimer 12/05/22 Piper Sandler Amgen price target raised to $297 from $278 at Piper Sandler HZNPAMGN HZNP Horizon Therapeutics $112.34 / +14.995 (+15.40%) 11/02/22 Horizon Therapeutics sees FY22 revenue s $3.59B-$3.61B  consensus $3.56B 11/02/22 Horizon Therapeutics reports Q3 EPS $1.25  consensus $1.01 08/03/22 Horizon Therapeutics cuts FY22 revenue view to $3.53B-$3.6B from $3.9B-$4B 08/03/22 Horizon Therapeutics reports Q2 adjusted EPS $1.07  consensus $1.35 AMGN Amgen $276.76 / -1.825 (-0.66%) 11/03/22 Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00 11/03/22 Amgen reports Q3 adjusted EPS $4.70  consensus $4.44 11/03/22 Notable companies reporting after market close 08/04/22 Amgen backs FY22 adjusted EPS view $17.00-$18.00  consensus $17.40 HZNPAMGN HZNP Horizon Therapeutics $112.34 / +14.995 (+15.40%) 12/11/22 Amgen nears deal to acquire Horizon Therapeutics  WSJ reports 12/04/22 J&J says won't make offer for Horizon Therapeutics  Bloomberg reports 11/04/22 Barclays' boosted stake in Horizon Therapeutics 'interesting ' DealReporter says AMGN Amgen $276.76 / -1.825 (-0.66%) 12/11/22 Amgen nears deal to acquire Horizon Therapeutics  WSJ reports 11/04/22 Supreme Court to hear Amgen appeal in Repatha patent dispute  Bloomberg says 08/01/22 Amgen battles IRS over $10.7B in back taxes  WSJ reports HZNPAMGN HZNP Horizon Therapeutics $112.34 / +14.995 (+15.40%) 16:25 Today What You Missed On Wall Street On Monday 12:17 Today What You Missed On Wall Street This Morning 09:00 Today Fly Intel: Pre-market Movers 12/05/22 What You Missed On Wall Street On Monday AMGN Amgen $276.76 / -1.825 (-0.66%) 16:25 Today What You Missed On Wall Street On Monday 12:17 Today What You Missed On Wall Street This Morning 11/30/22 What You Missed On Wall Street On Wednesday 11/30/22 What You Missed On Wall Street This Morning HZNPAMGN HZNP Horizon Therapeutics $112.34 / +14.995 (+15.40%) 09:40 Today Unusually active option classes on open December 12th 12/02/22 Horizon Pharma put volume heavy and directionally bearish 11/30/22 Unusually active option classes on open November 30th AMGN Amgen $276.76 / -1.825 (-0.66%) 10/11/22 Early notable gainers among liquid option names on October 11th 07/12/22 Amgen put volume heavy and directionally bearish 06/27/22 Amgen put volume heavy and directionally bearishHot Stocks Quotient trading resumes Quotient / + QTNT Show Hide Related Items >> << Company NewsStreet ResearchEarningsSyndicateOn The Fly QTNT Quotient / + 16:07 Today Quotient to delist shares from Nasdaq 16:00 Today Quotient trading halted  news pending 11/02/22 Quotient says reverse stock split effective Wednesday 10/31/22 Quotient to effect one-for-40 reverse stock split QTNT Quotient / + 06/29/22 Cowen Quotient price target lowered to $3 from $9 at Cowen 06/29/22 BTIG Quotient price target lowered to $1.50 from $9.00 at BTIG 05/09/22 BTIG Quotient transferred with a Buy at BTIG 12/16/21 BTIG Quotient price target lowered to $11 from $13 at BTIG QTNT Quotient / + 08/09/22 Quotient sees 2023 revenue $39M-$42M  consensus $40.87M 08/09/22 Quotient reports Q1 EPS (37c) vs. (27c) last year 06/24/22 Quotient sees 2023 revenue $39M-$42M  consensus $40.25M 06/24/22 Quotient reports 2022 EPS ($1.23)  consensus ($1.26) QTNT Quotient / + 07/11/22 Fly Insider: Karuna Therapeutics  HP among weeks notable insider trades 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/14/22 What You Missed On Wall Street This Morning",neutral,0.02,0.65,0.33,mixed,0.14,0.21,0.64,True,English,"['Deutsche Boerse', 'Overweight', 'JPMorgan', 'Fly Events Options USB U.S. Bancorp', 'Fly Options RTX Raytheon Technologies', 'Keefe Bruyette analyst David Konrad', 'Pre-market Movers RTX Raytheon Technologies', 'USB Keefe Bruyette analyst', 'potential $380M missile sale', 'Morgan Stanley Raytheon Technologies price', 'CFR Financial Analyst Demba', 'Company News Street Research', 'Baird Raytheon Technologies price', 'Baird RTX Raytheon Technologies', 'Benchmark Mana Capital Acquisition', 'Collins RTX Raytheon Technologies', 'Nasdaq CDIO Cardio Diagnostics', 'Wolfe Research CFR Cullen/Frost', 'Truist Cullen/Frost price target', 'Wolfe Research Wolfe', 'Raytheon Technologies board', '$6B share buyback', 'SPY-6 radar components', '$7.5M firm order', 'active option classes', 'prime lending rate', 'Syndicate Cardio Diagnostics', 'Wolfe Research Cullen', 'Free Trial Show', 'Citi Raytheon Technologies', 'Cowen Raytheon Technologies', 'Wall Street estimates', 'CDIO Show', 'research note', 'TTM Technologies', 'Collins Aerospace', 'Street Wrap', 'capital generation', 'STORE Capital', 'conference call', 'Related Items', 'Top 15 Upgrades', 'Hot Stocks', 'new spacesuits', 'Army contract', 'CPI Aerostructures', 'multi-year agreement', 'Best Idea', 'Notable companies', 'State Department', 'aircraft output', 'Defense companies', 'Chinese supplies', 'cheap stocks', 'bargain bin', 'open October', 'common stock', 'Speculative Buy', 'historical valuations', 'Union Bank', 'higher rates', 'recessionary periods', 'historical 10% premium', 'improved visibility', 'Berkshire Hathaway', 'Conference/Events Cullen/Frost', 'Q4 EPS', 'Q2 EPS', 'Earnings Periodicals', 'EPS view', 'earnings power', 'Market Perform', '11.9M shares', 'deep discount', 'Q3 EPS', '2024 estimates', '3% discount', 'Story', 'stories', 'Overweight', 'Zions', 'outperformance', 'consensus', 'Today', 'Downgrades', 'Initiations', 'NASA', 'pact', 'Neutral', 'tomorrow', 'Belgium', 'Reuters', 'Airbus', 'use', 'WSJ', 'IBM', 'CVS', 'Barron', 'Tuesday', 'Intel', 'volume', 'holders', 'trading', 'deal', 'investors', 'group', 'gap', 'TSMC', '2023']",2022-12-12,2022-12-12,thefly.com
14604,Deutsche Boerse,NewsApi.org,https://www.bangkokpost.com/business/2458832/microsoft-to-buy-4-of-london-stock-exchange-group-on-cloud-deal,Microsoft to buy 4% of London Stock Exchange Group on cloud deal,Microsoft Corp agreed to buy a 4% stake in London Stock Exchange Group Plc as part of a $2.8 billion cloud-computing deal that pushes big tech further into financial markets.,Microsoft to buy 4% of London Stock Exchange Group on cloud dealFILE PHOTO: A worker shelters from the rain under a Union Flag umbrella as he passes the London Stock Exchange in London  Britain  Oct 1  2008. (Reuters)Microsoft Corp agreed to buy a 4% stake in London Stock Exchange Group Plc as part of a $2.8 billion cloud-computing deal that pushes big tech further into financial markets.As part of the agreement  LSEG said it will spend at least that amount on cloud services with Microsoft over the next 10 years. The partnership will speed up the migration of its markets to the cloud and allow it to develop new products and services  it said Monday.The transaction adds to a recent trend of exchanges and tech firms linking up after similar partnerships between Nasdaq Inc. and Amazon.com Inc.  as well as Alphabet Inc.â€™s Google and CME Group. It points to increased demand from investors for information that gives them an edge in increasingly fast electronic markets.Global spending on financial market data and news rose 7.4% to a record $35.6 billion in 2021  according to an April report by Burton-Taylor International Consulting.â€œWe will be generating meaningful revenue growth in the coming years by accessing new products and enhancing our existing product capabilities â€ LSEG Chief Executive Officer David Schwimmer said in a phone interview.At Fridayâ€™s closing price  a 4% stake in LSEG was valued at around Â£1.6 billion ($2 billion).Microsoft will buy its stake from a consortium made up of Blackstone  Thomson Reuters Corp. and affiliates of the Canada Pension Plan Investment Board and Singaporeâ€™s GIC  according to the statement. Thomson Reuters said in a statement it plans to use its proceeds from the transaction â€œto pursue organic and inorganic opportunities in key growth segments and provide returns to shareholders.â€LSEGâ€™s shares were up 3.2% at 11.37am in London.Minimum spendThe deal underlines LSEGâ€™s increasing focus on data and analytics. The company completed a $27 billion purchase of Refinitiv last year  kicking off a new era where the majority of its revenues come from data. The parent company of Bloomberg News competes with Refinitiv to provide financial news  data and information.The Microsoft agreement is expected to cost LSEG between Â£250 million to Â£300 million between 2023 and 2025  including about Â£100 million in capital spending.Additional spending beyond the $2.8 billion minimum depends on the â€œsuccess of the strategic partnershipâ€ and demand for LSEGâ€™s data platform and professional services  according to the UK firm. Microsoft estimated in a separate statement that the â€œpartnership  and broader market opportunity  could generate an additional $5 billion in revenue for the company over the next 10 years.â€Scott Guthrie  Microsoftâ€™s executive vice president for cloud and artificial intelligence  will be appointed as a LSEG director.Data consolidationThe past few years has seen consolidation among the finance industryâ€™s biggest data providers. Last year  S&P Global Inc. agreed to buy IHS Markit Ltd. while Deutsche Boerse  LSEâ€™s biggest European rival  took a majority stake in Institutional Shareholder Services Inc.  the corporate-governance adviser.Itâ€™s not the first time Microsoft has struck a deal alongside unveiling a sizeable cloud deal. In 2018  it invested in Grab  with the ride-hailing firm agreeing to adopt Azure as its preferred cloud platform.These cross-selling deals donâ€™t always end in success. In 2012  the US tech firm spent $300 million in a stake in then struggling bookseller Barnes & Nobleâ€™s e-book division Nook.As part of the deal  Barnes & Noble agreed to make e-reading content for Microsoft. Two years later  Barnes & Noble bought out Microsoftâ€™s stake for about $125 million  after Nook struggled to win over customers.,neutral,0.0,0.99,0.0,negative,0.04,0.12,0.83,True,English,"['London Stock Exchange Group', 'cloud deal', 'Microsoft', 'LSEG Chief Executive Officer David Schwimmer', 'Canada Pension Plan Investment Board', 'London Stock Exchange Group Plc', 'S&P Global Inc.', 'Institutional Shareholder Services Inc.', 'executive vice president', 'Union Flag umbrella', 'Amazon.com Inc.', 'existing product capabilities', 'key growth segments', 'broader market opportunity', 'IHS Markit Ltd.', 'biggest European rival', 'fast electronic markets', 'meaningful revenue growth', 'biggest data providers', 'US tech firm', 'preferred cloud platform', 'financial market data', '$2.8 billion cloud-computing deal', 'Thomson Reuters Corp.', 'sizeable cloud deal', 'CME Group', 'Nasdaq Inc.', 'Alphabet Inc', 'Global spending', 'big tech', 'data platform', 'financial markets', '$27 billion purchase', '$2.8 billion minimum', 'UK firm', 'ride-hailing firm', 'cloud services', 'professional services', 'new products', 'recent trend', 'similar partnerships', 'April report', 'phone interview', 'closing price', 'inorganic opportunities', 'Minimum spend', 'increasing focus', 'new era', 'financial news', 'capital spending', 'Additional spending', 'Scott Guthrie', 'artificial intelligence', 'finance industry', 'Deutsche Boerse', 'corporate-governance adviser', 'first time', 'cross-selling deals', 'book division', 'reading content', 'next 10 years', 'coming years', 'LSEG director', 'Microsoft Corp', 'Bloomberg News', 'Data consolidation', 'parent company', 'strategic partnership', 'separate statement', 'Microsoft agreement', 'majority stake', '4% stake', 'PHOTO', 'worker', 'rain', 'Britain', 'amount', 'migration', 'transaction', 'exchanges', 'firms', 'Google', 'demand', 'investors', 'information', 'edge', 'record', 'Friday', 'consortium', 'Blackstone', 'affiliates', 'Singapore', 'proceeds', 'returns', 'shareholders', 'shares', 'analytics', 'Refinitiv', 'revenues', 'The', 'success', 'past', 'Grab', 'Azure', 'bookseller', 'Barnes', 'Noble', 'Nook', 'customers', '11.']",2022-12-12,2022-12-12,bangkokpost.com
14605,Deutsche Boerse,NewsApi.org,https://247wallst.com/investing/2022/12/12/opening-bell-analysts-research-calls-for-monday-december-12/,Opening Bell Analysts Research Calls for Monday  December 12 â€“ 24,Here's the complete round-up of Monday morning's analyst calls.,Opening Bell Analysts Research Calls for Monday  December 12This report was sent to Briefing.com subscribers earlier today. https://briefing.comUpgrades:> Acadia Healthcare (ACHC) upgraded to Buy from Hold at Loop Capital; tgt raised to $95> Becton Dickinson (BDX) upgraded to Neutral from Sell at Citigroup; tgt raised to $250> Best Buy (BBY) upgraded to Neutral from Sell at Goldman; tgt raised to $83> Bio-Techne (TECH) upgraded to Buy from Neutral at Citigroup; tgt raised to $100> Box (BOX) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $34> CAE (CAE) upgraded to Overweight from Equal-Weight at Morgan Stanley> Cielo SA (CIOXY) upgraded to Buy from Neutral at UBS> Colliers (CIGI) upgraded to Buy from Neutral at Goldman> Coupa Software (COUP) upgraded to Outperform from Neutral at SMBC Nikko> Crane (CR) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $129> Gap (GPS) upgraded to Buy from Neutral at Goldman; tgt $18> Glaukos (GKOS) upgraded to Buy from Neutral at Citigroup; tgt $57> John Wood Group plc (WDGJF) upgraded to Buy from Hold at Jefferies> Lam Research (LRCX) upgraded to Buy from Hold at Deutsche Bank; tgt raised to $520> Monday.com (MNDY) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $140> Montrose Environmental Group (MEG) upgraded to Buy from Neutral at BofA Securities> PerkinElmer (PKI) upgraded to Buy from Neutral at Citigroup; tgt raised to $170> Pulmonx (LUNG) upgraded to Buy from Neutral at Citigroup; tgt lowered to $10> QuidelOrtho (QDEL) upgraded to Buy from Neutral at Citigroup; tgt raised to $125> Southern (SO) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $76> Tapestry (TPR) upgraded to Buy from Neutral at Goldman; tgt raised to $44> Teledyne Tech (TDY) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $488> Under Armour (UAA) upgraded to Buy from Hold at Stifel; tgt raised to $12Downgrades:> Accenture (ACN) downgraded to Underweight from Neutral at Piper Sandler; tgt $268> Allogene (ALLO) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $9> Baxter (BAX) downgraded to Neutral from Buy at Citigroup; tgt lowered to $58> Boyd Gaming (BYD) downgraded to Mkt Perform from Mkt Outperform at JMP Securities> Brinker (EAT) downgraded to Sell from Neutral at Goldman; tgt lowered to $28> Cap Gemini S.A. (CGEMY) downgraded to Equal-Weight from Overweight at Morgan Stanley> Cheesecake Factory (CAKE) downgraded to Sell from Neutral at Goldman; tgt lowered to $29> Coterra Energy (CTRA) downgraded to Hold from Buy at Truist; tgt $26> Curtiss-Wright (CW) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $188> Deutsche Boerse (DBOEY) downgraded to Neutral from Overweight at JP Morgan> DraftKings (DKNG) downgraded to Neutral from Buy at ROTH Capital; tgt $15> Genuine Parts (GPC) downgraded to Sell from Neutral at Goldman; tgt raised to $147> HEICO (HEI) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $172> Illumina (ILMN) downgraded to Sell from Neutral at Citigroup; tgt lowered to $180> Johnson Controls (JCI) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $72> KLA Corporation (KLAC) downgraded to Hold from Buy at Deutsche Bank; tgt raised to $400> Lâ€™Oreal (LRLCY) downgraded to Underperform from Sector Perform at RBC Capital Mkts> Laboratory Corp (LH) downgraded to Neutral from Buy at Citigroup; tgt lowered to $250> Leggett & Platt (LEG) downgraded to Underweight from Neutral at Piper Sandler; tgt lowered to $24> Levi Strauss (LEVI) downgraded to Neutral from Buy at Goldman; tgt $17> Micron (MU) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $55> Moog (MOG.A) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt raised to $89> Murphy Oil (MUR) downgraded to Hold from Buy at Truist; tgt $46> Nevro (NVRO) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $43> Newmark Group (NMRK) downgraded to Sell from Neutral at Goldman; tgt $8> OceanFirst Finl (OCFC) downgraded to Neutral from Overweight at Piper Sandler; tgt $25> PDC Energy (PDCE) downgraded to Hold from Buy at Truist; tgt $68> Qualcomm (QCOM) downgraded to Underweight from Equal Weight at Wells Fargo; tgt $105> RH (RH) downgraded to Sell from Neutral at Goldman; tgt lowered to $215> Rockwell Automation (ROK) downgraded to Neutral from Buy at BofA Securities> RxSight (RXST) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $14> ShockWave Medical (SWAV) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $235> Spire (SR) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $61> Trane (TT) downgraded to Underperform from Neutral at BofA Securities; tgt $160> Ulta Beauty (ULTA) downgraded to Neutral from Buy at Goldman; tgt lowered to $508> Vontier (VNT) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $21Others:> Acrivon Therapeutics (ACRV) initiated with a Buy at Jefferies; tgt $17> Acrivon Therapeutics (ACRV) initiated with an Outperform at Cowen> Acrivon Therapeutics (ACRV) initiated with an Overweight at Piper Sandler; tgt $25> Affimed Therapeutics (AFMD) initiated with a Buy at H.C. Wainwright; tgt $6> Ageas SA/NV (AGESY) initiated with a Sell at Goldman> Alcon (ALC) assumed with a Buy at Citigroup> Ambarella (AMBA) initiated with a Positive at Susquehanna; tgt $90> Analog Devices (ADI) initiated with a Positive at Susquehanna; tgt $205> Coinbase Global (COIN) initiated with a Sector Weight at KeyBanc Capital Markets> Elekta AB (EKTAY) initiated with a Sell at Citigroup> Essilor International (ESLOY) initiated with a Buy at Citigroup> Fresenius SE (FSNUY) initiated with a Buy at Citigroup> GN Store Nord (GGNDF) initiated with a Buy at Citigroup> Kinsale Capital (KNSL) initiated with a Hold at Jefferies; tgt $295> Mativ Holdings (MATV) initiated with a Market Outperform at CJS Securities; tgt $32> NN Group (NNGPF) initiated with a Buy at Goldman> Palomar Holdings (PLMR) initiated with a Hold at Jefferies; tgt $55> Royal Gold (RGLD) assumed with a Neutral at Credit Suisse; tgt $120> Smith & Nephew (SNN) initiated with a Buy at Citigroup> Sonova (SONVY) initiated with a Sell at Citigroup> STMicroelectronics (STM) initiated with a Positive at Susquehanna; tgt $50> Straumann AG (SAUHY) initiated with a Sell at Citigroup> Wolfspeed (WOLF) initiated with a Neutral at Susquehanna; tgt $90> X4 Pharmaceuticals (XFOR) initiated with an Overweight at Piper Sandler; tgt $3> Xenon Pharmaceuticals (XENE) initiated with an Outperform at Cowen,neutral,0.0,1.0,0.0,negative,0.04,0.39,0.57,True,English,"['Bell Analysts Research', 'Monday', 'December', 'Cap Gemini S.A.', 'John Wood Group plc', 'Montrose Environmental Group', 'Bell Analysts Research', 'RBC Capital Mkts', 'Briefing.com subscribers', 'Newmark Group', 'Loop Capital', 'Lam Research', 'Wolfe Research', 'ROTH Capital', 'Acadia Healthcare', 'Becton Dickinson', 'JP Morgan', 'Morgan Stanley', 'Cielo SA', 'Coupa Software', 'SMBC Nikko', 'Deutsche Bank', 'BofA Securities', 'Southern (SO', 'Peer Perform', 'Piper Sandler', 'Boyd Gaming', 'Mkt Perform', 'Mkt Outperform', 'JMP Securities', 'Cheesecake Factory', 'Coterra Energy', 'Deutsche Boerse', 'Genuine Parts', 'Johnson Controls', 'KLA Corporation', 'Lâ€™Oreal', 'Sector Perform', 'Laboratory Corp', 'Murphy Oil', 'Wells Fargo', 'OceanFirst Finl', 'PDC Energy', 'Rockwell Automation', 'ShockWave Medical', 'Equal Weight', 'Teledyne Tech', 'Levi Strauss', 'Ulta Beauty', 'Best Buy', 'Monday', 'December', 'report', 'Upgrades', 'ACHC', 'Hold', 'tgt', 'BDX', 'Sell', 'Citigroup', 'BBY', 'Neutral', 'Goldman', 'Bio-Techne', 'Box', 'CAE', 'Overweight', 'Equal-Weight', 'CIOXY', 'Colliers', 'CIGI', 'Crane', 'Gap', 'GPS', 'Glaukos', 'GKOS', 'WDGJF', 'Jefferies', 'LRCX', 'MNDY', 'MEG', 'PerkinElmer', 'PKI', 'Pulmonx', 'LUNG', 'QuidelOrtho', 'Tapestry', 'TPR', 'TDY', 'Underweight', 'Armour', 'UAA', 'Stifel', 'Downgrades', 'Accenture', 'ACN', 'Allogene', 'Baxter', 'BYD', 'Brinker', 'EAT', 'CGEMY', 'CTRA', 'Truist', 'Curtiss-Wright', 'CW', 'DBOEY', 'DraftKings', 'DKNG', 'GPC', 'HEICO', 'Illumina', 'ILMN', 'JCI', 'KLAC', 'LRLCY', 'LH', 'Leggett', 'Platt', 'Micron', 'Moog', 'MOG.', 'Nevro', 'NVRO', 'NMRK', 'OCFC', 'PDCE', 'Qualcomm', 'QCOM', 'RH', 'ROK', 'RxSight', 'RXST', 'SWAV', 'Spire', 'SR', 'Trane', 'Vontier', 'VNT', 'Others', 'Acrivon']",2022-12-12,2022-12-12,247wallst.com
14606,Deutsche Boerse,NewsApi.org,https://www.investing.com/news/stock-market-news/germany-stocks-mixed-at-close-of-trade-dax-down-045-2962553,Germany stocks mixed at close of trade; DAX down 0.45% By Investing.com,Germany stocks mixed at close of trade; DAX down 0.45%,Â© Reuters. Germany stocks mixed at close of trade; DAX down 0.45%Investing.com â€“ Germany stocks were mixed after the close on Monday  as gains in the   and sectors led shares higher while losses in the   and sectors led shares lower.At the close in Frankfurt  the lost 0.45%  while the index declined 0.46%  and the index climbed 0.31%.The best performers of the session on the were Zalando SE (ETR: )  which rose 5.09% or 1.59 points to trade at 32.84 at the close. Meanwhile  Sartorius AG VZO O.N. (ETR: ) added 2.65% or 9.30 points to end at 360.10 and Beiersdorf AG O.N. (ETR: ) was up 1.42% or 1.50 points to 107.45 in late trade.The worst performers of the session were Fresenius SE & Co KGAA O.N. (ETR: )  which fell 2.44% or 0.65 points to trade at 26.02 at the close. Deutsche Boerse AG (ETR: ) declined 2.15% or 3.70 points to end at 168.45 and BASF SE NA O.N. (ETR: ) was down 2.14% or 1.02 points to 46.70.The top performers on the MDAX were Carl Zeiss Meditec AG (ETR: ) which rose 5.01% to 127.75  Stabilus (ETR: ) which was up 3.51% to settle at 63.40 and Befesa SA (ETR: ) which gained 2.84% to close at 42.80.The worst performers were Varta AG (ETR: ) which was down 3.99% to 28.15 in late trade  K&S AG (ETR: ) which lost 3.24% to settle at 18.96 and Tag Immobilien AG (ETR: ) which was down 3.11% to 5.77 at the close.The top performers on the TecDAX were Carl Zeiss Meditec AG (ETR: ) which rose 5.01% to 127.75  Sartorius AG VZO O.N. (ETR: ) which was up 2.65% to settle at 360.10 and Aixtron SE (ETR: ) which gained 1.99% to close at 31.27.The worst performers were Varta AG (ETR: ) which was down 3.99% to 28.15 in late trade  TeamViewer AG (ETR: ) which lost 2.84% to settle at 12.48 and SMA Solar Technology AG (ETR: ) which was down 1.97% to 67.10 at the close.Falling stocks outnumbered advancing ones on the Frankfurt Stock Exchange by 446 to 239 and 75 ended unchanged.Shares in Beiersdorf AG O.N. (ETR: ) rose to 52-week highs; up 1.42% or 1.50 to 107.45.The   which measures the implied volatility of DAX options  was up 5.45% to 22.82.Gold Futures for February delivery was down 1.00% or 18.05 to $1 792.65 a troy ounce. Elsewhere in commodities trading  Crude oil for delivery in January rose 3.28% or 2.33 to hit $73.35 a barrel  while the February Brent oil contract rose 2.58% or 1.96 to trade at $78.06 a barrel.EUR/USD was unchanged 0.03% to 1.05  while EUR/GBP unchanged 0.05% to 0.86.The US Dollar Index Futures was up 0.25% at 104.74.,neutral,0.01,0.99,0.01,mixed,0.14,0.02,0.84,True,English,"['Germany stocks', 'Investing.com', 'close', 'trade', 'DAX', 'Sartorius AG VZO O.N.', 'BASF SE NA O.N.', 'The US Dollar Index Futures', 'Co KGAA O.N.', 'Beiersdorf AG O.N.', 'Carl Zeiss Meditec AG', 'SMA Solar Technology AG', 'February Brent oil contract', 'Deutsche Boerse AG', 'K&S AG', 'Tag Immobilien AG', 'Frankfurt Stock Exchange', 'Gold Futures', 'Varta AG', 'TeamViewer AG', 'Crude oil', 'Zalando SE', 'Fresenius SE', 'Aixtron SE', 'February delivery', 'Germany stocks', 'best performers', 'worst performers', 'top performers', 'Befesa SA', 'Falling stocks', '52-week highs', 'implied volatility', 'troy ounce', 'commodities trading', 'late trade', 'DAX options', 'Reuters', 'close', 'Monday', 'gains', 'sectors', 'shares', 'losses', 'session', 'ETR', '9.30 points', 'MDAX', 'Stabilus', 'TecDAX', 'January', 'EUR/USD', 'EUR/GBP', 'Â©', '1.59', '0.', '3.', '1.02']",2022-12-12,2022-12-12,investing.com
14607,Deutsche Boerse,Bing API,https://www.msn.com/en-us/money/news/microsoft-to-buy-4-of-london-stock-exchange-on-cloud-deal/ar-AA15aH0k,Microsoft to Buy 4% of London Stock Exchange on Cloud Deal,Microsoft Corp. agreed to buy a 4% stake in London Stock Exchange Group Plc in a $2.8 billion cloud-computing deal that pushes big tech further into financial markets.,Â© Bloomberg The London Stock Exchange.(Bloomberg) -- Microsoft Corp. agreed to buy a 4% stake in London Stock Exchange Group Plc in a $2.8 billion cloud-computing deal that pushes big tech further into financial markets.Most Read from BloombergAs part of the agreement  LSEG said it will spend at least that amount on cloud services with Microsoft over the next 10 years. The partnership will speed up the migration of its markets to the cloud and allow it to develop new products and services  it said Monday.The transaction adds to a recent trend of exchanges and tech firms linking up after similar partnerships between Nasdaq Inc. and Amazon.com Inc.  as well as Alphabet Inc.â€™s Google and CME Group. It points to increased demand from investors for information that gives them an edge in increasingly fast electronic markets.Read more about financial services and the cloudGlobal spending on financial market data and news rose 7.4% to a record $35.6 billion in 2021  according to an April report by Burton-Taylor International Consulting.â€œWe will be generating meaningful revenue growth in the coming years by accessing new products and enhancing our existing product capabilities â€ LSEG Chief Executive Officer David Schwimmer said in a phone interview.At Fridayâ€™s closing price  a 4% stake in LSEG was valued at around Â£1.6 billion ($2 billion).Microsoft will buy its stake from a consortium made up of Blackstone  Thomson Reuters Corp. and affiliates of the Canada Pension Plan Investment Board and Singaporeâ€™s GIC  according to the statement. Thomson Reuters said in a statement it plans to use its proceeds from the transaction â€œto pursue organic and inorganic opportunities in key growth segments and provide returns to shareholders.â€Microsoft shares gained 1.4% in New York at 9:40 a.m. LSEGâ€™s shares rose as much as 4.9% in London trading.Minimum SpendThe deal underlines LSEGâ€™s increasing focus on data and analytics. The company completed a $27 billion purchase of Refinitiv last year  kicking off a new era where the majority of its revenues come from data. The parent company of Bloomberg News competes with Refinitiv to provide financial news  data and information.The Microsoft agreement is expected to cost LSEG between Â£250 million to Â£300 million between 2023 and 2025  including about Â£100 million in capital spending.Additional spending beyond the $2.8 billion minimum depends on the â€œsuccess of the strategic partnershipâ€ and demand for LSEGâ€™s data platform and professional services  according to the UK firm. Microsoft estimated in a separate statement that the â€œpartnership  and broader market opportunity  could generate an additional $5 billion in revenue for the company over the next 10 years.â€Scott Guthrie  Microsoftâ€™s executive vice president for cloud and artificial intelligence  will be appointed as a LSEG director.Data ConsolidationThe past few years has seen consolidation among the finance industryâ€™s biggest data providers. Last year  S&P Global Inc. agreed to buy IHS Markit Ltd. while Deutsche Boerse  LSEâ€™s biggest European rival  took a majority stake in Institutional Shareholder Services Inc.  the corporate-governance adviser.Read More: LSE Completes Refinitiv Deal to Kickstart Data-Driven EraItâ€™s not the first time Microsoft has struck a deal alongside unveiling a sizeable cloud deal. In 2018  it invested in Grab  with the ride-hailing firm agreeing to adopt Azure as its preferred cloud platform.These cross-selling deals donâ€™t always end in success. In 2012  the US tech firm spent $300 million in a stake in then struggling bookseller Barnes & Nobleâ€™s e-book division Nook.As part of the deal  Barnes & Noble agreed to make e-reading content for Microsoft. Two years later  Barnes & Noble bought out Microsoftâ€™s stake for about $125 million  after Nook struggled to win over customers.--With assistance from Chris Reiter.(Adds Microsoft share price in 8th paragraph.)Most Read from Bloomberg BusinessweekÂ©2022 Bloomberg L.P.,neutral,0.0,0.99,0.0,mixed,0.26,0.2,0.54,True,English,"['London Stock Exchange', 'Cloud Deal', 'Microsoft', 'LSEG Chief Executive Officer David Schwimmer', 'Canada Pension Plan Investment Board', 'London Stock Exchange Group Plc', 'The London Stock Exchange', 'S&P Global Inc.', 'Institutional Shareholder Services Inc.', 'executive vice president', 'Amazon.com Inc.', 'existing product capabilities', 'key growth segments', 'broader market opportunity', 'IHS Markit Ltd.', 'biggest European rival', 'Bloomberg L.P.', 'fast electronic markets', 'meaningful revenue growth', 'biggest data providers', 'US tech firm', 'Thomson Reuters Corp.', 'preferred cloud platform', '$2.8 billion cloud-computing deal', 'financial market data', 'Microsoft share price', 'sizeable cloud deal', 'London trading', 'CME Group', 'Nasdaq Inc.', 'Alphabet Inc', 'Global spending', 'big tech', 'closing price', 'financial services', 'data platform', '$27 billion purchase', '$2.8 billion minimum', 'UK firm', 'ride-hailing firm', 'financial markets', 'professional services', 'cloud services', 'new products', 'recent trend', 'similar partnerships', 'April report', 'phone interview', 'inorganic opportunities', 'New York', 'Minimum Spend', 'increasing focus', 'new era', 'capital spending', 'Additional spending', 'Scott Guthrie', 'artificial intelligence', 'finance industry', 'Deutsche Boerse', 'corporate-governance adviser', 'Data-Driven Era', 'first time', 'cross-selling deals', 'book division', 'reading content', 'Chris Reiter', '8th paragraph', 'Microsoft Corp.', 'financial news', 'next 10 years', 'coming years', 'LSEG director', 'Bloomberg Businessweek', 'Data Consolidation', 'Bloomberg News', 'parent company', 'strategic partnership', 'separate statement', 'Refinitiv Deal', 'Microsoft shares', 'Microsoft agreement', 'majority stake', '4% stake', 'amount', 'migration', 'transaction', 'exchanges', 'firms', 'Google', 'demand', 'investors', 'information', 'edge', 'record', 'Friday', 'consortium', 'Blackstone', 'affiliates', 'Singapore', 'proceeds', 'returns', 'shareholders', 'analytics', 'revenues', 'success', 'past', 'Grab', 'Azure', 'bookseller', 'Barnes', 'Noble', 'Nook', 'customers', 'assistance', '9:40']",2022-12-12,2022-12-12,msn.com
14608,Deutsche Boerse,Bing API,https://ca.finance.yahoo.com/video/microsoft-buys-stake-london-stock-144419311.html,Microsoft buys stake in London Stock Exchange in cloud deal,Microsoft buying a 4% stake in the London Stock Exchange. Video Transcript [AUDIO LOGO]- Let's talk about Microsoft a little bit more  which is,Yahoo Finance Live anchors discuss Microsoft buying a 4% stake in the London Stock Exchange.Video Transcript[AUDIO LOGO]- Let's talk about Microsoft a little bit more  which is on the lower left of that screen there. It's up a little bit today after announcing this morning it's taking a 4% equity stake in the London Stock Exchange. This is part of 10-year partnership that will migrate the UK exchange's data onto the Microsoft Cloud. Now  Microsoft shares are up a little bit.London Stock Exchange is getting a lot of positive feedback from analysts for doing this deal  which is quite interesting  because they say it'll bring credibility and sort of beef up its data offerings compared to some of its peers. So they seem to be pretty positive on this deal  you guys.- It comes at a time-- I remember speaking to NASDAQ CEO Adena Friedman on about six or seven months ago. They've been going through an Amazon Web Service upgrade just all in the pursuit of making these markets more efficient  even faster.- Yeah  and it seems like for Microsoft  this is going to net them some spending over the next 10 years of EG or-- well  yeah  LSEG is basically going to spend that amount on cloud services with Microsoft. And hopefully with this  this should give Microsoft a little bit more insight into and for the data that Microsoft is really trying to aggregate as well and bring onto its cloud services. This has been a big wave of deals that we've seen from Microsoft.They had  of course  along with some of the other cloud participants  a big Pentagon deal. That was made known last week. And that's going to be over the course of some years for about $10 billion as well all in. But then additionally here on the exchange front  just another deal to be able to see their web services or their cloud division propped up just a little bit more.- And a deal that doesn't need regulatory approval like the Activision Blizzard does.- Right. I guess there has been a lot of consolidation in the data exchange space in the past few years. Remember  S&P Global bought IHS Markit. Deutsche Boerse also took a big stake in Institutional Shareholder Services. So there's been some--Story continues- Tentative with London Stock Exchange.- Yeah  so there's been some of these combinations. So we'll see if this is the last of them or there are more to go.- It could be the tip of that spending to come forward  especially given the acquisition we were talking about earlier and perhaps just looking for good prices for deals right now  too.,neutral,0.0,0.99,0.0,positive,0.81,0.14,0.04,True,English,"['London Stock Exchange', 'cloud deal', 'Microsoft', 'stake', 'Yahoo Finance Live anchors', 'NASDAQ CEO Adena Friedman', 'Amazon Web Service upgrade', 'S&P Global', 'London Stock Exchange', 'Institutional Shareholder Services', 'other cloud participants', 'data exchange space', 'big Pentagon deal', 'web services', 'UK exchange', 'exchange front', 'cloud services', 'big wave', 'cloud division', 'Video Transcript', 'AUDIO LOGO', 'lower left', '10-year partnership', 'positive feedback', 'regulatory approval', 'Activision Blizzard', 'IHS Markit', 'Deutsche Boerse', 'big stake', 'good prices', 'data offerings', '4% equity stake', 'Microsoft Cloud', 'next 10 years', 'Microsoft shares', '4% stake', 'screen', 'lot', 'analysts', 'credibility', 'peers', 'time', 'pursuit', 'markets', 'spending', 'LSEG', 'amount', 'little', 'insight', 'deals', 'course', 'consolidation', 'past', 'Story', 'combinations', 'tip', 'acquisition']",2022-12-12,2022-12-12,ca.finance.yahoo.com
14609,Deutsche Boerse,Bing API,https://financefeeds.com/clearstream-goes-live-with-proxymitys-digital-proxy-voting-service/,Clearstream goes live with Proxymityâ€™s digital proxy voting service,"""We continue to develop our long-standing partnership with Clearstream and the Deutsche Borse Group  following on from the rollout of our Shareholder ID solution earlier in the year.""","""We continue to develop our long-standing partnership with Clearstream and the Deutsche Borse Group  following on from the rollout of our Shareholder ID solution earlier in the year.""",neutral,0.07,0.93,0.0,neutral,0.02,0.98,0.0,True,English,"['digital proxy voting service', 'Clearstream', 'Proxymity', 'Deutsche Borse Group', 'Shareholder ID solution', 'long-standing partnership', 'Clearstream', 'rollout', 'year']",2022-12-12,2022-12-12,financefeeds.com
14610,Deutsche Boerse,Bing API,https://www.euromoney.com/article/2b07fmunimqqvtf1bturk/fintech/what-went-wrong-with-the-asx-blockchain-landmark,What went wrong with the ASX blockchain landmark?,The Australian Securities Exchange took a leap of faith in commissioning Digital Asset to build a blockchain replacement for its clearing and settlement engine five years ago â€“ perhaps too big a leap.,It was supposed to be a game changer  the great step forward in the use of blockchain technology that would elevate it from a clever but nebulous idea to the heart of real-world financial markets.After two years of study  the Australian Securities Exchange appointed a company in 2017 called Digital Asset Holdings to build a distributed-ledger system to replace the ASXâ€™s 25-year-old clearing and settlement systems  called Chess (Clearing House Electronic Subregister System).Five years on  plenty of examples of blockchain technology exist in stock exchanges â€“ at Deutsche BÃ¶rse  for example  or Switzerlandâ€™s SIX Digital Exchange â€“ but back then it was seen as highly ambitious and attempting something on a greater scale of complexity than either of those examples.Too complex  it turned out.After multiple delays  in August Accenture was commissioned to look into the state of the project. The consultantâ€™s report identified problems from timelines to communication to complexity  and suggested that its implementation  which the ASX had indicated as near-ready  was no more than 63% complete.In the aftermath  in November  the ASX halted the project and said it would write off as much as A$255 million ($173 million) in technology costs. A parliamentary committee has followed and questions have been raised about the ASXâ€™s culture  governance and technology capability.,negative,0.0,0.0,1.0,mixed,0.25,0.03,0.72,True,English,"['ASX blockchain landmark', 'House Electronic Subregister System', 'real-world financial markets', 'Australian Securities Exchange', 'Deutsche BÃ¶rse', 'SIX Digital Exchange', 'distributed-ledger system', 'game changer', 'great step', 'blockchain technology', 'nebulous idea', 'two years', '25-year-old clearing', 'settlement systems', 'stock exchanges', 'greater scale', 'multiple delays', 'technology costs', 'parliamentary committee', 'technology capability', 'clever', 'heart', 'study', 'company', 'ASX', 'plenty', 'examples', 'Switzerland', 'something', 'complexity', 'August', 'Accenture', 'state', 'project', 'consultant', 'report', 'problems', 'timelines', 'communication', 'implementation', 'aftermath', 'November', 'questions', 'culture', 'governance']",2022-12-12,2022-12-12,euromoney.com
14611,Deutsche Boerse,Bing API,https://www.independent.ie/business/world/microsoft-takes-stake-in-london-stock-exchange-operator-42213346.html,Microsoft takes stake in London Stock Exchange operator,Microsoft has agreed to buy a stake in the London Stock Exchange Group Plc that will give the software company a 4pc equity holding  a deal that underlines the pivotal position data  analytics and technology play in increasingly computerized financial markets.,"Microsoft has agreed to buy a stake in the London Stock Exchange Group Plc that will give the software company a 4pc equity holding  a deal that underlines the pivotal position data  analytics and technology play in increasingly computerized financial markets. Microsoft will acquire the shares as part of a new long-term strategic partnership that will see it provide cloud computing services to the exchange  LSEG said in a statement on Monday. At Friday's closing price  a 4pc stake in the bourse was valued at around Â£1.6bn (â‚¬1.85bn). The stake is part of a broader  10-year agreement to help the London Stock Exchange owner improve its data analytics and cloud infrastructure using Microsoft's products. Scott Guthrie  Microsoft's executive vice president for cloud and artificial intelligence  will be appointed as a director. The agreement is the latest sign of surging demand from investors for information that gives them an edge in increasingly fast electronic markets. Global spending on financial market data and news rose 7.4pc to a record $35.6bn in 2021  according to an April report by Burton-Taylor International Consulting. ""We will be generating meaningful revenue growth in the coming years by accessing new products and enhancing our existing product capabilities "" LSEG Chief Executive Officer David Schwimmer said in a phone interview. Microsoft will buy its stake from a consortium made up of Blackstone  Thomson Reuters Corp. and affiliates of the Canada Pension Plan Investment Board and Singapore's GIC  according to the statement. Shares in LSEG rose 3.8pc at 10:01 a.m. in London. The deal underlines LSEG's increasing focus on data and analytics. The company completed a $27bn purchase of Refinitiv last year  kicking off a new era where the majority of its revenues come from data. The parent company of Bloomberg News competes with Refinitiv to provide financial news  data and information. The agreement is expected to cost LSEG between Â£250m to Â£300 million between 2023 and 2025  including about Â£100 million in capital spending. The group said it has made a contractual commitment with Microsoft to spend a minimum of $2.8bn on cloud-related services and support over the next 10 years. Additional spending depends on the ""success of the strategic partnership"" and demand for LSEG's data platform and professional services  according to the UK firm. Microsoft estimated in a separate statement that the ""partnership  and broader market opportunity  could generate an additional $5 billion in revenue for the company over the next 10 years."" Azure Platform Under the arrangement  LSEG's data platform and other key technology infrastructure will migrate to Microsoft's Azure cloud environment while its data and analytics will interface with certain Microsoft applications. The past few years has seen consolidation among the finance industry's biggest data providers. Last year  S&P Global Inc agreed to buy IHS Markit Ltd. while Deutsche Boerse  LSE's biggest European rival  took a majority stake in Institutional Shareholder Services Inc.  the corporate-governance adviser. It's not the first time Microsoft has struck a deal alongside unveiling a sizeable cloud deal. In 2018  it invested in Grab  with the ride-hailing firm agreeing to adopt Azure as its preferred cloud platform. These cross-selling deals don't always end in success. In 2012  the US tech firm spent $300m in a stake in then struggling bookseller Barnes & Noble's e-book division Nook. As part of the deal  Barnes & Noble agreed to make e-reading content for Microsoft. Two years later  Barnes & Noble bought out Microsoft's stake for about $125m  after Nook struggled to win over customers. (Bloomberg)",neutral,0.01,0.99,0.0,negative,0.12,0.1,0.78,True,English,"['London Stock Exchange operator', 'Microsoft', 'stake', 'LSEG Chief Executive Officer David Schwimmer', 'Canada Pension Plan Investment Board', 'London Stock Exchange Group Plc', 'London Stock Exchange owner', 'S&P Global Inc', 'Institutional Shareholder Services Inc.', 'other key technology infrastructure', 'new long-term strategic partnership', 'executive vice president', 'fast electronic markets', 'existing product capabilities', 'Thomson Reuters Corp.', 'broader market opportunity', 'IHS Markit Ltd.', 'biggest European rival', 'computerized financial markets', '4pc equity holding', 'US tech firm', 'cloud computing services', 'meaningful revenue growth', 'pivotal position data', 'biggest data providers', 'preferred cloud platform', 'broader, 10-year agreement', 'financial market data', 'Azure cloud environment', 'sizeable cloud deal', 'cloud infrastructure', 'technology play', 'Global spending', 'cloud-related services', 'professional services', 'new era', 'UK firm', 'ride-hailing firm', 'financial news', 'Azure Platform', 'new products', 'data platform', 'closing price', 'Scott Guthrie', 'artificial intelligence', 'latest sign', 'April report', 'phone interview', 'increasing focus', '$27bn purchase', 'capital spending', 'contractual commitment', 'Additional spending', 'finance industry', 'Deutsche Boerse', 'corporate-governance adviser', 'first time', 'cross-selling deals', 'book division', 'reading content', '4pc stake', 'coming years', 'next 10 years', 'software company', 'surging demand', 'parent company', 'separate statement', 'Bloomberg News', 'data analytics', 'Microsoft applications', 'majority stake', 'shares', 'Monday', 'Friday', 'bourse', 'director', 'investors', 'information', 'edge', 'record', 'consortium', 'Blackstone', 'affiliates', 'Singapore', '10:01 a', 'Refinitiv', 'revenues', 'minimum', 'support', 'success', 'arrangement', 'past', 'consolidation', 'Grab', 'bookseller', 'Barnes', 'Noble', 'Nook', 'customers']",2022-12-12,2022-12-12,independent.ie
14612,Deutsche Boerse,Bing API,https://ca.sports.yahoo.com/news/clearstream-chooses-proxymitys-digital-proxy-090000296.html,Clearstream Chooses Proxymity's Digital Proxy Voting Service for Nine Markets Across Europe,Proxymity's Vote Connect solution to be deployed across nine European countries  fueling further expansion of digital proxy voting in the region. Featured Image for  Featured Image for  LONDON  Dec. 12 ,"Proxymity's Vote Connect solution to be deployed across nine European countries  fueling further expansion of digital proxy voting in the region.Featured Image for ProxymityFeatured Image for ProxymityLONDON  Dec. 12  2022 (GLOBE NEWSWIRE) -- Proxymity  the leading digital investor communication platform  announced today that Clearstream has gone live with its digital proxy voting service  Vote Connect  across nine European markets. This digital proxy voting service connects issuers  intermediaries  and investors  ensuring that investor communications are delivered in real-time.Proxymity Vote Connect is the flagship digital proxy service powered by Proxymity's investor communications platform. The service includes ""issuer golden source"" meeting announcements published directly from issuers to investors. Many European markets benefit from the full end-to-end digital connectivity provided by the solution  enabling greater transparency  speed  and accuracy to the ecosystem.With Vote Connect  shareholders' votes are sent digitally to issuers or their agents in real-time and they receive digital confirmation that their votes have been cast and counted at the meeting. The inefficient and disjointed infrastructure of existing channels has seen a growing number of businesses reassess how they manage proxy voting  with Proxymity's platform increasingly seen as the solution of choice.Dean Little  CEO and Co-Founder  Proxymity  commented: ""We continue to develop our long-standing partnership with Clearstream and the Deutsche BÃ¶rse Group  following on from the rollout of our Shareholder ID solution earlier in the year. This is another fantastic milestone for Proxymity as we expand our market coverage  including the introduction of Vote Connect into the Baltic Markets and increasing our overall global footprint.""Sam Riley  Head of Clearstream Securities Services  added: ""At Clearstream  we always seek to optimise our clients' experience throughout the whole securities life cycle. Together with our partner Proxymity  we are seeking to provide the best in digital proxy voting solutions  driving transparency  and increasing efficiency in the European capital markets.""Story continuesAbout SRD IISRD II aims to make it easier for issuers to engage with shareholders  especially across different countries  encouraging the use of modern technology to aid communication between companies  their shareholders  and the intermediaries between them.The European-wide legislation impacts  amongst others  companies with registered offices and shares trading in the EU and EEA. This suggests new platforms and technologies like Proxymity may not only help upgrade existing processes to meet SRD II demands but could also be the most efficient and effective means of complying with the legislation.-Notes to editors-About ProxymityProxymity connects the world's ecosystem of issuers  intermediaries  and investors digitally in real-time  bringing unprecedented transparency  efficiency  and accuracy to traditional paper-based processes. Trusted by the world's largest financial institutions  it is the leading digital investor communications platform  serving over 25 markets world-wide. Proxymity's ground-breaking technology has also been recognised industry-wide  with recent awards including FSTech's ""Most Disruptive Technology in the FinTech Sector"" and GC Magazine's ""FinTech of the Year 2022"".Our solutions give public companies confidence that their AGM/EGM agendas are transmitted as ""golden source"" and provide institutional investors with the time to research and vote on corporate decisions  as well as actual digital confirmation that their votes have been received. The digital-native platform  built on highly scalable technology  provides full compliance with the latest regulations  such as the Shareholder Rights Directive (SRD II).Proxymity promotes enhanced environmental  social  and governance (ESG) by improving communication between issuers and investors while making it easier for intermediaries to provide efficient  timely and compliant client service.The company is backed by a global consortium of the industry's most influential financial institutions  representing seven of the world's top ten Global Custodians managing over $200 trillion in assets under custody (BNP Paribas  BNY Mellon  Citi  Computershare  Deutsche Bank  Deutsche BÃ¶rse  HSBC  J.P. Morgan  Mediant  State Street).For more information  visit www.proxymity.ioProxymity media contacts:Tel: +44 (0) 20 3195 3240 /Lauren Fraser: lfraser@sapiencecomms.co.ukJamie Gittings: jgittings@sapiencecomms.co.ukSergio Cortes Allsopp: scortesallsop@sapiencecomms.co.ukContact Information:Lauren FraserPR Teamlfraser@sapiencecomms.co.uk+44 20 3195 3240James GittingsPR Teamjgittings@sapiencecomms.co.uk+442031953240Related ImagesImage 1This content was issued through the press release distribution service at Newswire.com.Attachment",neutral,0.0,1.0,0.0,mixed,0.77,0.06,0.17,True,English,"['Digital Proxy Voting Service', 'Nine Markets', 'Clearstream', 'Proxymity', 'Europe', 'issuer golden source"" meeting announcements', 'leading digital investor communications platform', 'leading digital investor communication platform', 'press release distribution service', 'top ten Global Custodians', 'James Gittings PR Team', 'flagship digital proxy service', 'Deutsche BÃ¶rse Group', 'Lauren Fraser PR Team', 'digital proxy voting service', 'digital proxy voting solutions', 'compliant client service', 'actual digital confirmation', 'overall global footprint', 'securities life cycle', 'largest financial institutions', 'Shareholder Rights Directive', 'influential financial institutions', 'J.P. Morgan', 'Sergio Cortes Allsopp', 'nine European countries', 'traditional paper-based processes', 'nine European markets', 'Many European markets', 'European capital markets', 'Most Disruptive Technology', 'Shareholder ID solution', 'public companies confidence', 'Clearstream Securities Services', 'SRD II demands', 'Proxymity media contacts', 'Vote Connect solution', 'Proxymity Vote Connect', 'Proxymity Featured Image', 'digital connectivity', 'digital-native platform', 'global consortium', 'Deutsche Bank', 'Jamie Gittings', 'different countries', 'existing processes', 'Baltic Markets', 'modern technology', 'ground-breaking technology', 'scalable technology', 'GLOBE NEWSWIRE', 'disjointed infrastructure', 'existing channels', 'growing number', 'Dean Little', 'long-standing partnership', 'fantastic milestone', 'market coverage', 'Sam Riley', ""clients' experience"", 'registered offices', 'new platforms', 'effective means', 'recent awards', 'GC Magazine', 'AGM/EGM agendas', 'corporate decisions', 'full compliance', 'latest regulations', 'BNP Paribas', 'BNY Mellon', 'State Street', 'Related Images', 'Newswire.com', 'full end', 'greater transparency', 'European-wide legislation', 'FinTech Sector', 'efficient, timely', 'Contact Information', 'partner Proxymity', 'institutional investors', ""shareholders' votes"", '25 markets', 'expansion', 'region', 'LONDON', 'Dec.', 'issuers', 'intermediaries', 'real-time', 'speed', 'accuracy', 'ecosystem', 'agents', 'inefficient', 'businesses', 'choice', 'CEO', 'Founder', 'rollout', 'year', 'introduction', 'Head', 'efficiency', 'Story', 'use', 'The', 'shares', 'EEA', 'technologies', 'Notes', 'editors', 'world', 'FSTech', 'highly', 'governance', 'ESG', 'company', 'industry', 'assets', 'custody', 'Citi', 'Computershare', 'HSBC', 'Mediant', 'Tel', 'jgittings', 'content', 'Attachment', '44']",2022-12-12,2022-12-12,ca.sports.yahoo.com
14613,Deutsche Boerse,Bing API,https://www.brecorder.com/news/40213828/porsche-set-to-join-germanys-prestigious-dax-index,Porsche set to join Germanyâ€™s prestigious DAX index,BERLIN: Less than three months after a high-profile stock market debut  luxury carmaker Porsche is set to join Germanyâ€™s blue-chip DAX index  edging out sportsgear maker Puma. Porsche will be promoted onto the Frankfurt index of Germanyâ€™s 40 leading firms on December 19 ,BERLIN: Less than three months after a high-profile stock market debut  luxury carmaker Porsche is set to join Germanyâ€™s blue-chip DAX index  edging out sportsgear maker Puma. Porsche will be promoted onto the Frankfurt index of Germanyâ€™s 40 leading firms on December 19  stock exchange operator Deutsche Boerse said in a statement late Monday.The firmâ€™s â€œfast entryâ€ into the DAX showed that â€œour business model is robust and attractive to investors  even in a challenging environment â€ Porscheâ€™s chief finance officer Lutz Meschke said on Tuesday.The maker of the iconic 911 sports car raced onto the Frankfurt stock exchange in late September with one of Europeâ€™s biggest listings in years.Parent company Volkswagen raised around nine billion euros ($9.4 billion) in the IPO  money that will help finance the groupâ€™s costly shift to electric vehicles.Porsche has quickly become an investor favourite  its share price climbing by almost 30 percent from 82.50 euros initially to around 106 euros in early afternoon trading on Tuesday.The companyâ€™s current valuation  at just over 96 billion euros  now surpasses that of its parent VW at 83.5 billion euros  according to Bloomberg.Porsche has also outpaced fellow German carmakers Mercedes-Benz  valued at 68.8 billion euros  and BMW at 56.5 billion.Porscheâ€™s arrival in the top 40 will push Puma out of the DAX.It will instead be listed on the MDAX index for medium-sized companies  Deutsche Boerse said.Like its competitors  Puma is going a through turbulent time as high inflation and ongoing Covid 19-related restrictions in key market China weigh on demand. The company recently lost its CEO  Bjorn Gulden  to German rival Adidas.,neutral,0.01,0.98,0.0,negative,0.0,0.19,0.81,True,English,"['prestigious DAX index', 'Porsche', 'Germany', 'high-profile stock market debut, luxury carmaker Porsche', 'ongoing Covid 19-related restrictions', 'key market China', 'stock exchange operator', 'Frankfurt stock exchange', 'chief finance officer', 'iconic 911 sports car', 'early afternoon trading', 'fellow German carmakers', 'German rival Adidas', 'nine billion euros', 'blue-chip DAX index', 'Frankfurt index', 'MDAX index', '96 billion euros', '83.5 billion euros', '68.8 billion euros', '40 leading firms', 'Deutsche Boerse', 'fast entry', 'business model', 'challenging environment', 'Lutz Meschke', 'late September', 'biggest listings', 'costly shift', 'electric vehicles', 'share price', 'current valuation', 'parent VW', 'medium-sized companies', 'turbulent time', 'high inflation', 'Bjorn Gulden', 'sportsgear maker', 'Parent company', '82.50 euros', '106 euros', 'Germany', 'Puma', 'December', 'statement', 'investors', 'Tuesday', 'Europe', 'years', 'Volkswagen', 'IPO', 'money', 'group', '30 percent', 'Bloomberg', 'Mercedes-Benz', 'BMW', 'arrival', 'top', 'competitors', 'demand', 'CEO']",2022-12-12,2022-12-12,brecorder.com
14614,Deutsche Boerse,Twitter API,Twitter,At the right price i would buy $CME or $NAQ $DB1 (deutsche bÃ¶rse)  Euronext etc  without hesitation. (i thought mucâ€¦ https://t.co/EjjUjbhsYp,nan,At the right price i would buy $CME or $NAQ $DB1 (deutsche bÃ¶rse)  Euronext etc  without hesitation. (i thought mucâ€¦ https://t.co/EjjUjbhsYp,positive,0.95,0.04,0.01,positive,0.95,0.04,0.01,True,English,"['deutsche bÃ¶rse', 'right price', 'CME', 'Euronext', 'hesitation', 'EjjUjbhsYp', 'deutsche bÃ¶rse', 'right price', 'CME', 'Euronext', 'hesitation', 'EjjUjbhsYp']",2022-12-12,2022-12-12,Unknown
14615,EuroNext,NewsApi.org,https://finance.yahoo.com/news/awilco-drilling-plc-change-isin-151300875.html,Awilco Drilling PLC â€“ Change of ISIN and method of VPS registration â€“ reverse split - transfer of listing to Euronext Growth â€“ contemplated private placement,"Reference is made to the announcement on 23 November 2022 that Awilco Drilling PLC (""Awilco Drilling"") intended to apply for a transfer of its listing from...","Awilco Drilling PlcReference is made to the announcement on 23 November 2022 that Awilco Drilling PLC (""Awilco Drilling"") intended to apply for a transfer of its listing from Oslo BÃ¸rs to Euronext Growth Oslo and to the announcement on 1 November 2022 that Awilco Drilling will change its structure of VPS registration to Sponsored Norwegian Depository Receipts (""SNDRs"").The first day of trading on Euronext Growth Oslo is expected to occur on 16 December 2022 and the last day of trading on Oslo BÃ¸rs is expected to be on 15 December 2022.Following the listing on Euronext Growth Oslo  Awilco Drilling expects to carry out an equity offering of approx. USD 10 million  expected to be structured as combination of a private placement and a subsequent repair offering.As from the first day of trading on Euronext Growth Oslo  Awilco Drilling will change the form of registration of its securities with Euronext Securities Oslo (the ""VPS"") from SSL registration of beneficial interests in Awilco Drilling's shares to SNDRs representing Awilco Drilling's shares. This will also result in a change of ISIN. As described in the press related dated 1 November 2022  the change of registration to SNDRs is necessary as a result of the implementation of the EU Central Securities Depositories Regulation (Regulation EU no 909/2014) in Norway.Key information relating to change to SNDRs and related change of ISIN:Issuer name: Awilco Drilling PLCIssuer of the SNDRs: Nordic Issuer Services ASLast day of trading under previous ISIN and on SSL registration basis: 15 December 2022First day of trading under new ISIN and as SNDRs: 16 December 2022Date of ISIN change: 16 December 2022Previous ISIN: GB00B5LJSC86New ISIN: NO0012740218Further  due to technical reasons  Awilco Drilling will be traded with temporary ticker code AWDRT as from 15 December 2022. As from 16 December 2022  Awilco Drilling will be traded with the ordinary ticker code AWDR.Following the change of registration to SNDRs  the 100:1 reverse share split approved at the extraordinary general meeting on 8 December 2022 will be implemented. This will entail a new change of ISIN.Story continuesKey information relating to the reverse split:Issuer name: Awilco Drilling PLCIssuer of the SNDRs: Nordic Issuer Services ASReverse split ratio: 100 old SNDRs give 1 new SNDR (100:1)Last day including right - reverse split: 19 December 2022Ex date - reverse split: 20 December 2022Record date for reverse split: 21 December 2022Date on which reverse split was approved: 8 December 2022Previous ISIN: NO0012740218New ISIN: NO0012785098Date of ISIN change: 20 DecemberThe above time line is subject to the admission to trading to Euronext Growth Oslo taking place on 16 December 2022 as planned. In case of any delay in the timeline  updated information will be provided.The issuer of the SNDRs will be Nordic Issuer Services AS  which is Awilco Drilling's issuer account operator in the VPS. Nordic Issuer Services AS will continue to be registered as the nominal holder of all the shares of Awilco Drilling.Sponsored Norwegian Depository Receipts (""SNDR"") issued in the ES-OSL register have certain limitations and risks. You can read more about these limitations and risks in Nordic Issuer Services AS' general business terms available at www.nordicissuer.com. A service description for SNDRs is available at www.euronextvps.no. A copy of the terms and conditions of the Sponsored Norwegian Depository Receipts for Awilco Drilling is attached to this notice  and the terms and conditions are also available at the website of Awilco Drilling  www.awilcodrilling.com.The holders of SNDRs must look solely Nordic Issuer Services  as the issuer of the SNDRs  for payment of dividends  the exercise of voting rights and for all other rights arising in respect of the underlying shares in Awilco Drilling  on the basis of which the SNDRs are issued.Aberdeen  12 December 2022For further information  please contact:Eric Jacobs  Interim CEOPhone: +44 1224 737900Cathrine Haavind  Investor RelationsPhone: +47 93 42 84 64Email: ch@awilcodrilling.com (mailto:ch@awilcodrilling.com)This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.Attachment",neutral,0.0,1.0,0.0,positive,0.79,0.13,0.08,True,English,"['Awilco Drilling PLC', 'VPS registration', 'reverse split', 'Euronext Growth', 'private placement', 'Change', 'ISIN', 'method', 'transfer', 'listing', 'EU Central Securities Depositories Regulation', 'Sponsored Norwegian Depository Receipts', 'Nordic Issuer Services AS', 'Norwegian Securities Trading Act', 'Euronext Securities Oslo', 'Oslo BÃ¸rs', 'Euronext Growth Oslo', 'temporary ticker code', 'ordinary ticker code', 'extraordinary general meeting', 'subsequent repair offering', 'issuer account operator', 'general business terms', '100:1 reverse share split', 'Reverse split ratio', 'Awilco Drilling Plc', 'Regulation EU', 'SSL registration basis', 'equity offering', 'Issuer name', 'first day', 'private placement', 'beneficial interests', 'technical reasons', '1 new SNDR', 'time line', 'nominal holder', 'ES-OSL register', 'service description', 'voting rights', 'other rights', 'Eric Jacobs', 'Interim CEO', 'Cathrine Haavind', 'Investor Relations', 'disclosure requirements', 'previous ISIN', 'new ISIN', 'last day', 'Key information', 'updated information', 'related change', 'new change', 'Ex date', 'Record date', 'underlying shares', 'ISIN change', '100 old SNDRs', 'VPS registration', 'Reference', 'announcement', '23 November', 'transfer', 'listing', '1 November', 'structure', '16 December', '15 December', 'combination', 'press', 'result', 'implementation', 'Norway', 'AWDRT', '8 December', 'Story', '20 December', 'case', 'delay', 'timeline', 'limitations', 'risks', 'nordicissuer', 'copy', 'conditions', 'notice', 'website', 'holders', 'payment', 'dividends', 'exercise', 'respect', 'Aberdeen', '12 December', 'Phone', 'Email', 'mailto', 'section', 'Attachment', '19', '21']",2022-12-12,2022-12-12,finance.yahoo.com
14616,EuroNext,NewsApi.org,https://seekingalpha.com/article/4563877-abc-arbitrage-stock-intriguing-hedge-viel-better-option,ABC Arbitrage: Intriguing Hedge  But Viel Is A Better Option (OTCMKTS:ABCCF),ABC Arbitrage (ABCCF) is a French small-cap company that engages in arbitrage strategies in financial markets. See why I'm neutral on the stock.,"metamorworks/iStock via Getty ImagesABC Arbitrage: ticker ABCA.PA (Euronext Paris)Market cap: â‚¬380M ($400M)A few years ago  I introduced ABC Arbitrage (ABCA.PA  OTCPK:ABCCF)  a small-cap French stock with a very specific business model: arbitrage strategies  whereby the company takes advantage of mispriced assets in financial markets. These trading strategies thrive in times of elevated volatility  meaning that ABC Arbitrage performs especially well in downturns.The company's performance has been satisfactory  but not outstanding  in my opinion. It offers a generous dividend of about 6%  but this yield comes with a high payout ratio. With the stock too expensive for my liking  I prefer another Paris-listed stock  Viel & Cie (VIL.PA)  which also benefits from volatility. Viel's steady performance and undemanding valuation make it an excellent choice for income investors.Not all retail investors will have access to ABC Arbitrage or Viel  given that the stocks only trade on Euronext Paris (the OTC ticker ABCCF for ABC Arbitrage has very little liquidity). For those seeking exposure to larger companies in the long volatility niche  let me mention Virtu (VIRT)  Flow Traders (OTCPK:FLTDF) and BGC Partners (BGCP). A thorough analysis of Virtu can be found here.ABC Arbitrage: Making Money Out Of Market VolatilityABC Arbitrage was founded in 1995. It is headquartered in Paris  France  and also has offices in Dublin and Singapore. The company defines itself as a quantitative asset manager. It deploys a variety of arbitrage strategies  using both managed money and its own equity.These trading strategies can be broken down into four categories  per the company's website :Liquidity arbitrage: detecting and correcting differences in trading prices between linked assets.Risk arbitrage: taking advantage of risk mispricing in capital markets.Statistical arbitrage: pair-trading within an industry  lead-lag effects (e.g. interaction between commodity prices and inflation).Derivatives arbitrage: detecting mispricing in options and other derivatives.ABC Arbitrage has a successful track record  having generated 27 consecutive profitable years  with a ROE (Return on Equity) in excess of 10%. These results have convinced institutional clients to entrust the company with their funds  to the tune of â‚¬350M. In total  including its own equity  ABC Arbitrage manages around â‚¬500M - a rather small amount  but enough for the company to fund its arbitrage operations (some of which couldn't be scaled up anyway).H1 '22 presentationThe main driver of the company's performance  unsurprisingly  is volatility. Volatility  in fact  increases trading activity (velocity) and creates price dislocations that arbitrage strategies can exploit. The table below shows various drivers and their typical impact on ABC Arbitrage's financial performance.H1 '22 presentationAfter muted volatility levels for most of the 2010s  including some ""no life"" years  as the company calls them  the Covid crisis finally woke up financial markets.H1 '22 presentationThis resulted in strong financial performance for ABC Arbitrage in 2020  and  to a lesser extent  in 2021 and 2022 YTD. The record results of 2008  during the Great Recession  are further proof of volatility's impact on ABC Arbitrage.H1 '22 presentationNote: 2022A above is just an extrapolation of H1 performance  the actual yearly results of course remain unknown.ABC Arbitrage : A Generous Dividend Policy  But A High Payout RatioBased on its track record  ABC Arbitrage is seen to be a decent portfolio hedge  which tends to do especially well in periods when many stocks underperform. Financial performance in the first half of 2022 was satisfactory  though one might have expected the company to capitalize even more on the volatility generated by the war in Ukraine  and by the monetary tightening from central banks.H1 '22 results press releaseCentral banks' behavior  in fact  makes the company's management hopeful that markets in the 2020s will be more favorable for arbitrage strategies than the previous decade: ""The year 2022 seems to outline the end of the central bank paradigm established since 2012"".What about the distributions? The dividend history suggests a rather generous dividend payer  with a yield generally around 6% in the past couple of years. For 2022  based on the expected â‚¬0.40/share dividend (â‚¬0.1 quarterly)  the yield is 6.25% at the current share price of â‚¬6.40.Investors need to be aware  though  that ABC Arbitrage has a high payout ratio. In 2021 and 2020  it was around 80%. During the volatility lull of 2017-2019  the payout ratio exceeded 100% of earnings  and the distributions were made in part as return of capital to shareholders.abc-arbitrage.comABC Arbitrage is a good company with an original business model that it masters well  but at the end of the day  I make my decisions based on valuation. At a trailing P/E of 13  ABC Arbitrage is not cheap for a French small cap. Many European blue chips trade at multiples lower than this. I don't consider this valuation attractive enough for me to buy ABC Arbitrage's stock at this point  even if I used to have some in my portfolio a few years back.Instead  I prefer another French small cap stock that offers the same kind of disconnect from the economic cycle and positive exposure to volatility. This stock is Viel & Cie (VIL.PA).My Favorite Volatility Pick: Viel & CieViel  which also trades on Euronext Paris  is a holding company whose main asset is a controlling stake in Compagnie FinanciÃ¨re Tradition (SW:CFT  OTCPK:CFNCF)  a Swiss entity that is one of the top 3 interdealer brokers in the world. Tradition operates across many asset classes:Tradition's H1 '22 presentationI will not detail here the thesis supporting an investment in Viel  but readers can refer to my earlier article : Tradition: How To Get This Swiss Inter-Dealer Broker On The Cheap. In short  I like Viel for 3 reasons:Tradition performs well in volatile times  thus fulfilling the same function as ABC Arbitrage  Virtu  Flow Traders and peer BGC Partners  as a portfolio hedge.Viel enables investors to buy Tradition at a steep discount  thanks to the holding company discount.The other holdings of Viel  though minor compared to Tradition  perform well too.On the back on Tradition's strong performance in H1 '22  Viel posted excellent interim results. Net profit was â‚¬42M for the half-year (Group share).Viel's H1 '22 earningsFurthermore  when compared to other volatility plays  Viel gets an additional  direct  favorable impact from higher interest rates:A shift in central-bank monetary policy  away from quantitative easing and rate hikes  was beneficial for the Groupâ€™s operations. This positive trend was reflected in all regions  and particularly in foreign exchange and interest rate products and securities and security derivatives. Source: Tradition's earnings releaseThis bodes well for Viel in the coming quarters  even if volatility itself abates. For the full year 2022  even if we assume a conservative net profit (Group share) of â‚¬60M  Viel's shares are currently trading at a cheap P/E of 7 (based on the market cap of â‚¬420M). To be honest  I expect the company to do even better than this  given the strong Q3 '22 revenue announced by Tradition.In terms of distributions  Viel has paid a growing dividend in recent years  and offers a 5% yield based on the 2021 distribution. What's key is the low payout ratio of only 35%. Finally  I like the fact that the number of shares has been going down in recent years thanks to buybacks being performed at an attractive share price.TakeawayABC Arbitrage and Viel share some common performance drivers  above all the level of volatility in financial markets. They trade on the same exchange  have more or less the same market cap  and their dividend yields are pretty similar.However  their valuations differ greatly. I like to look at my stocks through the prism of earnings yield: at a P/E of 7  Viel's earnings yield is ~14% (1/7). In the case of ABC Arbitrage  it is 1/13  meaning less than 8%. This is why Viel is by far my preferred option when it comes to small-cap stocks bringing something different to the portfolio.",positive,0.91,0.02,0.07,mixed,0.29,0.06,0.65,True,English,"['ABC Arbitrage', 'Intriguing Hedge', 'Better Option', 'Viel', 'ABCCF', 'Many European blue chips', ""H1 '22 results press release"", 'specific business model', 'quantitative asset manager', 'decent portfolio hedge', 'original business model', 'central bank paradigm', 'high payout ratio', 'actual yearly results', 'current share price', 'Generous Dividend Policy', ""Central banks' behavior"", 'generous dividend payer', 'small-cap French stock', '27 consecutive profitable years', 'French small cap', 'successful track record', 'long volatility niche', 'strong financial performance', 'OTC ticker ABCCF', 'record results', 'Market cap', 'small amount', 'price dislocations', 'many stocks', 'â‚¬0.40/share dividend', ""H1 '22 presentation"", 'H1 performance', 'Getty Images', 'mispriced assets', 'Paris-listed stock', 'undemanding valuation', 'excellent choice', 'little liquidity', 'larger companies', 'Flow Traders', 'BGC Partners', 'thorough analysis', 'four categories', 'trading prices', 'linked assets', 'commodity prices', 'other derivatives', 'institutional clients', 'main driver', 'trading activity', 'various drivers', 'life"" years', 'Covid crisis', 'lesser extent', 'Great Recession', 'first half', 'monetary tightening', 'previous decade', 'past couple', 'trailing P/E', 'ABC Arbitrage', 'Liquidity arbitrage', 'Risk arbitrage', 'Statistical arbitrage', 'Derivatives arbitrage', 'financial markets', 'steady performance', 'Euronext Paris', 'income investors', 'retail investors', 'elevated volatility', 'Market Volatility', 'volatility levels', 'volatility lull', 'OTCPK:FLTDF', 'risk mispricing', 'typical impact', 'trading strategies', 'VIL.PA', 'capital markets', 'good company', 'ABCA', 'advantage', 'times', 'downturns', 'opinion', 'yield', 'liking', 'Viel', 'Cie', 'access', 'exposure', 'Virtu', 'BGCP', 'Money', 'France', 'offices', 'Dublin', 'Singapore', 'variety', 'managed', 'equity', 'website', 'differences', 'industry', 'interaction', 'inflation', 'options', 'ROE', 'Return', 'excess', 'funds', 'tune', 'operations', 'fact', 'velocity', '2010s', '2022 YTD.', 'proof', 'Note', 'extrapolation', 'course', 'periods', 'war', 'Ukraine', 'management', '2020s', 'distributions', 'history', 'earnings', 'shareholders', 'day', 'decisions', 'multiples']",2022-12-12,2022-12-12,seekingalpha.com
14617,EuroNext,NewsApi.org,https://finance.yahoo.com/news/exor-n-v-periodic-report-071000363.html,Exor N.V.: Periodic Report on the Buyback Program,EXOR N.V. (AMS: EXO) (â€œExorâ€ or the â€œCompanyâ€) announces that  under the second tranche of the share buyback program of up to â‚¬250 million announced on 29...,EXOR N.V. (AMS: EXO) (â€œExorâ€ or the â€œCompanyâ€) announces that  under the second tranche of the share buyback program of up to â‚¬250 million announced on 29 July 2022 (the â€œsecond trancheâ€)  the Company has completed the following transactions on Euronext Amsterdam:Trading Date Number of ordinary shares purchased Average price per share excluding fees (â‚¬) Total consideration excluding fees (â‚¬) 5 December 2022 26 850 76.4480 2 052 628.80 6 December 2022 38 046 76.1888 2 898 679.08 7 December 2022 36 088 74.6917 2 695 474.07 8 December 2022 39 624 74.0543 2 934 327.58 9 December 2022 22 973 73.9245 1 698 267.54 TOTAL 163 581 12 279 377.07After these purchases  the total invested amount under the second tranche is approximately â‚¬128.9 million for a total amount of 1 930 000 ordinary shares purchased.As of 9 December 2022  the Company held in total 12 727 181 ordinary shares in treasury (5.28% of total ordinary issued share capital).A comprehensive overview of the transactions carried out under the share buyback program  as well as the details of the above transactions  are available on Exorâ€™s corporate website under the Share Buyback section.Attachment,neutral,0.01,0.99,0.0,neutral,0.0,1.0,0.0,True,English,"['Exor N.V.', 'Periodic Report', 'Buyback Program', 'total ordinary issued share capital', 'share buyback program', 'Share Buyback section', 'EXOR N.V.', 'ordinary shares', 'second tranche', 'Euronext Amsterdam', 'Trading Date', 'Average price', 'Total consideration', 'comprehensive overview', 'corporate website', 'total amount', 'following transactions', 'Company', '29 July', 'Number', 'fees', '5 December', '8 December', 'purchases', '9 December', 'treasury', 'details', 'Attachment']",2022-12-12,2022-12-12,finance.yahoo.com
14618,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221211005012/en/Dassault-Syst%C3%A8mes-and-Ecole-Normale-Sup%C3%A9rieure-Paris-Saclay-Sign-MoU-to-Boost-Virtual-Twin-Knowledge-and-Know-How,Dassault SystÃ¨mes and Ecole Normale SupÃ©rieure Paris-Saclay Sign MoU to Boost Virtual Twin Knowledge and Know-How,VELIZY-VILLACOUBLAY  France--(BUSINESS WIRE)-- #3DEXPERIENCE--Dassault SystÃ¨mes (Euronext Paris: FR0014003TT8  DSY.PA) (Paris:DSY) today announced that it has signed a memorandum of understanding with Ecole normale supÃ©rieure Paris-Saclay  founding member of â€¦,VELIZY-VILLACOUBLAY  France--(BUSINESS WIRE)--Dassault SystÃ¨mes (Euronext Paris: FR0014003TT8  DSY.PA) (Paris:DSY) today announced that it has signed a memorandum of understanding with Ecole normale supÃ©rieure Paris-Saclay  founding member of Franceâ€™s leading university for students preparing for careers in higher education and research. The MoU aims to accelerate sustainable innovation by driving knowledge and know-how on the use of virtual twins in academia and research. The announcement was made at a ceremony marking the 40th anniversary of LURPA  the universityâ€™s research laboratory in automated production  with a testimonial from Bernard CharlÃ¨s  Vice Chairman and CEO of Dassault SystÃ¨mes  alumnus of ENS Paris-Saclay and sponsor of the lab.Under the MoU  ENS Paris-Saclay will deploy Dassault SystÃ¨mesâ€™ 3DEXPERIENCE platform to offer new  innovative learning experiences as part of its university curriculum as well as its continuing education programs. The two organizations will work together to share platform best practices with the universityâ€™s professors and researchers that will be used for experiential learning in classes spanning multiple disciplines and addressing sectors such as health  infrastructure and cities  and manufacturing.In addition to the deployment  Dassault SystÃ¨mes and ENS Paris-Saclay will create a virtual twin think tank combining their respective expertise on virtual twins. The objective is to deliver a shared scientific vision on the definition and use of virtual twins in education  health  sustainable innovation and industry through joint research projects  white papers  conferences and other thought leadership initiatives.â€œAs a founding member of one of Franceâ€™s leading universities  we have a mission to offer the highest-caliber curriculum to future educators that infuses the latest in technological innovation. Research and education are particularly relevant in nurturing solutions to todayâ€™s challenges in manufacturing  healthcare and cities. This MoU extends and deepens our long-standing relationship with Dassault SystÃ¨mes. Together  we can drive new opportunities to advance the impacts of virtual twins in these sectors â€ said Nathalie Carrasco  President  ENS Paris-Saclay.â€œENS Paris-Saclay is a founding member of a leading university in France  with a focus on educating the countryâ€™s top professors and reseachers. By initiating 3DEXPERIENCE platform training early on in its curriculum  ENS Paris-Saclay can empower its students with expertise they can then leverage throughout their careers as professors and share with their own students â€ said Florence Verzelen  Executive Vice President  Industry  Marketing and Sustainability  Dassault SystÃ¨mes. â€œTheir multidiscipline approach  coupled with our joint initiative to drive a greater understanding of the role of virtual twins in enabling sustainable innovations  are two steps forward in helping society tackle some of the major challenges it faces.â€###FOR MORE INFORMATIONDassault SystÃ¨mesâ€™ 3DEXPERIENCE platform  3D design software  3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.comSHARE THIS ON TWITTER@Dassault3DS and @ENS_Paris-Saclay sign MoU to boost #virtualtwin knowledge and know-how #3DEXPERIENCEConnect with Dassault SystÃ¨mes onTwitter | Facebook | LinkedIn | YoutubeABOUT DASSAULT SYSTÃˆMESDassault SystÃ¨mes  the 3DEXPERIENCE Company  is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications  our customers push the boundaries of innovation  learning and production to achieve a more sustainable world for patients  citizens  and consumers. Dassault SystÃ¨mes brings value to more than 300 000 customers of all sizes  in all industries  in more than 140 countries. For more information  visit www.3ds.comABOUT THE Ã‰COLE NORMALE SUPÃ‰RIEURE PARIS-SACLAYThe ENS Paris-Saclay  a major multidisciplinary school for research and higher education  aims to lead its students to a doctoral degree. They are rigorously selected and follow reinforced courses in basic sciences  humanities and social sciences  as well as engineering sciences. The School also offers them several original research training courses on subjects such as quantity technology  artificial intelligence  etc.  along with immersion in the largest international laboratories. It has a public service mission to guide the best pupils and students to academic careers  as well as to careers in the public and private sectors requiring a high level of scientific expertise. Founding member of University Paris-Saclay.Â© Dassault SystÃ¨mes. All rights reserved. 3DEXPERIENCE  the Compass icon  the 3DS logo  CATIA  BIOVIA  GEOVIA  SOLIDWORKS  3DVIA  ENOVIA  NETVIBES  MEDIDATA  CENTRIC PLM  3DEXCITE  SIMULIA  DELMIA  and IFWE are commercial trademarks or registered trademarks of Dassault SystÃ¨mes  a French â€œsociÃ©tÃ© europÃ©enneâ€ (Versailles Commercial Register # B 322 306 440)  or its subsidiaries in the United States and/or other countries.,neutral,0.01,0.99,0.0,neutral,0.05,0.95,0.0,True,English,"['Ecole Normale SupÃ©rieure Paris-Saclay Sign MoU', 'Dassault SystÃ¨mes', 'Virtual Twin Knowledge', 'French â€œsociÃ©tÃ© europÃ©enne', 'Ecole normale supÃ©rieure Paris-Saclay', 'Ã‰COLE NORMALE SUPÃ‰RIEURE PARIS-SACLAY', 'several original research training courses', 'other thought leadership initiatives', '3D Digital Mock Up', 'Dassault SystÃ¨mesâ€™ 3DEXPERIENCE platform', 'collaborative 3D virtual environments', 'virtual twin think tank', 'new, innovative learning experiences', '3D design software', 'virtual twin experiences', '3DEXPERIENCE platform training', 'Bernard CharlÃ¨s', 'Product Lifecycle Management', 'largest international laboratories', 'Versailles Commercial Register', 'major multidisciplinary school', 'continuing education programs', 'joint research projects', 'Executive Vice President', 'public service mission', 'new opportunities', 'virtual twins', 'Vice Chairman', 'joint initiative', '3DEXPERIENCE Company', 'experiential learning', 'founding member', '40th anniversary', 'research laboratory', 'best practices', 'multiple disciplines', 'scientific vision', 'white papers', 'leading universities', 'future educators', 'long-standing relationship', 'Nathalie Carrasco', 'ENS Paris-Saclay', 'Florence Verzelen', 'multidiscipline approach', 'sustainable innovations', 'major challenges', 'human progress', 'real world', 'sustainable world', 'doctoral degree', 'basic sciences', 'social sciences', 'engineering sciences', 'The School', 'quantity technology', 'artificial intelligence', 'best pupils', 'high level', 'Compass icon', '3DS logo', 'CENTRIC PLM', 'commercial trademarks', 'higher education', 'technological innovation', 'leading university', 'respective expertise', 'highest-caliber curriculum', 'scientific expertise', 'University Paris-Saclay', 'BUSINESS WIRE', 'Euronext Paris', 'automated production', 'two organizations', 'greater understanding', 'PLM) solutions', 'virtualtwin knowledge', 'university curriculum', 'top professors', 'private sectors', 'academic careers', 'The MoU', 'VELIZY-VILLACOUBLAY', 'France', 'DSY', 'memorandum', 'students', 'use', 'academia', 'announcement', 'ceremony', 'LURPA', 'testimonial', 'CEO', 'alumnus', 'sponsor', 'part', 'researchers', 'classes', 'health', 'infrastructure', 'cities', 'manufacturing', 'addition', 'deployment', 'objective', 'definition', 'industry', 'conferences', 'nurturing', 'today', 'impacts', 'focus', 'country', 'reseachers', 'Marketing', 'Sustainability', 'role', 'society', 'MORE', 'INFORMATION', 'TWITTER', 'Facebook', 'LinkedIn', 'Youtube', 'catalyst', 'people', 'applications', 'customers', 'boundaries', 'patients', 'citizens', 'consumers', 'value', 'sizes', 'industries', '140 countries', 'humanities', 'subjects', 'immersion', 'rights', 'CATIA', 'BIOVIA', 'GEOVIA', 'SOLIDWORKS', '3DVIA', 'ENOVIA', 'NETVIBES', 'MEDIDATA', '3DEXCITE', 'SIMULIA', 'DELMIA', 'IFWE', 'registered', 'Â©']",2022-12-12,2022-12-12,businesswire.com
14619,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221211005015/en/Cramer-Rosenthal-Mcglynn-Selects-Linedata-Adaptable-Technology-and-Streamlined-Operations-Empower-Next-Generation-of-Growth,Cramer Rosenthal Mcglynn Selects Linedata: Adaptable Technology and Streamlined Operations Empower Next Generation of Growth,PARIS & BOSTON & NEW YORK & LONDON & LUXEMBOURG & HONG KONG--(BUSINESS WIRE)--Linedata  (Euronext Paris: LIN)  a global provider of asset management and credit technology data and services  announced today that Cramer Rosenthal McGlynn  LLC (â€œCRMâ€)  a US baseâ€¦,PARIS & BOSTON & NEW YORK & LONDON & LUXEMBOURG & HONG KONG--(BUSINESS WIRE)--Linedata  (Euronext Paris: LIN)  a global provider of asset management and credit technology data and services  announced today that Cramer Rosenthal McGlynn  LLC (â€œCRMâ€)  a US based value equity manager serving institutions and individuals  chose Linedata to implement a highly adaptable operational model at CRM that positions it for growth  while at the same time keeping in place unique capabilities for the firm.CRM has implemented robust investment operations that aim to maximize efficiency and mitigate risk by reducing manual processes spread across multiple internal systems  which has been in place for several years  including through the previous vendor. This has allowed CRM to reduce operational costs by more than 50%  including the consolidation of systems and simplifying workflows across Linedata Longview OMS suite  trading  pre- and post-trade compliance  reporting  and operations.â€œOur relationship with Linedata has been a true collaboration from the start that has positioned our business for long-term growth â€ said Steven Fellin  Chief Financial Officer at Cramer Rosenthal McGlynn. â€œWe continue to work with Linedata with the goal of integrating additional innovative solutions to further streamline our investment processes from idea generation through trade execution.â€Leveraging Linedataâ€™s Asset Management Platform (AMP)  CRM configured a comprehensive  easy to understand process to manage their account base  facilitate onboarding  and handle trading instructions remotely. The CRM team gains access to new capabilities quickly with continuous integration and delivery (CI/CD)  and non-traditional users  such as risk managers and senior management who need to monitor business at a higher  more-macro level  can now do so via Linedata Accumen.â€œIn today's evolving investment landscape  your asset management technology platform must be adaptable to keep up with the everchanging environment â€ added Bob Moitoso  Head of Asset Management North America at Linedata. â€œWe are thrilled to be a strategic partner to Cramer Rosenthal McGlynn  bringing our technology expertise and flexible solutions to improve their operations so they have more time to spend focused on their clients and ultimately driving their business forward.â€To learn more  please visit our website: https://www.linedata.com/reimagine-your-operations-amp-asset-management-platformABOUT CRAMER ROSENTHAL MCGLYNNCramer Rosenthal McGlynn  LLC is a value equity manager with a focus on the U.S. small and mid-cap space. CRM believes its track record  spanning over four decades  is a testament to its success in serving clients and providing strong risk-adjusted investment performance. Clients benefit from a consistent approach and application of a central philosophy and process  implemented by a team with diverse experience in identifying change  neglect  and the intrinsic value of businesses.CRMâ€™s client list includes corporate and public pension plans  endowments and foundations  hospitals  community and religious organizations  Taft-Hartley and multi-employer funds  private banks  sub-advisory  as well as individuals and family trusts.https://www.crmllc.com/ABOUT LINEDATAWith 20 yearsâ€™ experience and 700+ clients in 50 countries  Linedataâ€™s 1100 employees in 20 offices provide global humanized technology solutions and services for the asset management and credit industries that help its clients to evolve and to operate at the highest levels.Headquartered in France  Linedata achieved revenues of EUR 160.2 million in 2021 and is listed on Euronext Paris compartment B FR0004156297-LIN â€“ Reuters LDSV.PA â€“ Bloomberg LIN:FP.linedata.com,neutral,0.01,0.99,0.0,positive,0.99,0.01,0.0,True,English,"['Cramer Rosenthal Mcglynn', 'Adaptable Technology', 'Streamlined Operations', 'Next Generation', 'Linedata', 'Growth', 'comprehensive, easy to understand process', 'US based value equity manager', 'strong risk-adjusted investment performance', 'Linedata Longview OMS suite', 'global humanized technology solutions', 'asset management technology platform', 'Cramer Rosenthal McGlynn', 'Chief Financial Officer', 'additional innovative solutions', 'evolving investment landscape', 'U.S. small', 'public pension plans', 'credit technology data', 'Asset Management Platform', 'adaptable operational model', 'multiple internal systems', 'robust investment operations', 'Euronext Paris compartment', 'The CRM team', 'intrinsic value', 'technology expertise', 'global provider', 'investment processes', 'flexible solutions', 'operational costs', 'senior management', 'credit industries', 'NEW YORK', 'HONG KONG', 'unique capabilities', 'manual processes', 'several years', 'previous vendor', 'post-trade compliance', 'true collaboration', 'Steven Fellin', 'idea generation', 'trade execution', 'account base', 'new capabilities', 'continuous integration', 'non-traditional users', 'everchanging environment', 'Bob Moitoso', 'North America', 'strategic partner', 'mid-cap space', 'track record', 'four decades', 'consistent approach', 'central philosophy', 'diverse experience', 'client list', 'religious organizations', 'multi-employer funds', 'private banks', 'family trusts', '20 yearsâ€™ experience', 'highest levels', 'Reuters LDSV', 'same time', 'long-term growth', 'Leveraging Linedata', 'trading instructions', 'risk managers', 'Linedata Accumen', 'Bloomberg LIN', 'BUSINESS WIRE', '700+ clients', 'BOSTON', 'LONDON', 'services', 'LLC', 'institutions', 'individuals', 'place', 'firm', 'efficiency', 'consolidation', 'workflows', 'reporting', 'relationship', 'start', 'goal', 'AMP', 'onboarding', 'access', 'delivery', 'CI/CD', 'today', 'Head', 'website', 'asset-management-platform', 'focus', 'testament', 'success', 'application', 'change', 'neglect', 'businesses', 'corporate', 'endowments', 'foundations', 'hospitals', 'community', 'Taft-Hartley', 'sub-advisory', '50 countries', '1100 employees', '20 offices', 'France', 'revenues']",2022-12-12,2022-12-12,businesswire.com
14620,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221212005500/en/Nomitri-Selects-Verimatrix-XTD-to-Protect-Innovative-Cashierless-Checkout-for-Cart-Mounted-Smartphones,Nomitri Selects Verimatrix XTD to Protect Innovative Cashierless Checkout for Cart-Mounted Smartphones,AIX-EN-PROVENCE  France & SAN DIEGO--(BUSINESS WIRE)--Regulatory News: Verimatrix  (Euronext Paris: VMX) (Paris:VMX)  the leader in powering the modern connected world with people-centered security  today announced that Berlin  Germany-based AI software compaâ€¦,AIX-EN-PROVENCE  France & SAN DIEGO--(BUSINESS WIRE)--Regulatory News:Verimatrix  (Euronext Paris: VMX) (Paris:VMX)  the leader in powering the modern connected world with people-centered security  today announced that Berlin  Germany-based AI software company Nomitri  selected Verimatrix XTD technologies  among others  to protect its embedded visual AI technologies used by brick and mortar retail shoppers.Nomitri turns cutting-edge research in the field of embedded visual deep learning into innovative solutions for retail and quick commerce. Nomitri's modular software stack can turn any camera into a smart camera. Their EmCartÂ® enables retailers such as Edeka LÃ¼ning to offer their customers a frictionless shopping experience including self-checkout  fraud-prevention and data insights. Nomitriâ€™s smart Pick&Pack solution leverages AI-enabled human-centered automation and improves operations in micro-fulfilment centers at minimal cost.Implementing these technologies comes with threats for all parties involved. Convenience and efficiency can abound  but only with the ongoing confidence that all parties are protecting their innovative application code at important  foundational levels that prevent numerous types of cyberattacks seeking to cause interruptions or gain customer or company information.â€œBringing some of the foremost advancements in business enablement technologies to retailers and quick commerce players  we know that security is an important topic for our business â€ said Trinh Le Fiedler  Co-Founder and CEO at Nomitri. â€œWeâ€™re pleased to work together with Verimatrix XTD technologies on security.â€â€œItâ€™s clear that the worldâ€™s foremost technology innovators are placing an ever-increasing emphasis on the foundational safety of their technologies as well as the security of associated customer and company information â€ said Juha HÃ¶gmander  vice president  cybersecurity business at Verimatrix. â€œBy offering a cost-effective  zero-code approach to deploying robust protections that prevent and remove potential cybersecurity blind spots  weâ€™re proud to stand alongside our customers as an unwavering force for ongoing peace of mind that is appreciated by all stakeholders.â€About NomitriNomitri is an AI software company from Berlin on a mission to use cutting-edge technology in AI to enable human-centered automation in retail and logistics. Nomitri's smartphone-based vision AI software stack enables retailers to offer their customers a frictionless shopping experience including self-checkout  fraud-prevention and data insights and quick commerce players to significantly improve their operations and reduce human errors. Visit: www.nomitri.com.About VerimatrixVerimatrix (Euronext Paris: VMX) helps power the modern connected world with security made for people. We protect digital content  applications  and devices with intuitive  people-centered and frictionless security. Leading brands turn to Verimatrix to secure everything from premium movies and live streaming sports  to sensitive financial and healthcare data  to mission-critical mobile applications. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster  scale easily  protect valuable revenue streams  and win new business. Visit: www.verimatrix.com.,neutral,0.02,0.98,0.0,mixed,0.69,0.02,0.29,True,English,"['Innovative Cashierless Checkout', 'Verimatrix XTD', 'Cart-Mounted Smartphones', 'Nomitri', 'smartphone-based vision AI software stack', 'smart Pick&Pack solution', 'potential cybersecurity blind spots', 'Germany-based AI software company', 'modular software stack', 'visual deep learning', 'Edeka LÃ¼ning', 'Trinh Le Fiedler', 'Juha HÃ¶gmander', 'cost-effective, zero-code approach', 'live streaming sports', 'valuable revenue streams', 'frictionless shopping experience', 'visual AI technologies', 'innovative application code', 'quick commerce players', 'AI-enabled human-centered automation', 'important, foundational levels', 'foremost technology innovators', 'critical mobile applications', 'mortar retail shoppers', 'business enablement technologies', 'Verimatrix XTD technologies', 'cybersecurity business', 'company information', 'innovative solutions', 'smart camera', 'foremost advancements', 'important topic', 'foundational safety', 'cutting-edge technology', 'SAN DIEGO', 'BUSINESS WIRE', 'Regulatory News', 'cutting-edge research', 'data insights', 'micro-fulfilment centers', 'minimal cost', 'ongoing confidence', 'numerous types', 'increasing emphasis', 'vice president', 'robust protections', 'unwavering force', 'ongoing peace', 'human errors', 'digital content', 'intuitive, people-centered', 'frictionless security', 'Leading brands', 'premium movies', 'sensitive financial', 'healthcare data', 'trusted connections', 'compelling content', 'new business', 'Euronext Paris', 'people-centered security', 'AIX-EN-PROVENCE', 'France', 'VMX', 'leader', 'modern', 'world', 'Berlin', 'Nomitri', 'others', 'embedded', 'brick', 'field', 'EmCartÂ®', 'retailers', 'customers', 'self-checkout', 'fraud-prevention', 'operations', 'threats', 'parties', 'Convenience', 'efficiency', 'cyberattacks', 'interruptions', 'Co-Founder', 'CEO', 'associated', 'mind', 'stakeholders', 'mission', 'logistics', 'devices', 'everything', 'experiences', 'millions', 'consumers', 'partners', 'Visit']",2022-12-12,2022-12-12,businesswire.com
14621,EuroNext,NewsApi.org,https://finance.yahoo.com/news/information-total-number-voting-rights-070000108.html,Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA,Negma Group has converted 380 convertible bonds in Oxurion resulting in a EUR 950 000 capital increase. This is part of Negma Groupâ€™s EUR 30 million Capital ...,Oxurion NVNegma Group has converted 380 convertible bonds in Oxurion resulting in a EUR 950 000 capital increase. This is part of Negma Groupâ€™s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.Leuven  BELGIUM  Boston  MA  US â€“ December 12  2022 â€“ 08.00 AM CET â€“ In accordance with article 15 of the Belgian Act of May 2  2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions  Oxurion NV (Euronext Brussels: OXUR) (the â€œCompanyâ€ or â€œOxurionâ€)  announces the below information  following the issuance of 99 789 915 new ordinary shares on December 9  2022  for a total amount of EUR 950 000  as the result of the conversion of 380 class B convertible bonds  pursuant to the Capital Commitment entered into with Negma Group.Following completion of the capital increase through the conversion of the convertible bonds  the total number of shares issued by Oxurion amounts to 411 071 559  outstanding ordinary shares carrying voting rights (compared to 311 281 644 outstanding ordinary shares previously). This number will be used as the denominator for the calculation of the percentages of shareholdings.Therefore  Oxurion publishes the following updated information:Share capital (EUR) 75 856 161.32 Total number of securities with voting rights (all ordinary shares) 411 071 559 Total number of ordinary shares (= denominator) 411 071 559 Number of outstanding  granted rights to subscribe to securities carrying voting rights not yet issued: 719 500 subscription rights (â€œSRsâ€) issued on November 20  2017  entitling their holders to subscribe to a total number of 719 500 securities carrying voting rights (all ordinary shares);60 000 SRs issued on December 23  2020  entitling their holders to subscribe to a total number of 60 000 securities carrying voting rights (all ordinary shares);1 007 250 SRs issued on April 14  2021  entitling their holders to subscribe to a total number of 1 007 250 securities carrying voting rights (all ordinary shares);550 000 SRs issued on September 22  2021  entitling their holders to subscribe to a total number of 550 000 securities carrying voting rights (all ordinary shares);725 749 SRs issued on December 30  2021  entitling their holders to subscribe to a total number of 725 749 securities carrying voting rights (all ordinary shares);200 convertible bonds issued on September 5  2022  October 21  2022  and November 28  2022  entitling their holder (Negma Group) to subscribe to a total number of securities carrying voting rights (all ordinary shares) in accordance with the terms and conditions set forth in the issuance and subscription agreement entered into between the Company and Negma Group on August 26  2021  and the addendum thereto dated September 2  2022; and100 convertible bonds issued on December 20  2021  entitling their holders (Kreos Capital VI (UK) Limited  Pontifax Medison Finance (Israel) L.P. and Pontifax Medison Finance (Cayman) L.P.) to subscribe to a total number of securities carrying voting rights (all ordinary shares) in accordance with the terms and conditions of these convertible bonds as attached to the Agreement for the provision of a Loan Facility entered into between the Company  Kreos Capital VI (UK) Limited  Pontifax Medison Finance (Israel) L.P. and Pontifax Medison Finance (Cayman) L.P.  on November 21  2021.ENDAbout OxurionOxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies  which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME)  the leading cause of vision loss in working-age people  as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders  including the successful development of THR-149  its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to 50% of DME patients showing suboptimal response to anti-VEGF therapy. Oxurion is headquartered in Leuven  Belgium  with corporate operations in Boston  MA. More information is available at www.oxurion.com.Story continuesImportant information about forward-looking statementsCertain statements in this press release may be considered â€œforward-lookingâ€. Such forward-looking statements are based on current expectations  and  accordingly  entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement  whether as a result of new information  future events  or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Companyâ€™s Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933  as amended  or in compliance with an exemption therefrom  and in accordance with any applicable U.S. state securities laws.For further information please contact:Oxurion NVTom GraneyChief Executive OfficerTel: +32 16 75 13 10tom.graney@oxurion.comMichaÃ«l DillenChief Business OfficerTel: +32 16 75 13 10michael.dillen@oxurion.com USConway CommunicationsBeth Kurthbkurth@conwaycommsir.comICR WestwickeChristopher BrinzeyTel: +1 617 835 9304chris.brinzey@westwicke.com1 Press release Oxurion  06/04/2021 and Press release Oxurion  02/09/2022Attachment,neutral,0.0,1.0,0.0,mixed,0.31,0.23,0.46,True,English,"['Total Number', 'Voting Rights', 'Conversion Notice', 'Information', 'Denominator', 'NEGMA', 'potent plasma kallikrein inhibitor', 'EUR 30 million Capital Commitment1', '380 class B convertible bonds', 'eye drug candidate', 'Pontifax Medison Finance', 'next generation standard', 'diabetic macular edema', 'EUR 950,000 capital increase', 'Kreos Capital VI', 'potential new standard', 'potential market opportunities', 'care ophthalmic therapies', '59, outstanding ordinary shares', '311,281,644 outstanding ordinary shares', 'Such forward-looking statements', '99,789,915 new ordinary shares', 'Israel) L.P.', 'Share capital', '380 convertible bonds', '200 convertible bonds', '100 convertible bonds', 'regulated market', 'new information', 'Negma Group', 'Belgian Act', 'major participations', 'miscellaneous provisions', 'Euronext Brussels', 'total amount', 'Loan Facility', 'retinal disorders', 'leading cause', 'working-age people', 'important role', 'successful development', 'suboptimal response', 'anti-VEGF therapy', 'corporate operations', 'press release', 'current expectations', 'future events', 'other reason', 'other facto', 'voting rights', '719,500 subscription rights', 'updated information', 'More information', 'Important information', 'Additional information', 'total number', 'subscription agreement', 'vision loss', 'novel therapeutic', 'various risks', 'biopharmaceutical company', 'The Company', 'other conditions', 'Oxurion NV', 'DME patients', 'back', 'Leuven', 'BELGIUM', 'Boston', 'December', '08.00 AM', 'accordance', 'article', 'May', 'disclosure', 'issuers', 'issuance', 'result', 'conversion', 'completion', 'denominator', 'calculation', 'percentages', 'shareholdings', 'securities', 'SRs', 'November', 'holders', 'April', 'September', 'October', 'terms', 'August', 'addendum', 'UK', 'Limited', 'Cayman', 'treatment', 'THR-149', 'Story', 'uncertainties', 'assurance', 'obligation', 'business', '411']",2022-12-12,2022-12-12,finance.yahoo.com
14622,EuroNext,NewsApi.org,https://finance.yahoo.com/news/south-korean-government-grants-patent-094600277.html,South Korean government grants a new patent to Lleida.net  and it now has 218 patents worldwide,Spanish listed company Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) has been granted a new 20-year patent by the South Korean government.,"MADRID  Dec. 12  2022 /PRNewswire/ -- Spanish listed company Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) has been granted a new 20-year patent by the South Korean government.The recognition  which refers to its EIDAS-certified sourcing method  is the fourth recognition from the Seoul authorities and the 218th globally.With this patent  Lleida.net reinforces its position as the leading company in the registered electronic signature  notification  and contracting industry  also in terms of innovation.""South Korea is one of the world's leading markets in terms of adoption of new technology. Receiving one patent in South Korea is a milestone in itself  but to already have four makes it clear what our strength is in the East Asian markets "" explained Sisco Sapena  CEO and Founder of the company.The company has described the concession as 'the first patented method acting under the EIDAS umbrella  which requires identification by electronic signature of the signing parties to be indubitable in a court of law'.As Lleida.net told the market today  this patent has the potential to  directly and indirectly  generate three million euros in revenue over the next two decades.In the region  the company has received patents in powers such as China  Japan  and India or the Gulf Cooperation Council.Lleida.net's growth strategy in the electronic signature  notification  and contracting market in the countries where it is present and those it plans to be in the future includes a solid growth policy in intellectual property and R&D  as well as a reinforcement of its internationalization policy.More than 60 countries in the five continents have granted patents to the company  including the European Union  United States  China  Russia  India  Mexico  Japan  Colombia  Argentina  Peru  South Africa  Nigeria  Australia and New Zealand.Lleida.net is listed on the OTCQX index in New York  on Euronext Growth in Paris  and on BME Growth in Madrid.Story continuesIn the first nine months of 2022  the company's sales grew by 25% compared to last year's period. Between January and September of this year  cumulative sales reached â‚¬15.7 million.Likewise  its EBIDTA increased by 44% compared to the same period of the previous year.Learn more about Lleida.net IP strategy at https://investors.lleida.net/enCisionView original content:https://www.prnewswire.com/news-releases/south-korean-government-grants-a-new-patent-to-lleidanet-and-it-now-has-218-patents-worldwide-301700089.htmlSOURCE Lleida.net",neutral,0.0,1.0,0.0,neutral,0.05,0.93,0.02,True,English,"['South Korean government', 'new patent', 'Lleida.net', '218 patents', 'Lleida.net IP strategy', 'EIDAS-certified sourcing method', 'first patented method', 'three million euros', 'next two decades', 'Gulf Cooperation Council', 'first nine months', 'East Asian markets', 'South Korean government', 'solid growth policy', 'Spanish listed company', 'new 20-year patent', 'growth strategy', 'leading markets', 'internationalization policy', 'new technology', 'South Africa', 'New Zealand', 'New York', 'Euronext Growth', 'SOURCE Lleida', 'Seoul authorities', 'electronic signature', 'contracting industry', 'Sisco Sapena', 'EIDAS umbrella', 'signing parties', 'intellectual property', 'R&D', 'five continents', 'European Union', 'United States', 'original content', 'one patent', 'BME Growth', 'last year', 'previous year', 'fourth recognition', 'contracting market', 'OTCQX index', 'cumulative sales', 'same period', 'leading company', 'MADRID', 'Dec.', 'PRNewswire', 'LLN', 'EPA', 'LLEIF', 'position', 'notification', 'terms', 'innovation', 'world', 'adoption', 'milestone', 'strength', 'CEO', 'Founder', 'concession', 'identification', 'court', 'law', 'potential', 'revenue', 'region', 'patents', 'powers', 'China', 'Japan', 'India', 'countries', 'future', 'reinforcement', 'More', 'Russia', 'Mexico', 'Colombia', 'Argentina', 'Peru', 'Nigeria', 'Australia', 'Paris', 'Story', 'January', 'September', 'EBIDTA', 'Cision', 'new-patent', 'lleidanet']",2022-12-12,2022-12-12,finance.yahoo.com
14623,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221211005059/en/Teleperformance-Named-to-PEOPLE%E2%80%99s-Annual-List-of-%E2%80%9C100-Companies-that-Care%E2%80%9D-for-2022,Teleperformance Named to PEOPLEâ€™s Annual List of â€œ100 Companies that Careâ€ for 2022,PARIS--(BUSINESS WIRE)--Regulatory News: Teleperformance (Paris:TEP)  the global leader in outsourced customer and citizen experience management and related digital services  was named to PEOPLEâ€™s â€œ100 Companies that Careâ€ for 2022. This is the sixth year thaâ€¦,"PARIS--(BUSINESS WIRE)--Regulatory News:Teleperformance (Paris:TEP)  the global leader in outsourced customer and citizen experience management and related digital services  was named to PEOPLEâ€™s â€œ100 Companies that Careâ€ for 2022. This is the sixth year that PEOPLE has partnered with Great Places to WorkÂ® to spotlight employers that have gone above and beyond to create positive workplaces for their staff and the community at large. Companies That Care is the only company culture award in America that selects winners based on the level of care and concern for their employees  their communities  and the environment.Teleperformance was selected for its outstanding community giving activities  noting that Teleperformance employees donated more than US$2 million and more than 2 500 hours to global charities in 2022. The Teleperformance team in the United States supported a wide range of charities  most notably Feed the Childrenâ€™s programs that supported more than 2 400 families in Texas  Kentucky  Virginia  and Georgia  and a long-standing partnership with the American Red Cross  with whom Teleperformance helped provide food and essentials to 400 military families in need through its Fort Knox  Kentucky branch. Teleperformance employees applauded the companyâ€™s commitment to giving back  saying it gave them a sense of pride to contribute to something larger.â€œChanging the workplace changes lives "" says Michael C. Bush  CEO of Great Place To Work. ""These companies show the impact engaged business leaders can have on their communities. They invest in the well-being of their people where they live and are committed to diversity  equity  inclusion  and belonging.â€â€œWe couldnâ€™t be more proud to be a part of such an esteemed list of U.S. companies  all of which have a strong legacy of community building and employee pride.â€ said Alan Winters  Chief People Officer and Chief Diversity Officer at Teleperformance Group. â€œTaking care of our people is always our number one priority and it is a tremendous vote of confidence to have PEOPLE and Great Places to Work honor us with the â€˜100 Companies that Careâ€™ designation.â€With a top global priority of people care  over 97% of Teleperformance employees worldwide currently work in independently certified great employer operations. The company welcomes applicants from across the globe to apply for the opportunity to be part of the Teleperformance family. Interested applicants can apply here.PEOPLE once again partnered with global workplace culture authority Great Place To Work to identify the top U.S. companies that best fit the criteria  analyzing survey responses that represent the experience of more than six million employees. Winning companies score highly on how well they create great employee experiences that cut across race  gender  age  disability status  or any aspect of who employees are or their roles. Great Place To Work also assessed the level of generosity of each organizationâ€™s benefits and philanthropic and community support.*******************About Teleperformance GroupTeleperformance (TEP â€“ ISIN: FR0000051807 â€“ Reuters: TEPRF.PA - Bloomberg: TEP FP)  the global leader in outsourced customer and citizen experience management and related digital services  serves as a strategic partner to the worldâ€™s largest companies in many industries. It offers a One Office support services model including end-to-end digital solutions  which guarantee successful customer interaction and optimized business processes  anchored in a unique  comprehensive high touch  high tech approach. Nearly 420 000 employees  based in 88 countries  support billions of connections every year in over 265 languages and around 170 markets  in a shared commitment to excellence as part of the â€œSimpler  Faster  Saferâ€ process. This mission is supported by the use of reliable  flexible  intelligent technological solutions and compliance with the industryâ€™s highest security and quality standards  based on Corporate Social Responsibility excellence. In 2021  Teleperformance reported consolidated revenue of â‚¬7 115 million (US$8.4 billion  based on â‚¬1 = $1.18) and net profit of â‚¬557 million.Teleperformance shares are traded on the Euronext Paris market  Compartment A  and are eligible for the deferred settlement service. They are included in the following indices: CAC 40  STOXX 600  S&P Europe 350  MSCI Global Standard and Euronext Tech Leaders. In the area of corporate social responsibility  Teleperformance shares are included in the CAC 40 ESG since September 2022  the Euronext Vigeo Euro 120 index since 2015  the EURO STOXX 50 ESG index since 2020  the MSCI Europe ESG Leaders index since 2019  the FTSE4Good index since 2018 and the S&P Global 1200 ESG index since 2017.For more information: www.teleperformance.com Follow us on Twitter: @teleperformance",neutral,0.01,0.99,0.0,positive,0.89,0.11,0.0,True,English,"['Annual List', 'Teleperformance', 'PEOPLE', '100 Companies', '2022', 'unique, comprehensive high touch, high tech approach', 'reliable, flexible, intelligent technological solutions', 'One Office support services model', 'MSCI Europe ESG Leaders index', 'S&P Global 1200 ESG index', 'EURO STOXX 50 ESG index', 'Euronext Vigeo Euro 120 index', 'outstanding community giving activities', 'Great Place To Work', 'global workplace culture authority', 'Corporate Social Responsibility excellence', 'top U.S. companies', 'S&P Europe', 'Euronext Tech Leaders', 'number one priority', 'MSCI Global Standard', 'top global priority', 'related digital services', 'American Red Cross', 'Michael C. Bush', 'deferred settlement service', 'great employer operations', 'great employee experiences', 'citizen experience management', 'successful customer interaction', 'optimized business processes', 'company culture award', 'Chief Diversity Officer', 'Euronext Paris market', 'six million employees', 'The Teleperformance team', 'Chief People Officer', 'digital solutions', 'FTSE4Good index', 'community support', 'business leaders', 'CAC 40 ESG', 'global leader', 'Great Places', 'global charities', 'BUSINESS WIRE', 'outsourced customer', 'community building', 'Regulatory News', 'positive workplaces', 'United States', 'wide range', 'standing partnership', 'Fort Knox', 'esteemed list', 'strong legacy', 'employee pride', 'Alan Winters', 'tremendous vote', 'survey responses', 'disability status', 'strategic partner', 'many industries', 'Saferâ€ process', 'highest security', 'quality standards', 'consolidated revenue', 'net profit', 'Compartment A', 'following indices', 'Winning companies', 'largest companies', 'Teleperformance Group', 'Teleperformance family', 'Teleperformance shares', '400 military families', 'Kentucky branch', 'Interested applicants', 'Teleperformance employees', 'TEP FP', 'people care', '100 Companies', '420,000 employees', '2,400 families', 'sixth', 'employers', 'staff', 'winners', 'level', 'concern', 'communities', 'environment', '2,500 hours', 'Children', 'programs', 'Texas', 'Virginia', 'Georgia', 'long', 'food', 'essentials', 'need', 'commitment', 'sense', 'something', 'lives', 'CEO', 'impact', 'well-being', 'equity', 'inclusion', 'confidence', 'designation', 'globe', 'opportunity', 'criteria', 'race', 'gender', 'aspect', 'roles', 'generosity', 'organization', 'benefits', 'ISIN', 'Reuters', 'TEPRF', 'Bloomberg', 'world', '88 countries', 'billions', 'connections', 'languages', '170 markets', 'mission', 'use', 'compliance', 'industry', 'area', 'September', 'information', 'Twitter', '2022']",2022-12-12,2022-12-12,businesswire.com
14624,EuroNext,NewsApi.org,https://finance.yahoo.com/news/teco-2030-signs-supplier-partnership-060000279.html,TECO 2030 Signs Supplier Partnership Agreement with SinoHyKey,TECO 2030 (OSE:TECO)(OTCQX:TECFF) ISIN: NO0010887516) and SinoHyKey (SHK) have entered into a strategic partnership that will allow SHK to provide MEA  one...,"LYSAKER  NORWAY / ACCESSWIRE / December 12  2022 / TECO 2030 (OSE:TECO)(OTCQX:TECFF) ISIN: NO0010887516) and SinoHyKey (SHK) have entered into a strategic partnership that will allow SHK to provide MEA  one of the key components in the TECO 2030 fuel cell system to decarbonize the marine transportation. The collaboration has already sparked off and is expected to last if the key milestones in the development can be achieved successfully.TECO 2030 ASA  Monday  December 12  2022  Press release picture""I am pleased to announce our supplier agreement with SinoHyKey in Vancouver and looking forward to a great partnership for many years "" says Tore Enger  Group CEO of TECO 2030. ""Together we will be able to provide zero emissions energy solutions to the world "" Enger adds.""SinoHyKey is very excited to partner with TECO 2030 to demonstrate the potential of the hydrogen fuel cell in marine and other heavy duty applications - not just in Europe  but across the globe. SHK MEAs destined for the TECO 2030 project employ a state-of-the-art design which offers superb power density  durability  and cost efficiency "" says Dr. Yuquan Zou  CEO of SinoHyKey Technology Company.TECO 2030 has recently announced progress in several projects. Implenia Norway has ordered an 800kW HydroPilot container  with an option to increase the power capacity up to 1.6MW. The project will demonstrate that construction sites can operate emission-free. Additionally  TECO 2030's HydroPilot project  supported by ENOVA  is planned to be delivered in Q3 2023. The order value is NOK 20 million  and if the option is exercised the total will be brought up to NOK 30 million.Another pioneering project is the announced HyEkoTank  where TECO 2030  Shell and partners received EUR 5 million from Horizon Europe. The HyEkoTank project aims to retrofit a product tanker with 2.4MW fuel cells during 2024 for zero-emission port operations and up to 100% emissions reduction.TECO 2030 has also signed a letter of intent with development partner AVL for the delivery of 12MW fuel cell stacks to be deployed in 30 heavy-duty trucks for an undisclosed owner.Story continuesContact:TECO 2030: Tore Enger  Group CEO of TECO 2030  +47 920 83 800  tore.enger@teco2030.noAbout TECO 2030:TECO 2030 accelerates the green transition in the maritime sector by delivering technology that helps ships to reduce their environmental and climate impacts. TECO 2030 is developing hydrogen fuel cells that enable ships and other heavy-duty applications to become emissions-free. The company is also developing other solutions that can help the maritime industry to reduce its emissions  such as exhaust gas cleaning and carbon capture systems for ships. TECO 2030 was founded in 2019 and is headquartered at Lysaker  Norway. The company is listed on Euronext Growth on Oslo Stock Exchange under the ticker TECO. TECO 2030 has its roots in the TECO Maritime Group  a group that has provided technology and repair services to the global shipping industry since 1994. For more information  please visit www.teco2030.noAbout SinoHyKeyFocusing on the design and mass production of CCMs and MEAs for hydrogen fuel cell applications  SinoHyKey Technology Company was founded in 2017 and currently consists of about 350 employees around the world. Based in Guangzhou  China  with a secondary production facility in Foshan - also located in Guangdong Province - and an overseas business center in Vancouver  Canada  SHK provides the international market with high-efficiency  cost-friendly hydrogen solutions for all modes of transportation. In 2021  SHK successfully distributed more than 1 million of its MEAs to more than twenty customers worldwide; in 2022  an estimated 1.7 million SHK MEAs were delivered globally  placing the company as an international leader in MEA supply.SOURCE: TECO 2030 ASAView source version on accesswire.com:https://www.accesswire.com/731242/TECO-2030-Signs-Supplier-Partnership-Agreement-with-SinoHyKey",neutral,0.0,0.99,0.0,positive,0.76,0.16,0.08,True,English,"['Supplier Partnership Agreement', 'TECO 2030', 'SinoHyKey', '12MW fuel cell stacks', 'up to 100% emissions reduction', 'high-efficiency, cost-friendly hydrogen solutions', 'other heavy duty applications', 'hydrogen fuel cell applications', 'zero emissions energy solutions', 'TECO 2030 fuel cell system', 'hydrogen fuel cells', '2.4MW fuel cells', 'other heavy-duty applications', 'Press release picture', 'Dr. Yuquan Zou', 'zero-emission port operations', 'exhaust gas cleaning', 'carbon capture systems', 'Oslo Stock Exchange', 'overseas business center', 'superb power density', '800kW HydroPilot container', 'global shipping industry', 'secondary production facility', 'The HyEkoTank project', 'other solutions', '1.7 million SHK MEAs', 'TECO Maritime Group', 'SinoHyKey Technology Company', 'maritime industry', 'power capacity', 'HydroPilot project', '30 heavy-duty trucks', 'mass production', 'maritime sector', 'strategic partnership', 'key components', 'key milestones', 'supplier agreement', 'great partnership', 'many years', 'cost efficiency', 'several projects', 'construction sites', 'order value', 'pioneering project', 'product tanker', 'undisclosed owner', 'green transition', 'climate impacts', 'Euronext Growth', 'repair services', 'Guangdong Province', 'international market', 'twenty customers', 'international leader', 'Group CEO', 'Tore Enger', 'Horizon Europe', 'development partner', 'MEA supply', 'source version', 'TECO 2030 ASA', 'TECO 2030 project', 'Implenia Norway', 'marine transportation', 'LYSAKER', 'ACCESSWIRE', 'December', 'ISIN', 'collaboration', 'Monday', 'Vancouver', 'world', 'potential', 'globe', 'state', 'design', 'durability', 'progress', 'option', '1.6MW', 'ENOVA', 'Q3', 'NOK', 'total', 'Shell', 'letter', 'intent', 'AVL', 'delivery', 'Story', 'Contact', 'ships', 'environmental', 'ticker', 'roots', 'information', 'CCMs', '350 employees', 'Guangzhou', 'China', 'Foshan', 'Canada', 'modes', 'TECO-2030-Signs-Supplier-Partnership-Agreement', '2024']",2022-12-12,2022-12-12,finance.yahoo.com
14625,EuroNext,NewsApi.org,https://finance.yahoo.com/news/share-repurchase-program-kbc-ancora-164000184.html,Update on share repurchase program KBC Ancora until 09 December 2022,Regulated information  inside information  Leuven  12 December 2022 (17:40 CET) Update on share repurchase program KBC Ancora until 09 December 2022 As part ...,KBC AncoraRegulated information  inside information  Leuven  12 December 2022 (17:40 CET)Update on share repurchase program KBC Ancora until 09 December 2022As part of the EUR 50 million share repurchase program  as confirmed on 20 May 2022  KBC Ancora has announced that it bought back a total of 34 500 shares in the period from 05 December 2022 to 09 December 2022.The following transactions were carried out during the period in question:Transaction date Number of shares Average price (EUR) Lowest price (EUR) Highest price (EUR) Total amount (EUR) Mon 5 December 2022 5 000 41.56 40.74 41.76 207 815.00 Tue 6 December 2022 6 000 41.54 41.00 41.64 249 244.80 Wed 7 December 2022 7 000 41.41 41.08 41.74 289 860.20 Thu 8 December 2022 9 500 40.70 40.28 41.56 386 668.05 Fri 9 December 2022 7 000 40.61 40.10 40.86 284 248.30 TOTAL(period concerned) 34 500 41.10 40.10 41.76 1 417 836.35 TOTAL (overall repurchase program) 873 493 35.42 31.68 41.76 30 942 415.86All transactions were carried out in the central order book of Euronext Brussels.Since the start of the share repurchase program on 10 June 2022  KBC Ancora has bought back 873 493 of its own shares  or 1.12% of the total number of shares issued (i.e. 78 301 314)  for an average price of 35.42 euros per share and for a total amount of 30 942 416 euros. KBC Ancora has currently implemented 61.88% of the repurchase program.The repurchase program runs within the limits of the share repurchase authorization granted by the Extraordinary General Meeting of Shareholders on 30 October 2020.---------------------------------KBC Ancora is a listed company that holds 18.6% of the shares in KBC Group. Together with Cera  MRBB and the Other Permanent Shareholders  it ensures shareholder stability and the ongoing development of the KBC Group. As core shareholders of KBC Group  they have concluded a shareholdersâ€™ agreement to this end.Financial calendar:27 January 2023 Interim financial report (1H)1 September 2023 Annual press release for the financial year 2022/202327 October 2023 Annual General Meeting of ShareholdersStory continuesThis press release is available in Dutch  French and English on the website www.kbcancora.be.KBC Ancora Investor Relations & Press contact: Jan BergmansTel. +32 (0)16 27 96 72email: jan.bergmans@kbcancora.be or mailbox@kbcancora.beAttachment,neutral,0.0,1.0,0.0,neutral,0.01,0.97,0.02,True,English,"['share repurchase program', 'KBC Ancora', 'Update', '09 December', 'EUR 50 million share repurchase program', 'KBC Ancora Investor Relations', 'central order book', 'Extraordinary General Meeting', 'Annual General Meeting', 'share repurchase authorization', 'Interim financial report', 'Annual press release', 'Other Permanent Shareholders', 'Financial calendar', 'financial year', 'Press contact', 'KBC Group', 'Transaction date', 'Average price', 'Lowest price', 'Highest price', 'Euronext Brussels', 'listed company', 'shareholder stability', 'ongoing development', 'core shareholders', 'shareholdersâ€™ agreement', 'Total amount', 'Regulated information', 'following transactions', 'Tue 6 December', 'Fri 9 December', 'total number', 'Jan Bergmans', '12 December', '09 December', '05 December', '7 December', 'Leuven', 'Update', 'part', '20 May', '34,500 shares', 'period', 'question', 'Mon', 'start', '10 June', '35.42 euros', 'limits', '30 October', 'Cera', 'MRBB', '27 January', '1 September', '27 October', 'Story', 'Dutch', 'French', 'English', 'website', 'Tel.', 'email', 'kbcancora', 'Attachment']",2022-12-12,2022-12-12,finance.yahoo.com
14626,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221212005656/en/Public-Storage-Opens-State-of-the-Art-Self-Storage-Facility-in-Silicon-Valley%E2%80%99s-Cupertino-Market,Public Storage Opens State-of-the-Art Self-Storage Facility in Silicon Valleyâ€™s Cupertino Market,GLENDALE  Calif.--(BUSINESS WIRE)--Public Storage (NYSE:PSA)  the nationâ€™s leading owner  acquirer  developer  and operator of self-storage properties  announced today the reopening of a facility adjacent to Apple  Inc. offices in Cupertino  California. The Pâ€¦,GLENDALE  Calif.--(BUSINESS WIRE)--Public Storage (NYSE:PSA)  the nationâ€™s leading owner  acquirer  developer  and operator of self-storage properties  announced today the reopening of a facility adjacent to Apple  Inc. offices in Cupertino  California.The Public Storage  20565 Valley Green Drive  Cupertino location now features two five-level state-of-the-art buildings that offer our industry-leading customer experience  including app-enabled digital property access and account management  eRentalÂ® capability  and smart security cameras.We enhanced an existing  forty year old facility from 51 000 square feet to 195 000 square feet and built it with sustainability in mindâ€”including energy-efficient solar panels  motion-sensor LED lighting  and sustainable landscaping improvements. The site previously housed 585 first generation storage units and has been expanded to 2 593 climate controlled units. The facility is also being certified to LEED SilverÂ® standards.â€œWe are pleased to reopen our Cupertino facility and provide customers with a broad array of storage options â€ said Joe Russell  Public Storage Chief Executive Officer. â€œThis Cupertino location reflects one of Public Storageâ€™s unique competitive advantages; specifically the ability to redevelop and expand properties driven by our experienced development team. This development exemplifies how we are enhancing our 200 million square foot portfolio across the country through acquisition  development  and redevelopment.â€The Companyâ€™s current total development pipeline of approximately $1 billion includes over $500 million in redevelopment opportunities with 20 projects totaling 3 million square feet of new space.â€œWe thank the City of Cupertino for its support in enhancing this tremendous location â€ said Andres Friedman  Public Storage Senior Vice President of Development. â€œFor nearly five years  numerous team members across Public Storage  the City of Cupertino  and vendors have been closely aligned in the redesign  approval  construction  and completion of this landmark storage facility.â€To learn more about the project  read here.Company InformationPublic Storage  a member of the S&P 500 and FT Global 500  is a REIT that primarily acquires  develops  owns  and operates self-storage facilities. At September 30  2022  we had: (i) interests in 2 836 self-storage facilities located in 40 states with approximately 202 million net rentable square feet in the United States and (ii) a 35% common equity interest in Shurgard Self-Storage SA (Euronext Brussels:SHUR)  which owned 259 self-storage facilities located in seven Western European nations with approximately 14 million net rentable square feet operated under the ShurgardÂ® brand. Our headquarters are located in Glendale  California.Additional information about Public Storage is available on the Companyâ€™s website at PublicStorage.com.,neutral,0.0,1.0,0.0,positive,0.95,0.05,0.0,True,English,"['Art Self-Storage Facility', 'Public Storage', 'Silicon Valley', 'Cupertino Market', 'State', 'existing, forty year old facility', '202 million net rentable square feet', '14 million net rentable square feet', 'Public Storage Chief Executive Officer', 'app-enabled digital property access', 'seven Western European nations', '200 million square foot portfolio', '585 first generation storage units', 'current total development pipeline', '3 million square feet', '2,593 climate controlled units', '20565 Valley Green Drive', 'two five-level state', 'industry-leading customer experience', 'smart security cameras', 'energy-efficient solar panels', 'motion-sensor LED lighting', 'sustainable landscaping improvements', 'LEED SilverÂ® standards', 'unique competitive advantages', 'Senior Vice President', 'numerous team members', '35% common equity interest', 'landmark storage facility', 'experienced development team', 'The Public Storage', 'Shurgard Self-Storage SA', '51,000 square feet', '195,000 square feet', 'storage options', 'ShurgardÂ® brand', 'self-storage facilities', 'The Company', 'BUSINESS WIRE', 'leading owner', 'Inc. offices', 'art buildings', 'account management', 'broad array', 'Joe Russell', 'new space', 'tremendous location', 'Andres Friedman', 'five years', 'S&P 500', 'FT Global 500', 'Euronext Brussels', 'Additional information', 'Cupertino facility', 'self-storage properties', 'Company Information', 'Cupertino location', 'redevelopment opportunities', 'United States', '40 states', 'GLENDALE', 'Calif.', 'PSA', 'acquirer', 'developer', 'operator', 'reopening', 'Apple', 'California', 'Â® capability', 'sustainability', 'mind', 'site', 'customers', 'country', 'acquisition', '20 projects', 'City', 'support', 'vendors', 'redesign', 'approval', 'construction', 'completion', 'REIT', 'September', 'interests', 'headquarters', 'PublicStorage']",2022-12-12,2022-12-12,businesswire.com
14627,EuroNext,NewsApi.org,https://www.cnbc.com/2022/12/12/elon-musk-is-no-longer-the-richest-person-in-the-world.html,Elon Musk is no longer the richest person in the world,Bernard Arnault is now the richest man in the world  dethroning Tesla CEO Elon Musk after a continued decline in Tesla share price  according to Forbes.,SpaceX owner and Tesla CEO Elon Musk speaks during a conversation with legendary game designer Todd Howard (not pictured) at the E3 gaming convention in Los Angeles  California  June 13  2019.Tesla CEO Elon Musk is no longer the richest person in the world. He ceded that title to LVMH chairman and CEO Bernard Arnault at the close on Monday  according to Forbes.Tesla shares closed down about 6.3% for the day  and have more than halved in value this year partially due to a sell-off that accelerated in the wake of Musk's $44 billion Twitter acquisition.Musk's wealth  mostly tied to Tesla stock  was propelled by a meteoric rise in the carmaker's share price  which rocketed more than 1 000% in two years.Arnault  through holding vehicles and family trusts  owns a little over 60% of LVMH's voting share class  according to SEC filings. Arnault is worth $186.2 billion  according to Forbes.According to FactSet data  Musk presently owns 14.11% of Tesla's outstanding shares  with a market value of $530 billion. Musk also owns more than 40% of SpaceX shares  adding billions on paper to his net worth  based on a $125 billion private market valuation from June 2022.In a down year for stocks  LVMH shares have dropped just 1.5% in 2022. LVMH is based in Paris and is listed on Euronext Paris.,negative,0.08,0.2,0.71,neutral,0.01,0.94,0.05,True,English,"['Elon Musk', 'richest person', 'world', '$125 billion private market valuation', 'Tesla CEO Elon Musk', '$44 billion Twitter acquisition', 'legendary game designer', 'E3 gaming convention', 'voting share class', 'CEO Bernard Arnault', 'Tesla shares', 'Tesla stock', 'share price', 'market value', 'SpaceX owner', 'Todd Howard', 'Los Angeles', 'richest person', 'meteoric rise', 'two years', 'family trusts', 'SEC filings', 'FactSet data', 'outstanding shares', 'SpaceX shares', 'net worth', 'down year', 'LVMH chairman', 'LVMH shares', 'Euronext Paris', 'conversation', 'California', 'June', 'world', 'title', 'close', 'Monday', 'Forbes', 'sell-off', 'wake', 'wealth', 'carmaker', 'holding', 'vehicles', 'billions', 'paper', 'stocks']",2022-12-12,2022-12-12,cnbc.com
14628,EuroNext,NewsApi.org,https://finance.yahoo.com/news/inventiva-draws-down-25-million-073000578.html,Inventiva draws down â‚¬25 million tranche under Finance Contract with the European Investment Bank,Inventiva intends to use the proceeds to fund part of the pivotal Phase III clinical trial evaluating lanifibranor in patients with NASHThe â‚¬25 million...,"INVENTIVAInventiva intends to use the proceeds to fund part of the pivotal Phase III clinical trial evaluating lanifibranor in patients with NASHThe â‚¬25 million supports Inventivaâ€™s anticipated cash runway1 through the fourth quarter of 2023Daix (France)  Long Island City (New York  United States)  December 12  2022 â€“ Inventiva (Euronext Paris and Nasdaq: IVA) (the â€œCompanyâ€)  a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis (â€œNASHâ€) and other diseases with significant unmet medical needs  today announced the receipt of the â‚¬25 million payment under the first tranche of the unsecured loan agreement executed with the European Investment Bank (â€œEIBâ€) on May 16  2022 with a maturity date of December 2026 (the ""Finance Contract"").Jean Volatier  Chief Financial Officer of Inventiva  stated: â€œWe are pleased to see that our long-term partnership with the EIB is bearing fruit. This payment of the first tranche of â‚¬25 million  triggered by the progress made on our NATiV3 Phase III trial and the completion of the cash injections condition precedent for this tranche  will further support the development of lanifibranor. We remain strongly focused on the recruitment of patients in our Phase III trial and are hoping to satisfy all conditions for the disbursement of the second tranche of â‚¬25 million from the EIB.â€As previously announced  the Finance Contract provides funding in two tranches of â‚¬25 million each  which are both subject to the completion of certain conditions precedent. Any drawings under the terms of the Finance Contract that have not been disbursed within 36 months from the signing of the Finance Contract  (i.e.  before May 16  2025)  cannot be completed at a later date. There is no assurance that the Company will be able to satisfy the conditions precedent for the drawing of the second tranche2.The disbursement of the first tranche (with 8% interest capitalized annually  a maturity of 4 years and a repayment in fine) was subject to  among other conditions  (i) the Company issuing warrants to EIB in accordance with the terms and conditions of the warrants agreements entered into July 1  2022  and (ii) the Companyâ€™s receipt from the date of the Finance Contract of an aggregate amount of â‚¬18 million  paid either in exchange for new shares of the Company or through the receipt of upfront or milestone payments.Story continuesOn June 15  2022  the Company raised â‚¬9.3 million through a capital increase under its ATM program. On November 4  2022  the Company received an upfront payment of $12 million under its collaboration agreement with Sino Biopharm.On November 28  2022  the Company issued 2 266 023 warrants to EIB  in accordance of the terms of the 25th resolution of the combined general meeting of shareholders of May 19  2022 and Article L.225-138 of the French Commercial Code  as a condition to the financing of the first tranche  representing approximately 5.4% of the Company's share capital outstanding as of the date hereof.The exercise price of the warrants is equal to â‚¬4.0152 and corresponds to 95% of the volume-weighted average price of the Company's shares on the regulated market of Euronext Paris during the last trading session preceding the decision to issue the warrants.As previously announced  the warrants have a maturity of twelve years and shall be exercisable following the earliest to occur of (i) the maturity date of the first tranche (i.e. on December 8  2026)  (ii) a change of control event  (iii) an event of default under the Finance Contract  or (iv) a repayment demand by EIB under the Finance Contract. The warrants will automatically be deemed null and void if not exercised within the twelve-year period.EIB has a put option which may require the Company to repurchase all or part of the unexercised warrants then exercisable at their intrinsic value (subject to a cap equal to the amount drawn under the Finance Contract) under certain circumstances (for example  in the event of a change of control or on the maturity date of the first tranche or in the event of default). The Company (or a substitute third party) has a call option to require EIB to sell all shares and other securities of the Company  including the warrants  to the Company  subject to certain terms and conditions. In addition  the Company has a right of first refusal to buy-back all warrants offered for sale to a third party  subject to certain terms and conditions.On the basis of the 2 266 023 new shares of the Company issuable upon exercise of all the warrants at a price of â‚¬4.0152 per new share  the Company could potentially receive gross proceeds of up to â‚¬9 098 535. There is no assurance that EIB will exercise any or all of the warrants or that the Company will receive any proceeds from the exercise of the warrants.About InventivaInventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with NASH  mucopolysaccharidoses (MPS) and other diseases with significant unmet medical needs. The Company benefits from a strong expertise and experience in the domain of compounds targeting nuclear receptors  transcription factors and epigenetic modulation. Inventiva is currently advancing one clinical candidate  has a pipeline of two preclinical programs and continues to explore other development opportunities to add to its pipeline.Inventivaâ€™s lead product candidate  lanifibranor  is currently in a pivotal Phase III clinical trial  NATiV3  for the treatment of adult patients with NASH  a common and progressive chronic liver disease for which there are currently no approved therapies. In 2020  Inventiva reported positive results from its Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH and received Breakthrough Therapy and Fast Track status from the U.S. Food and Drug Administration (â€œFDAâ€) for lanifibranor in the treatment of NASH.Inventivaâ€™s pipeline also includes odiparcil  a drug candidate for the treatment of adult MPS VI patients. As part of Inventivaâ€™s decision to focus clinical efforts on the development of lanifibranor  it suspended its clinical efforts relating to odiparcil and is reviewing available options with respect to its potential further development. Inventiva is in the process of selecting an oncology development candidate for its Hippo signaling pathway program.The Company has a scientific team of approximately 80 people with deep expertise in the fields of biology  medicinal and computational chemistry  pharmacokinetics and pharmacology  and clinical development. It owns an extensive library of approximately 240 000 pharmacologically relevant molecules  approximately 60% of which are proprietary  as well as a wholly-owned research and development facility.Inventiva is a public company listed on compartment C of the regulated market of Euronext Paris (ticker: IVA - ISIN: FR0013233012) and on the Nasdaq Global Market in the United States (ticker: IVA). www.inventivapharma.com.ContactsInventivaPascaline ClercVP of Global External Affairsmedia@inventivapharma.com+1 240 620 9175 Brunswick GroupTristan Roquet Montegon /Aude Lepreux /Matthieu BenoistMedia relationsinventiva@brunswickgroup.com+33 1 53 96 83 83 Westwicke  an ICR CompanyPatricia L. BankInvestor relationspatti.bank@westwicke.com+1 415 513-1284Important NoticeThis press release contains â€œforward-looking statementsâ€ within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements  other than statements of historical facts  included in this press release are forward-looking statements. These statements include  but are not limited to  expectations with respect to the pivotal Phase III clinical trial evaluating lanifibranor in patients with NASH  including recruitment of patients for that trial  the Companyâ€™s ability to satisfy conditions precedent to draw down on the second tranche under the EIB facility  potential future financings or strategic transactions  milestone payments and royalties  the Companyâ€™s ability to exercise its rights under the EIB facility  including its call right and right of first refusal  expectations with respect to EIBâ€™s rights under the EIB facility and EIBâ€™s potential exercise of warrants  the expected use of proceeds from the EIB facility  and the sufficiency of Inventivaâ€™s cash resources and cash runway. Certain of these statements  forecasts and estimates can be recognized by the use of words such as  without limitation  â€œbelievesâ€  â€œanticipatesâ€  â€œexpectsâ€  â€œintendsâ€  â€œplansâ€  â€œseeksâ€  â€œestimatesâ€  â€œmayâ€  â€œwillâ€  â€œwouldâ€  â€œcouldâ€  â€œmightâ€  â€œshouldâ€  and â€œcontinueâ€ and similar expressions. Such statements are not historical facts but rather are statements of future expectations and other forward-looking statements that are based on management's beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results  performance or future events to differ materially from those expressed or implied in such statements. Future events are difficult to predict and may depend upon factors that are beyond Inventiva's control. There can be no guarantees with respect to pipeline product candidates that the clinical trial results will be available on their anticipated timeline  that future clinical trials will be initiated as anticipated  that product candidates will receive the necessary regulatory approvals. Actual results may turn out to be materially different from the anticipated future results  performance or achievements expressed or implied by such statements  forecasts and estimates  due to a number of factors  including that Inventiva is a clinical-stage company with no approved products and no historical product revenues  Inventiva has incurred significant losses since inception  Inventiva has a limited operating history and has never generated any revenue from product sales  Inventiva will require additional capital to finance its operations  Inventiva's future success is dependent on the successful clinical development  regulatory approval and subsequent commercialization of current and any future product candidates  preclinical studies or earlier clinical trials are not necessarily predictive of future results and the results of Inventiva's clinical trials may not support Inventiva's product candidate claims  Inventiva may encounter substantial delays in its clinical trials or Inventiva may fail to demonstrate safety and efficacy to the satisfaction of applicable regulatory authorities  enrolment and retention of patients in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside Inventiva's control  Inventiva's product candidates may cause adverse drug reactions or have other properties that could delay or prevent their regulatory approval  or limit their commercial potential  Inventiva faces substantial competition and Inventivaâ€™s business  and preclinical studies and clinical development programs and timelines  its financial condition and results of operations could be materially and adversely affected by the current COVID-19 pandemic and geopolitical events  such as the conflict between Russia and Ukraine  related sanctions and related impacts and potential impacts on the initiation  enrolment and completion of Inventivaâ€™s clinical trials on anticipated timelines and macroeconomic conditions  including global inflation and uncertain financial markets or at all. Given these risks and uncertainties  no representations are made as to the accuracy or fairness of such forward-looking statements  forecasts and estimates. Furthermore  forward-looking statements  forecasts and estimates only speak as of the date of this press release. Readers are cautioned not to place undue reliance on any of these forward-looking statements.Please refer to the Universal Registration Document for the year ended December 31  2021 filed with the AutoritÃ© des MarchÃ©s Financiers on March 11  2022  the Annual Report on Form 20-F for the year ended December 31  2021 filed with the Securities and Exchange Commission on March 11  2022 and the financial report for the first half of 2022 filed with the Securities and Exchange Commission on September 22  2022 for additional information in relation to such factors  risks and uncertainties.All information in this press release is as of the date of the release. Except as required by law  Inventiva has no intention and is under no obligation to update or review the forward-looking statements referred to above.1 This estimate is based on the Companyâ€™s current business plan and excludes any potential milestones payable to or by the Company and any additional expenditures related to the potential continued development of the odiparcil program or resulting from the potential in-licensing or acquisition of additional product candidates or technologies  or any associated development the Company may pursue. The Company may have based this estimate on assumptions that are incorrect and the Company may end up using its resources sooner than anticipated.2 The disbursement of the second tranche is subject to  among other conditions  (i) the full drawdown of the first tranche  (ii) the receipt by the Company from the date of the EIB credit facility of an aggregate amount of at least â‚¬70 million (inclusive of the â‚¬18 million that was a condition for the disbursement of the first tranche)  paid either in exchange for Company shares  or through upfront or milestone payments  (iii) an out-licensing  partnership or royalty transaction with an upfront payment of at least â‚¬10 million; and (iv) operational criteria based on patient enrollment and number of sites activated in the Companyâ€™s Phase III clinical trial of lanifibranor in patients with NASH.Attachment",neutral,0.0,0.98,0.02,positive,0.63,0.36,0.01,True,English,"['European Investment Bank', 'â‚¬25 million tranche', 'Finance Contract', 'Inventiva', 'pivotal Phase III clinical trial', 'oral small molecule therapies', 'significant unmet medical needs', 'NATiV3 Phase III trial', 'Long Island City', 'European Investment Bank', 'Chief Financial Officer', 'combined general meeting', 'French Commercial Code', 'last trading session', 'unsecured loan agreement', 'volume-weighted average price', 'substitute third party', 'cash injections condition', 'clinical-stage biopharmaceutical company', 'cash runway1', 'collaboration agreement', 'fourth quarter', 'New York', 'United States', 'Euronext Paris', 'non-alcoholic steatohepatitis', 'other diseases', 'Finance Contract', 'Jean Volatier', 'long-term partnership', 'two tranches', 'milestone payments', 'capital increase', 'ATM program', 'Sino Biopharm', '25th resolution', 'share capital', 'regulated market', 'twelve-year period', 'put option', 'intrinsic value', 'call option', 'other securities', 'first refusal', 'new share', 'first tranche', 'second tranche', 'â‚¬25 million payment', 'later date', 'aggregate amount', 'twelve years', 'repayment demand', 'conditions precedent', 'other conditions', 'exercise price', 'gross proceeds', 'maturity date', 'The Company', 'upfront payment', 'warrants agreements', 'unexercised warrants', 'control event', '4 years', 'shares', '2,266,023 warrants', 'INVENTIVA', 'lanifibranor', 'patients', 'NASH', 'Daix', 'France', 'Nasdaq', 'development', 'treatment', 'receipt', 'EIB', 'May', 'December', 'fruit', 'progress', 'completion', 'recruitment', 'disbursement', 'funding', 'drawings', 'terms', '36 months', 'signing', 'assurance', '8% interest', 'fine', 'accordance', 'July', 'exchange', 'Story', 'June', 'November', 'shareholders', 'Article', 'financing', 'decision', 'default', 'circumstances', 'example', 'addition', 'right', 'sale', 'basis', 'research']",2022-12-12,2022-12-12,finance.yahoo.com
14629,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221212005354/en/R%C3%A9my-Cointreau-Commits-to-Increasing-the-Circularity-of-Its-Bottles-With-the-OneBottleForEternity-Project,RÃ©my Cointreau Commits to Increasing the Circularity of Its Bottles With the #OneBottleForEternity Project,PARIS--(BUSINESS WIRE)--Regulatory News: The glass bottle is infinitely reusable. Based on this premise  the RÃ©my Cointreau Group (Paris:RCO) has been working for several years now on its â€œOne Bottle for Eternityâ€ project  which aims to increase the circulariâ€¦,PARIS--(BUSINESS WIRE)--Regulatory News:The glass bottle is infinitely reusable. Based on this premise  the RÃ©my Cointreau Group (Paris:RCO) has been working for several years now on its â€œOne Bottle for Eternityâ€ project  which aims to increase the circularity of the Groupâ€™s bottles and thus significantly reduce the emissions associated with glass production.The Group is delighted to announce the launch of three pilots to be conducted by its brands  to explore different circularity formats:The Mount Gay brand is testing a deposit system in Barbados  its island of origin and production. The empty bottles are collected  cleaned and refilled. The brand hopes to reuse 30-40% of all bottles sold locally  with an estimated 60% CO2 saving per bottle.The Cointreau and Mount Gay brands have announced a partnership with ecoSPIRITS in the UK to promote greater circularity in the on-trade. The 4.5 litre ecoTOTES will be deployed in selected London bars  restaurants and hotels and then collected  cleaned and refilled locally. This pilot programme aims to achieve a 30-50% reduction in backroom storage and a 95% reduction in daily glass and cardboard waste in the participating locations. With this launch  Cointreau is becoming the first international liqueur to partner with ecoSPIRITS  and RÃ©my Cointreau  the first spirits Group in the UK.Finally  true to its vision of always being ahead of its time  the LOUIS XIII brand is continuing its quest for â€œThe Sustainable Exceptionâ€  which is at the heart of the values dear to the House of RÃ©my Martin. LOUIS XIII THE INFINITY WHEEL now offers the opportunity to refill its decanter an unlimited number of times in LOUIS XIII boutiques. The ceremony is personalised  and the life of the decanter is extended indefinitely.These actions are part of a global approach to sobriety and circularity  and support the commitments of the Group's CSR transformation roadmap  The Sustainable Exception. As part of the plan  RÃ©my Cointreau aims to reduce its carbon emissions per bottle by 50% by 2030 and to achieve Net Zero by 2050.RÃ©my Cointreauâ€™s Chief Executive Officer  Eric Vallat  said: â€œGroupâ€™s objective is clear: we want to reduce our carbon emissions per bottle from 2kg to 1kg by 2030. In order to achieve this  rethinking our glass bottles through an active eco-design approach and increasing their circularity in different formats are key levers. These circular initiatives mark the beginning of a collective journey  undertaken hand-in-hand with our stakeholders  from our glassmakers to our clients!â€About RÃ©my CointreauThere are clients all over the world seeking exceptional experiences â€“ clients who know that a wide range of terroirs means a variety of flavours. Their exacting standards are matched by our expertise â€“ the finely honed skills we pass down from generation to generation. The time these clients devote to savouring our products is a tribute to all who have laboured to develop them. It is for these men and women that family-owned French group RÃ©my Cointreau protects its terroirs  cultivates centuries-old premium spirits and is committed to keeping them forever modern. The Groupâ€™s portfolio includes 14 singular brands  among them the RÃ©my Martin and Louis XIII cognacs and Cointreau liqueur. RÃ©my Cointreau has just one ambition: to become the global leader in premium spirits. To this end  it draws on the commitment and creativity of its 1924 employees and on distribution subsidiaries based in the Groupâ€™s core markets.RÃ©my Cointreau is listed on Euronext Paris.,neutral,0.01,0.98,0.0,positive,0.98,0.02,0.0,True,English,"['RÃ©my Cointreau', 'Circularity', 'Bottles', 'The Mount Gay brand', 'RÃ©my Cointreau Group', 'RÃ©my Martin', 'Mount Gay brands', 'CSR transformation roadmap', 'Chief Executive Officer', 'finely honed skills', 'The Sustainable Exception', 'first international liqueur', 'LOUIS XIII boutiques', 'active eco-design approach', 'Louis XIII cognacs', 'LOUIS XIII brand', 'centuries-old premium spirits', 'family-owned French group', 'first spirits Group', 'different circularity formats', 'The Cointreau', 'Cointreau liqueur', 'different formats', 'The Group', 'THE INFINITY WHEEL', 'global approach', 'BUSINESS WIRE', 'Regulatory News', 'several years', 'Eternityâ€ project', 'three pilots', 'deposit system', '60% CO2 saving', '4.5 litre ecoTOTES', 'London bars', 'pilot programme', 'backroom storage', 'daily glass', 'cardboard waste', 'participating locations', 'unlimited number', 'Net Zero', 'Eric Vallat', 'key levers', 'circular initiatives', 'collective journey', 'exceptional experiences', 'wide range', 'exacting standards', '14 singular brands', 'one ambition', 'global leader', 'distribution subsidiaries', 'core markets', 'Paris:RCO', 'carbon emissions', 'Euronext Paris', 'greater circularity', 'glass production', 'empty bottles', '30-50% reduction', 'glass bottles', 'One Bottle', '95% reduction', 'premise', 'launch', 'Barbados', 'island', 'origin', 'partnership', 'ecoSPIRITS', 'UK', 'trade', 'restaurants', 'hotels', 'vision', 'time', 'quest', 'heart', 'values', 'House', 'opportunity', 'decanter', 'ceremony', 'life', 'actions', 'sobriety', 'commitments', 'plan', 'objective', '2kg', '1kg', 'order', 'beginning', 'hand', 'stakeholders', 'glassmakers', 'clients', 'world', 'terroirs', 'variety', 'flavours', 'expertise', 'generation', 'products', 'tribute', 'women', 'portfolio', 'end', 'creativity', '1924 employees']",2022-12-12,2022-12-12,businesswire.com
14630,EuroNext,NewsApi.org,https://finance.yahoo.com/news/bghl-eur-nav-063000165.html,BGHL (EUR): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for...,"BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 09 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5919 Â£ 24.2440 Estimated MTD return 0.24 % 0.31 % Estimated YTD return -5.51 % -4.19 % Estimated ITD return 175.92 % 142.44 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.20 N/A Premium/discount to estimated NAV -19.54 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.51 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 241.2422 Class GBP A Shares (estimated) Â£ 129.3125The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.Story continuesFor further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,mixed,0.08,0.2,0.72,True,English,"['BGHL', 'EUR', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'Class GBP A Shares', 'A N/A Average Price', 'London Stock Exchange plc', 'N/A Sterling Shares Amsterdam', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Euro Shares Amsterdam', 'Sterling Shares Shares', 'A N/A Range', 'US Investment Company Act', 'GAVAUDAN HOLDING LIMITED', 'expert financial advice', 'Guernsey Policy Council', 'collective investment scheme', 'other professional advice', 'BG Fund ICAV', 'closed-ended investment company', 'UK Listing Authority', 'US Securities Act', 'Gavaudan Investment Management', 'investment manager fees', 'BG Fund NAV', 'N/A Shares', 'The Shares', 'Dutch Authority', 'Price N', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Emmanuel Gavaudan', 'Financial Markets', 'The Directors', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'United States', 'following information', 'information purposes', 'necessary approval', 'main market', 'future results', 'listed securities', 'Market information', 'BOUSSARD', 'business', 'returns', 'AEX', 'LSE', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'Story', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-12,2022-12-12,finance.yahoo.com
14631,EuroNext,NewsApi.org,https://finance.yahoo.com/news/bghl-gbp-nav-063000071.html,BGHL (GBP): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for...,"BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 09 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5919 Â£ 24.2440 Estimated MTD return 0.24 % 0.31 % Estimated YTD return -5.51 % -4.19 % Estimated ITD return 175.92 % 142.44 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.20 N/A Premium/discount to estimated NAV -19.54 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.51 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 241.2422 Class GBP A Shares (estimated) Â£ 129.3125The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.Story continuesFor further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,mixed,0.08,0.2,0.72,True,English,"['BGHL', 'GBP', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'GAVAUDAN HOLDING LIMITED Ordinary Shares', 'A N/A Average Price', 'Class GBP A Shares', 'London Stock Exchange plc', 'N/A Sterling Shares Amsterdam', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Sterling Shares Shares', 'Euro Shares Amsterdam', 'A N/A Range', 'US Investment Company Act', 'expert financial advice', 'Guernsey Policy Council', 'collective investment scheme', 'other professional advice', 'BG Fund ICAV', 'Gavaudan Investment Management', 'closed-ended investment company', 'UK Listing Authority', 'US Securities Act', 'investment manager fees', 'N/A Shares', 'BG Fund NAV', 'The Shares', 'Dutch Authority', 'Price N', 'Emmanuel Gavaudan', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Financial Markets', 'The Directors', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'United States', 'following information', 'information purposes', 'necessary approval', 'main market', 'future results', 'listed securities', 'Market information', 'BOUSSARD', 'business', 'returns', 'AEX', 'LSE', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'Story', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-12,2022-12-12,finance.yahoo.com
14632,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/TITAN-CEMENT-INTERNATIONA-62465406/news/Titan-Cement-International-Share-buyback-programme-42524831/?utm_medium=RSS&utm_content=20221212,Titan Cement International : Share buyback programme,(marketscreener.com)   Media Release   Regulated Information   Share buyback programme   Brussels  12 December 2022  08:30 CET - Titan Cement International SA announces that the Company and its subsidiary TITAN Cement Company SA purchased in total â€¦,Media ReleaseRegulated InformationShare buyback programmeBrussels  12 December 2022  08:30 CET - Titan Cement International SA (the Company) (Euronext Brussels  ATHEX and Euronext Paris  TITC) announces that the Company and its subsidiary TITAN Cement Company SA purchased in total 17 308 shares of Titan Cement International SA on Euronext Brussels and the Athens Stock Exchange in the period from December 5  2022  until December 9  2022. The programme is implemented in compliance with the applicable buyback rules and regulations.Date Number of Total amount Average Lowest Highest Regulated shares (Eur) price (Eur) price (Eur) price (Eur) market 05/12/2022 538 6 725.00 12.5000 12.50 12.50 Euronext 05/12/2022 3 250 39 650.00 12.2000 12.20 12.20 Î‘Î¤Î—Î•Î§ 06/12/2022 540 6 652.80 12.3200 12.32 12.32 Euronext 06/12/2022 3 500 42 620.00 12.1771 12.16 12.20 Î‘Î¤Î—Î•Î§ 07/12/2022 526 6 469.80 12.3000 12.30 12.30 Euronext 07/12/2022 3 000 36 510.00 12.1700 12.12 12.22 Î‘Î¤Î—Î•Î§ 08/12/2022 522 6 431.04 12.3200 12.32 12.32 Euronext 08/12/2022 3 155 38 730.30 12.2758 12.20 12.32 Î‘Î¤Î—Î•Î§ 09/12/2022 503 6 146.66 12.2200 12.22 12.22 Euronext 09/12/2022 1 774 21.794.72 12.2856 12.28 12.30 Î‘Î¤Î—Î•Î§ Total 17 308 211 730.32 12.2331Following the above transactions  Titan Cement International SA owns (directly or indirectly through its subsidiary Titan Cement Company SA) 3 342 252 shares  representing 4.27% of the voting rights of the Company.This press release may be consulted on the website of Titan Cement International SA via this link: https://ir.titan-cement.com/en/regulatory-stock-exchange-announcementsthe website of Titan Cement International SA via this link: For further information  please contact Investor Relations at +30 210 2591 257About Titan Cement International SATitan Cement International  parent company of TITAN Group  is a multiregional cement and building materials producer. Business activities cover the production  transportation and distribution of cement  concrete  aggregates  fly ash  mortars and other building materials. The Group employs about 5 500 people and is present in more than 15 countries  operating cement plants in 10 of them  the USA  Greece  Albania  Bulgaria  North Macedonia  Kosovo  Serbia  Egypt  Turkey and Brazil. Throughout its history  the Group has aspired to serve the needs of society  while contributing to sustainable growth with responsibility and integrity.Page 1/1Page 1/1,neutral,0.01,0.99,0.0,positive,0.86,0.13,0.0,True,English,"['Titan Cement International', 'Share buyback programme', 'Average Lowest Highest Regulated shares', 'subsidiary TITAN Cement Company SA', 'Titan Cement International SA', 'Athens Stock Exchange', 'applicable buyback rules', 'building materials producer', 'other building materials', 'Share buyback programme', 'TITAN Group', 'multiregional cement', 'cement plants', 'Regulated Information', 'parent company', 'Media Release', 'Date Number', 'voting rights', 'press release', 'Investor Relations', 'Business activities', 'North Macedonia', 'sustainable growth', 'The Group', 'Euronext Paris', 'Total amount', 'Euronext Brussels', '17,308 shares', '3,342,252 shares', '32 Euronext', '12 December', '08:30 CET', 'ATHEX', 'TITC', 'period', 'compliance', 'regulations', 'price', 'market', 'transactions', 'website', 'link', 'titan-cement', 'regulatory-stock-exchange-announcements', 'production', 'transportation', 'distribution', 'concrete', 'aggregates', 'ash', 'mortars', '5,500 people', '15 countries', 'USA', 'Greece', 'Albania', 'Bulgaria', 'Kosovo', 'Serbia', 'Egypt', 'Turkey', 'Brazil', 'history', 'needs', 'society', 'responsibility', 'integrity', 'Page', 'Î‘Î¤Î—Î•Î§']",2022-12-12,2022-12-12,marketscreener.com
14633,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/GROUPE-BRUXELLES-LAMBERT-5953/news/Groupe-Bruxelles-Lambert-Transactions-on-GBL-shares-from-December-5-2022-until-December-9-2022--42529324/?utm_medium=RSS&utm_content=20221212,Groupe Bruxelles Lambert : Transactions on GBL shares from December 5  2022 until December 9  2022 (included),(marketscreener.com)   December 12  2022 - After 5:45pm CET   Regulated information   Delivering meaningful growth   Transactions on GBL Shares   Disclosure of transaction on GBL shares from December 5  2022 until December 9  2022    Implemenâ€¦,December 12  2022 - After 5:45pm CET Regulated information Delivering meaningful growth Transactions on GBL Shares Disclosure of transaction on GBL shares from December 5  2022 until December 9  2022 (included) Implementation of the authorization of the Extraordinary General Shareholders' Meeting of April 28  2020 Purchases GBL  directly and through its subsidiaries  acquired during the period from December 5  2022 until December 9  2022 included  as part of: The share buyback program: 0 GBL shareThe share buyback program (by an independent financial institution on the basis of a discretionary mandate until December 15  2022): 140 000 GBL shares Number of Average Lowest Highest Amount Trade date price price Negotiation method / market shares price (EUR) (EUR) (EUR) (EUR) 12/05/2022 30 000 77.88 77.58 78.56 2 336 358 Stock Exchange Euronext 12/06/2022 29 000 77.22 76.88 77.70 2 239 273 Stock Exchange Euronext 12/07/2022 28 000 76.94 76.58 77.38 2 154 264 Stock Exchange Euronext 12/08/2022 22 000 76.39 76.00 77.12 1 680 481 Stock Exchange Euronext 12/09/2022 31 000 76.82 76.32 77.06 2 381 445 Stock Exchange Euronext Total 140 000 77.08 10 791 821 Regulated information of December 12  2022 // Page 1 / 3 // For more information: www.gbl.beThe liquidity agreement: 19 600 GBL shares Number of Average Lowest Highest Amount Trade date price price Negotiation method / market shares price (EUR) (EUR) (EUR) (EUR) 12/05/2022 5 250 78.07 77.58 78.62 409 847 Stock Exchange Euronext 12/06/2022 1 500 77.39 76.88 77.72 116 084 Stock Exchange Euronext 12/07/2022 3 350 77.02 76.56 77.40 258 017 Stock Exchange Euronext 12/08/2022 1 500 76.43 75.96 77.14 114 642 Stock Exchange Euronext 12/09/2022 8 000 76.91 76.30 77.06 615 273 Stock Exchange Euronext Total 19 600 77.24 1 513 863 Sales GBL  directly and through its subsidiaries  sold during the period from December 5  2022 until December 9  2022 included  as part of: The liquidity agreement: 11 600 GBL shares Number of Average Lowest Highest Amount Trade date price price Negotiation method / market shares price (EUR) (EUR) (EUR) (EUR) 12/05/2022 3 250 78.08 77.58 78.62 253 767 Stock Exchange Euronext 12/07/2022 1 350 77.25 76.56 77.40 104 288 Stock Exchange Euronext 12/09/2022 7 000 76.96 76.30 77.06 538 723 Stock Exchange Euronext Total 11 600 77.31 896 778 As of December 9  2022  GBL holds directly and through its subsidiaries 11 841 168 GBL shares representing 7.7% of the issued capital  and holds 8 000 shares under the liquidity agreement. On that date  57.1% of the fifth share buyback program is executed1. 1 cf. http://www.gbl.be/en/transactions-gbl-shares Regulated information of December 12  2022 // Page 2 / 3 // For more information: www.gbl.be,neutral,0.0,1.0,0.0,neutral,0.04,0.92,0.05,True,English,"['Groupe Bruxelles Lambert', 'GBL shares', 'Transactions', 'December', 'Average Lowest Highest Amount Trade date price price Negotiation method', ""Extraordinary General Shareholders' Meeting"", 'fifth share buyback program', 'market shares price', 'meaningful growth Transactions', 'independent financial institution', 'Stock Exchange Euronext', '358 Stock Exchange', '0 GBL share', 'GBL Shares', 'discretionary mandate', 'liquidity agreement', '863 Sales GBL', 'gbl.be', '8,000 shares', 'December', '5:45pm', 'information', 'Disclosure', 'Implementation', 'authorization', 'April', 'subsidiaries', 'period', 'part', 'basis', 'Number', 'Page', 'capital', 'transactions-gbl-shares', '19']",2022-12-12,2022-12-12,marketscreener.com
14634,EuroNext,NewsApi.org,https://www.marketscreener.com/news/latest/Paris-wheat-higher-as-Black-Sea-risks-back-in-focus--42529857/?utm_medium=RSS&utm_content=20221212,Paris wheat higher as Black Sea risks back in focus,(marketscreener.com) Euronext wheat regained groundon Monday  tracking a similar rebound in Chicago  as a stoppageat Ukraine's Odesa port after Russian strikes on energy supplyas well as the onset of winter weather shifted attention back toBlack Sea supplâ€¦,"PARIS  Dec 12 (Reuters) - Euronext wheat regained ground on Monday  tracking a similar rebound in Chicago  as a stoppage at Ukraine's Odesa port after Russian strikes on energy supply as well as the onset of winter weather shifted attention back to Black Sea supply risks.News that Algeria will hold an import tender on Wednesday to buy wheat also supported Euronext  with the February shipment period potentially favouring European Union supplies if winter conditions hamper logistics in Russia and Ukraine  traders said.March wheat on Paris-based Euronext settled up 1.2% at 306.25 euros ($322.24) a tonne to move away from a nine-month low of 299.75 euros struck last week.Chicago wheat also rose to recover from last week's one-year low.The Ukrainian government said the port of Odesa suspended operations on Sunday after Russian strikes hit energy supply in the region  before activity resumed on Monday.""This highlights the logistical problems in this zone  whether it's power supply in the war or the challenge of moving grain in winter "" a dealer said.Russian grain exports fell to 550 000 tonnes last week from 1.0 million tonnes in the previous week due to storms in the Black Sea and the lower water level in the Azov sea  consultancy Sovecon said  citing port data.Wheat futures have fallen in recent weeks as increasing exports of a record Russian harvest and the continuation of a wartime shipping channel from Ukraine eased global supply concerns.Wintry weather in western Europe was causing less concern  with freezing temperatures not seen as severe enough to threaten wheat crops.Monday was the last trading session for December futures on Euronext. The contract settled at 304.25 euros  up 0.5% from Friday.February rapeseed settled 1.8% down at 555.25 euros a tonne  after earlier hitting a lowest front-month price since August last year at 552.75 euros.Oilseed markets including U.S. soybeans and Malaysian palm oil were cooled by worries over rising COVID-19 infections in China.($1 = 0.9504 euros) (Reporting by Gus Trompiz in Paris Editing by Mark Potter)",neutral,0.05,0.6,0.36,negative,0.0,0.01,0.99,True,English,"['Black Sea risks', 'Paris wheat', 'focus', 'Black Sea supply risks', 'European Union supplies', 'The Ukrainian government', 'lower water level', 'wartime shipping channel', 'lowest front-month price', 'U.S. soybeans', 'Malaysian palm oil', 'rising COVID-19 infections', 'global supply concerns', 'record Russian harvest', 'last trading session', 'February shipment period', 'Russian grain exports', 'Azov sea', 'energy supply', 'power supply', 'Russian strikes', 'last week', 'increasing exports', 'similar rebound', 'import tender', 'nine-month low', 'logistical problems', 'previous week', 'consultancy Sovecon', 'recent weeks', 'Wintry weather', 'western Europe', 'less concern', 'freezing temperatures', 'December futures', 'Oilseed markets', 'Gus Trompiz', 'Mark Potter', 'March wheat', 'Wheat futures', 'wheat crops', 'winter weather', 'winter conditions', 'port data', 'Paris-based Euronext', '1.0 million tonnes', 'Euronext wheat', 'Chicago wheat', 'Odesa port', '550,000 tonnes', 'Reuters', 'ground', 'Monday', 'stoppage', 'Ukraine', 'onset', 'attention', 'News', 'Algeria', 'Wednesday', 'logistics', 'traders', '306.25 euros', '299.75 euros', 'one-year', 'operations', 'Sunday', 'region', 'activity', 'zone', 'challenge', 'dealer', 'storms', 'continuation', 'contract', '304.25 euros', 'Friday', '555.25 euros', 'August', '552.75 euros', 'worries', 'China', '0.9504 euros']",2022-12-12,2022-12-12,marketscreener.com
14635,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/SES-IMAGOTAG-5151/news/Ses-imagotag-SES-imagotag-joins-the-SBF-120-index-42524140/?utm_medium=RSS&utm_content=20221212,Ses-imagotag :  SES-imagotag joins the SBF 120 index,(marketscreener.com)  SES-imagotag joins the SBF 120 indexSES-imagotag   the global leader in digital solutions for physical retail  today announced that it has joined the SBF 120 index  one of the major indexes of the Paris stock exchange. The SBF 120 indâ€¦,"SES-imagotag joins the SBF 120 indexSES-imagotag (Euronext: SESL  FR0010282822)  the global leader in digital solutions for physical retail  today announced that it has joined the SBF 120 index  one of the major indexes of the Paris stock exchange. The SBF 120 index encompasses the 120 largest stocks listed on Euronext Paris  as measured by market capitalization and trading liquidity.During its quarterly review of Euronext Paris indexes held on December 8  2022  the Expert Indices Committee made the decision to include SES-imagotag in the SBF 120. SES-imagotag's admittance to the index becomes effective December 16  after the close of the Paris stock market.Thierry Gadou  Chairman and CEO of SES-imagotag  commented: â€œThis new stage in the trading history of SES-imagotag's shares is very encouraging. We were delighted to be chosen to join the Euronext Tech Leaders index last June  an affirmation of the high-growth and tech leadership profile of SES-imagotag. Our inclusion in the SBF 120 index reflects the company's higher market capitalization  resulting from our accelerating top-line and profitability growth as we continue to drive the digital transformation of the physical retail sector. It also recognizes the expanding free float and liquidity of our shares. We are confident that the company will continue to grow rapidly as we work to attain the objectives of our VUSION '27 strategic plan.â€About SES-imagotag and the VUSION Retail IoT platformSES-imagotag is a world leader in smart digital labels and IoT solutions for physical retail  serving over 350 large retailer groups around the world in Europe  Asia and North America.SES-imagotag has developed the VUSION Retail IOT technology platform to help retailers transform their physical stores into high value digital assets  more automated  data-driven  and connected in real-time to suppliers and consumers. VUSION improves the agility  precision and accuracy of prices  whilst ensuring the omnichannel synchronization of prices  product information and marketing campaigns. The platform developed by SES-imagotag also optimizes in-store order preparation and restocking.VUSION improves employee satisfaction by freeing up time from cumbersome low value-added tasks and allowing them to focus on customer service and merchandizing tasks. VUSION connects shelves to the Cloud  providing real-time accurate information on product availability and location  allowing for reduced inventory  out-of-stock  and waste  as well as improved on-shelf availability and merchandizing compliance. VUSION empowers consumers with better product  nutritional and traceability information at the shelf and enables a frictionless in-store shopping experience with features such as product search  pathfinding and cashier-less scan & pay features.SES-imagotag supports the United Nations' Global Compact initiative and has received in 2022 the Platinum Sustainability Rating from EcoVadis  the world's reference of business sustainability ratings.SES-imagotag is listed in compartment A of the Euronextâ„¢ Paris exchangeTicker symbol: SESL â€“ ISIN code: FR0010282822 â€“ Reuters: SESL.PA â€“ Bloomberg: SESwww.ses-imagotag.comInvestor Relations contact:Labrador - Raquel Lizarraga / +33 (0)6 46 71 55 20 / raquel.lizarraga.ext@ses-imagotag.comThis publication embed ""ðŸ”’ Actusnews SECURITY MASTER "".- SECURITY MASTER Key: nGpvlJ1oZ2iUy2xvlMhqamdompuUkmPHZ2GVmGJqlpabnZ1onGhhacnGZnBom2Zn- Check this key: https://www.security-master-key.com.Regulated information:Inside Information:- other releases Full and original press release in PDF: https://www.actusnews.com/news/77611-sbf_120_eng_final.pdfReceive by email the next press releases of the company by registering on www.actusnews.com  it's freeÂ© 2022 ActusNews",neutral,0.0,1.0,0.0,positive,0.87,0.1,0.02,True,English,"['SBF 120 index', 'imagotag', ""United Nations' Global Compact initiative"", 'Euronextâ„¢ Paris exchange Ticker symbol', 'VUSION Retail IOT technology platform', 'cumbersome low value-added tasks', 'high value digital assets', 'Euronext Tech Leaders index', 'VUSION Retail IoT platform', 'Paris stock exchange', 'Expert Indices Committee', 'expanding free float', '350 large retailer groups', 'store order preparation', 'store shopping experience', 'Platinum Sustainability Rating', 'business sustainability ratings', 'Investor Relations contact', 'original press release', 'smart digital labels', 'Euronext Paris indexes', 'next press releases', 'physical retail sector', ""VUSION '27 strategic plan"", 'Paris stock market', 'higher market capitalization', 'The SBF 120 index', 'SECURITY MASTER Key', 'real-time accurate information', 'Actusnews SECURITY MASTER', 'IoT solutions', 'global leader', 'merchandizing tasks', 'digital solutions', 'digital transformation', 'major indexes', 'other releases', 'physical stores', '120 largest stocks', 'quarterly review', 'Thierry Gadou', 'new stage', 'trading history', 'leadership profile', 'accelerating top-line', 'profitability growth', 'North America', 'omnichannel synchronization', 'product information', 'marketing campaigns', 'employee satisfaction', 'customer service', 'product availability', 'traceability information', 'product search', 'cashier-less scan', 'compartment A', 'ISIN code', 'Regulated information', 'trading liquidity', 'shelf availability', 'pay features', 'Raquel Lizarraga', 'world leader', 'SESL.PA', 'SES-imagotag', 'December', 'decision', 'admittance', 'close', 'Chairman', 'CEO', 'shares', 'affirmation', 'high-growth', 'inclusion', 'company', 'objectives', 'Europe', 'Asia', 'retailers', 'driven', 'suppliers', 'consumers', 'agility', 'precision', 'accuracy', 'prices', 'restocking', 'shelves', 'Cloud', 'location', 'reduced', 'inventory', 'waste', 'compliance', 'nutritional', 'frictionless', 'pathfinding', 'EcoVadis', 'reference', 'Reuters', 'Bloomberg', 'Labrador', 'publication', 'Full', 'PDF', 'email', '2022', '6']",2022-12-12,2022-12-12,marketscreener.com
14636,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/AWILCO-DRILLING-PLC-8148918/news/Awilco-Drilling-PLC-ndash-Change-of-ISIN-and-method-of-VPS-registration-ndash-reverse-split-tr-42528605/?utm_medium=RSS&utm_content=20221212,Awilco Drilling PLC â€“ Change of ISIN and method of VPS registration â€“ reverse split - transfer of listing to Euronext Growth â€“ contemplated private placement,(marketscreener.com)  Reference is made to the announcement on 23 November 2022 that Awilco Drilling PLC intended to apply for a transfer of its listing from Oslo BÃ¸rs to Euronext Growth Oslo and to the announcement on 1 November 2022 that Awilco Drilling wiâ€¦,"Reference is made to the announcement on 23 November 2022 that Awilco Drilling PLC (""Awilco Drilling"") intended to apply for a transfer of its listing from Oslo BÃ¸rs to Euronext Growth Oslo and to the announcement on 1 November 2022 that Awilco Drilling will change its structure of VPS registration to Sponsored Norwegian Depository Receipts (""SNDRs"").The first day of trading on Euronext Growth Oslo is expected to occur on 16 December 2022 and the last day of trading on Oslo BÃ¸rs is expected to be on 15 December 2022.Following the listing on Euronext Growth Oslo  Awilco Drilling expects to carry out an equity offering of approx. USD 10 million  expected to be structured as combination of a private placement and a subsequent repair offering.As from the first day of trading on Euronext Growth Oslo  Awilco Drilling will change the form of registration of its securities with Euronext Securities Oslo (the ""VPS"") from SSL registration of beneficial interests in Awilco Drilling's shares to SNDRs representing Awilco Drilling's shares. This will also result in a change of ISIN. As described in the press related dated 1 November 2022  the change of registration to SNDRs is necessary as a result of the implementation of the EU Central Securities Depositories Regulation (Regulation EU no 909/2014) in Norway.Key information relating to change to SNDRs and related change of ISIN:Issuer name: Awilco Drilling PLCIssuer of the SNDRs: Nordic Issuer Services ASLast day of trading under previous ISIN and on SSL registration basis: 15 December 2022First day of trading under new ISIN and as SNDRs: 16 December 2022Date of ISIN change: 16 December 2022Previous ISIN: GB00B5LJSC86New ISIN: NO0012740218Further  due to technical reasons  Awilco Drilling will be traded with temporary ticker code AWDRT as from 15 December 2022. As from 16 December 2022  Awilco Drilling will be traded with the ordinary ticker code AWDR.Following the change of registration to SNDRs  the 100:1 reverse share split approved at the extraordinary general meeting on 8 December 2022 will be implemented. This will entail a new change of ISIN.Key information relating to the reverse split:Issuer name: Awilco Drilling PLCIssuer of the SNDRs: Nordic Issuer Services ASReverse split ratio: 100 old SNDRs give 1 new SNDR (100:1)Last day including right - reverse split: 19 December 2022Ex date - reverse split: 20 December 2022Record date for reverse split: 21 December 2022Date on which reverse split was approved: 8 December 2022Previous ISIN: NO0012740218New ISIN: NO0012785098Date of ISIN change: 20 DecemberThe above time line is subject to the admission to trading to Euronext Growth Oslo taking place on 16 December 2022 as planned. In case of any delay in the timeline  updated information will be provided.The issuer of the SNDRs will be Nordic Issuer Services AS  which is Awilco Drilling's issuer account operator in the VPS. Nordic Issuer Services AS will continue to be registered as the nominal holder of all the shares of Awilco Drilling.Sponsored Norwegian Depository Receipts (""SNDR"") issued in the ES-OSL register have certain limitations and risks. You can read more about these limitations and risks in Nordic Issuer Services AS' general business terms available at www.nordicissuer.com. A service description for SNDRs is available at www.euronextvps.no. A copy of the terms and conditions of the Sponsored Norwegian Depository Receipts for Awilco Drilling is attached to this notice  and the terms and conditions are also available at the website of Awilco Drilling  www.awilcodrilling.com.The holders of SNDRs must look solely Nordic Issuer Services  as the issuer of the SNDRs  for payment of dividends  the exercise of voting rights and for all other rights arising in respect of the underlying shares in Awilco Drilling  on the basis of which the SNDRs are issued.Aberdeen  12 December 2022For further information  please contact:Eric Jacobs  Interim CEOPhone: +44 1224 737900Cathrine Haavind  Investor RelationsPhone: +47 93 42 84 64Email: ch@awilcodrilling.com (mailto:ch@awilcodrilling.com)This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.45,0.55,True,English,"['Awilco Drilling PLC', 'VPS registration', 'reverse split', 'Euronext Growth', 'private placement', 'Change', 'ISIN', 'method', 'transfer', 'listing', 'EU Central Securities Depositories Regulation', 'Sponsored Norwegian Depository Receipts', 'Nordic Issuer Services AS', 'Norwegian Securities Trading Act', 'Euronext Securities Oslo', 'Oslo BÃ¸rs', 'Euronext Growth Oslo', 'temporary ticker code', 'ordinary ticker code', 'extraordinary general meeting', 'subsequent repair offering', 'issuer account operator', 'general business terms', '100:1 reverse share split', 'Reverse split ratio', 'Awilco Drilling PLC', 'Regulation EU', 'SSL registration basis', 'equity offering', 'Issuer name', 'first day', 'last day', 'private placement', 'beneficial interests', 'technical reasons', 'time line', 'nominal holder', 'ES-OSL register', 'service description', 'voting rights', 'other rights', 'Eric Jacobs', 'Interim CEO', 'Cathrine Haavind', 'Investor Relations', 'disclosure requirements', 'previous ISIN', 'new ISIN', 'Key information', 'updated information', 'related change', 'new change', '1 new SNDR', 'Ex date', 'Record date', 'underlying shares', 'ISIN change', '100 old SNDRs', 'VPS registration', 'Reference', 'announcement', '23 November', 'transfer', 'listing', '1 November', 'structure', '16 December', '15 December', 'combination', 'press', 'result', 'implementation', 'Norway', 'AWDRT', '8 December', '20 December', 'case', 'delay', 'timeline', 'limitations', 'risks', 'nordicissuer', 'copy', 'conditions', 'notice', 'website', 'holders', 'payment', 'dividends', 'exercise', 'respect', 'Aberdeen', '12 December', 'Phone', 'Email', 'mailto', 'section', 'Attachment', '19', '21']",2022-12-12,2022-12-12,marketscreener.com
14637,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/SOFINA-SA-5960/news/Sofina-Share-buyback-ndash-12-12-2022-42529444/?utm_medium=RSS&utm_content=20221212,Sofina : Share buyback â€“ 12/12/2022,(marketscreener.com)   12 December 2022 - after 5.40pm Regulated information   PRESS RELEASE   Sofina announced the launch of its Share Buyback Programme 2022 in a press release dated 25 October 2022. This programme started on 26 October 2022 and willâ€¦,12 December 2022 - after 5.40pm Regulated informationPRESS RELEASESofina announced the launch of its Share Buyback Programme 2022 in a press release dated 25 October 2022. This programme started on 26 October 2022 and will end on or before 31 December 2022. Under the programme  Sofina may acquire  through the appointed independent intermediary  a maximum of 150 000 Sofina shares on Euronext Brussels for a total maximum amount of EUR 32.5 million.In the framework of the Share Buyback Programme 2022  Sofina has carried out the following treasury share buyback transactions on Euronext Brussels during the period from 5 December2022 to 9 December 2022:PURCHASE DATE NUMBER OF AVERAGE PRICE MAXIMUM PRICE MINIMUM PRICE TOTAL SHARES (EUR) (EUR) (EUR) (EUR) 05/12/2022 2 980 218.97 220.00 215.40 652 522.85 06/12/2022 4 600 215.77 218.80 213.80 992 535.56 07/12/2022 4 000 214.78 217.60 212.20 859 102.00 08/12/2022 3 500 214.25 217.00 211.60 749 865.55 09/12/2022 2 600 217.96 219.40 215.20 566 685.60 TOTAL 17 680 216.10 220.00 211.60 3 820 711.56Sofina holds 882 508 treasury shares on 9 December 2022.Sofina is a Belgian investment company  listed on Euronext Brussels. Sofina's mission is to accompany entrepreneurs and families by supporting their growth projects with advice and patient capital. A shared vision and alignment of interests with those of its partners guide all its decisions. Sofina has investments in Europe  Asia and the United States in various sectors  with a particular focus on Consumer and retail  Digital transformation  Education and Healthcare. For more information please visit www.sofinagroup.comWauthier de BassompierreTel. : +32 2 551 06 11 - E-mail :info@sofinagroup.comSOFINA SA | Nijverheidstraat  31 - 1040 Brussels | RLE Brussels : 0403.219.397Listed on Euronext Brussels (ISIN BE0003717312) | www.sofinagroup.com,neutral,0.0,1.0,0.0,neutral,0.03,0.97,0.0,True,English,"['Share buyback', 'Sofina', 'AVERAGE PRICE MAXIMUM PRICE MINIMUM PRICE TOTAL SHARES', 'treasury share buyback transactions', 'total maximum amount', 'PURCHASE DATE NUMBER', 'Belgian investment company', 'Share Buyback Programme', '882,508 treasury shares', '150,000 Sofina shares', 'PRESS RELEASE', 'independent intermediary', 'growth projects', 'patient capital', 'shared vision', 'United States', 'various sectors', 'particular focus', 'Digital transformation', 'Euronext Brussels', 'RLE Brussels', 'SOFINA SA', '1040 Brussels', 'December', 'information', 'launch', '26 October', 'framework', 'period', 'mission', 'entrepreneurs', 'families', 'advice', 'alignment', 'interests', 'partners', 'decisions', 'investments', 'Europe', 'Asia', 'Consumer', 'retail', 'Education', 'Healthcare', 'sofinagroup', 'Wauthier', 'Bassompierre', 'Tel.', 'mail', 'Nijverheidstraat', 'ISIN', '5.']",2022-12-12,2022-12-12,marketscreener.com
14638,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/KTESIOS-REAL-ESTATE-SOCIM-123269049/news/KTESIOS-Real-Estate-Socimi-S-A-informs-about-an-offer-for-acquisition-of-shares-QUID-PRO-QUO-ALQ-42529329/?utm_medium=RSS&utm_content=20221212,"KTESIOS Real Estate Socimi S A : informs about an offer for acquisition of shares -""QUID PRO QUO ALQUILER SEGURO SOCIMI S.A.""",(marketscreener.com)   KTESIOS SOCIMI   Madrid  12 December 2022   In accordance with Article 17 of Regulation No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse   Article 61004/2 of the Euronext I Standardbook â€¦,"KTESIOS SOCIMIMadrid  12 December 2022In accordance with Article 17 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)  Article 61004/2 of the Euronext I Standardbook Harmonised standards and related provisions  on the standing obligations of companies listed on Euronext  Ktesios Real Estate SOCIMI  S.A. (hereinafter  the ""Company"") notifies the following:INSIDER INFORMATIONThe Company has submitted an offer in which it has expressed its interest in the acquisition of shares of ""QUID PRO QUO ALQUILER SEGURO SOCIMI S.A."" (QPQ). All the shares that constitute the share capital of QPQ are listed on BME Growth.The price per share offered is one euro and twentyâ€five cents (â‚¬ 1.25 and the purchase will be made as follows: i) thirty percent (30.00%) will be paid to each shareholder of QPQ in cash - upfront and ii) the remaining seventy percent (70.00%) will be paid within a period of twelve (12) months from the payment described above  increasing the amount by six percent (6.00%) per year of the amount deferred at the time of payment.To date  the offer has had a commitment of acceptance by QPQ shareholders of 92.43%  of which there is an irrevocable commitment signed of 55.63% and 12.79%  pending signature in the next 48 hours.This transaction is subject to favourable due diligence by Ktesios within 30 working days from the date of the transaction.We remain at your disposal for any clarification you may need.Henry GallegoCEOKtesios Real Estate SOCIMI  S.A.Ktesios Real Estate SOCIMI S.A. CIF: A88346614 - C/ Sagasta 15  7Âº Izda.- 28004 - MadridRegistrada en el Registro Mercantil de Madrid al Tomo 38.976  Folio 30  SecciÃ³n 1  Hoja M-692614Email: info@ktesios-socimi.es | Tel: +34 910 638 011 | www.ktesios-socimi.es",neutral,0.0,1.0,0.0,positive,0.98,0.02,0.0,True,English,"['KTESIOS Real Estate Socimi S A', 'SOCIMI S.A', 'offer', 'acquisition', 'shares', 'QUID', 'ALQUILER', 'QUID PRO QUO ALQUILER SEGURO SOCIMI S.A', 'Ktesios Real Estate SOCIMI S.A.', 'Euronext I Standardbook Harmonised standards', 'twentyâ€five cents', 'favourable due diligence', 'Henry Gallego CEO', 'remaining seventy percent', 'KTESIOS SOCIMI', 'Market Abuse Regulation', 'thirty percent', 'six percent', 'European Parliament', 'related provisions', 'standing obligations', 'INSIDER INFORMATION', 'BME Growth', 'one euro', 'twelve (12) months', 'next 48 hours', '30 working days', 'C/ Sagasta', 'Registro Mercantil', 'SecciÃ³n', 'share capital', 'irrevocable commitment', 'QPQ shareholders', 'Madrid', '12 December', 'accordance', 'Article', 'No', 'Council', '16 April', 'companies', 'Company', 'The', 'offer', 'interest', 'acquisition', 'shares', 'price', 'purchase', 'cash', 'period', 'payment', 'amount', 'year', 'time', 'date', 'acceptance', 'signature', 'transaction', 'disposal', 'clarification', 'CIF', '7Âº Izda.', 'Tomo', 'Folio', 'Hoja', 'Email', 'ktesios-socimi', 'Tel', '34']",2022-12-12,2022-12-12,marketscreener.com
14639,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/SIT-S-P-A-37186625/news/SIT-S-p-A-UPDATE-ON-THE-EXECUTION-OF-THE-BUY-BACK-PROGRAMME-42529849/?utm_medium=RSS&utm_content=20221212,SIT S p A : UPDATE ON THE EXECUTION OF THE BUY-BACK PROGRAMME.,(marketscreener.com)   Update on the execution of the buy-back programme   Padua  December 12nd   2022 - SIT S.p.a.   listed on the Euronext Milan market   with reference to the buy-back programme approved by the shareholders on April 29th  2022 and launâ€¦,"Update on the execution of the buy-back programmePadua  December 12nd   2022 - SIT S.p.a. (""SIT""  or the ""Company"")  listed on the Euronext Milan market (ex MTA market)  with reference to the buy-back programme approved by the shareholders on April 29th  2022 and launched with a resolution of the Board of Directors of May 11th  2022  informs that in the period between December 5th  2022  and December 12nd  2022  acquired n. 2.844 SIT's ordinary shares at an average unit price of EUR 6 2418 per share  for a total amount of EUR 17.751 80.Details of the transactions on a daily basis:Data Numero Prezzo medio unitario (Euro) Controvalore (Euro) azioni acquistate 05.12.2022 250 6 3800 1595 00 06.12.2022 100 6 4000 640 00 07.12.2022 900 6 3400 5.706 00 08.12.2022 250 6 2000 1.550 00 09.12.2022 900 6 1200 5.508 00 12.12.2022 444 6 2000 2752 80 Totale 2.844 6 2418 17.751 80Following to such operations  the Company owns  as at December 12nd  2022  n. 800.409 ordinary shares  amounting to 3 1876% of the share capital.*** Investor Relations Media Relations SIT Paul Fogolin Stefano Campolo E. paul.fogolin@sitgroup.it E. stefano@twin.services T. +39 049 829 3111 M. +39 329 0894649 Mara Di Giorgio Tommaso Pesa E. mara@twin.services E. tommaso@twin.services M +39 335 7737417 M. +39 347 0735670Alessandra Capuzzo",neutral,0.04,0.94,0.01,neutral,0.07,0.93,0.0,True,English,"['SIT S', 'BUY-BACK PROGRAMME', 'UPDATE', 'EXECUTION', 'THE', 'Mara Di Giorgio Tommaso Pesa E.', 'Data Numero Prezzo medio unitario', 'Paul Fogolin Stefano Campolo E', 'Investor Relations Media Relations', 'SIT S.p.a.', 'Euronext Milan market', 'ex MTA market', 'average unit price', 'E. stefano', 'buy-back programme', 'ordinary shares', 'total amount', 'daily basis', 'Alessandra Capuzzo', 'share capital', 'services T.', 'Update', 'execution', 'Padua', 'December', 'Company', 'reference', 'shareholders', 'April', 'resolution', 'Board', 'Directors', 'May', 'period', 'Details', 'transactions', 'Controvalore', 'azioni', 'operations', '2.8']",2022-12-12,2022-12-12,marketscreener.com
14640,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/EXOR-N-V-142350737/news/Exor-N-V-Periodic-Report-on-the-Buyback-Program-42524330/?utm_medium=RSS&utm_content=20221212,Exor N.V.: Periodic Report on the Buyback Program,(marketscreener.com)  EXOR N.V. announces that  under the second tranche of the share buyback program of up to â‚¬250 million announced on 29 July 2022   the Company has completed the following transactions on Euronext Amsterdam: Trading DateNumber of ordinaryâ€¦,EXOR N.V. (AMS: EXO) (â€œExorâ€ or the â€œCompanyâ€) announces that  under the second tranche of the share buyback program of up to â‚¬250 million announced on 29 July 2022 (the â€œsecond trancheâ€)  the Company has completed the following transactions on Euronext Amsterdam:Trading Date Number of ordinary shares purchased Average price per share excluding fees (â‚¬) Total consideration excluding fees (â‚¬) 5 December 2022 26 850 76.4480 2 052 628.80 6 December 2022 38 046 76.1888 2 898 679.08 7 December 2022 36 088 74.6917 2 695 474.07 8 December 2022 39 624 74.0543 2 934 327.58 9 December 2022 22 973 73.9245 1 698 267.54 TOTAL 163 581 12 279 377.07After these purchases  the total invested amount under the second tranche is approximately â‚¬128.9 million for a total amount of 1 930 000 ordinary shares purchased.As of 9 December 2022  the Company held in total 12 727 181 ordinary shares in treasury (5.28% of total ordinary issued share capital).A comprehensive overview of the transactions carried out under the share buyback program  as well as the details of the above transactions  are available on Exorâ€™s corporate website under the Share Buyback section.Attachment,neutral,0.01,0.99,0.0,neutral,0.0,1.0,0.0,True,English,"['Exor N.V.', 'Periodic Report', 'Buyback Program', 'total ordinary issued share capital', 'share buyback program', 'Share Buyback section', 'EXOR N.V.', 'ordinary shares', 'second tranche', 'Euronext Amsterdam', 'Trading Date', 'Average price', 'Total consideration', 'comprehensive overview', 'corporate website', 'total amount', 'following transactions', 'Company', '29 July', 'Number', 'fees', '5 December', '8 December', 'purchases', '9 December', 'treasury', 'details', 'Attachment']",2022-12-12,2022-12-12,marketscreener.com
14641,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/GAROFALO-HEALTH-CARE-S-P-47103079/news/GHC-treasury-shares-buy-back-announcement-42525276/?utm_medium=RSS&utm_content=20221212,GHC: treasury shares buy-back announcement,(marketscreener.com)   Press Release   GAROFALO HEALTH CARE S.P.A.: TREASURY SHARE BUY-BACK ANNOUNCEMENT   Rome  December 12  2022- Garofalo Health Care S.p.A.   listed on the Euronext STAR segment of the Italian Stock Exchange   with regards to the tâ€¦,"Press ReleaseGAROFALO HEALTH CARE S.P.A.: TREASURY SHARE BUY-BACK ANNOUNCEMENTRome  December 12  2022- Garofalo Health Care S.p.A. (""GHC"")  listed on the Euronext STAR segment of the Italian Stock Exchange (LEI code 815600C851C90CAE6438)  with regards to the treasury share buy- back programme authorized by the Shareholders' Meeting of April 29  2022  as announced to the market on the same date as per Article 144-bis of Consob Regulation No. 11971/1999  announces that between December 5  2022 and December 9  2022  it acquired on the Euronext Milan segment of the Italian Stock Exchange 5 440 GHC shares (ISIN code: IT0005345233)  equal to 0.01% of the share capital  at an average price of Euro 3.8128 per share  for a total of Euro 20 741.56.The purchases were made through the intermediary Equita SIM S.p.A.  LEI code 815600E3E9BFBC8FAA85.Purchases of GHC shares on the Euronext Milan segment of the Italian Stock Exchange on a daily aggregated basis in this period are presented below:Date No. of shares acquired Average price (Euro) Value (Euro) 05/12/2022 1 500 3.8246 5 736.86 06/12/2022 1 300 3.7851 4 920.65 07/12/2022 1 850 3.8111 7 050.56 08/12/2022 340 3.8250 1 300.50 09/12/2022 450 3.8511 1 733.00 TOTAL 5 440 3.8128 20 741.56Following the above stated purchases  GHC currently holds 1 245 624 treasury shares  equal to 1.38% of the share capital.The breakdown of daily transactions is presented below.Garofalo Health Care S.p.A. - Share Capital: Euro 31 570 000 fully paid-in Economic & Administrative Register No.: Rome No. 947074 - VAT NO.03831150366 - TAX NO. 06103021009Registered office: Piazzale delle Belle Arti  6 - 00196 Rome - Switchboard: 06 6848911",neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['treasury shares', 'GHC', 'announcement', 'GAROFALO HEALTH CARE S.P.A.', 'Equita SIM S.p.A.', 'treasury share buy- back programme', 'Piazzale delle Belle Arti', 'TREASURY SHARE BUY-BACK ANNOUNCEMENT', 'Euronext STAR segment', 'Italian Stock Exchange', 'Euronext Milan segment', 'daily aggregated basis', '1,245,624 treasury shares', 'share capital', 'daily transactions', 'Press Release', 'LEI code', ""Shareholders' Meeting"", 'same date', 'Consob Regulation', 'ISIN code', 'average price', 'Date No.', 'Administrative Register', 'Registered office', '5,440 GHC shares', 'Euro) Value', 'Rome', 'regards', 'April', 'market', 'Article', 'December', 'total', 'purchases', 'intermediary', 'period', 'breakdown', 'Economic', 'VAT', 'TAX', 'Switchboard']",2022-12-12,2022-12-12,marketscreener.com
14642,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/GAZTRANSPORT-TECHNIGAZ-15821825/news/Gaztransport-Technigaz-GTT-receives-its-first-order-from-Yangzijiang-to-design-the-tanks-of-two-42529597/?utm_medium=RSS&utm_content=20221212,Gaztransport & Technigaz : GTT receives its first order from Yangzijiang to design the tanks of two new LNG Carriers,(marketscreener.com)    Press Release   GTT receives its first order from Yangzijiang to design the tanks of two new LNG Carriers   Paris - December 12  2022. GTT announces that it has received its first order for the tank design of two LNGCs1 from iâ€¦,Press ReleaseGTT receives its first order from Yangzijiang to design the tanks of two new LNG CarriersParis - December 12  2022. GTT announces that it has received its first order for the tank design of two LNGCs1 from its new partner the Chinese shipyard Yangzijiang  on behalf of a European ship owner.GTT will design the tanks of these two vessels  which will each offer a cargo capacity of 175 000 m3. The tanks will be fitted with the MarkIII Flexmembrane containment system developed by GTT.The delivery of the vessels is scheduled between the fourth quarter of 2025 and the second quarter of 2026.About GTTGTT is a technological expert in containment systems with cryogenic membranes used to transport and store liquefied gases. For over 50 years  GTT has been designing and providing cutting-edge technologies for a better energy performance  which combine operational efficiency and safety  to equip LNG carriers  floating terminals  land storage  and multi-gas carriers. GTT also develops systems dedicated to the use of LNG as fuel  as well as a full range of services  including digital services in the field of Smart Shipping. The Group is also active in hydrogen through its subsidiary Elogen  which designs and assembles electrolysers notably for the production of green hydrogen.GTT is listed on Euronext Paris  Compartment A (ISIN FR0011726835 Euronext Paris: GTT) and is notably included in SBF 120 and MSCI Small Cap indices.For more information  visit www.gtt.fr.Media contact:press@gtt.fr/ +33 (0)1 30 23 20 43Investor Relations contact:information-financiere@gtt.fr/+ 33 (0)1 30 23 20 87,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['two new LNG Carriers', 'first order', 'Gaztransport', 'Technigaz', 'GTT', 'Yangzijiang', 'tanks', 'MSCI Small Cap indices', 'MarkIII Flexmembrane containment system', 'two new LNG Carriers', 'European ship owner', 'Investor Relations contact', 'Chinese shipyard Yangzijiang', 'new partner', 'two LNGCs1', 'multi-gas carriers', 'containment systems', 'Media contact', 'two vessels', 'first order', 'tank design', 'cargo capacity', 'fourth quarter', 'second quarter', 'technological expert', 'cryogenic membranes', 'cutting-edge technologies', 'energy performance', 'operational efficiency', 'floating terminals', 'land storage', 'full range', 'Smart Shipping', 'The Group', 'Compartment A', 'Euronext Paris', 'Press Release', 'digital services', 'green hydrogen', 'GTT', 'tanks', 'December', 'behalf', 'delivery', 'liquefied', 'gases', '50 years', 'safety', 'use', 'fuel', 'field', 'subsidiary', 'Elogen', 'electrolysers', 'production', 'SBF 120', 'information', 'fr', 'financiere', '175,000']",2022-12-12,2022-12-12,marketscreener.com
14643,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/ALPHA-MOS-61956556/news/Alpha-MOS-BOYDSense-awarded-by-the-DCB-Innovation-Challenge-2022-Expert-Jury-42529607/?utm_medium=RSS&utm_content=20221212,Alpha MOS : BOYDSense awarded by the DCB Innovation Challenge 2022 Expert Jury,"(marketscreener.com)   Press Release 12/12/2022   BOYDSense awarded by the DCB Innovation Challenge 2022 Expert Jury   BOYDSense SAS  subsidiary of Alpha MOS   announces that they have been recognized and awarded in the category ""diabetes devices"" froâ€¦","Press Release 12/12/2022BOYDSense awarded by the DCB Innovation Challenge 2022 Expert JuryBOYDSense SAS  subsidiary of Alpha MOS (Euronext Paris  ISIN: FR0013421286 ALNEO)  announces that they have been recognized and awarded in the category ""diabetes devices"" from the DCB Innovation Challenge 2022.Held every year  the DCB Open Innovation Challenge aims at fostering new initiatives and innovative projects in the domain of diabetes management.BOYDSense breath-based glucose monitoring device competed alongside 70 projects from 22 countries in the 2022 edition.BOYDSense project successfully passed the first selection step and was among the 3 finalists presenting their work during the Start-Up Night and Award Ceremony end of November.At the end of the Challenge  the Expert Jury  composed of leading scientists  leading Health Care Professionals and Patients living with Diabetes  decided to award BOYDSense with a financial reward.Ben Delhey  CEO of BOYDSense  comments: ""We feel honored and proud to be awarded from the DCB Innovation Challenge 2022 leading expert jury for our work we do to develop a non-invasive health monitoring platform to monitor chronic diseases  starting with Diabetes.This distinction will also open us new networking and collaboration perspectives and leverage the development of our breath-based glucose monitoring device.""ContactBen Delhey - CEO of BOYDSense - ben.delhey@boydsense.comAlpha MOSAlpha MOS (Euronext Paris  ISIN: FR0013421286 ALNEO)  an expert in sensory analysis  the company is a global leader in the creation of electronic noses  tongues and eyes for industrial use. Founded in 1993  Alpha MOS is an international corporation with subsidiaries in France  China and the USA.More information: www.alpha-mos.comBOYDSenseBOYDSense SAS  a subsidiary of Alpha MOS  is a pioneer in the development of non-invasive breath analysis solutions for monitoring of chronic conditions. The first application under development is a miniaturized breath analyzer for monitoring glucose concentration.More information: https://www.boydsense.com",neutral,0.01,0.99,0.0,neutral,0.06,0.94,0.0,True,English,"['DCB Innovation Challenge', 'Alpha MOS', 'Expert Jury', 'BOYDSense', 'DCB Innovation Challenge 2022 leading expert jury', 'DCB Innovation Challenge 2022 Expert Jury', 'BOYDSense breath-based glucose monitoring device', 'DCB Open Innovation Challenge', 'leading Health Care Professionals', 'non-invasive breath analysis solutions', 'miniaturized breath analyzer', 'first selection step', 'leading scientists', 'glucose concentration', 'sensory analysis', 'first application', 'Press Release', 'Euronext Paris', 'new initiatives', 'Start-Up Night', 'Award Ceremony', 'financial reward', 'chronic diseases', 'new networking', 'collaboration perspectives', 'global leader', 'electronic noses', 'industrial use', 'international corporation', 'More information', 'chronic conditions', 'Alpha MOS', 'BOYDSense SAS', 'BOYDSense project', 'Ben Delhey', 'diabetes devices', 'innovative projects', 'diabetes management', '70 projects', 'subsidiary', 'ISIN', 'ALNEO', 'category', 'domain', '22 countries', '2022 edition', '3 finalists', 'November', 'end', 'Patients', 'CEO', 'distinction', 'development', 'Contact', 'company', 'creation', 'tongues', 'eyes', 'subsidiaries', 'France', 'China', 'USA', 'pioneer']",2022-12-12,2022-12-12,marketscreener.com
14644,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/12/2571524/0/en/Inventiva-draws-down-25-million-tranche-under-Finance-Contract-with-the-European-Investment-Bank.html,Inventiva draws down â‚¬25 million tranche under Finance Contract with the European Investment Bank,Daix (France)  Long Island City (New York  United States)  December 12  2022 â€“ Inventiva (Euronext Paris and Nasdaq: IVA) (the â€œCompanyâ€)  a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatmentâ€¦,"English FrenchInventiva intends to use the proceeds to fund part of the pivotal Phase III clinical trial evaluating lanifibranor in patients with NASHThe â‚¬25 million supports Inventivaâ€™s anticipated cash runway1 through the fourth quarter of 2023Daix (France)  Long Island City (New York  United States)  December 12  2022 â€“ Inventiva (Euronext Paris and Nasdaq: IVA) (the â€œCompanyâ€)  a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis (â€œNASHâ€) and other diseases with significant unmet medical needs  today announced the receipt of the â‚¬25 million payment under the first tranche of the unsecured loan agreement executed with the European Investment Bank (â€œEIBâ€) on May 16  2022 with a maturity date of December 2026 (the ""Finance Contract"").Jean Volatier  Chief Financial Officer of Inventiva  stated: â€œWe are pleased to see that our long-term partnership with the EIB is bearing fruit. This payment of the first tranche of â‚¬25 million  triggered by the progress made on our NATiV3 Phase III trial and the completion of the cash injections condition precedent for this tranche  will further support the development of lanifibranor. We remain strongly focused on the recruitment of patients in our Phase III trial and are hoping to satisfy all conditions for the disbursement of the second tranche of â‚¬25 million from the EIB.â€As previously announced  the Finance Contract provides funding in two tranches of â‚¬25 million each  which are both subject to the completion of certain conditions precedent. Any drawings under the terms of the Finance Contract that have not been disbursed within 36 months from the signing of the Finance Contract  (i.e.  before May 16  2025)  cannot be completed at a later date. There is no assurance that the Company will be able to satisfy the conditions precedent for the drawing of the second tranche2.The disbursement of the first tranche (with 8% interest capitalized annually  a maturity of 4 years and a repayment in fine) was subject to  among other conditions  (i) the Company issuing warrants to EIB in accordance with the terms and conditions of the warrants agreements entered into July 1  2022  and (ii) the Companyâ€™s receipt from the date of the Finance Contract of an aggregate amount of â‚¬18 million  paid either in exchange for new shares of the Company or through the receipt of upfront or milestone payments.On June 15  2022  the Company raised â‚¬9.3 million through a capital increase under its ATM program. On November 4  2022  the Company received an upfront payment of $12 million under its collaboration agreement with Sino Biopharm.On November 28  2022  the Company issued 2 266 023 warrants to EIB  in accordance of the terms of the 25th resolution of the combined general meeting of shareholders of May 19  2022 and Article L.225-138 of the French Commercial Code  as a condition to the financing of the first tranche  representing approximately 5.4% of the Company's share capital outstanding as of the date hereof.The exercise price of the warrants is equal to â‚¬4.0152 and corresponds to 95% of the volume-weighted average price of the Company's shares on the regulated market of Euronext Paris during the last trading session preceding the decision to issue the warrants.As previously announced  the warrants have a maturity of twelve years and shall be exercisable following the earliest to occur of (i) the maturity date of the first tranche (i.e. on December 8  2026)  (ii) a change of control event  (iii) an event of default under the Finance Contract  or (iv) a repayment demand by EIB under the Finance Contract. The warrants will automatically be deemed null and void if not exercised within the twelve-year period.EIB has a put option which may require the Company to repurchase all or part of the unexercised warrants then exercisable at their intrinsic value (subject to a cap equal to the amount drawn under the Finance Contract) under certain circumstances (for example  in the event of a change of control or on the maturity date of the first tranche or in the event of default). The Company (or a substitute third party) has a call option to require EIB to sell all shares and other securities of the Company  including the warrants  to the Company  subject to certain terms and conditions. In addition  the Company has a right of first refusal to buy-back all warrants offered for sale to a third party  subject to certain terms and conditions.On the basis of the 2 266 023 new shares of the Company issuable upon exercise of all the warrants at a price of â‚¬4.0152 per new share  the Company could potentially receive gross proceeds of up to â‚¬9 098 535. There is no assurance that EIB will exercise any or all of the warrants or that the Company will receive any proceeds from the exercise of the warrants.About InventivaInventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with NASH  mucopolysaccharidoses (MPS) and other diseases with significant unmet medical needs. The Company benefits from a strong expertise and experience in the domain of compounds targeting nuclear receptors  transcription factors and epigenetic modulation. Inventiva is currently advancing one clinical candidate  has a pipeline of two preclinical programs and continues to explore other development opportunities to add to its pipeline.Inventivaâ€™s lead product candidate  lanifibranor  is currently in a pivotal Phase III clinical trial  NATiV3  for the treatment of adult patients with NASH  a common and progressive chronic liver disease for which there are currently no approved therapies. In 2020  Inventiva reported positive results from its Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH and received Breakthrough Therapy and Fast Track status from the U.S. Food and Drug Administration (â€œFDAâ€) for lanifibranor in the treatment of NASH.Inventivaâ€™s pipeline also includes odiparcil  a drug candidate for the treatment of adult MPS VI patients. As part of Inventivaâ€™s decision to focus clinical efforts on the development of lanifibranor  it suspended its clinical efforts relating to odiparcil and is reviewing available options with respect to its potential further development. Inventiva is in the process of selecting an oncology development candidate for its Hippo signaling pathway program.The Company has a scientific team of approximately 80 people with deep expertise in the fields of biology  medicinal and computational chemistry  pharmacokinetics and pharmacology  and clinical development. It owns an extensive library of approximately 240 000 pharmacologically relevant molecules  approximately 60% of which are proprietary  as well as a wholly-owned research and development facility.Inventiva is a public company listed on compartment C of the regulated market of Euronext Paris (ticker: IVA - ISIN: FR0013233012) and on the Nasdaq Global Market in the United States (ticker: IVA). www.inventivapharma.com.ContactsInventivaPascaline ClercVP of Global External Affairsmedia@inventivapharma.com+1 240 620 9175 Brunswick GroupTristan Roquet Montegon /Aude Lepreux /Matthieu BenoistMedia relationsinventiva@brunswickgroup.com+33 1 53 96 83 83 Westwicke  an ICR CompanyPatricia L. BankInvestor relationspatti.bank@westwicke.com+1 415 513-1284Important NoticeThis press release contains â€œforward-looking statementsâ€ within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements  other than statements of historical facts  included in this press release are forward-looking statements. These statements include  but are not limited to  expectations with respect to the pivotal Phase III clinical trial evaluating lanifibranor in patients with NASH  including recruitment of patients for that trial  the Companyâ€™s ability to satisfy conditions precedent to draw down on the second tranche under the EIB facility  potential future financings or strategic transactions  milestone payments and royalties  the Companyâ€™s ability to exercise its rights under the EIB facility  including its call right and right of first refusal  expectations with respect to EIBâ€™s rights under the EIB facility and EIBâ€™s potential exercise of warrants  the expected use of proceeds from the EIB facility  and the sufficiency of Inventivaâ€™s cash resources and cash runway. Certain of these statements  forecasts and estimates can be recognized by the use of words such as  without limitation  â€œbelievesâ€  â€œanticipatesâ€  â€œexpectsâ€  â€œintendsâ€  â€œplansâ€  â€œseeksâ€  â€œestimatesâ€  â€œmayâ€  â€œwillâ€  â€œwouldâ€  â€œcouldâ€  â€œmightâ€  â€œshouldâ€  and â€œcontinueâ€ and similar expressions. Such statements are not historical facts but rather are statements of future expectations and other forward-looking statements that are based on management's beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results  performance or future events to differ materially from those expressed or implied in such statements. Future events are difficult to predict and may depend upon factors that are beyond Inventiva's control. There can be no guarantees with respect to pipeline product candidates that the clinical trial results will be available on their anticipated timeline  that future clinical trials will be initiated as anticipated  that product candidates will receive the necessary regulatory approvals. Actual results may turn out to be materially different from the anticipated future results  performance or achievements expressed or implied by such statements  forecasts and estimates  due to a number of factors  including that Inventiva is a clinical-stage company with no approved products and no historical product revenues  Inventiva has incurred significant losses since inception  Inventiva has a limited operating history and has never generated any revenue from product sales  Inventiva will require additional capital to finance its operations  Inventiva's future success is dependent on the successful clinical development  regulatory approval and subsequent commercialization of current and any future product candidates  preclinical studies or earlier clinical trials are not necessarily predictive of future results and the results of Inventiva's clinical trials may not support Inventiva's product candidate claims  Inventiva may encounter substantial delays in its clinical trials or Inventiva may fail to demonstrate safety and efficacy to the satisfaction of applicable regulatory authorities  enrolment and retention of patients in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside Inventiva's control  Inventiva's product candidates may cause adverse drug reactions or have other properties that could delay or prevent their regulatory approval  or limit their commercial potential  Inventiva faces substantial competition and Inventivaâ€™s business  and preclinical studies and clinical development programs and timelines  its financial condition and results of operations could be materially and adversely affected by the current COVID-19 pandemic and geopolitical events  such as the conflict between Russia and Ukraine  related sanctions and related impacts and potential impacts on the initiation  enrolment and completion of Inventivaâ€™s clinical trials on anticipated timelines and macroeconomic conditions  including global inflation and uncertain financial markets or at all. Given these risks and uncertainties  no representations are made as to the accuracy or fairness of such forward-looking statements  forecasts and estimates. Furthermore  forward-looking statements  forecasts and estimates only speak as of the date of this press release. Readers are cautioned not to place undue reliance on any of these forward-looking statements.Please refer to the Universal Registration Document for the year ended December 31  2021 filed with the AutoritÃ© des MarchÃ©s Financiers on March 11  2022  the Annual Report on Form 20-F for the year ended December 31  2021 filed with the Securities and Exchange Commission on March 11  2022 and the financial report for the first half of 2022 filed with the Securities and Exchange Commission on September 22  2022 for additional information in relation to such factors  risks and uncertainties.All information in this press release is as of the date of the release. Except as required by law  Inventiva has no intention and is under no obligation to update or review the forward-looking statements referred to above.1 This estimate is based on the Companyâ€™s current business plan and excludes any potential milestones payable to or by the Company and any additional expenditures related to the potential continued development of the odiparcil program or resulting from the potential in-licensing or acquisition of additional product candidates or technologies  or any associated development the Company may pursue. The Company may have based this estimate on assumptions that are incorrect and the Company may end up using its resources sooner than anticipated.2 The disbursement of the second tranche is subject to  among other conditions  (i) the full drawdown of the first tranche  (ii) the receipt by the Company from the date of the EIB credit facility of an aggregate amount of at least â‚¬70 million (inclusive of the â‚¬18 million that was a condition for the disbursement of the first tranche)  paid either in exchange for Company shares  or through upfront or milestone payments  (iii) an out-licensing  partnership or royalty transaction with an upfront payment of at least â‚¬10 million; and (iv) operational criteria based on patient enrollment and number of sites activated in the Companyâ€™s Phase III clinical trial of lanifibranor in patients with NASH.Attachment",neutral,0.0,0.98,0.02,positive,0.67,0.32,0.01,True,English,"['European Investment Bank', 'â‚¬25 million tranche', 'Finance Contract', 'Inventiva', 'pivotal Phase III clinical trial', 'oral small molecule therapies', 'significant unmet medical needs', 'NATiV3 Phase III trial', 'Long Island City', 'European Investment Bank', 'Chief Financial Officer', 'combined general meeting', 'last trading session', 'unsecured loan agreement', 'French Commercial Code', 'volume-weighted average price', 'substitute third party', 'cash injections condition', 'clinical-stage biopharmaceutical company', 'English French', 'cash runway1', 'collaboration agreement', 'fourth quarter', 'New York', 'United States', 'Euronext Paris', 'non-alcoholic steatohepatitis', 'other diseases', 'Finance Contract', 'Jean Volatier', 'long-term partnership', 'two tranches', 'milestone payments', 'capital increase', 'ATM program', 'Sino Biopharm', '25th resolution', 'share capital', 'regulated market', 'twelve-year period', 'put option', 'intrinsic value', 'call option', 'other securities', 'first refusal', 'new share', 'first tranche', 'second tranche', 'â‚¬25 million payment', 'later date', 'aggregate amount', 'twelve years', 'repayment demand', 'conditions precedent', 'other conditions', 'exercise price', 'gross proceeds', 'maturity date', 'The Company', 'upfront payment', 'warrants agreements', 'unexercised warrants', 'control event', '4 years', 'shares', '2,266,023 warrants', 'Inventiva', 'lanifibranor', 'patients', 'NASH', 'Daix', 'France', 'Nasdaq', 'development', 'treatment', 'receipt', 'EIB', 'May', 'December', 'fruit', 'progress', 'completion', 'recruitment', 'disbursement', 'funding', 'drawings', 'terms', '36 months', 'signing', 'assurance', '8% interest', 'fine', 'accordance', 'July', 'exchange', 'June', 'November', 'shareholders', 'Article', 'financing', 'decision', 'default', 'circumstances', 'example', 'addition', 'right', 'sale', 'basis', 'research']",2022-12-12,2022-12-12,globenewswire.com
14645,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/ARGENX-SE-16911676/news/argenx-Appoints-Ana-Cespedes-to-Board-of-Directors-42530356/?utm_medium=RSS&utm_content=20221212,argenx Appoints Ana Cespedes to Board of Directors,(marketscreener.com) December 12  2022 Amsterdam  the Netherlands â€“ argenx SE   a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases  announced that during the extraordinary general meeting of sharehâ€¦,December 12  2022Amsterdam  the Netherlands â€“ argenx SE (Euronext & Nasdaq: ARGX)  a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases  announced that during the extraordinary general meeting of shareholders held today at 12:00pm CET  Ana Cespedes was appointed as non-executive director to its Board of Directors.Ana Cespedes brings robust experience across a broad range of critical areas for commercialization and access  as well as for organizational effectiveness. The voting result and all documents relating to the shareholdersâ€™ meeting will be available on the argenx website at www.argenx.com/investors/shareholder-meetings.About argenxargenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP)  argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S.  Japan  and the EU. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information  visit www.argenx.com and follow us on LinkedIn  Twitter  and Instagram.For further information  please contact:Media:Kelsey Kirkkkirk@argenx.comInvestors:Beth DelGiaccobdelgiacco@argenx.com,neutral,0.03,0.97,0.0,negative,0.01,0.34,0.65,True,English,"['Ana Cespedes', 'argenx', 'Board', 'Directors', 'several earlier stage experimental medicines', 'multiple serious autoimmune diseases', 'novel antibody-based medicines', 'severe autoimmune diseases', 'leading academic researchers', 'neonatal Fc receptor', 'Immunology Innovation Program', 'extraordinary general meeting', 'global immunology company', 'immunology breakthroughs', 'The Company', 'Ana Cespedes', 'executive director', 'robust experience', 'broad range', 'critical areas', 'organizational effectiveness', 'voting result', 'shareholdersâ€™ meeting', 'world-class portfolio', 'FcRn) blocker', 'U.S.', 'therapeutic franchises', 'Kelsey Kirk', 'Beth DelGiacco', 'argenx SE', 'argenx website', 'Amsterdam', 'Netherlands', 'Euronext', 'Nasdaq', 'ARGX', 'lives', 'people', '12:00pm', 'Board', 'Directors', 'commercialization', 'access', 'documents', 'investors/shareholder-meetings', 'IIP', 'Japan', 'efgartigimod', 'information', 'LinkedIn', 'Twitter', 'Instagram', 'Media', 'bdelgiacco']",2022-12-12,2022-12-12,marketscreener.com
14646,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/FERMENTALG-16118042/news/Fermentalg-Industrial-production-and-first-order-for-the-new-natural-blue-food-colorant-42525406/?utm_medium=RSS&utm_content=20221212,Fermentalg :  Industrial production and first order for the new natural blue food colorant,(marketscreener.com)  Libourne - December 1st  2022 â€“ Fermentalg   the French microalgae expert  announces the launch of the production of the first industrial batches of its natural blue food colorant and a first order received from its partner DDW  a subsâ€¦,"Libourne - December 1st  2022 â€“ Fermentalg (Euronext - FALG)  the French microalgae expert  announces the launch of the production of the first industrial batches of its natural blue food colorant and a first order received from its partner DDW  a subsidiary of the Givaudan Group  as part of the pre-commercialization of this new natural ingredient resulting from the Blue OriginsÂ® program.This first open order of the 2nd Fermentalg product platform  for a maximum amount of 750 Kâ‚¬  will allow DDW/Givaudan to provide samples to worldwide leaders of food and beverage industries  especially in the beverage sector.As a reminder  the partnership between Fermentalg and DDW  a subsidiary of the Givaudan Group  was established in June 2020. The first phase of technological development and industrialization was completed in June 2022  after having achieved the technical milestones on schedule.Since then  Givaudan has started the commercialization phase of the product  under the name Galdieria Blue Extract. The competitive advantage of the product  the only natural blue food colorant stable in an acidic environment and resistant to heat treatment  opens up the sports drinks and confectionery segments  which are looking for alternatives to chemical colorants.In this pre-commercial phase  Fermentalg has planned up to three production campaigns with a leading German manufacturer  a number that will be adjusted according to the performance and needs of the sales teams. The first production campaign  carried out between early November and January 2023  represents a turnover of â‚¬250K. In addition  the regulatory process with the European Food Safety Authority (EFSA) and the US Food and Drug Administration (FDA) continues according to the announced schedule  and market authorization for this natural and sustainable alternative to synthetic dyes is expected in the second half of 2023.Next publication: 2022 sales January 19  2023 (after market close)About FermentalgAs an expert in research and bioindustrial exploitation of microalgae  Fermentalg's objective is to offer sustainable solutions and innovative products contributing to the development of healthy  natural and efficient products. Our business: the development  production and marketing of sustainable solutions and active ingredients from microalgae for nutrition  health and the environment. Nutritional lipids  alternative proteins  natural food colorings and innovative environmental solutions make up our company's current and future offer.Fermentalg shares are listed on Euronext Paris (FR0011271600 - FALG) and are eligible for the PEA-PME and the ""SRD long-only"". It is part of the GaÃ¯a index  designed for Socially Responsible Investment (SRI)  which groups together the SMEs with the best ratings in terms of environmental  social and governance (ESG) performance.For more information: www.fermentalg.comJournalists contact : Investor contact: ACTUS finance & communicationNawel NAAMANEphone : +33 (0)1 53 67 36 75nnaamane@actus.fr ACTUS finance & communicationAnne-Catherine BONJOURphone: +33 (0)1 53 67 36 93fermentalg@actus.frThis publication embed ""ðŸ”’ Actusnews SECURITY MASTER "".- SECURITY MASTER Key: m5ifaJlvamjHnJ1sY5yWbGdra2+VxmaZamaYlGJwY8jIbZ2VlGliacmbZnBom2Zo- Check this key: https://www.security-master-key.com.Regulated information:Inside Information:- other releases Full and original press release in PDF: https://www.actusnews.com/news/77612-fermentalg_20221201_cp_industrial-production-and-first-order-bo_engl.pdfReceive by email the next press releases of the company by registering on www.actusnews.com  it's freeÂ© 2022 ActusNews",neutral,0.01,0.99,0.0,positive,0.65,0.34,0.01,True,English,"['new natural blue food colorant', 'Industrial production', 'first order', 'Fermentalg', 'European Food Safety Authority', 'natural blue food colorant', '2nd Fermentalg product platform', 'Blue OriginsÂ® program', 'Galdieria Blue Extract', 'leading German manufacturer', 'GaÃ¯a index', 'Socially Responsible Investment', 'Nawel NAAMANE phone', 'Anne-Catherine BONJOUR phone', 'original press release', 'new natural ingredient', 'natural food colorings', 'first industrial batches', 'first open order', 'three production campaigns', 'next press releases', 'innovative environmental solutions', 'SECURITY MASTER Key', 'first production campaign', 'Actusnews SECURITY MASTER', 'French microalgae expert', 'first order', 'US Food', 'healthy, natural', 'first phase', 'innovative products', 'other releases', 'sustainable solutions', 'maximum amount', 'worldwide leaders', 'beverage industries', 'beverage sector', 'technical milestones', 'commercialization phase', 'competitive advantage', 'heat treatment', 'sports drinks', 'confectionery segments', 'chemical colorants', 'up to', 'early November', 'regulatory process', 'Drug Administration', 'sustainable alternative', 'synthetic dyes', 'second half', 'Next publication', 'bioindustrial exploitation', 'efficient products', 'active ingredients', 'Nutritional lipids', 'alternative proteins', 'future offer', 'best ratings', 'Journalists contact', 'Investor contact', 'Givaudan Group', 'ACTUS finance', 'Fermentalg shares', 'acidic environment', 'sales teams', 'market authorization', 'Euronext Paris', 'ESG) performance', 'technological development', 'Regulated information', '2022 sales', 'Libourne', 'December', 'FALG', 'launch', 'partner', 'DDW', 'subsidiary', 'pre-commercialization', '750 K', 'samples', 'reminder', 'June', 'industrialization', 'schedule', 'name', 'alternatives', 'number', 'needs', 'January', 'turnover', 'addition', 'EFSA', 'FDA', 'research', 'objective', 'business', 'marketing', 'company', 'current', 'PEA-PME', 'SRD', 'SRI', 'SMEs', 'terms', 'governance', 'communication', 'Full', 'PDF', 'cp_industrial-production', 'first-order', 'email', '1']",2022-12-12,2022-12-12,marketscreener.com
14647,EuroNext,NewsApi.org,https://www.hospitalitynet.org/news/4113994.html,A Sustainable Future: Our Planet  Accorâ€™s Commitment,Sustainability is an essential component of our hotelsâ€™ operations  which are leading the way with innovative initiatives  while being mindful of their locales. Deeply anchored in their local communities and ecosystems  our hotels strive to preserve biodiversâ€¦,Sustainability is an essential component of our hotelsâ€™ operations  which are leading the way with innovative initiatives  while being mindful of their locales. Deeply anchored in their local communities and ecosystems  our hotels strive to preserve biodiversity for inhabitants  visitors and future generations. Remaining highly committed to its protection  we are seizing the occasion of the UN Biodiversity Conference in Montreal (COP15) to shine light on our teamsâ€™ efforts and achievements  through the launch of our mini-series.By embedding sustainability across all activities  we aim to encourage and empower every team member  guest  owner and partner to take action and play an active role in pioneering a more sustainable kind of hospitality. Meaningful programs and initiatives â€“ including protecting local flora and fauna contributing to biodiversity conservation and animal welfare â€“ are developed and implemented locally to protect the ecosystems  natural environments and resources at each site  while also forging constructive synergies with local communities and preserving the destinationsâ€™ attractiveness. Take a glimpse at the ways our teams around the world are creating positive change  on the â€˜Our Planet  Our Commitmentâ€™ series.Fostering Biodiversity by the Nile: Discover How the MÃ¶venpick Resort Aswan Team Steps UpWith 404 rooms  suites and villas  7 restaurants and bars  MÃ¶venpick Resort Aswan is built on its own Arcadian island  which is home to some of the oldest trees in the area and an ideal habitat for wild birds â€“ a birdwatcherâ€™s paradise with rare species coming from colder countries to enjoy the warm weather. During the opening episode of our series  you can find out more about the array of biodiversity initiatives from Sherine Zineldin  Director of E-Commerce  Marketing & Communications at MÃ¶venpick Hotels & Resorts  Egypt.Flourishing Flora and Fauna Initiatives at MÃ¶venpick Resort Aswan30 000m2 organic farm : the hotel grows a wide variety of local produce including herbs like mint and coriander. Over 3 000 fruit trees â€“ papaya  mango and dragon fruit  to name but a few â€“ have been planted so far with the aim of totaling 5 000 trees by mid-2023. In 2021  the farm provided over 20 tons of fresh produce for guests to savor.: the hotel grows a wide variety of local produce including herbs like mint and coriander. Over 3 000 fruit trees â€“ papaya  mango and dragon fruit  to name but a few â€“ have been planted so far with the aim of totaling 5 000 trees by mid-2023. In 2021  the farm provided over 20 tons of fresh produce for guests to savor. Compost from food waste : during 2021  the hotel produced over 30 tons of natural compost from waste and leftovers  covering the needs of the farm  as well as micro projects and farmers in surrounding villages in partnership with the Faculty of Agriculture in Aswan.: during 2021  the hotel produced over 30 tons of natural compost from waste and leftovers  covering the needs of the farm  as well as micro projects and farmers in surrounding villages in partnership with the Faculty of Agriculture in Aswan. Flower Nursery : more than 5 000 flowers have been grown and used for lobby decorations.: more than 5 000 flowers have been grown and used for lobby decorations. Birdwatching: the hotel has built a sustainable birdwatching station from wood & date seeds where a specially trained team works with Nature Conservation Egypt (NCE) to identify birds and raise awareness.Sustainable birdwatching station - MÃ¶venpick Resort Aswan â€” Photo by AccorAbout Accor  a world-leading hospitality groupAccor is a world leading hospitality group consisting of 5 300 properties and 10 000 food and beverage venues throughout 110 countries. The group has one of the industry's most diverse and fully-integrated hospitality ecosystems encompassing more than 40 luxury  premium  midscale and economy hotel brands  entertainment and nightlife venues  restaurants and bars  branded private residences  shared accommodation properties  concierge services  co-working spaces and more. Accor's unmatched position in lifestyle hospitality â€“ one of the fastest growing categories in the industry â€“ is led by Ennismore  a joint venture  which Accor holds a majority shareholding. Ennismore is a creative hospitality company with a global collective of entrepreneurial and founder-built brands with purpose at their heart. Accor boasts an unrivalled portfolio of distinctive brands and more than 230 000 team members worldwide. Members benefit from the company's comprehensive loyalty program â€“ ALL â€“ Accor Live Limitless â€“ a daily lifestyle companion that provides access to a wide variety of rewards  services and experiences. Through its global sustainability commitments (such as achieving Net Zero Carbon emissions by 2050  global elimination of single use plastics in its hotels' guest experience  etc.)  Accor Solidarity  RiiSE and ALL Heartist Fund initiatives  the Group is focused on driving positive action through business ethics  responsible tourism  environmental sustainability  community engagement  diversity and inclusivity. Founded in 1967  Accor SA is headquartered in France and publicly listed on the Euronext Paris Stock Exchange (ISIN code: FR0000120404) and on the OTC Market (Ticket: ACCYY) in the United States. For more information visit group.accor.com or follow Accor on Twitter  Facebook  LinkedIn  and Instagram.,neutral,0.14,0.86,0.0,neutral,0.05,0.95,0.0,True,English,"['Sustainable Future', 'Planet', 'Accor', 'Commitment', 'MÃ¶venpick Resort Aswan Team', 'Net Zero Carbon emissions', 'ALL Heartist Fund initiatives', 'world leading hospitality group', 'MÃ¶venpick Hotels', 'comprehensive loyalty program', 'single use plastics', 'daily lifestyle companion', 'sustainable birdwatching station', 'world-leading hospitality group', 'UN Biodiversity Conference', 'creative hospitality company', 'Nature Conservation Egypt', '30,000m2 organic farm', ""hotels' guest experience"", 'global sustainability commitments', 'economy hotel brands', 'lifestyle hospitality', 'sustainable kind', 'team member', 'global collective', 'founder-built brands', 'distinctive brands', 'global elimination', 'biodiversity conservation', 'hotelsâ€™ operations', 'innovative initiatives', 'essential component', 'local communities', 'future generations', 'active role', 'Meaningful programs', 'local flora', 'animal welfare', 'natural environments', 'constructive synergies', 'destinationsâ€™ attractiveness', 'positive change', 'Arcadian island', 'ideal habitat', 'rare species', 'warm weather', 'opening episode', 'biodiversity initiatives', 'Sherine Zineldin', 'Flourishing Flora', 'wide variety', 'local produce', 'fresh produce', 'micro projects', 'surrounding villages', 'Flower Nursery', 'lobby decorations', 'date seeds', 'beverage venues', 'nightlife venues', 'private residences', 'working spaces', 'unmatched position', 'growing categories', 'joint venture', 'majority shareholding', 'unrivalled portfolio', 'business ethics', 'responsible tourism', 'community engagement', 'environmental sustainability', 'Fauna Initiatives', 'natural compost', 'oldest trees', 'teamsâ€™ efforts', 'Commitmentâ€™ series', 'wild birds', 'colder countries', 'accommodation properties', 'concierge services', 'positive action', 'Accor Live', 'Accor Solidarity', '3,000 fruit trees', 'food waste', '5,000 trees', '5,300 properties', '10,000 food', '110 countries', 'Members', 'way', 'locales', 'ecosystems', 'inhabitants', 'visitors', 'protection', 'occasion', 'Montreal', 'COP', 'light', 'achievements', 'launch', 'mini-series', 'activities', 'owner', 'partner', 'resources', 'site', 'glimpse', 'Planet', 'Nile', '404 rooms', 'suites', 'villas', '7 restaurants', 'bars', 'area', 'birdwatcher', 'paradise', 'array', 'Director', 'Marketing', 'Communications', 'Resorts', 'herbs', 'mint', 'coriander', 'papaya', 'mango', 'dragon', 'aim', 'mid-20', '20 tons', 'guests', '30 tons', 'leftovers', 'needs', 'farmers', 'Faculty', 'Agriculture', '5,000 flowers', 'wood', 'awareness', 'Photo', 'industry', 'diverse', 'midscale', 'entertainment', 'fastest', 'Ennismore', 'purpose', 'access', 'rewards', 'experiences', 'RiiSE']",2022-12-12,2022-12-12,hospitalitynet.org
14648,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/FERMENTALG-16118042/news/Fermentalg-Fermentalg-committed-to-the-Food-needs-of-Tomorrow-with-the-support-of-Bpifranc-42529250/?utm_medium=RSS&utm_content=20221212,"Fermentalg :  Fermentalg committed to the "" Food needs of Tomorrow "" with the support of Bpifrance",(marketscreener.com)  Libourne - December 6  2022 - Fermentalg   the French microalgae expert  is accelerating the development of its 2nd product platform  dedicated to a natural and bioactive blue dye and alternative proteins   with the support of Bpifrancâ€¦,"Libourne - December 6  2022 - Fermentalg (Euronext - FALG)  the French microalgae expert  is accelerating the development of its 2nd product platform  dedicated to a natural and bioactive blue dye (BLUE ORIGINSÂ®) and alternative proteins (KALVEAâ„¢)  with the support of Bpifrance as part of the ""Food needs of Tomorrow"" call for projects for a ""Sustainable and Health-Friendly Food"".Beyond the partnership with DDW  a subsidiary of the Givaudan Group  for the commercialization of a natural blue food colorant (already in industrial production)  Fermentalg pursues the deployment of its Galdieria platform for a wider valorization in the food and nutraceutical fields.Already at the origin of a natural alternative to chemical dyes in food  the innovative character and the maturity reached by the platform today allow Fermentalg to prepare the industrialization of new functional solutions with high added value addressing new market segments:- an antioxidant bioactive in nutraceuticals;- a superfood rich in antioxidants  vitamins and minerals for the animal nutrition market (petfood  aquafeed) or specialized for specific audiences  such as athletes or seniors.Microalgal fermentation for a new generation of ingredientsNutritional  health and wellness benefits are crucial issues in food. Today  they must also be addressed through solutions reducing impacts on biodiversity and climate  and favorable to the preservation of natural ecosystems.Through its bioindustrial innovations  Fermentalg is resolutely committed to an economic development approach that respects the environment  as the signatory countries of the COP-15[1] have committed to do by 2050. Among the priorities set for the current decade are the preservation of natural and fisheries resources  better traceability  the circular economy and the valorization of co-products  as well as preventive nutrition and the agroecological transition.To address these challenges  Bpifrance wishes to promote the development of healthier  more sustainable foodstuffs that meet consumer expectations  in particular by reducing or replacing additives and processing aids from petroleum-based chemistry. It also aims to develop new sources of plant proteins produced in our territories to contribute to the food sovereignty of our country.To support innovations targeting high-growth markets and responding to major societal issues  and in a logic of sovereignty to limit dependence on protein imports  Bpifrance has awarded Fermentalg a â‚¬4.4 million grant as part of the 4th Future Investment Program (PIA) of the ""France 2030"" plan.On this occasion  Philippe Lavielle  CEO of Fermentalg  declares:""The production of microalgal biomass by fermentation offers a very large field of applications for a more responsible  safer and more functional food. This development is possible with the tremendous commitment of all economic actors and we are very proud to put our expertise in marine biology at the service of this cause  which is essential for the sustainable health of our planet and future generations. Thanks to this support  we will be able to accelerate the development of applications from our second platform and thus continue to expand our product offering.""Next publication: 2022 sales January 19  2023 (after market close)About FermentalgAs an expert in research and bioindustrial exploitation of microalgae  Fermentalg's objective is to offer sustainable solutions and innovative products contributing to the development of healthy  natural and efficient products. Our business: the development  production and marketing of sustainable solutions and active ingredients from microalgae for nutrition  health and the environment. Nutritional lipids  alternative proteins  natural food colorings and innovative environmental solutions make up our company's current and future offer.Fermentalg shares are listed on Euronext Paris (FR0011271600 - FALG) and are eligible for the PEA-PME and the ""SRD long-only"". It is part of the GaÃ¯a index  designed for Socially Responsible Investment (SRI)  which groups together the SMEs with the best ratings in terms of environmental  social and governance (ESG) performance.For more information: www.fermentalg.comJournalists contact : Investor contact: ACTUS finance & communicationNawel NAAMANEphone : +33 (0)1 53 67 36 75nnaamane@actus.fr ACTUS finance & communicationAnne-Catherine BONJOURphone: +33 (0)1 53 67 36 93fermentalg@actus.fr[1] Post-2020 global biodiversity frameworkCOP-15  7 to 19 December 2022 (Montreal  Canada)This publication embed ""ðŸ”’ Actusnews SECURITY MASTER "".- SECURITY MASTER Key: yZ2alJ2XZWaWyG9xl8iZl2RqZ29llmbGmGmWmpdoZJmVbnBjlGthZp2dZnBom2hn- Check this key: https://www.security-master-key.com.Regulated information:Inside Information:- other releases Full and original press release in PDF: https://www.actusnews.com/news/77631-fermentalg_cp_food-of-tomorrow_vdef_veng.pdfReceive by email the next press releases of the company by registering on www.actusnews.com  it's freeÂ© 2022 ActusNews",neutral,0.15,0.85,0.0,positive,0.82,0.17,0.0,True,English,"['Food needs', 'Fermentalg', 'Tomorrow', 'support', 'Bpifrance', 'Post-2020 global biodiversity framework', '4th Future Investment Program', 'natural blue food colorant', 'high added value', 'GaÃ¯a index', 'Socially Responsible Investment', 'Nawel NAAMANE phone', 'Anne-Catherine BONJOUR phone', 'original press release', 'bioactive blue dye', 'major societal issues', 'next press releases', 'new market segments', 'innovative environmental solutions', '2nd product platform', 'animal nutrition market', 'new functional solutions', 'natural food colorings', 'SECURITY MASTER Key', 'Actusnews SECURITY MASTER', 'economic development approach', 'French microalgae expert', 'BLUE ORIGINSÂ®', 'future generations', 'future offer', 'antioxidant bioactive', 'new generation', 'crucial issues', 'new sources', 'responsible, safer', 'functional food', 'economic actors', 'product offering', 'other releases', 'innovative character', 'natural alternative', 'natural ecosystems', 'healthy, natural', 'alternative proteins', 'Food needs', 'Health-Friendly Food', 'Givaudan Group', 'Galdieria platform', 'nutraceutical fields', 'chemical dyes', 'specific audiences', 'wellness benefits', 'signatory countries', 'fisheries resources', 'circular economy', 'preventive nutrition', 'agroecological transition', 'consumer expectations', 'processing aids', 'petroleum-based chemistry', 'plant proteins', 'high-growth markets', 'protein imports', 'â‚¬4.4 million grant', 'France 2030"" plan', 'Philippe Lavielle', 'microalgal biomass', 'large field', 'tremendous commitment', 'marine biology', 'second platform', 'Next publication', 'bioindustrial exploitation', 'sustainable solutions', 'innovative products', 'Nutritional lipids', 'best ratings', 'ESG) performance', 'Investor contact', 'sustainable foodstuffs', 'Nutritional, health', 'efficient products', 'ACTUS finance', 'wider valorization', 'Microalgal fermentation', 'bioindustrial innovations', 'current decade', 'food sovereignty', 'active ingredients', 'Euronext Paris', 'sustainable health', 'industrial production', 'Regulated information', 'Fermentalg shares', 'Libourne', 'December', 'FALG', 'KALVEAâ„¢', 'support', 'Bpifrance', 'part', 'Tomorrow', 'call', 'projects', 'DDW', 'subsidiary', 'commercialization', 'deployment', 'maturity', 'industrialization', 'nutraceuticals', 'superfood', 'antioxidants', 'vitamins', 'minerals', 'petfood', 'athletes', 'seniors', 'impacts', 'climate', 'preservation', 'COP', 'priorities', 'traceability', 'challenges', 'additives', 'territories', 'country', 'dependence', 'PIA', 'occasion', 'CEO', 'applications', 'expertise', 'service', 'cause', 'planet', '2022 sales', 'January', 'research', 'objective', 'business', 'marketing', 'company', 'PEA-PME', 'SRD', 'SRI', 'SMEs', 'terms', 'governance', 'Journalists', 'communication', 'Montreal', 'Canada', 'Full', 'PDF', 'fermentalg_cp_food', 'veng', 'email', '1']",2022-12-12,2022-12-12,marketscreener.com
14649,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/12/2571503/0/en/Information-on-the-Total-Number-of-Voting-Rights-Denominator-following-Conversion-Notice-from-NEGMA.html,Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA,Negma Group has converted 380 convertible bonds in Oxurion resulting in a EUR 950 000 capital increase. This is part of Negma Groupâ€™s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eâ€¦,English DutchNegma Group has converted 380 convertible bonds in Oxurion resulting in a EUR 950 000 capital increase. This is part of Negma Groupâ€™s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.Leuven  BELGIUM  Boston  MA  US â€“ December 12  2022 â€“ 08.00 AM CET â€“ In accordance with article 15 of the Belgian Act of May 2  2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions  Oxurion NV (Euronext Brussels: OXUR) (the â€œCompanyâ€ or â€œOxurionâ€)  announces the below information  following the issuance of 99 789 915 new ordinary shares on December 9  2022  for a total amount of EUR 950 000  as the result of the conversion of 380 class B convertible bonds  pursuant to the Capital Commitment entered into with Negma Group.Following completion of the capital increase through the conversion of the convertible bonds  the total number of shares issued by Oxurion amounts to 411 071 559  outstanding ordinary shares carrying voting rights (compared to 311 281 644 outstanding ordinary shares previously). This number will be used as the denominator for the calculation of the percentages of shareholdings.Therefore  Oxurion publishes the following updated information:Share capital (EUR) 75 856 161.32 Total number of securities with voting rights (all ordinary shares) 411 071 559 Total number of ordinary shares (= denominator) 411 071 559 Number of outstanding  granted rights to subscribe to securities carrying voting rights not yet issued: 719 500 subscription rights (â€œSRsâ€) issued on November 20  2017  entitling their holders to subscribe to a total number of 719 500 securities carrying voting rights (all ordinary shares);60 000 SRs issued on December 23  2020  entitling their holders to subscribe to a total number of 60 000 securities carrying voting rights (all ordinary shares);1 007 250 SRs issued on April 14  2021  entitling their holders to subscribe to a total number of 1 007 250 securities carrying voting rights (all ordinary shares);550 000 SRs issued on September 22  2021  entitling their holders to subscribe to a total number of 550 000 securities carrying voting rights (all ordinary shares);725 749 SRs issued on December 30  2021  entitling their holders to subscribe to a total number of 725 749 securities carrying voting rights (all ordinary shares);200 convertible bonds issued on September 5  2022  October 21  2022  and November 28  2022  entitling their holder (Negma Group) to subscribe to a total number of securities carrying voting rights (all ordinary shares) in accordance with the terms and conditions set forth in the issuance and subscription agreement entered into between the Company and Negma Group on August 26  2021  and the addendum thereto dated September 2  2022; and100 convertible bonds issued on December 20  2021  entitling their holders (Kreos Capital VI (UK) Limited  Pontifax Medison Finance (Israel) L.P. and Pontifax Medison Finance (Cayman) L.P.) to subscribe to a total number of securities carrying voting rights (all ordinary shares) in accordance with the terms and conditions of these convertible bonds as attached to the Agreement for the provision of a Loan Facility entered into between the Company  Kreos Capital VI (UK) Limited  Pontifax Medison Finance (Israel) L.P. and Pontifax Medison Finance (Cayman) L.P.  on November 21  2021.ENDAbout OxurionOxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies  which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME)  the leading cause of vision loss in working-age people  as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders  including the successful development of THR-149  its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to 50% of DME patients showing suboptimal response to anti-VEGF therapy. Oxurion is headquartered in Leuven  Belgium  with corporate operations in Boston  MA. More information is available at www.oxurion.com.Important information about forward-looking statementsCertain statements in this press release may be considered â€œforward-lookingâ€. Such forward-looking statements are based on current expectations  and  accordingly  entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement  whether as a result of new information  future events  or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Companyâ€™s Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933  as amended  or in compliance with an exemption therefrom  and in accordance with any applicable U.S. state securities laws.For further information please contact:Oxurion NVTom GraneyChief Executive OfficerTel: +32 16 75 13 10tom.graney@oxurion.comMichaÃ«l DillenChief Business OfficerTel: +32 16 75 13 10michael.dillen@oxurion.com USConway CommunicationsBeth Kurthbkurth@conwaycommsir.comICR WestwickeChristopher BrinzeyTel: +1 617 835 9304chris.brinzey@westwicke.com1 Press release Oxurion  06/04/2021 and Press release Oxurion  02/09/2022Attachment,neutral,0.0,1.0,0.0,mixed,0.28,0.23,0.49,True,English,"['Total Number', 'Voting Rights', 'Conversion Notice', 'Information', 'Denominator', 'NEGMA', 'potent plasma kallikrein inhibitor', 'EUR 30 million Capital Commitment1', '380 class B convertible bonds', 'eye drug candidate', 'Pontifax Medison Finance', 'next generation standard', 'diabetic macular edema', 'EUR 950,000 capital increase', 'Kreos Capital VI', 'potential new standard', 'potential market opportunities', 'care ophthalmic therapies', '59, outstanding ordinary shares', '311,281,644 outstanding ordinary shares', 'Such forward-looking statements', '99,789,915 new ordinary shares', 'Israel) L.P.', 'Share capital', '380 convertible bonds', '200 convertible bonds', '100 convertible bonds', 'regulated market', 'new information', 'English Dutch', 'Negma Group', 'Belgian Act', 'major participations', 'miscellaneous provisions', 'Euronext Brussels', 'total amount', 'Loan Facility', 'retinal disorders', 'leading cause', 'working-age people', 'important role', 'successful development', 'suboptimal response', 'anti-VEGF therapy', 'corporate operations', 'press release', 'current expectations', 'future events', 'other reason', 'other factors', 'voting rights', '719,500 subscription rights', 'updated information', 'More information', 'Important information', 'Additional information', 'total number', 'subscription agreement', 'vision loss', 'novel therapeutic', 'various risks', 'biopharmaceutical company', 'The Company', 'other conditions', 'Oxurion NV', 'DME patients', 'back', 'USD', 'Leuven', 'BELGIUM', 'Boston', 'December', '08.00 AM', 'accordance', 'article', 'May', 'disclosure', 'issuers', 'issuance', 'result', 'conversion', 'completion', 'denominator', 'calculation', 'percentages', 'shareholdings', 'securities', 'SRs', 'November', 'holders', 'April', 'September', 'October', 'terms', 'August', 'addendum', 'UK', 'Limited', 'Cayman', 'treatment', 'THR-149', 'uncertainties', 'assurance', 'obligation', 'business', '411']",2022-12-12,2022-12-12,globenewswire.com
14650,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/SOCIETE-GENERALE-4702/news/Societe-Generale-Information-regarding-executed-transactions-within-the-framework-of-a-share-buybac-42529271/?utm_medium=RSS&utm_content=20221212,Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement),(marketscreener.com) INFORMATION REGARDING EXECUTED TRANSACTIONS WITHIN THE FRAMEWORK OF A SHARE BUYBACK PROGRAM Regulated Information Paris  12th December 2022 No 596/2014 on Market Abuse Regulation and Article 3 of Delegated Regulation 2016/1052 supplementiâ€¦,INFORMATION REGARDING EXECUTED TRANSACTIONS WITHIN THE FRAMEWORK OF A SHARE BUYBACK PROGRAM (OUTSIDE THE LIQUIDITY AGREEMENT)Regulated InformationParis  12th December 2022(In accordance with Article 5 of Regulation (EU) No 596/2014 on Market Abuse Regulation and Article 3(3) of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 through regulatory technical standards concerning the conditions applicable to buyback programs and stabilization measures)Societe Generale launched  on Monday 8th August 2022  an ordinary share buyback program for EUR 914.1 million for the purpose of shares cancellation. This buyback will be carried out by the end of the year.Societe Generale received all necessary authorizations from supervisory authorities. These buybacks will be carried out in compliance with the authorizations provided by the General Meeting of 17th May 2022  in particular regarding the maximum price  as well as in accordance with the Market Abuse Regulation. They will be performed on the trading platforms on which Societe Generale shares are listed for trading or are traded  including the regulated market of Euronext Paris.The liquidity contract concluded with Rothschild has also temporarily been suspended throughout the buyback period.Issuer name: Societe Generale - LEI O2RNE8IBXP4R0TD8PU41Reference of the financial instrument: ISIN FR0000130809Period: From 05 to 09 December 2022Purchases performed by Societe Generale during the periodAggregated presentation by day and marketIssuer name Issuer code (LEI) Transaction date ISIN Code Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 07/12/2022 FR0000130809 65 296 22 3991 XPAR SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 07/12/2022 FR0000130809 20 924 22 3926 CEUX SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 07/12/2022 FR0000130809 10 266 22 3892 TQEX SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 07/12/2022 FR0000130809 8 289 22 3994 AQEU SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 08/12/2022 FR0000130809 100 000 22 3965 XPAR SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 09/12/2022 FR0000130809 529 386 22 4119 XPAR SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 09/12/2022 FR0000130809 185 643 22 4077 CEUX SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 09/12/2022 FR0000130809 41 951 22 4082 TQEX SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41 09/12/2022 FR0000130809 29 816 22 4057 AQEU TOTAL 991 571 22 4076Detailed presentation by transactionThe detailed presentation by transaction is available within the Chapter 6 Description of the buyback programs  reports on share buyback and statements on the liquidity agreement:Regulated Information - SociÃ©tÃ© GÃ©nÃ©rale (societegenerale.com)Press contact:Jean-Baptiste Froville_+33 1 58 98 68 00_ jean-baptiste.froville@socgen.comFanny Rouby_+33 1 57 29 11 12_ fanny.rouby@socgen.comSociete GeneraleSociete Generale is one of the leading European financial services groups. Based on a diversified and integrated banking model  the Group combines financial strength and proven expertise in innovation with a strategy of sustainable growth. Committed to the positive transformations of the worldâ€™s societies and economies  Societe Generale and its teams seek to build  day after day  together with its clients  a better and sustainable future through responsible and innovative financial solutions.Active in the real economy for over 150 years  with a solid position in Europe and connected to the rest of the world  Societe Generale has over 117 000 members of staff in 66 countries and supports on a daily basis 25 million individual clients  businesses and institutional investors around the world by offering a wide range of advisory services and tailored financial solutions. The Group is built on three complementary core businesses:French Retail Banking which encompasses the Societe Generale  Credit du Nord and Boursorama brands. Each offers a full range of financial services with omnichannel products at the cutting edge of digital innovation;International Retail Banking  Insurance and Financial Services  with networks in Africa  Central and Eastern Europe and specialised businesses that are leaders in their markets;with networks in Africa  Central and Eastern Europe and specialised businesses that are leaders in their markets; Global Banking and Investor Solutions  which offers recognised expertise  key international locations and integrated solutions.Societe Generale is included in the principal socially responsible investment indices: DJSI (Europe)  FTSE4Good (Global and Europe)  Bloomberg Gender-Equality Index  Refinitiv Diversity and Inclusion Index  Euronext Vigeo (Europe and Eurozone)  STOXX Global ESG Leaders indexes  and the MSCI Low Carbon Leaders Index (World and Europe).In case of doubt regarding the authenticity of this press release  please go to the end of Societe Generaleâ€™s newsroom page where official Press Releases sent by Societe Generale can be certified using blockchain technology. A link will allow you to check the documentâ€™s legitimacy directly on the web page.For more information  you can follow us on Twitter @societegenerale or visit our website www.societegenerale.com.Attachment,neutral,0.0,1.0,0.0,mixed,0.34,0.2,0.46,True,English,"['share buyback program', 'Societe Generale', 'liquidity agreement', 'Information', 'transactions', 'framework', 'SociÃ©tÃ© GÃ©nÃ©rale', 'MSCI Low Carbon Leaders Index', 'leading European financial services groups', 'socially responsible investment indices', 'three complementary core businesses', 'Daily weighted average price', 'Platform SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41', 'XPAR SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41', 'TQEX SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41', 'Global ESG Leaders indexes', 'ordinary share buyback program', 'Issuer name Issuer code', 'AQEU SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41', 'CEUX SOCIETE GENERALE O2RNE8IBXP4R0TD8PU41', 'Bloomberg Gender-Equality Index', 'regulatory technical standards', 'Monday 8th August', 'Credit du Nord', 'key international locations', 'French Retail Banking', 'International Retail Banking', 'Daily total volume', 'official Press Releases', 'integrated banking model', 'innovative financial solutions', 'tailored financial solutions', '25 million individual clients', 'Societe Generale shares', 'Market Abuse Regulation', 'AQEU TOTAL', 'Inclusion Index', 'LEI O2RNE8IBXP4R0TD8PU41', 'Global Banking', 'maximum price', 'daily basis', 'integrated solutions', 'advisory services', 'financial instrument', 'financial strength', 'ISIN Code', 'Investor Solutions', 'Press contact', 'buyback programs', 'specialised businesses', 'Delegated Regulation', 'supplementing Regulation', 'EXECUTED TRANSACTIONS', 'LIQUIDITY AGREEMENT', 'stabilization measures', 'supervisory authorities', 'General Meeting', '17th May', 'liquidity contract', 'proven expertise', 'sustainable growth', 'positive transformations', 'sustainable future', 'real economy', 'solid position', 'institutional investors', 'wide range', 'Boursorama brands', 'full range', 'omnichannel products', 'cutting edge', 'recognised expertise', 'Refinitiv Diversity', 'Euronext Vigeo', 'newsroom page', 'blockchain technology', 'shares cancellation', 'Regulated Information', 'Detailed presentation', 'buyback period', '12th December', 'necessary authorizations', 'trading platforms', 'Euronext Paris', 'Jean-Baptiste Froville', 'Fanny Rouby', 'digital innovation', 'Transaction date', 'Eastern Europe', 'The Group', '09 December', 'FRAMEWORK', 'accordance', 'Article', 'conditions', 'purpose', 'year', 'buybacks', 'compliance', 'Rothschild', 'Reference', 'Purchases', 'number', 'Chapter', 'Description', 'reports', 'statements', 'diversified', 'strategy', 'world', 'societies', 'economies', 'teams', 'rest', '117,000 members', 'staff', '66 countries', 'Insurance', 'networks', 'Africa', 'Central', 'markets', 'DJSI', 'FTSE4Good', 'Eurozone', 'case', 'doubt', 'authenticity', 'link', 'document', '05']",2022-12-12,2022-12-12,marketscreener.com
14651,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/LLEIDANETWORKS-SERVEIS-TE-111615945/news/Lleidanetworks-Serveis-Telematics-S-A-South-Korean-government-grants-a-new-patent-to-Lleida-net-a-42524425/?utm_medium=RSS&utm_content=20221212,Lleidanetworks Serveis TelemÃ tics S A : South Korean government grants a new patent to Lleida.net  and it now has 218 patents worldwide.,(marketscreener.com)   South Korean government grants a new patent to Lleida.net  and it now has 218 patents worldwide.      12 Dec 2022 07:30 CET    Subscribe     Issuer   LLEIDA.NET      South Korean...https://www.marketscreener.coâ€¦,"South Korean government grants a new patent to Lleida.net  and it now has 218 patents worldwide.South Korean government grants a new patent to Lleida.net  and it now has 218 patents worldwide. Madrid  December 12 - Spanish listed company Lleida.net (BME:LLN) EPA:ALLLN) (OTCQX:LLEIF) has been granted a new 20-year patent by the South Korean government. The recognition  which refers to its EIDAS-certified sourcing method  is the fourth recognition from the Seoul authorities and the 218th globally. With this patent  Lleida.net reinforces its position as the leading company in the registered electronic signature  notification  and contracting industry  also in terms of innovation. ""South Korea is one of the world's leading markets in terms of adoption of new technology. Receiving one patent in South Korea is a milestone in itself  but to already have four makes it clear what our strength is in the East Asian markets "" explained Sisco Sapena  CEO and founder of the company. The company has described the concession as ""the first patented method acting under the EIDAS umbrella  which requires identification by electronic signature of the signing parties to be indubitable in a court of law"". As Lleida.net told the market today  this patent has the potential to  directly and indirectly  generate three million euros in revenue over the next two decades. In the region  the company has received patents in powers such as China  Japan  and India or the Gulf Cooperation Council. Lleida.net's growth strategy in the electronic signature  notification  and contracting market in the countries where it is present and those it plans to be in the future includes a solid growth policy in intellectual property and R&D  as well as a reinforcement of its internationalization policy. More than 60 countries in the five continents have granted patents to the company  including the European Union  United States  China  Russia  India  Mexico  Japan  Colombia  Argentina  Peru  South Africa  Nigeria  Australia and New Zealand. Lleida.net is listed on the OTCQX index in New York  on Euronext Growth in Paris  and on BME Growth in Madrid. In the first nine months of 2022  the company's sales grew by 25% compared to last year's period. Between January and September of this year  cumulative sales reached â‚¬15.7 million. Likewise  its EBIDTA increased by 44% compared to the same period of the previous year.",neutral,0.0,1.0,0.0,negative,0.0,0.38,0.62,True,English,"['TelemÃ tics S A', 'South Korean government', 'new patent', 'Lleida.net', 'Lleidanetworks', '218 patents', 'EIDAS-certified sourcing method', 'first patented method', 'three million euros', 'next two decades', 'Gulf Cooperation Council', 'first nine months', 'South Korean government', 'East Asian markets', 'solid growth policy', 'Spanish listed company', 'new 20-year patent', 'leading markets', 'internationalization policy', 'South Africa', 'growth strategy', 'Euronext Growth', 'new technology', 'New Zealand', 'New York', 'new patent', 'Lleida.net', 'Seoul authorities', 'electronic signature', 'contracting industry', 'Sisco Sapena', 'EIDAS umbrella', 'signing parties', 'intellectual property', 'R&D', 'five continents', 'European Union', 'United States', 'OTCQX index', 'one patent', 'BME Growth', 'last year', 'previous year', 'fourth recognition', 'contracting market', 'cumulative sales', 'same period', 'leading company', '218 patents', 'Madrid', 'LLN', 'EPA', 'LLEIF', 'position', 'notification', 'terms', 'innovation', 'world', 'adoption', 'milestone', 'strength', 'CEO', 'founder', 'concession', 'identification', 'court', 'law', 'potential', 'revenue', 'region', 'powers', 'China', 'Japan', 'India', 'countries', 'future', 'reinforcement', 'More', 'Russia', 'Mexico', 'Colombia', 'Argentina', 'Peru', 'Nigeria', 'Australia', 'Paris', 'January', 'September', 'EBIDTA']",2022-12-12,2022-12-12,marketscreener.com
14652,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/SANOFI-4698/news/Press-Release-Statement-from-Sanofi-regarding-Horizon-Therapeutics-plc-ldquo-Horizon-rdquo--42523468/?utm_medium=RSS&utm_content=20221211,Press Release: Statement from Sanofi regarding Horizon Therapeutics plc (â€œHorizonâ€),(marketscreener.com) Â  NOT FOR RELEASE  PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN  INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.THIS IS AN ANNOUNCEMENT FALLING UNDEâ€¦,NOT FOR RELEASE  PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN  INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE IRISH TAKEOVER PANEL ACT  1997  TAKEOVER RULES  2022 (THE â€œTAKEOVER RULESâ€). THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.Statement from Sanofi regarding Horizon Therapeutics plc (â€œHorizonâ€)Paris  December 11  2022. Sanofi S.A. (â€œSanofiâ€) regularly evaluates a wide variety of business development opportunities and this has included the evaluation of a possible transaction involving Horizon. As transaction price expectations do not meet our value creation criteria  Sanofi announces it is no longer in discussions with Horizon and it does not intend to make an offer for Horizon.This announcement is intended to be treated as a statement to which Rule 2.8 of the Takeover Rules applies.About SanofiWe are an innovative global healthcare company  driven by one purpose: we chase the miracles of science to improve peopleâ€™s lives. Our team  across some 100 countries  is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally  while putting sustainability and social responsibility at the center of our ambitions.Sanofi is listed on EURONEXT: SAN and NASDAQ: SNYMedia RelationsSandrine Guendoul | + 33 6 25 09 14 25 | sandrine.guendoul@sanofi.comEvan Berland | +1 215 432 0234 | evan.berland@sanofi.comNicolas Obrist | + 33 6 77 21 27 55 | nicolas.obrist@sanofi.comVictor Rouault | + 33 6 70 93 71 40 | victor.rouault@sanofi.comInvestor RelationsEva Schaefer-Jansen | + 33 7 86 80 56 39 | eva.schaefer-jansen@sanofi.comArnaud DelÃ©pine | + 33 6 73 69 36 93 | arnaud.delepine@sanofi.comCorentine Driancourt | + 33 6 40 56 92 21 | corentine.driancourt@sanofi.comFelix Lauscher | + 1 908 612 7239 | felix.lauscher@sanofi.comPriya Nanduri | + 1 617 764 6418 | priya.nanduri@sanofi.comNathalie Pham | + 33 7 85 93 30 17 | nathalie.pham@sanofi.comSanofi Forward-Looking StatementsThe directors of Sanofi accept responsibility for the information contained in this announcement. To the best of their knowledge and belief (having taken all reasonable care to ensure such is the case)  the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.Attachment,neutral,0.0,0.99,0.0,mixed,0.32,0.09,0.59,True,English,"['Horizon Therapeutics plc', 'Press Release', 'Statement', 'Sanofi', 'innovative global healthcare company', 'IRISH TAKEOVER PANEL ACT', 'business development opportunities', 'value creation criteria', 'life-changing treatment options', 'life-saving vaccine protection', 'Arnaud DelÃ©pine', 'transaction price expectations', 'SNY Media Relations', 'Sanofi S.A.', 'Sanofi Forward-Looking Statements', 'Horizon Therapeutics plc', 'TAKEOVER RULES', 'possible transaction', 'Investor Relations', 'RELEVANT LAWS', 'wide variety', 'one purpose', 'Corentine Driancourt', 'reasonable care', 'social responsibility', 'Sandrine Guendoul', 'Evan Berland', 'Nicolas Obrist', 'Eva Schaefer-Jansen', 'Felix Lauscher', 'Priya Nanduri', 'INSIDE INFORMATION', 'Victor Rouault', 'Nathalie Pham', 'RELEASE', 'DISTRIBUTION', 'WHOLE', 'PART', 'INTO', 'JURISDICTION', 'VIOLATION', 'REGULATIONS', 'ANNOUNCEMENT', 'Paris', 'December', 'evaluation', 'discussions', 'offer', 'miracles', 'science', 'people', 'lives', 'team', '100 countries', 'practice', 'medicine', 'impossible', 'millions', 'sustainability', 'center', 'ambitions', 'EURONEXT', 'NASDAQ', 'directors', 'knowledge', 'belief', 'case', 'accordance', 'facts', 'import', 'Attachment']",2022-12-11,2022-12-12,marketscreener.com
14653,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/ECONOCOM-GROUP-SE-35111311/news/Econocom-Group-Se-ECONOCOM-REGULATED-INFORMATION-TREASURY-SHARES-42529286/?utm_medium=RSS&utm_content=20221212,Econocom Group Se :  ECONOCOM: REGULATED INFORMATION: TREASURY SHARES,(marketscreener.com)  Treasury sharesAs part of the treasury shares buybacks approved by the general meeting of shareholders on 30 November 2021  Econocom Group SE carried out  from 5 December 2022 to 11 December 2022  the following transactions concerningâ€¦,"Treasury sharesAs part of the treasury shares buybacks approved by the general meeting of shareholders on 30 November 2021  Econocom Group SE carried out  from 5 December 2022 to 11 December 2022  the following transactions concerning the Econocom Group share:Date Negotiation method Transactions Quantities Averageprice(â‚¬) Minimumprice(â‚¬) Maximumprice(â‚¬) 05/12/2022 Stock Exchange Purchase 6 703 2.8967 2.8400 2.9550 06/12/2022 Stock Exchange Purchase 9 174 2.8428 2.7900 2.9600 07/12/2022 Stock Exchange Purchase 9 800 2.8493 2.7650 2.8900 08/12/2022 Stock Exchange Purchase 9 500 2.8099 2.7650 2.8500 09/12/2022 Stock Exchange Purchase 9 900 2.9155 2.8150 2.9450 Total 40 889On 12 December 2022  Econocom Group SE held 37 241 361 Econocom Group shares out of a total number of 222 929 980 securities issued  amounting to 16.71% of the firm's securities.Furthermore  an indirect subsidiary of Econocom Group SE  namely Econocom Digital Finance Ltd  also held 6 782 703 Econocom Group shares.On this date  Econocom Group and its direct and indirect subsidiaries together held 44 024 064 Econocom Group shares  amounting to 19.75% of the firm's shares.All press releases about the treasury shares buyback programme are published in the section â€˜Regulated Information â€“ Treasury Shares Buyback' on the financial part of Econocom's website.ABOUT ECONOCOMEconocom is a digital general contractor. It conceives  finances and facilitates the digital transformation of large firms and public organisations. It has forty-nine years' experience and is the only market player offering versatile expertise through a combination of project financing  equipment distribution and digital services. The group operates in sixteen countries  with over 8 200 employees. It made â‚¬2 505m in revenue in 2021. Econocom is listed on Euronext in Brussels  on the BEL Mid and Family Business indexes. FOR MORE INFORMATIONwww.econocom.comFollow us on LinkedIn and TwitterInvestor and shareholder relations contact:benhjamin.pehau@econocom.comPress relations contact:info@capvalue.frTel. +33 (0)1 80 81 50 00This publication embed ""ðŸ”’ Actusnews SECURITY MASTER "".- SECURITY MASTER Key: lZlsYMiYlpfHmHKdZZeYmJRqm2xok2DHmGielGKbl5qbmp1llGmUl5iaZnBom2dr- Check this key: https://www.security-master-key.com.Regulated information:Total number of voting rights and capital:- Information on the total number of voting rights and shares making up the share capital Full and original press release in PDF: https://www.actusnews.com/news/77625-cp-rachat-d_actions-propres-2022-12-12_en.pdfReceive by email the next press releases of the company by registering on www.actusnews.com  it's freeÂ© 2022 ActusNews",neutral,0.01,0.99,0.0,positive,0.53,0.44,0.03,True,English,"['REGULATED INFORMATION', 'TREASURY SHARES', 'Econocom Group', 'Date Negotiation method Transactions Quantities Average price', 'Econocom Digital Finance Ltd', 'treasury shares buyback programme', 'Stock Exchange Purchase', ""forty-nine years' experience"", 'Family Business indexes', 'shareholder relations contact', 'Press relations contact', 'original press release', 'treasury shares buybacks', 'digital general contractor', 'next press releases', 'Econocom Group SE', 'SECURITY MASTER Key', '37,241,361 Econocom Group shares', '6,782,703 Econocom Group shares', '44,024,064 Econocom Group shares', 'Actusnews SECURITY MASTER', 'following transactions', 'Minimum price', 'Maximum price', 'digital transformation', 'digital services', 'general meeting', 'total number', 'indirect subsidiary', 'indirect subsidiaries', 'large firms', 'public organisations', 'market player', 'versatile expertise', 'project financing', 'equipment distribution', 'sixteen countries', 'BEL Mid', 'voting rights', 'share capital', 'Regulated Information', 'financial part', 'shareholders', '30 November', '5 December', '11 December', '12 December', '222,929,980 securities', 'section', 'website', 'finances', 'combination', '8,200 employees', 'revenue', 'Euronext', 'Brussels', 'MORE', 'LinkedIn', 'Twitter', 'Investor', 'capvalue', 'Tel.', 'publication', 'Full', 'PDF', 'email', 'company']",2022-12-12,2022-12-12,marketscreener.com
14654,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/VILMORIN-CIE-5048/news/Vilmorin-Cie-Result-of-the-vote-on-the-resolutions-of-the-Combined-Annual-General-Meeting-Ordin-42529744/?utm_medium=RSS&utm_content=20221212,Vilmorin & Cie : Result of the vote on the resolutions of the Combined Annual General Meeting (Ordinary and Extraordinary) of December 9  2022,(marketscreener.com) Eligible for Deferred Settlement Order Indices: CAC Small  CAC Mid & Small and CAC All-Tradable   December 12  2022   RESULT OF THE VOTE ON THE RESOLUTIONS OF THE COMBINED ANNUAL GENERAL MEETING    OF DECEMBER 9  2022   Numberâ€¦,Vilmorin & Cie SAPublic limited company with Board of Directors with a capital of 349 488 703 eurosHead Office: 4  Quai de la MÃ©gisserie - F-75001 PARIS SIREN Paris 377 913 728Fiscal year from July 1st to June 30thEuronext Paris (Compartment A) - Eligible for Deferred Settlement Order Indices: CAC Small  CAC Mid & Small and CAC All-TradableDecember 12  2022RESULT OF THE VOTE ON THE RESOLUTIONS OF THE COMBINED ANNUAL GENERAL MEETING (ORDINARY AND EXTRAORDINARY)OF DECEMBER 9  2022Number of shares comprising the capital stock: 22 917 292.Number of shares with voting rights: 22 913 271.Number of shareholders present  represented or having voted by correspondence at the Ordinary Annual General Meeting: 848.Number of shares present  represented or having voted by correspondence at the Ordinary Annual General Meeting: 19 833 475.Number of votes present  represented or having voted by correspondence at the Ordinary Annual General Meeting: 35 534 614.Number of shareholders present  represented or having voted by correspondence at the Extraordinary Annual General Meeting: 847.Number of shares present  represented or having voted by correspondence at the Extraordinary Annual General Meeting: 19 833 386.Number of votes present  represented or having voted by correspondence at the Extraordinary Annual General Meeting: 35 534 525.RESOLUTIONS OF AN ORDINARY NATUREFirst resolutionApproval of the annual corporate financial statements - approval of non-tax-deductible expenses and chargesResult of the voteNumber of shares % of capital stock 19 833 475 86.56 Number of Votes % Total Votes For 35 521 606 99.99 Against 2 382 0.01 Abstention 10 626 - Total 35 534 614 100.001 â€¢ RESULT OF THE VOTE ON THE RESOLUTIONS OF THE COMBINED ANNUAL GENERAL MEETING (ORDINARY AND EXTRAORDINARY) OF DECEMBER 9  2022,neutral,0.0,1.0,0.0,positive,0.96,0.03,0.01,True,English,"['Combined Annual General Meeting', 'Vilmorin', 'Cie', 'vote', 'resolutions', 'Ordinary', 'December', 'Deferred Settlement Order Indices', 'COMBINED ANNUAL GENERAL MEETING', 'annual corporate financial statements', 'Ordinary Annual General Meeting', 'Public limited company', 'la MÃ©gisserie', 'AN ORDINARY NATURE', 'PARIS SIREN Paris', 'Euronext Paris', 'Cie SA', 'Head Office', 'Fiscal year', 'Compartment A', 'voting rights', 'First resolution', 'tax-deductible expenses', 'capital stock', 'CAC Small', 'EXTRAORDINARY', 'Total Votes', 'Vilmorin', 'Board', 'Directors', 'Quai', 'July', 'June', 'RESULT', 'RESOLUTIONS', 'THE', 'DECEMBER', 'Number', 'shares', 'shareholders', 'correspondence', 'Approval', 'charges', 'Abstention', '8,703']",2022-12-12,2022-12-12,marketscreener.com
14655,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/AHOLD-DELHAIZE-N-V-29752127/news/Ahold-Delhaize-announces-closing-of-upsized-1-5-billion-Sustainability-Linked-Revolving-Credit-Faci-42525074/?utm_medium=RSS&utm_content=20221212,Ahold Delhaize announces closing of upsized Â€1.5 billion Sustainability-Linked Revolving Credit Facility,(marketscreener.com) Zaandam  the Netherlands  December 12  2022 â€“ Today  Ahold Delhaize announces the closing of its â‚¬1.5 billion Sustainability-linked Revolving Credit Facility .Â  The new Facility increases the total revolving commitments from â‚¬1.0 billion â€¦,Zaandam  the Netherlands  December 12  2022 â€“ Today  Ahold Delhaize announces the closing of its â‚¬1.5 billion Sustainability-linked Revolving Credit Facility (the â€˜Facilityâ€™).The new Facility increases the total revolving commitments from â‚¬1.0 billion to â‚¬1.5 billion  reduces Ahold Delhaizeâ€™s borrowing costs  and extends the maturity date to December 2027  which may be further extended pursuant to two twelve-month extension options.The Facility links the cost of borrowing to Ahold Delhaizeâ€™s annual performance on sustainability KPIs that are aligned with its â€œGrounded in Goodnessâ€ strategy  that focuses on healthier people and a healthier planet. Specifically  the Facility includes three sustainability KPIs to reduce Ahold Delhaizeâ€™s carbon emissions within its own operations (scope 1 and 2)  reduce food waste and help customers make healthier choices. The Facility also includes the opportunity to add scope 3 carbon emissions reduction performance targets by 2025. Ahold Delhaize will report progress on its performance targets in its annual reports.ABN AMRO Bank N.V. and SociÃ©tÃ© GÃ©nÃ©rale acted as Coordinators and Sustainability Coordinators on the Facility.- Ends -Cautionary noticeThis communication includes forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Words such as may  further  subject to  will or other similar words or expressions are typically used to identify forward-looking statements.Forward-looking statements are subject to risks  uncertainties and other factors that are difficult to predict and that may cause actual results of Koninklijke Ahold Delhaize N.V. (the â€œCompany  or â€œAhold Delhaizeâ€) to differ materially from future results expressed or implied by such forward-looking statements. Such factors include  but are not limited to the risk factors set forth in the Companyâ€™s public filings and other disclosures. Forward-looking statements reflect the current views of the Companyâ€™s management and assumptions based on information currently available to the Companyâ€™s management. Forward-looking statements speak only as of the date they are made and the Company does not assume any obligation to update such statements  except as required by law.For more informationPress office: +31 88 6595134 / media.relations@aholddelhaize.comInvestor relations: +31 88 659 5213 / investor.relations@aholddelhaize.comSocial media: Instagram: @Ahold-Delhaize | LinkedIn: @Ahold-Delhaize | Twitter: @AholdDelhaizeAbout Ahold DelhaizeAhold Delhaize is one of the worldâ€™s largest food retail groups and a leader in both supermarkets and e-commerce. Its family of great local brands serves 55 million customers each week  both in stores and online  in the United States  Europe  and Indonesia. Together  these brands employ more than 413 000 associates in 7 452 grocery and specialty stores and include the top online retailer in the Benelux and the leading online grocers in the Benelux and the United States. Ahold Delhaize brands are at the forefront of sustainable retailing  sourcing responsibly  supporting local communities and helping customers make healthier choices. The companyâ€™s focus on four growth drivers â€“ drive omnichannel growth  elevate healthy and sustainable  cultivate best talent and strengthen operational excellence â€“ is helping to fulfil its purpose  achieve its vision and prepare its brands and businesses for tomorrow. Headquartered in Zaandam  the Netherlands  Ahold Delhaize is listed on the Euronext Amsterdam and Brussels stock exchanges (ticker: AD) and its American Depositary Receipts are traded on the over-the-counter market in the U.S. and quoted on the OTCQX International marketplace (ticker: ADRNY). For more information  please visit:www.aholddelhaize.com.,neutral,0.01,0.99,0.0,mixed,0.19,0.3,0.5,True,English,"['upsized 1.5 billion Sustainability-Linked Revolving Credit Facility', 'Ahold Delhaize', 'closing', 'ABN AMRO Bank N.V.', 'SociÃ©tÃ© GÃ©nÃ©rale', 'scope 3 carbon emissions reduction performance targets', 'â‚¬1.5 billion Sustainability-linked Revolving Credit Facility', 'Koninklijke Ahold Delhaize N.V.', 'two twelve-month extension options', 'largest food retail groups', 'total revolving commitments', 'top online retailer', 'leading online grocers', 'Brussels stock exchanges', 'American Depositary Receipts', 'OTCQX International marketplace', 'four growth drivers', 'three sustainability KPIs', 'information Press office', 'great local brands', 'other similar words', 'Ahold Delhaize brands', 'annual performance', 'food waste', 'local communities', 'omnichannel growth', 'other factors', 'other disclosures', 'new Facility', 'The Facility', 'healthier people', 'healthier planet', 'healthier choices', 'annual reports', 'Cautionary notice', 'historical facts', 'actual results', 'future results', 'Such factors', 'risk factors', 'public filings', 'current views', 'Social media', 'United States', 'sustainable retailing', 'best talent', 'operational excellence', 'Euronext Amsterdam', 'counter market', 'U.S.', 'Sustainability Coordinators', 'forward-looking statements', 'borrowing costs', 'maturity date', 'specialty stores', '55 million customers', 'Investor relations', 'Zaandam', 'Netherlands', 'closing', 'December', 'Goodness', 'strategy', 'operations', 'opportunity', 'progress', 'Ends', 'communication', 'will', 'expressions', 'risks', 'uncertainties', 'Company', 'management', 'assumptions', 'obligation', 'law', 'aholddelhaize', 'Instagram', 'LinkedIn', 'Twitter', 'world', 'leader', 'supermarkets', 'e-commerce', 'family', 'Europe', 'Indonesia', '413,000 associates', '7,452 grocery', 'Benelux', 'forefront', 'focus', 'healthy', 'purpose', 'vision', 'businesses', 'tomorrow', 'ADRNY', '2025']",2022-12-12,2022-12-12,marketscreener.com
14656,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/12/2572150/0/en/Update-on-share-repurchase-program-KBC-Ancora-until-09-December-2022.html,Update on share repurchase program KBC Ancora until 09 December 2022,Regulated information  inside information  Leuven  12 December 2022 (17:40 CET)  Update on share repurchase program KBC Ancora until 09 December 2022 ...,English Dutch FrenchRegulated information  inside information  Leuven  12 December 2022 (17:40 CET)Update on share repurchase program KBC Ancora until 09 December 2022As part of the EUR 50 million share repurchase program  as confirmed on 20 May 2022  KBC Ancora has announced that it bought back a total of 34 500 shares in the period from 05 December 2022 to 09 December 2022.The following transactions were carried out during the period in question:Transaction date Number of shares Average price (EUR) Lowest price (EUR) Highest price (EUR) Total amount (EUR) Mon 5 December 2022 5 000 41.56 40.74 41.76 207 815.00 Tue 6 December 2022 6 000 41.54 41.00 41.64 249 244.80 Wed 7 December 2022 7 000 41.41 41.08 41.74 289 860.20 Thu 8 December 2022 9 500 40.70 40.28 41.56 386 668.05 Fri 9 December 2022 7 000 40.61 40.10 40.86 284 248.30 TOTAL(period concerned) 34 500 41.10 40.10 41.76 1 417 836.35 TOTAL (overall repurchase program) 873 493 35.42 31.68 41.76 30 942 415.86All transactions were carried out in the central order book of Euronext Brussels.Since the start of the share repurchase program on 10 June 2022  KBC Ancora has bought back 873 493 of its own shares  or 1.12% of the total number of shares issued (i.e. 78 301 314)  for an average price of 35.42 euros per share and for a total amount of 30 942 416 euros. KBC Ancora has currently implemented 61.88% of the repurchase program.The repurchase program runs within the limits of the share repurchase authorization granted by the Extraordinary General Meeting of Shareholders on 30 October 2020.---------------------------------KBC Ancora is a listed company that holds 18.6% of the shares in KBC Group. Together with Cera  MRBB and the Other Permanent Shareholders  it ensures shareholder stability and the ongoing development of the KBC Group. As core shareholders of KBC Group  they have concluded a shareholdersâ€™ agreement to this end.Financial calendar:27 January 2023 Interim financial report (1H)1 September 2023 Annual press release for the financial year 2022/202327 October 2023 Annual General Meeting of ShareholdersThis press release is available in Dutch  French and English on the website www.kbcancora.be.KBC Ancora Investor Relations & Press contact: Jan BergmansTel. +32 (0)16 27 96 72email: jan.bergmans@kbcancora.be or mailbox@kbcancora.beAttachment,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['share repurchase program', 'KBC Ancora', 'Update', '09 December', 'EUR 50 million share repurchase program', 'KBC Ancora Investor Relations', 'central order book', 'Extraordinary General Meeting', 'Annual General Meeting', 'share repurchase authorization', 'Interim financial report', 'Annual press release', 'Other Permanent Shareholders', 'English Dutch French', 'Financial calendar', 'financial year', 'Press contact', 'KBC Group', 'Transaction date', 'Average price', 'Lowest price', 'Highest price', 'Euronext Brussels', 'listed company', 'shareholder stability', 'ongoing development', 'Jan Bergmans', 'jan.bergmans', 'core shareholders', 'shareholdersâ€™ agreement', 'Total amount', 'Regulated information', 'following transactions', 'Tue 6 December', 'Fri 9 December', 'total number', '12 December', '09 December', '05 December', '7 December', 'Leuven', 'Update', 'part', '20 May', '34,500 shares', 'period', 'question', 'Mon', 'start', '10 June', '35.42 euros', 'limits', '30 October', 'Cera', 'MRBB', '27 January', '1 September', '27 October', 'website', 'Tel.', 'email', 'kbcancora', 'mailbox', 'Attachment']",2022-12-12,2022-12-12,globenewswire.com
14657,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/KBC-ANCORA-SA-53036/news/Update-on-share-repurchase-program-KBC-Ancora-until-09-December-2022-42529223/?utm_medium=RSS&utm_content=20221212,Update on share repurchase program KBC Ancora until 09 December 2022,(marketscreener.com) Regulated information  inside information  Leuven  12 December 2022 Update on share repurchase program KBC Ancora until 09 December 2022 As part of the EUR 50 million share repurchase program  as confirmed on 20 May 2022  KBC Ancora has aâ€¦,Regulated information  inside information  Leuven  12 December 2022 (17:40 CET)Update on share repurchase program KBC Ancora until 09 December 2022As part of the EUR 50 million share repurchase program  as confirmed on 20 May 2022  KBC Ancora has announced that it bought back a total of 34 500 shares in the period from 05 December 2022 to 09 December 2022.The following transactions were carried out during the period in question:Transaction date Number of shares Average price (EUR) Lowest price (EUR) Highest price (EUR) Total amount (EUR) Mon 5 December 2022 5 000 41.56 40.74 41.76 207 815.00 Tue 6 December 2022 6 000 41.54 41.00 41.64 249 244.80 Wed 7 December 2022 7 000 41.41 41.08 41.74 289 860.20 Thu 8 December 2022 9 500 40.70 40.28 41.56 386 668.05 Fri 9 December 2022 7 000 40.61 40.10 40.86 284 248.30 TOTAL(period concerned) 34 500 41.10 40.10 41.76 1 417 836.35 TOTAL (overall repurchase program) 873 493 35.42 31.68 41.76 30 942 415.86All transactions were carried out in the central order book of Euronext Brussels.Since the start of the share repurchase program on 10 June 2022  KBC Ancora has bought back 873 493 of its own shares  or 1.12% of the total number of shares issued (i.e. 78 301 314)  for an average price of 35.42 euros per share and for a total amount of 30 942 416 euros. KBC Ancora has currently implemented 61.88% of the repurchase program.The repurchase program runs within the limits of the share repurchase authorization granted by the Extraordinary General Meeting of Shareholders on 30 October 2020.---------------------------------KBC Ancora is a listed company that holds 18.6% of the shares in KBC Group. Together with Cera  MRBB and the Other Permanent Shareholders  it ensures shareholder stability and the ongoing development of the KBC Group. As core shareholders of KBC Group  they have concluded a shareholdersâ€™ agreement to this end.Financial calendar:27 January 2023 Interim financial report (1H)1 September 2023 Annual press release for the financial year 2022/202327 October 2023 Annual General Meeting of ShareholdersThis press release is available in Dutch  French and English on the website www.kbcancora.be.KBC Ancora Investor Relations & Press contact: Jan BergmansTel. +32 (0)16 27 96 72email: jan.bergmans@kbcancora.be or mailbox@kbcancora.beAttachment,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['share repurchase program', 'KBC Ancora', 'Update', '09 December', 'EUR 50 million share repurchase program', 'KBC Ancora Investor Relations', 'central order book', 'Extraordinary General Meeting', 'Annual General Meeting', 'share repurchase authorization', 'Interim financial report', 'Annual press release', 'Other Permanent Shareholders', 'Financial calendar', 'financial year', 'Press contact', 'KBC Group', 'Transaction date', 'Average price', 'Lowest price', 'Highest price', 'Euronext Brussels', 'listed company', 'shareholder stability', 'ongoing development', 'core shareholders', 'shareholdersâ€™ agreement', 'Total amount', 'Regulated information', 'following transactions', 'Tue 6 December', 'Fri 9 December', 'total number', 'Jan Bergmans', '12 December', '09 December', '05 December', '7 December', '8 December', 'Leuven', 'Update', 'part', '20 May', '34,500 shares', 'period', 'question', 'Mon', 'start', '10 June', '35.42 euros', 'limits', '30 October', 'Cera', 'MRBB', '27 January', '1 September', '27 October', 'Dutch', 'English', 'website', 'Tel.', 'email', 'kbcancora', 'Attachment']",2022-12-12,2022-12-12,marketscreener.com
14658,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/PUBLIC-STORAGE-14115/news/Public-Storage-Opens-State-of-the-Art-Self-Storage-Facility-in-Silicon-Valley-s-Cupertino-Market-42530421/?utm_medium=RSS&utm_content=20221212,Public Storage Opens State-of-the-Art Self-Storage Facility in Silicon Valley's Cupertino Market,(marketscreener.com) Public Storage   the nationâ€™s leading owner  acquirer  developer  and operator of self-storage properties  announced today the reopening of a facility adjacent to Apple  Inc. offices in Cupertino  California.This press release features â€¦,Public Storage (NYSE:PSA)  the nationâ€™s leading owner  acquirer  developer  and operator of self-storage properties  announced today the reopening of a facility adjacent to Apple  Inc. offices in Cupertino  California.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221212005656/en/State-of-the-Art Public Storage Facility in Cupertino  CA. (Photo: Business Wire)The Public Storage  20565 Valley Green Drive  Cupertino location now features two five-level state-of-the-art buildings that offer our industry-leading customer experience  including app-enabled digital property access and account management  eRentalÂ® capability  and smart security cameras.We enhanced an existing  forty year old facility from 51 000 square feet to 195 000 square feet and built it with sustainability in mindâ€”including energy-efficient solar panels  motion-sensor LED lighting  and sustainable landscaping improvements. The site previously housed 585 first generation storage units and has been expanded to 2 593 climate controlled units. The facility is also being certified to LEED SilverÂ® standards.â€œWe are pleased to reopen our Cupertino facility and provide customers with a broad array of storage options â€ said Joe Russell  Public Storage Chief Executive Officer. â€œThis Cupertino location reflects one of Public Storageâ€™s unique competitive advantages; specifically the ability to redevelop and expand properties driven by our experienced development team. This development exemplifies how we are enhancing our 200 million square foot portfolio across the country through acquisition  development  and redevelopment.â€The Companyâ€™s current total development pipeline of approximately $1 billion includes over $500 million in redevelopment opportunities with 20 projects totaling 3 million square feet of new space.â€œWe thank the City of Cupertino for its support in enhancing this tremendous location â€ said Andres Friedman  Public Storage Senior Vice President of Development. â€œFor nearly five years  numerous team members across Public Storage  the City of Cupertino  and vendors have been closely aligned in the redesign  approval  construction  and completion of this landmark storage facility.â€To learn more about the project  read here.Company InformationPublic Storage  a member of the S&P 500 and FT Global 500  is a REIT that primarily acquires  develops  owns  and operates self-storage facilities. At September 30  2022  we had: (i) interests in 2 836 self-storage facilities located in 40 states with approximately 202 million net rentable square feet in the United States and (ii) a 35% common equity interest in Shurgard Self-Storage SA (Euronext Brussels:SHUR)  which owned 259 self-storage facilities located in seven Western European nations with approximately 14 million net rentable square feet operated under the ShurgardÂ® brand. Our headquarters are located in Glendale  California.Additional information about Public Storage is available on the Companyâ€™s website at PublicStorage.com.View source version on businesswire.com: https://www.businesswire.com/news/home/20221212005656/en/,neutral,0.0,1.0,0.0,positive,0.83,0.17,0.0,True,English,"['Art Self-Storage Facility', 'Public Storage', 'Silicon Valley', 'Cupertino Market', 'State', 'existing, forty year old facility', '202 million net rentable square feet', '14 million net rentable square feet', 'Public Storage Chief Executive Officer', 'app-enabled digital property access', 'seven Western European nations', '200 million square foot portfolio', '585 first generation storage units', 'current total development pipeline', '3 million square feet', 'Art Public Storage Facility', '2,593 climate controlled units', '20565 Valley Green Drive', 'industry-leading customer experience', 'smart security cameras', 'energy-efficient solar panels', 'motion-sensor LED lighting', 'sustainable landscaping improvements', 'LEED SilverÂ® standards', 'unique competitive advantages', 'Senior Vice President', 'numerous team members', '35% common equity interest', 'landmark storage facility', 'two five-level state', 'experienced development team', 'The Public Storage', 'Shurgard Self-Storage SA', '51,000 square feet', '195,000 square feet', 'art buildings', 'storage options', 'ShurgardÂ® brand', 'self-storage facilities', 'The Company', 'Cupertino facility', 'leading owner', 'press release', 'full release', 'Business Wire', 'account management', 'broad array', 'Joe Russell', 'new space', 'tremendous location', 'Andres Friedman', 'five years', 'S&P 500', 'FT Global 500', 'Euronext Brussels', 'Additional information', 'source version', 'self-storage properties', 'Company Information', 'redevelopment opportunities', 'United States', 'Cupertino location', '40 states', 'NYSE', 'PSA', 'acquirer', 'developer', 'operator', 'reopening', 'Apple', 'California', 'multimedia', 'businesswire', 'Photo', 'Â® capability', 'sustainability', 'mind', 'site', 'customers', 'country', 'acquisition', '20 projects', 'City', 'support', 'vendors', 'redesign', 'approval', 'construction', 'completion', 'REIT', 'September', 'interests', 'headquarters', 'Glendale', 'PublicStorage']",2022-12-12,2022-12-12,marketscreener.com
14659,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/12/2571565/0/en/Ahold-Delhaize-announces-closing-of-upsized-1-5-billion-Sustainability-Linked-Revolving-Credit-Facility.html,Ahold Delhaize announces closing of upsized â‚¬1.5 billion Sustainability-Linked Revolving Credit Facility,Zaandam  the Netherlands  December 12  2022 â€“ Today  Ahold Delhaize announces the closing of its â‚¬1.5 billion Sustainability-linked Revolving Credit Facility (the â€˜Facilityâ€™).,Zaandam  the Netherlands  December 12  2022 â€“ Today  Ahold Delhaize announces the closing of its â‚¬1.5 billion Sustainability-linked Revolving Credit Facility (the â€˜Facilityâ€™).The new Facility increases the total revolving commitments from â‚¬1.0 billion to â‚¬1.5 billion  reduces Ahold Delhaizeâ€™s borrowing costs  and extends the maturity date to December 2027  which may be further extended pursuant to two twelve-month extension options.The Facility links the cost of borrowing to Ahold Delhaizeâ€™s annual performance on sustainability KPIs that are aligned with its â€œGrounded in Goodnessâ€ strategy  that focuses on healthier people and a healthier planet. Specifically  the Facility includes three sustainability KPIs to reduce Ahold Delhaizeâ€™s carbon emissions within its own operations (scope 1 and 2)  reduce food waste and help customers make healthier choices. The Facility also includes the opportunity to add scope 3 carbon emissions reduction performance targets by 2025. Ahold Delhaize will report progress on its performance targets in its annual reports.ABN AMRO Bank N.V. and SociÃ©tÃ© GÃ©nÃ©rale acted as Coordinators and Sustainability Coordinators on the Facility.- Ends -Cautionary noticeThis communication includes forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Words such as may  further  subject to  will or other similar words or expressions are typically used to identify forward-looking statements.Forward-looking statements are subject to risks  uncertainties and other factors that are difficult to predict and that may cause actual results of Koninklijke Ahold Delhaize N.V. (the â€œCompany  or â€œAhold Delhaizeâ€) to differ materially from future results expressed or implied by such forward-looking statements. Such factors include  but are not limited to the risk factors set forth in the Companyâ€™s public filings and other disclosures. Forward-looking statements reflect the current views of the Companyâ€™s management and assumptions based on information currently available to the Companyâ€™s management. Forward-looking statements speak only as of the date they are made and the Company does not assume any obligation to update such statements  except as required by law.For more informationPress office: +31 88 6595134 / media.relations@aholddelhaize.comInvestor relations: +31 88 659 5213 / investor.relations@aholddelhaize.comSocial media: Instagram: @Ahold-Delhaize | LinkedIn: @Ahold-Delhaize | Twitter: @AholdDelhaizeAbout Ahold DelhaizeAhold Delhaize is one of the worldâ€™s largest food retail groups and a leader in both supermarkets and e-commerce. Its family of great local brands serves 55 million customers each week  both in stores and online  in the United States  Europe  and Indonesia. Together  these brands employ more than 413 000 associates in 7 452 grocery and specialty stores and include the top online retailer in the Benelux and the leading online grocers in the Benelux and the United States. Ahold Delhaize brands are at the forefront of sustainable retailing  sourcing responsibly  supporting local communities and helping customers make healthier choices. The companyâ€™s focus on four growth drivers â€“ drive omnichannel growth  elevate healthy and sustainable  cultivate best talent and strengthen operational excellence â€“ is helping to fulfil its purpose  achieve its vision and prepare its brands and businesses for tomorrow. Headquartered in Zaandam  the Netherlands  Ahold Delhaize is listed on the Euronext Amsterdam and Brussels stock exchanges (ticker: AD) and its American Depositary Receipts are traded on the over-the-counter market in the U.S. and quoted on the OTCQX International marketplace (ticker: ADRNY). For more information  please visit:www.aholddelhaize.com.,neutral,0.01,0.98,0.0,mixed,0.19,0.3,0.5,True,English,"['Sustainability-Linked Revolving Credit Facility', 'Ahold Delhaize', 'closing', '1.5', 'ABN AMRO Bank N.V.', 'SociÃ©tÃ© GÃ©nÃ©rale', 'scope 3 carbon emissions reduction performance targets', 'â‚¬1.5 billion Sustainability-linked Revolving Credit Facility', 'Koninklijke Ahold Delhaize N.V.', 'two twelve-month extension options', 'largest food retail groups', 'total revolving commitments', 'top online retailer', 'leading online grocers', 'Brussels stock exchanges', 'American Depositary Receipts', 'OTCQX International marketplace', 'four growth drivers', 'three sustainability KPIs', 'information Press office', 'great local brands', 'other similar words', 'Ahold Delhaize brands', 'annual performance', 'food waste', 'local communities', 'omnichannel growth', 'other factors', 'other disclosures', 'new Facility', 'The Facility', 'healthier people', 'healthier planet', 'healthier choices', 'annual reports', 'Cautionary notice', 'historical facts', 'actual results', 'future results', 'Such factors', 'risk factors', 'public filings', 'current views', 'Social media', 'United States', 'sustainable retailing', 'best talent', 'operational excellence', 'Euronext Amsterdam', 'counter market', 'U.S.', 'Sustainability Coordinators', 'forward-looking statements', 'borrowing costs', 'maturity date', 'specialty stores', '55 million customers', 'Investor relations', 'Zaandam', 'Netherlands', 'closing', 'December', 'Goodness', 'strategy', 'operations', 'opportunity', 'progress', 'Ends', 'communication', 'will', 'expressions', 'risks', 'uncertainties', 'Company', 'management', 'assumptions', 'obligation', 'law', 'aholddelhaize', 'Instagram', 'LinkedIn', 'Twitter', 'world', 'leader', 'supermarkets', 'e-commerce', 'family', 'Europe', 'Indonesia', '413,000 associates', '7,452 grocery', 'Benelux', 'forefront', 'focus', 'healthy', 'purpose', 'vision', 'businesses', 'tomorrow', 'ADRNY', '2025']",2022-12-12,2022-12-12,globenewswire.com
14660,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/STMICROELECTRONICS-N-V-4710/news/STMicroelectronics-Announces-Status-of-Common-Share-Repurchase-Program-42526953/?utm_medium=RSS&utm_content=20221212,STMicroelectronics Announces Status of Common Share Repurchase Program,(marketscreener.com) STMicroelectronics Announces Status ofCommon Share Repurchase Program Disclosure of Transactions in Own Shares â€“ Period from Dec 05  2022 to Dec 09  2022 AMSTERDAM â€“ December 12  2022 -- STMicroelectronics N.V.   a global semiconductor leâ€¦,STMicroelectronics Announces Status ofCommon Share Repurchase ProgramDisclosure of Transactions in Own Shares â€“ Period from Dec 05  2022 to Dec 09  2022AMSTERDAM â€“ December 12  2022 -- STMicroelectronics N.V. (the â€œCompanyâ€ or â€œSTMicroelectronicsâ€)  a global semiconductor leader serving customers across the spectrum of electronics applications  announces full details of its common share repurchase program (the â€œProgramâ€) disclosed via a press release dated July 1  2021. The Program was approved by a shareholder resolution dated May 27  2021 and by the supervisory board.STMicroelectronics N.V. (registered with the trade register under number 33194537) (LEI: 213800Z8NOHIKRI42W10) (Ticker: â€œSTMâ€) announces the repurchase (by a broker acting for the Company) on the regulated market of Euronext Paris  in the period between Dec 05  2022 to Dec 09  2022 (the â€œPeriodâ€)  of 109 534 ordinary shares (equal to 0.01% of its issued share capital) at the weighted average purchase price per share of EUR 36.3388 and for an overall price of EUR 3 980 338.09.The purpose of these transactions under article 5(2) of Regulation (EU) 596/2014 (the Market Abuse Regulation) was to meet obligations arising from share option programmes  or other allocations of shares  to employees or to members of the administrative  management or supervisory bodies of the issuer or of an associate company.The shares may be held in treasury prior to being used for such purpose and  to the extent that they are not ultimately needed for such purpose  they may be used for any other lawful purpose under article 5(2) of the Market Abuse Regulation.Below is a summary of the repurchase transactions made in the course of the Period in relation to the ordinary shares of STM (ISIN: NL0000226223)  in detailed form.Transactions in PeriodDates of transaction Number of shares purchased Weighted average purchase price per share (EUR) Total amount paid (EUR) Market on which the shares were bought (MIC code) 05/12/2022 20 921 36.6346 766 432.47 XPAR 06/12/2022 20 922 36.5123 763 910.34 XPAR 07/12/2022 22 991 35.7922 822 898.47 XPAR 08/12/2022 22 671 36.0110 816 405.38 XPAR 09/12/2022 22 029 36.8011 810 691.43 XPAR Total for Period 109 534 36.3388 3 980 338.09Following the share buybacks detailed above  the Company holds in total 7 207 880 treasury shares  which represents approximately 0.8% of the Companyâ€™s issued share capital.In accordance with Article 5(1)(b) of the Market Abuse Regulation and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052  a full breakdown of the individual trades in the Program are disclosed on the ST website (https://investors.st.com/stock-and-bond-information/share-buyback).About STMicroelectronicsAt ST  we are 48 000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities. An integrated device manufacturer  we work with more than 200 000 customers and thousands of partners to design and build products  solutions  and ecosystems that address their challenges and opportunities  and the need to support a more sustainable world. Our technologies enable smarter mobility  more efficient power and energy management  and the wide-scale deployment of the Internet of Things and connectivity. ST is committed to becoming carbon neutral by 2027. Further information can be found at www.st.com.For further information  please contact:INVESTOR RELATIONS:CÃ©line BerthierGroup VP  Investor RelationsTel: +41.22.929.58.12celine.berthier@st.comMEDIA RELATIONS:Alexis BretonCorporate External CommunicationsTel: +33.6.59.16.79.08alexis.breton@st.comAttachment,neutral,0.0,1.0,0.0,negative,0.0,0.3,0.7,True,English,"['Common Share Repurchase Program', 'STMicroelectronics', 'Status', 'CÃ©line Berthier Group VP', 'Common Share Repurchase Program', 'art manufacturing facilities', 'integrated device manufacturer', 'Corporate External Communications', 'global semiconductor leader', 'average purchase price', 'semiconductor supply chain', 'Commission Delegated Regulation', 'share option programmes', 'Market Abuse Regulation', 'STMicroelectronics N.V.', 'other lawful purpose', 'overall price', 'other allocations', 'regulated market', 'share capital', 'share buybacks', 'semiconductor technologies', 'electronics applications', 'full details', 'press release', 'shareholder resolution', 'supervisory board', 'trade register', 'Euronext Paris', 'administrative, management', 'supervisory bodies', 'repurchase transactions', 'detailed form', 'MIC code', 'full breakdown', 'individual trades', 'sustainable world', 'smarter mobility', 'efficient power', 'energy management', 'wide-scale deployment', 'INVESTOR RELATIONS', 'MEDIA RELATIONS', 'Total amount', 'Own Shares', '109,534 ordinary shares', 'ST website', 'investors.st', 'Alexis Breton', 'Further information', 'associate company', 'Period Dates', '7,207,880 treasury shares', 'XPAR Total', 'Status', 'Disclosure', 'Dec', 'AMSTERDAM', 'customers', 'spectrum', 'number', 'Ticker', 'broker', 'article', 'obligations', 'employees', 'members', 'issuer', 'extent', 'summary', 'course', 'ISIN', 'accordance', 'bond', '48,000 creators', 'makers', 'state', 'thousands', 'partners', 'products', 'solutions', 'ecosystems', 'challenges', 'opportunities', 'need', 'Internet', 'Things', 'connectivity', 'Attachment']",2022-12-12,2022-12-12,marketscreener.com
14661,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/PIQUADRO-S-P-A-373104/news/Piquadro-S-p-A-309CS-Piquadro-buy-back-purchase-week-December-5-9-2022-42527486/?utm_medium=RSS&utm_content=20221212,Piquadro S p A : 309CS Piquadro buy back purchase week December 5 9 2022,(marketscreener.com)   Press release   REPORT ON THE TREASURY SHARES BUY-BACK PLAN OF   PIQUADRO S.P.A.   Silla di Gaggio Montano   December 12  2022. With reference to treasury shares buy-backplan  Piquadro S.p.A. hereby announces that  during theâ€¦,Press releaseREPORT ON THE TREASURY SHARES BUY-BACK PLAN OFPIQUADRO S.P.A.Silla di Gaggio Montano (BO)  December 12  2022. With reference to treasury shares buy-backplan  Piquadro S.p.A. hereby announces that  during the period from December 5th to December 9th  2022  it purchased no. 6 585 treasury shares for a total consideration of 12 848.30 Euro  as authorized by the shareholders' meeting on July 25th  2022  already disclosed pursuant to Art. 144- bis of Consob Regulation no. 11971/1999.Details of the daily transactions on the Euronext Milan are as follows:Number of ordinary Average price (Euro) Consideration Date shares purchased (Euro) 12/05/2022 3 331 1.9297 6 427.83 12/06/2022 449 1.9550 877.80 12/07/2022 1 198 1.9771 2 368.57 12/08/2022 1 267 1.9779 2 506.00 12/09/2022 340 1.9650 668.10 Total 6 585 1.9511 12 848.30Following the above purchases and considering the treasury shares already in portfolio  as of December 9th  2022 Piquadro S.p.A. holds no. 1 775 962 treasury shares  equal to 3.5519% of the share capital.Piquadro GroupThe Piquadro Group operates in the sector of leather accessories through the Piquadro  The Bridge and Lancel brands. Cornerstones for the three brands is attention to details and the quality of the workmanship as well as the leather but the Piquadro product stands out for its innovative design and technological content  while The Bridge emphasizes the vintage flavor of Tuscan craftsmanship and finally the Lancel collections embody the Parisian allure of a fashion house founded in 1876.The origins of the Group date back to 1987 when Marco Palmieri  now President and Chief Executive Officer  founded his company near Bologna  where it is still headquartered. The distribution network extends over 50 countries around the world and counts 176 outlets including 81 Piquadro boutiques (53 in Italy and 28 abroad including 48 DOS directly operated stores and 33 franchised stores)  13 The Bridge boutiques (13 in Italy including 11 DOS directly operated stores and 2 franchised) and 82 Lancel boutiques (61 in France and 21 abroad  of which 75 DOS directly operated stores and 7 franchised). The Group's consolidated turnover for the year 2021/2022 ended on March 31  2022  is â‚¬ 149 4 million. Piquadro S.p.A. has been listed on the Italian Stock Exchange since October 2007.,neutral,0.0,1.0,0.0,neutral,0.01,0.96,0.03,True,English,"['Piquadro S', '309CS Piquadro', 'purchase', 'December', 'PIQUADRO S.P.A.', 'TREASURY SHARES BUY-BACK PLAN', 'ordinary Average price', 'Chief Executive Officer', 'Italian Stock Exchange', 'Consideration Date shares', 'The Piquadro Group', 'The Bridge boutiques', '81 Piquadro boutiques', '6,585 treasury shares', '1,775,962 treasury shares', 'Piquadro product', 'total consideration', '82 Lancel boutiques', 'The Group', 'Press release', 'Gaggio Montano', ""shareholders' meeting"", 'Consob Regulation', 'daily transactions', 'Euronext Milan', 'share capital', 'Lancel brands', 'three brands', 'innovative design', 'technological content', 'vintage flavor', 'Tuscan craftsmanship', 'Lancel collections', 'Parisian allure', 'fashion house', 'Marco Palmieri', 'distribution network', 'leather accessories', '33 franchised stores', 'REPORT', 'Silla', 'December', 'reference', 'backplan', 'period', '8.30 Euro', 'July', 'Art.', 'Details', 'Number', 'purchases', 'portfolio', 'sector', 'Cornerstones', 'attention', 'quality', 'workmanship', 'origins', 'President', 'company', 'Bologna', '50 countries', 'world', '176 outlets', 'Italy', '48 DOS', '11 DOS', 'France', '75 DOS', 'turnover', 'year', 'March', 'October', '12', '3.5', '13']",2022-12-12,2022-12-12,marketscreener.com
14662,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/INVENTIVA-34031212/news/Inventiva-draws-down-25-million-tranche-under-Finance-Contract-with-the-European-Investment-Bank-42524490/?utm_medium=RSS&utm_content=20221212,Inventiva draws down Â€25 million tranche under Finance Contract with the European Investment Bank,(marketscreener.com) Inventiva intends to use the proceeds to fund part of the pivotal Phase III clinical trial evaluating lanifibranor in patients with NASHThe â‚¬25 million supports Inventivaâ€™s anticipated cash runway1 through the fourth quarter of 2023 Daix â€¦,"Inventiva intends to use the proceeds to fund part of the pivotal Phase III clinical trial evaluating lanifibranor in patients with NASHThe â‚¬25 million supports Inventivaâ€™s anticipated cash runway1 through the fourth quarter of 2023Daix (France)  Long Island City (New York  United States)  December 12  2022 â€“ Inventiva (Euronext Paris and Nasdaq: IVA) (the â€œCompanyâ€)  a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis (â€œNASHâ€) and other diseases with significant unmet medical needs  today announced the receipt of the â‚¬25 million payment under the first tranche of the unsecured loan agreement executed with the European Investment Bank (â€œEIBâ€) on May 16  2022 with a maturity date of December 2026 (the ""Finance Contract"").Jean Volatier  Chief Financial Officer of Inventiva  stated: â€œWe are pleased to see that our long-term partnership with the EIB is bearing fruit. This payment of the first tranche of â‚¬25 million  triggered by the progress made on our NATiV3 Phase III trial and the completion of the cash injections condition precedent for this tranche  will further support the development of lanifibranor. We remain strongly focused on the recruitment of patients in our Phase III trial and are hoping to satisfy all conditions for the disbursement of the second tranche of â‚¬25 million from the EIB.â€As previously announced  the Finance Contract provides funding in two tranches of â‚¬25 million each  which are both subject to the completion of certain conditions precedent. Any drawings under the terms of the Finance Contract that have not been disbursed within 36 months from the signing of the Finance Contract  (i.e.  before May 16  2025)  cannot be completed at a later date. There is no assurance that the Company will be able to satisfy the conditions precedent for the drawing of the second tranche2.The disbursement of the first tranche (with 8% interest capitalized annually  a maturity of 4 years and a repayment in fine) was subject to  among other conditions  (i) the Company issuing warrants to EIB in accordance with the terms and conditions of the warrants agreements entered into July 1  2022  and (ii) the Companyâ€™s receipt from the date of the Finance Contract of an aggregate amount of â‚¬18 million  paid either in exchange for new shares of the Company or through the receipt of upfront or milestone payments.On June 15  2022  the Company raised â‚¬9.3 million through a capital increase under its ATM program. On November 4  2022  the Company received an upfront payment of $12 million under its collaboration agreement with Sino Biopharm.On November 28  2022  the Company issued 2 266 023 warrants to EIB  in accordance of the terms of the 25th resolution of the combined general meeting of shareholders of May 19  2022 and Article L.225-138 of the French Commercial Code  as a condition to the financing of the first tranche  representing approximately 5.4% of the Company's share capital outstanding as of the date hereof.The exercise price of the warrants is equal to â‚¬4.0152 and corresponds to 95% of the volume-weighted average price of the Company's shares on the regulated market of Euronext Paris during the last trading session preceding the decision to issue the warrants.As previously announced  the warrants have a maturity of twelve years and shall be exercisable following the earliest to occur of (i) the maturity date of the first tranche (i.e. on December 8  2026)  (ii) a change of control event  (iii) an event of default under the Finance Contract  or (iv) a repayment demand by EIB under the Finance Contract. The warrants will automatically be deemed null and void if not exercised within the twelve-year period.EIB has a put option which may require the Company to repurchase all or part of the unexercised warrants then exercisable at their intrinsic value (subject to a cap equal to the amount drawn under the Finance Contract) under certain circumstances (for example  in the event of a change of control or on the maturity date of the first tranche or in the event of default). The Company (or a substitute third party) has a call option to require EIB to sell all shares and other securities of the Company  including the warrants  to the Company  subject to certain terms and conditions. In addition  the Company has a right of first refusal to buy-back all warrants offered for sale to a third party  subject to certain terms and conditions.On the basis of the 2 266 023 new shares of the Company issuable upon exercise of all the warrants at a price of â‚¬4.0152 per new share  the Company could potentially receive gross proceeds of up to â‚¬9 098 535. There is no assurance that EIB will exercise any or all of the warrants or that the Company will receive any proceeds from the exercise of the warrants.About InventivaInventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with NASH  mucopolysaccharidoses (MPS) and other diseases with significant unmet medical needs. The Company benefits from a strong expertise and experience in the domain of compounds targeting nuclear receptors  transcription factors and epigenetic modulation. Inventiva is currently advancing one clinical candidate  has a pipeline of two preclinical programs and continues to explore other development opportunities to add to its pipeline.Inventivaâ€™s lead product candidate  lanifibranor  is currently in a pivotal Phase III clinical trial  NATiV3  for the treatment of adult patients with NASH  a common and progressive chronic liver disease for which there are currently no approved therapies. In 2020  Inventiva reported positive results from its Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH and received Breakthrough Therapy and Fast Track status from the U.S. Food and Drug Administration (â€œFDAâ€) for lanifibranor in the treatment of NASH.Inventivaâ€™s pipeline also includes odiparcil  a drug candidate for the treatment of adult MPS VI patients. As part of Inventivaâ€™s decision to focus clinical efforts on the development of lanifibranor  it suspended its clinical efforts relating to odiparcil and is reviewing available options with respect to its potential further development. Inventiva is in the process of selecting an oncology development candidate for its Hippo signaling pathway program.The Company has a scientific team of approximately 80 people with deep expertise in the fields of biology  medicinal and computational chemistry  pharmacokinetics and pharmacology  and clinical development. It owns an extensive library of approximately 240 000 pharmacologically relevant molecules  approximately 60% of which are proprietary  as well as a wholly-owned research and development facility.Inventiva is a public company listed on compartment C of the regulated market of Euronext Paris (ticker: IVA - ISIN: FR0013233012) and on the Nasdaq Global Market in the United States (ticker: IVA). www.inventivapharma.com.ContactsInventivaPascaline ClercVP of Global External Affairsmedia@inventivapharma.com+1 240 620 9175 Brunswick GroupTristan Roquet Montegon /Aude Lepreux /Matthieu BenoistMedia relationsinventiva@brunswickgroup.com+33 1 53 96 83 83 Westwicke  an ICR CompanyPatricia L. BankInvestor relationspatti.bank@westwicke.com+1 415 513-1284Important NoticeThis press release contains â€œforward-looking statementsâ€ within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements  other than statements of historical facts  included in this press release are forward-looking statements. These statements include  but are not limited to  expectations with respect to the pivotal Phase III clinical trial evaluating lanifibranor in patients with NASH  including recruitment of patients for that trial  the Companyâ€™s ability to satisfy conditions precedent to draw down on the second tranche under the EIB facility  potential future financings or strategic transactions  milestone payments and royalties  the Companyâ€™s ability to exercise its rights under the EIB facility  including its call right and right of first refusal  expectations with respect to EIBâ€™s rights under the EIB facility and EIBâ€™s potential exercise of warrants  the expected use of proceeds from the EIB facility  and the sufficiency of Inventivaâ€™s cash resources and cash runway. Certain of these statements  forecasts and estimates can be recognized by the use of words such as  without limitation  â€œbelievesâ€  â€œanticipatesâ€  â€œexpectsâ€  â€œintendsâ€  â€œplansâ€  â€œseeksâ€  â€œestimatesâ€  â€œmayâ€  â€œwillâ€  â€œwouldâ€  â€œcouldâ€  â€œmightâ€  â€œshouldâ€  and â€œcontinueâ€ and similar expressions. Such statements are not historical facts but rather are statements of future expectations and other forward-looking statements that are based on management's beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results  performance or future events to differ materially from those expressed or implied in such statements. Future events are difficult to predict and may depend upon factors that are beyond Inventiva's control. There can be no guarantees with respect to pipeline product candidates that the clinical trial results will be available on their anticipated timeline  that future clinical trials will be initiated as anticipated  that product candidates will receive the necessary regulatory approvals. Actual results may turn out to be materially different from the anticipated future results  performance or achievements expressed or implied by such statements  forecasts and estimates  due to a number of factors  including that Inventiva is a clinical-stage company with no approved products and no historical product revenues  Inventiva has incurred significant losses since inception  Inventiva has a limited operating history and has never generated any revenue from product sales  Inventiva will require additional capital to finance its operations  Inventiva's future success is dependent on the successful clinical development  regulatory approval and subsequent commercialization of current and any future product candidates  preclinical studies or earlier clinical trials are not necessarily predictive of future results and the results of Inventiva's clinical trials may not support Inventiva's product candidate claims  Inventiva may encounter substantial delays in its clinical trials or Inventiva may fail to demonstrate safety and efficacy to the satisfaction of applicable regulatory authorities  enrolment and retention of patients in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside Inventiva's control  Inventiva's product candidates may cause adverse drug reactions or have other properties that could delay or prevent their regulatory approval  or limit their commercial potential  Inventiva faces substantial competition and Inventivaâ€™s business  and preclinical studies and clinical development programs and timelines  its financial condition and results of operations could be materially and adversely affected by the current COVID-19 pandemic and geopolitical events  such as the conflict between Russia and Ukraine  related sanctions and related impacts and potential impacts on the initiation  enrolment and completion of Inventivaâ€™s clinical trials on anticipated timelines and macroeconomic conditions  including global inflation and uncertain financial markets or at all. Given these risks and uncertainties  no representations are made as to the accuracy or fairness of such forward-looking statements  forecasts and estimates. Furthermore  forward-looking statements  forecasts and estimates only speak as of the date of this press release. Readers are cautioned not to place undue reliance on any of these forward-looking statements.Please refer to the Universal Registration Document for the year ended December 31  2021 filed with the AutoritÃ© des MarchÃ©s Financiers on March 11  2022  the Annual Report on Form 20-F for the year ended December 31  2021 filed with the Securities and Exchange Commission on March 11  2022 and the financial report for the first half of 2022 filed with the Securities and Exchange Commission on September 22  2022 for additional information in relation to such factors  risks and uncertainties.All information in this press release is as of the date of the release. Except as required by law  Inventiva has no intention and is under no obligation to update or review the forward-looking statements referred to above.1 This estimate is based on the Companyâ€™s current business plan and excludes any potential milestones payable to or by the Company and any additional expenditures related to the potential continued development of the odiparcil program or resulting from the potential in-licensing or acquisition of additional product candidates or technologies  or any associated development the Company may pursue. The Company may have based this estimate on assumptions that are incorrect and the Company may end up using its resources sooner than anticipated.2 The disbursement of the second tranche is subject to  among other conditions  (i) the full drawdown of the first tranche  (ii) the receipt by the Company from the date of the EIB credit facility of an aggregate amount of at least â‚¬70 million (inclusive of the â‚¬18 million that was a condition for the disbursement of the first tranche)  paid either in exchange for Company shares  or through upfront or milestone payments  (iii) an out-licensing  partnership or royalty transaction with an upfront payment of at least â‚¬10 million; and (iv) operational criteria based on patient enrollment and number of sites activated in the Companyâ€™s Phase III clinical trial of lanifibranor in patients with NASH.Attachment",neutral,0.0,1.0,0.0,positive,0.84,0.15,0.01,True,English,"['European Investment Bank', '25 million tranche', 'Finance Contract', 'Inventiva', 'pivotal Phase III clinical trial', 'oral small molecule therapies', 'significant unmet medical needs', 'NATiV3 Phase III trial', 'Long Island City', 'European Investment Bank', 'Chief Financial Officer', 'combined general meeting', 'French Commercial Code', 'last trading session', 'unsecured loan agreement', 'volume-weighted average price', 'substitute third party', 'clinical-stage biopharmaceutical company', 'collaboration agreement', 'cash runway1', 'fourth quarter', 'New York', 'United States', 'Euronext Paris', 'non-alcoholic steatohepatitis', 'other diseases', 'Finance Contract', 'Jean Volatier', 'long-term partnership', 'cash injections', 'two tranches', 'milestone payments', 'capital increase', 'ATM program', 'Sino Biopharm', '25th resolution', 'share capital', 'regulated market', 'twelve-year period', 'put option', 'intrinsic value', 'call option', 'other securities', 'first refusal', 'new share', 'first tranche', 'second tranche', 'â‚¬25 million payment', 'later date', 'aggregate amount', 'twelve years', 'repayment demand', 'conditions precedent', 'other conditions', 'exercise price', 'gross proceeds', 'maturity date', 'The Company', 'upfront payment', 'warrants agreements', 'unexercised warrants', 'control event', '4 years', 'shares', '2,266,023 warrants', 'Inventiva', 'lanifibranor', 'patients', 'NASH', 'Daix', 'France', 'Nasdaq', 'development', 'treatment', 'receipt', 'EIB', 'May', 'December', 'fruit', 'progress', 'completion', 'recruitment', 'disbursement', 'funding', 'drawings', 'terms', '36 months', 'signing', 'assurance', '8% interest', 'fine', 'accordance', 'July', 'exchange', 'June', 'November', 'shareholders', 'Article', 'financing', 'decision', 'default', 'circumstances', 'example', 'addition', 'right', 'sale', 'basis', 'research', 'mucopolysaccharid']",2022-12-12,2022-12-12,marketscreener.com
14663,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/GRIFOLS-S-A-25530828/news/Grifols-S-A-December-12-2022Grifols-recognized-as-one-of-the-world-s-most-sustainable-companies-by-42525454/?utm_medium=RSS&utm_content=20221212,Grifols S A : December 12 2022Grifols recognized as one of the world's most sustainable companies by Dow Jones Sustainability Index for third consecutive year,(marketscreener.com)   Grifols recognized as one of the world's most   sustainable companies by Dow Jones Sustainability   Index for third consecutive year    Grifols has been included in the Dow Jones Sustainability World Index for the second conâ€¦,"Grifols recognized as one of the world's most sustainable companies by Dow Jones Sustainability Index for third consecutive year Grifols has been included in the Dow Jones Sustainability World Index (DJSI World) for the second consecutive year and the Dow Jones Sustainability Europe Index (DJSI Europe) for third straight yearGrifols continues to rank among the five top-scoring biotechnology companies  excelling in corporate citizenship and philanthropy  climate strategy  human rights  environmental and social reporting  and marketing practicestop-scoring biotechnology companies  excelling in corporate citizenship and philanthropy  climate strategy  human rights  environmental and social reporting  and marketing practices This strong positioning in the DJSI reflects Grifols' standing as a sustainability leader  on the back of recent efforts to strengthen its longstanding corporate responsibility actions in diversity and inclusion  equality and climate change Barcelona  Spain  December 12  2022.- Grifols (MCE: GRF  MCE: GRF.P  NASDAQ: GRFS)  a global healthcare company and leading manufacturer of plasma-derived medicines that has been enhancing people's health and well-being for more than 110 years  has announced it has been included in the Dow Jones Sustainability World Index for the second consecutive year and the Dow Jones Sustainability Europe Index for the third straight year. The company's inclusion in these two prestigious indices evidences its longstanding leadership position and commitment to transparency in environmental  social and governance (ESG) matters. Grifols ranked among the five top-scoring global leaders in its industry. This year  the Dow Jones Sustainability Index (DJSI) posted a record number of 1 728 companies assessed in 2022  an increase of 9% over last year. The DJSI are investor-led and serve as a benchmark for investors who integrate sustainability considerations into their portfolios and seek best-in-class performance. They are considered to be among the most prestigious global indicators of corporate sustainability leadership and ESG performance thanks to the extensive number of companies assessed and the rigorous nature of the annual assessment process. ""We are once again truly honored to be included in the prestigious Dow Jones Sustainability Index as one of the world's most sustainable companies. The recognition reflects our unwavering and longstanding commitment to prioritizing the health and safety of donors and patients  contributing to society and the environment while supporting our employees. Page 1 of 4""Sustainability is and has been at the core of all we do as a company and is therefore also a priority in our agenda for 2030 as we continue to grow and meet evolving changes in society. ""Our efforts are always guided by our strong values and the aim to demonstrate true leadership in our industry and the world we operate in "" said Thomas Glanzmann  Chairperson of the Grifols' Board Sustainability Committee. Grifols' strong performance this year was driven largely by its top scores in corporate citizenship and philanthropy  environmental and social reporting  and marketing practices  coupled with the significant improvements recorded in human rights  risk and crisis management and health outcome contribution. ""We have achieved this excellent outcome again thanks to the dedication of Grifols' employees  who are crucial to making sustainability an essential part of our culture  business model and practices. We are more than ready to continue addressing the defining issues of our time and to respond to the global challenges of climate  health and equity "" said Nuria Pascual  Vice President and Investor Relations and Sustainability Officer. For more information on Grifols' ESG initiatives and progress  please visit Sustainability | Grifolsand read more about our commitment in Integrated and Sustainability Annual Report. About the Dow Jones Sustainability Index (DJSI) The Dow Jones Sustainability Index (DJSI)  jointly developed by S&P Dow Jones Index and RobecoSAM  are corporate sustainability evaluation indices for environmental  social and governance (ESG) investment that serve as a benchmark for investors who integrate sustainability considerations into their portfolios and look for best-in-class performance. The indices have achieved an iconic status as the global standard for measuring and advancing corporate ESG practices. More specifically  the DJSI World targets the top 10% of ESG performers which S&P Global considers key to generating long-term stakeholder value. To prepare the Dow Jones Sustainability Index  S&P Dow Jones applies a transparent  rules- based constituent selection process based on companies' S&P Global Corporate Sustainability Assessment (CSA). The CSA consists of an extended questionnaire assessing both public and non-public data submitted by participating companies. This year  more than 10 000 publicly traded companies were invited to participate in the S&P Global CSA. Grifols Sustainability recognitions Grifols has been included in the FTSE4Good Global  FTSE4Good Europe and FTSE4Good Ibex sustainability stock market indices since 2018  and on the Euronext Vigeo Europe 120 and Euronext Vigeo Eurozone 120 indices  based on the Vigeo Eiris assessment  since 2020. Since 2021  Grifols has also been included in the Bloomberg Gender-Equality Index (GEI) in recognition of its commitment to addressing gender inequality. Page 2 of 4Investor contact: Investor Relations and Sustainability inversores@grifols.com- investors@grifols.com sostenibilidad@grifols.com- sustainability@grifols.comTel. +34 93 571 02 21 Media contacts: Raquel Lumbreras Raquel_lumbreras@duomocomunicacion.com Grifols Borja GÃ³mez Press Office Borja_gomez@duomocomunicacion.com media@grifols.com Duomo ComunicaciÃ³n - Grifols Press Office Tel. +34 93 571 00 02 Tel. +34 91 311 92 89 - 91 311 92 90 +34 659 57 21 85 / +34 650 40 22 25 About Grifols Grifols is a global healthcare company which was founded in Barcelona in 1909 and is committed to improving the health and well-being of people around the world. Its three main business units - Biopharma  Diagnostic and Bio Supplies - develop  produce and market innovative solutions and services that are sold in more than 110 countries. A pioneer in the plasma industry  Grifols operates a growing network of donation centers worldwide. It transforms collected plasma into essential medicines to treat rare  chronic and  at times  life-threatening conditions. As a recognized leader in transfusion medicine  Grifols also offers a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion. In addition  the company supplies tools  information and services that enable hospitals  pharmacies and healthcare professionals to efficiently deliver expert medical care. Grifols  with more than 27 000 employees in more than 30 countries  is committed to a sustainable business model that sets the standard for continuous innovation  quality  safety and ethical leadership. In 2021  Grifols' economic impact in its core countries of operation was EUR 7.7 billion. The company also generated 141 500 jobs  including indirect and induced jobs. The company's class A shares are listed on the Spanish Stock Exchange  where they are part of the Ibex-35 (MCE:GRF). Grifols non-voting class B shares are listed on the Spanish Main Market (MCE:GRF.P) and on the U.S. NASDAQ through ADRs (NASDAQ:GRFS). For more information about Grifols  please visit www.grifols.com Page 3 of 4",neutral,0.01,0.99,0.0,positive,0.9,0.1,0.0,True,English,"['Dow Jones Sustainability Index', 'Grifols S A', 'third consecutive year', 'sustainable companies', 'world', 'transparent, rules- based constituent selection process', 'S&P Global Corporate Sustainability Assessment', 'S&P Dow Jones Index', 'Dow Jones Sustainability Europe Index', 'prestigious Dow Jones Sustainability Index', 'The Dow Jones Sustainability Index', 'Dow Jones Sustainability World Index', 'five top-scoring global leaders', 'S&P Global CSA', 'longstanding corporate responsibility actions', 'corporate sustainability evaluation indices', ""Grifols' Board Sustainability Committee"", 'five top-scoring biotechnology companies', 'annual assessment process', 'prestigious global indicators', 'Sustainability Annual Report', 'corporate sustainability leadership', 'two prestigious indices', 'long-term stakeholder value', 'third consecutive year', 'second consecutive year', 'third straight year', 'longstanding leadership position', 'Grifols Sustainability recognitions', 'global healthcare company', 'corporate ESG practices', 'health outcome contribution', ""Grifols' ESG initiatives"", 'DJSI Europe', 'sustainability considerations', 'Sustainability Officer', 'The CSA', 'corporate citizenship', 'global challenges', 'global standard', 'FTSE4Good Global', 'last year', 'true leadership', 'The DJSI', 'excellent outcome', 'ESG) matters', 'ESG performance', 'ESG) investment', 'ESG performers', 'longstanding commitment', 'human rights', 'marketing practices', 'strong positioning', 'leading manufacturer', 'plasma-derived medicines', 'record number', 'class performance', 'extensive number', 'rigorous nature', 'evolving changes', 'strong values', 'Thomas Glanzmann', 'strong performance', 'top scores', 'significant improvements', 'crisis management', 'essential part', 'business model', 'defining issues', 'Nuria Pascual', 'Vice President', 'Investor Relations', 'iconic status', 'extended questionnaire', 'non-public data', 'DJSI World', 'sustainable companies', 'participating companies', 'climate strategy', 'climate change', 'social reporting', 'recent efforts', ""Grifols' employees"", '1,728 companies', 'environmental', 'back', 'diversity', 'inclusion', 'equality', 'Barcelona', 'Spain', 'MCE', 'GRF', 'NASDAQ', 'people', 'well-being', '110 years', 'transparency', 'governance', 'industry', 'increase', 'benchmark', 'investors', 'portfolios', 'unwavering', 'safety', 'donors', 'patients', 'society', 'Page', 'priority', 'agenda', 'aim', 'Chairperson', 'risk', 'dedication', 'culture', 'time', 'equity', 'information', 'progress', 'Grifolsand', 'Integrated', 'RobecoSAM', '10,000 publicly']",2022-12-12,2022-12-12,marketscreener.com
14664,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/12/2571496/0/en/BGHL-GBP-NAV-s.html,BGHL (GBP): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED      Ordinary Shares      The Directors of Boussard & Gavaudan...,"BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 09 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5919 Â£ 24.2440 Estimated MTD return 0.24 % 0.31 % Estimated YTD return -5.51 % -4.19 % Estimated ITD return 175.92 % 142.44 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.20 N/A Premium/discount to estimated NAV -19.54 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.51 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 241.2422 Class GBP A Shares (estimated) Â£ 129.3125The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.For further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.2,0.8,True,English,"['BGHL', 'GBP', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'Class GBP A Shares', 'A N/A Average Price', 'London Stock Exchange plc', 'N/A Sterling Shares Amsterdam', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Euro Shares Amsterdam', 'Sterling Shares Shares', 'A N/A Range', 'US Investment Company Act', 'expert financial advice', 'GAVAUDAN HOLDING LIMITED', 'Guernsey Policy Council', 'collective investment scheme', 'UK Listing Authority', 'other professional advice', 'BG Fund ICAV', 'closed-ended investment company', 'US Securities Act', 'Gavaudan Investment Management', 'investment manager fees', 'BG Fund NAV', 'N/A Shares', 'The Shares', 'Dutch Authority', 'Price N', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Financial Markets', 'The Directors', 'Emmanuel Gavaudan', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'main market', 'United States', 'following information', 'information purposes', 'necessary approval', 'future results', 'listed securities', 'Market information', 'LSE) Market', 'BOUSSARD', 'business', 'returns', 'AEX', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-12,2022-12-12,globenewswire.com
14665,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/FERRARI-N-V-25600249/news/Ferrari-N-v-Periodic-Report-on-the-Buyback-Program-42530103/?utm_medium=RSS&utm_content=20221212,Ferrari N.v.: Periodic Report on the Buyback Program,(marketscreener.com) Maranello   December 12  2022 â€“ Ferrari N.V. informs that the Company has purchased  under the Euro 200 million share buyback program announced on December 1  2022  as the second tranche of the multi-year share buyback program of approximâ€¦,Maranello (Italy)  December 12  2022 â€“ Ferrari N.V. (NYSE/EXM: RACE) (â€œFerrariâ€ or the â€œCompanyâ€) informs that the Company has purchased  under the Euro 200 million share buyback program announced on December 1  2022  as the second tranche of the multi-year share buyback program of approximately Euro 2 billion expected to be executed by 2026 in line with the disclosure made during the 2022 Capital Markets Day (the â€œSecond Trancheâ€)  the additional common shares - reported in aggregate form  on a daily basis - on the Euronext Milan (EXM) and on the New York Stock Exchange (NYSE) as follows:EXM NYSE Total Trading Number of common shares purchased Average price per share Consideration excluding fees Number of common shares purchased Average price per share Consideration excluding fees Consideration excluding fees Number of common shares purchased Average price per share Consideration excluding fees Date excluding fees excluding fees excluding fees (d/m/y) (â‚¬) (â‚¬) ($) ($) (â‚¬)* (â‚¬)* (â‚¬)* 02/12/2022 6 405 215.3180 1 379 111.79 - - - - 6 405 215.3180 1 379 111.79 05/12/2022 6 470 214.7257 1 389 275.28 - - - - 6 470 214.7257 1 389 275.28 06/12/2022 7 370 212.2501 1 564 283.24 7 565 220.0351 1 664 565.53 1 582 888.49 14 935 210.7246 3 147 171.73 07/12/2022 7 715 210.5572 1 624 448.80 5 329 220.3548 1 174 270.73 1 115 272.80 13 044 210.0369 2 739 721.60 08/12/2022 8 000 209.0239 1 672 191.20 - - - - 8 000 209.0239 1 672 191.20 09/12/2022 7 650 209.0428 1 599 177.42 - - - - 7 650 209.0428 1 599 177.42 43 610 211.6140 9 228 487.73 12 894 220.1672 2 838 836.26 2 698 161.28 56 504 211.0762 11 926 649.01 Total(*) translated at the European Central Bank EUR/USD exchange reference rate as of the date of each purchaseSince the announcement of such Second Tranche till December 9  2022  the total invested consideration has been:Euro 9 228 487.73 for No. 43 610 common shares purchased on the EXMUSD 2 838 836.26 (Euro 2 698 161.28*) for No. 12 894 common shares purchased on the NYSE.On December 2  2022  in the Ferrari Group employeesâ€™ granting share process  the Company assigned No. 11 218 common shares held in treasury. On the same day Ferrari purchased  in a â€œcross orderâ€ transaction executed on the EXM  No. 3 366 common shares in order to cover individual's taxable income as standard practice (Sell to Cover) at the average price of Euro 215.7000 per share.As of December 9  2022  the Company held in treasury No. 11 884 133 common shares equal to 4.62% of the total issued share capital including the common shares and the special voting shares  net of shares assigned under the Companyâ€™s equity incentive plan.Since July 1  2022 until December 9  2022  the Company has purchased a total of 830 241 own common shares on EXM and NYSE  including transactions for Sell to Cover  for a total consideration of Euro 162 652 328.72.A comprehensive overview of the transactions carried out under the buyback program  as well as the details of the above transactions  are available on Ferrariâ€™s corporate website under the Buyback Programs section ( https://www.ferrari.com/en-EN/corporate/buyback-programs ).Attachment,neutral,0.0,1.0,0.0,neutral,0.0,0.99,0.01,True,English,"['Ferrari N.v.', 'Periodic Report', 'Buyback Program', 'Ferrari Group employeesâ€™ granting share process', 'New York Stock Exchange', 'EUR/USD exchange reference rate', 'EXM NYSE Total Trading Number', '200 million share buyback program', 'multi-year share buyback program', 'Buyback Programs section', 'European Central Bank', 'equity incentive plan', 'special voting shares', 'Ferrari N.V.', '2022 Capital Markets Day', 'cross orderâ€ transaction', 'additional common shares', 'No. 43,610 common shares', 'No. 12,894 common shares', 'No. 11,218 common shares', 'No. 3,366 common shares', 'share capital', '884,133 common shares', 'same day', 'treasury No.', 'second tranche', 'aggregate form', 'daily basis', 'Euronext Milan', 'Average price', 'taxable income', 'standard practice', 'comprehensive overview', 'corporate website', 'total consideration', 'Maranello', 'Italy', 'December', 'NYSE/EXM', 'RACE', 'Company', 'line', 'disclosure', 'fees', 'Date', 'purchase', 'announcement', 'individual', 'July', 'transactions', 'Sell', 'Cover', 'details', 'buyback-programs', 'Attachment', '830,241']",2022-12-12,2022-12-12,marketscreener.com
14666,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/BOUSSARD-GAVAUDAN-HOLDI-36044/news/BGHL-EUR-NAV-s-42524081/?utm_medium=RSS&utm_content=20221212,BGHL (EUR): NAV(s),(marketscreener.com)  Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited...https://www.marketscreener.com/quote/stock/BOUSSARD-GAVAUDAN-HOLDI-36044/news/BGHL-EUR-NAV-â€¦,"BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 09 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5919 Â£ 24.2440 Estimated MTD return 0.24 % 0.31 % Estimated YTD return -5.51 % -4.19 % Estimated ITD return 175.92 % 142.44 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.20 N/A Premium/discount to estimated NAV -19.54 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.51 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 241.2422 Class GBP A Shares (estimated) Â£ 129.3125The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.For further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.2,0.8,True,English,"['BGHL', 'EUR', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'Class GBP A Shares', 'A N/A Average Price', 'London Stock Exchange plc', 'N/A Sterling Shares Amsterdam', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Euro Shares Amsterdam', 'Sterling Shares Shares', 'A N/A Range', 'US Investment Company Act', 'expert financial advice', 'GAVAUDAN HOLDING LIMITED', 'Guernsey Policy Council', 'collective investment scheme', 'UK Listing Authority', 'other professional advice', 'BG Fund ICAV', 'closed-ended investment company', 'US Securities Act', 'Gavaudan Investment Management', 'investment manager fees', 'BG Fund NAV', 'N/A Shares', 'The Shares', 'Dutch Authority', 'Price N', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Financial Markets', 'The Directors', 'Emmanuel Gavaudan', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'main market', 'United States', 'following information', 'information purposes', 'necessary approval', 'future results', 'listed securities', 'Market information', 'LSE) Market', 'BOUSSARD', 'business', 'returns', 'AEX', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-12,2022-12-12,marketscreener.com
14667,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/HYDROGENE-DE-FRANCE-124047110/news/Hydrogene-De-France-HDF-Energy-global-pioneer-of-hydrogen-power-plants-celebrates-its-10th-a-42529451/?utm_medium=RSS&utm_content=20221212,HydrogÃ¨ne De France :  HDF Energy  global pioneer of hydrogen power plants  celebrates its 10th anniversary!,(marketscreener.com)  Bordeaux  December 12  2022 â€“ HDF Energy proudly celebrates its 10th anniversary. Over the course of a decade  the company has become an expert in high-power hydrogen power plants.A major accomplishment of the company's industrial devâ€¦,"Bordeaux  December 12  2022 â€“ HDF Energy proudly celebrates its 10th anniversary. Over the course of a decade  the company has become an expert in high-power hydrogen power plants.A major accomplishment of the company's industrial development will be the opening of its ""gigafactory"". This manufacturing plant will mass-produce high-powered fuel cells serving not only the power industry  but also the heavy maritime and rail mobility sectors.HDF Energy was founded in December 2012 by Damien Havard with the vision that hydrogen could be a perfect means to massively store clean power whilst offsetting the intermittency of renewable energy. Today  HDF Energy provides a competitive solution to produce decarbonized electricity through its power plants  and its fuel cell factory which will be operational at the end of 2023.Below are the milestones of the last 10 years:2012 : Creation of the company.: Creation of the company. 2013/2014 : Development of a hydrogen ecosystem for mobility purposes  natural gas networks and power production from fuel cells.Creation of the â€œH2Bus Franceâ€ cluster to promote hydrogen buses and initiate the deployment of 300 buses on the continent  in coordination with other European clusters.: Development of a hydrogen ecosystem for mobility purposes  natural gas networks and power production from fuel cells. Creation of the â€œH2Bus Franceâ€ cluster to promote hydrogen buses and initiate the deployment of 300 buses on the continent  in coordination with other European clusters. 2015/2016 : Launch of the Cleargen project in Martinique: first installation of a high-powered fuel cell producing electricity from excess hydrogen from the SARA refinery.: Launch of the Cleargen project in Martinique: first installation of a high-powered fuel cell producing electricity from excess hydrogen from the SARA refinery. 2017/2018 : Launch of the CEOG project in French Guiana: this is the world's first high-power hydrogen power plant  which is now being replicated in more than 20 countries. Meridiam joined the project as the main investor.: Launch of the CEOG project in French Guiana: this is the world's first high-power hydrogen power plant  which is now being replicated in more than 20 countries. Meridiam joined the project as the main investor. 2020 : Opening of HDF's offices in Indonesia and in Australia. The partnership with Ballard to develop and manufacture high-power fuel cells was formed in the same year.: Opening of HDF's offices in Indonesia and in Australia. The partnership with Ballard to develop and manufacture high-power fuel cells was formed in the same year. 2021: Initial public offering. Financial closing and start of construction of the CEOG project. In this same year  HDF opens offices in South Africa  Mexico  and the Caribbean.Today   HDF Energy is the leading developer of hydrogen power plants with a presence in 25 countries spanning five continents and 26 nationalities among its employees. The company is developing a business portfolio of more than 5 billion euros. This is notably in Australia  Barbados  Ecuador  French Guiana  Indonesia  Mexico  Namibia  New Caledonia  the Philippines  South Africa  and Trinidad and Tobago.The year 2023 will be marked by the construction of the company's ""gigafactory"" near Bordeaux in France where HDF Energy will mass-produce the most strategic component of its power plants: high-power fuel cells. By taking part in this industrial activity  HDF Energy  which is already a worldwide major player in the power sector  will also become a major player in the heavy marine and rail mobility. Together with strategic partners  the company is developing hydrogen freight locomotives and projects for the propulsion of large ships and the generation of their auxiliary power.Damien Havard  CEO of HDF Energy  declared : ""Over the past decade  HDF has positioned itself as the leading pioneer in hydrogen power. Our development â€“ especially since our IPO â€“ has been fast and we now have projects all over the world. And there is much more to come! In 2023  we will continue to grow through the construction of our gigafactory and the development of new large-scale products. What great opportunities! We can be very proud of our concrete everyday action in the global energy transition process.""ABOUT HDF ENERGYHDF Energy is the global pioneer of high-power hydrogen power plants. The company develops  finances  builds  and operates two power plant models that produce non-intermittent  non-polluting renewable energy  24/7:RenewstableÂ® (POWER TO POWER): Multi-megawatt power plants producing firm power from an intermittent renewable energy source (wind or solar) and massive energy storage in the form of green hydrogen generated on site;HyPowerÂ® (GAS TO POWER): Multi-megawatt power plants producing electricity on demand from decarbonized hydrogen coming from gas transport networks or from industries wasting unvalued hydrogen.HDF Energy is also an industrial company that will mass produce from 2023 in its French factory the most strategic component of its power plants: high-power fuel cells. By taking part in this industrial activity  HDF Energy  which is already a worldwide major player in the power sector  will also become a player in the heavy marine and rail mobility. Together with strategic partners  the company is developing hydrogen freight locomotives and projects for the propulsion of large ships and the generation of their auxiliary power.Present on five continents  HDF Energy has a business portfolio of more than 5 billion euros to date.HDF Energy is listed on Euronext Paris.More information about HDF Energy here:www.hdf-energy.comMedia contactInvestor relations Media relations Margaux ROUILLARD+ 33 (0)1 53 67 36 32hdf-energy@actus.fr Serena BONI+33 (0)4 72 18 04 92sboni@actus.frThis publication embed ""ðŸ”’ Actusnews SECURITY MASTER "".- SECURITY MASTER Key: mmhuZ8WXZpidx3KfZcmXb5OUbZeVx2GbmpfGk5ObZJycbG+Vx2uXa8eVZnBom2dq- Check this key: https://www.security-master-key.com.Unregulated information:Full and original press release in PDF: https://www.actusnews.com/news/77624-hdf_pr-10-years_en_final.pdfReceive by email the next press releases of the company by registering on www.actusnews.com  it's freeÂ© 2022 ActusNews",neutral,0.02,0.98,0.0,mixed,0.7,0.17,0.13,True,English,"['HydrogÃ¨ne De France', 'hydrogen power plants', 'HDF Energy', 'global pioneer', '10th anniversary', 'first high-power hydrogen power plant', 'two power plant models', 'global energy transition process', 'intermittent renewable energy source', 'high-power hydrogen power plants', 'high-power fuel cells', 'natural gas networks', 'other European clusters', 'Initial public offering', 'concrete everyday action', 'gas transport networks', 'high-powered fuel cell', 'hydrogen freight locomotives', 'Multi-megawatt power plants', 'GAS TO POWER', 'new large-scale products', 'massive energy storage', 'H2Bus Franceâ€ cluster', 'fuel cell factory', 'worldwide major player', 'rail mobility sectors', 'manufacturing plant', 'first installation', 'global pioneer', 'hydrogen ecosystem', 'excess hydrogen', 'green hydrogen', 'decarbonized hydrogen', 'unvalued hydrogen', 'power industry', 'clean power', 'power production', 'power sector', 'auxiliary power', 'firm power', 'New Caledonia', 'French factory', 'major accomplishment', 'mobility purposes', 'hydrogen buses', 'HDF Energy', '10th anniversary', 'heavy maritime', 'Damien Havard', 'perfect means', 'competitive solution', 'last 10 years', 'SARA refinery', 'French Guiana', 'main investor', 'Financial closing', 'South Africa', 'leading developer', 'five continents', 'business portfolio', '5 billion euros', 'strategic component', 'industrial activity', 'heavy marine', 'strategic partners', 'large ships', 'leading pioneer', 'great opportunities', 'same year', 'Cleargen project', 'CEOG project', 'past decade', 'decarbonized electricity', 'industrial development', 'industrial company', '300 buses', 'Bordeaux', 'December', 'course', 'expert', 'opening', 'gigafactory', 'vision', 'intermittency', 'end', 'milestones', 'Creation', 'deployment', 'coordination', 'Launch', 'Martinique', '20 countries', 'Meridiam', 'offices', 'Indonesia', 'Australia', 'partnership', 'Ballard', 'start', 'construction', 'Mexico', 'Caribbean', 'presence', '25 countries', '26 nationalities', 'employees', 'Barbados', 'Ecuador', 'Namibia', 'Philippines', 'Trinidad', 'projects', 'propulsion', 'generation', 'IPO', 'wind', 'solar', 'form', 'site', 'HyPowerÂ®', 'demand', 'industries', 'produce', '2023']",2022-12-12,2022-12-12,marketscreener.com
14668,EuroNext,NewsApi.org,https://www.marketscreener.com/quote/stock/UCB-5963/news/UCB-Changes-in-UCB-s-Board-of-Directors-42529608/?utm_medium=RSS&utm_content=20221212,UCB : Changes in UCB's Board of Directors,(marketscreener.com)  Changes in UCB's Board of Directors   Brussels   12 December 2022 - 18:00 - Regulated information  Inside information - UCB SA/NV announces that the Board of Directors accepted today the resignation of Stefan Oschmann as Chairman andâ€¦,"Brussels (Belgium)  12 December 2022 - 18:00 (CET) - Regulated information  Inside information - UCB SA/NV announces that the Board of Directors accepted today the resignation of Stefan Oschmann as Chairman and Board member of UCB. Fiona du Monceau  currently Vice Chair of the Board  will take the role of Chair ad interim until a new Chair is announced.Stefan Oschmann joined UCB as Chairman in 2021 and decided to step down for personal reasons.We would like to thank Stefan for sharing with us his strategic business experience in life sciences and wealth of external expertise. We wish him well in his future endeavors.Fiona du Monceau brings 20 years of experience in life sciences. She is COO of ExeVir Bio and a board member of FinanciÃ¨re de Tubize SA since 2014. Previously  Fiona was Venture Partner at UCB Ventures and UCB Evenity Commercial Lead and Head of EU for the Bone business. Prior to UCB  she led various teams at Eli Lilly  managed business units and implemented new models. Fiona also worked for McKinsey & Company covering healthcare clients in the US and Europe and worked in business development at GSK Biologicals. She has an MBA from Harvard Business School and a MSc in Management from the Belgian Solvay Business School (ULB). She is a Fulbright and a Belgian American Education Foundation (BAEF) scholar. Fiona was a governor of the London Business School and a member of their audit and risk committee until May 2022.For further information  contact UCB:Investor RelationsAntje WitteT +32.2.559.94.14 email antje.witte@ucb.comCorporate CommunicationsLaurent SchotsT +32.2.559.92.64 email laurent.schots@ucb.comAbout UCBUCB  Brussels  Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With approximately 8 600 people in approximately 40 countries  the company generated revenue of â‚¬5.8 billion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news.Forward looking statementsThis press release may contain forward-looking statements including  without limitation  statements containing the words ""believes""  ""anticipates""  ""expects""  ""intends""  ""plans""  ""seeks""  ""estimates""  ""may""  ""will""  ""continue"" and similar expressions. These forward-looking statements are based on current plans  estimates and beliefs of management. All statements  other than statements of historical facts  are statements that could be deemed forward-looking statements  including estimates of revenues  operating margins  capital expenditures  cash  other financial information  expected legal  arbitration  political  regulatory or clinical results or practices and other such estimates and results. By their nature  such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks  uncertainties and assumptions which might cause the actual results  financial condition  performance or achievements of UCB  or industry results  to differ materially from those that may be expressed or implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: the global spread and impact of COVID-19  changes in general economic  business and competitive conditions  the inability to obtain necessary regulatory approvals or to obtain them on acceptable terms or within expected timing  costs associated with research and development  changes in the prospects for products in the pipeline or under development by UCB  effects of future judicial decisions or governmental investigations  safety  quality  data integrity or manufacturing issues; potential or actual data security and data privacy breaches  or disruptions of our information technology systems  product liability claims  challenges to patent protection for products or product candidates  competition from other products including biosimilars  changes in laws or regulations  exchange rate fluctuations  changes or uncertainties in tax laws or the administration of such laws  and hiring and retention of its employees. There is no guarantee that new product candidates will be discovered or identified in the pipeline  will progress to product approval or that new indications for existing products will be developed and approved. Movement from concept to commercial product is uncertain; preclinical results do not guarantee safety and efficacy of product candidates in humans. So far  the complexity of the human body cannot be reproduced in computer models  cell culture systems or animal models. The length of the timing to complete clinical trials and to get regulatory approval for product marketing has varied in the past and UCB expects similar unpredictability going forward. Products or potential products  which are the subject of partnerships  joint ventures or licensing collaborations may be subject to differences disputes between the partners or may prove to be not as safe  effective or commercially successful as UCB may have believed at the start of such partnership. UCB's efforts to acquire other products or companies and to integrate the operations of such acquired companies may not be as successful as UCB may have believed at the moment of acquisition. Also  UCB or others could discover safety  side effects or manufacturing problems with its products and/or devices after they are marketed. The discovery of significant problems with a product similar to one of UCB's products that implicate an entire class of products may have a material adverse effect on sales of the entire class of affected products. Moreover  sales may be impacted by international and domestic trends toward managed care and health care cost containment  including pricing pressure  political and public scrutiny  customer and prescriber patterns or practices  and the reimbursement policies imposed by third-party payers as well as legislation affecting biopharmaceutical pricing and reimbursement activities and outcomes. Finally  a breakdown  cyberattack or information security breach could compromise the confidentiality  integrity and availability of UCB's data and systems.Given these uncertainties  you should not place undue reliance on any of such forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labelling in any market  or at any particular time  nor can there be any guarantee that such products will be or will continue to be commercially successful in the future.UCB is providing this information  including forward-looking statements  only as of the date of this press release and it does not reflect any potential impact from the evolving COVID-19 pandemic  unless indicated otherwise. UCB is following the worldwide developments diligently to assess the financial significance of this pandemic to UCB. UCB expressly disclaims any duty to update any information contained in this press release  either to confirm the actual results or to report or reflect any change in its forward-looking statements with regard thereto or any change in events  conditions or circumstances on which any such statement is based  unless such statement is required pursuant to applicable laws and regulations.Additionally  information contained in this document shall not constitute an offer to sell or the solicitation of an offer to buy any securities  nor shall there be any offer  solicitation or sale of securities in any jurisdiction in which such offer  solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such jurisdiction.",neutral,0.0,1.0,0.0,mixed,0.58,0.18,0.24,True,English,"['UCB', 'Changes', 'Board', 'Directors', 'FinanciÃ¨re de Tubize SA', 'Belgian American Education Foundation', 'Belgian Solvay Business School', 'UCB Evenity Commercial Lead', 'Harvard Business School', 'London Business School', 'exchange rate fluctuations', 'cell culture systems', 'general economic, business', 'actual data security', 'data privacy breaches', 'central nervous system', 'Chair ad interim', 'necessary regulatory approvals', 'future judicial decisions', 'product liability claims', 'information technology systems', 'Fiona du Monceau', 'strategic business experience', 'Forward looking statements', 'global biopharmaceutical company', 'new product candidates', 'other financial information', 'commercial product', 'Bone business', 'business units', 'data integrity', 'new Chair', 'immune system', 'financial condition', 'global spread', 'Vice Chair', 'future endeavors', 'political, regulatory', 'product approval', 'product marketing', 'new models', 'new indications', 'Regulated information', 'personal reasons', 'life sciences', 'external expertise', 'ExeVir Bio', 'Venture Partner', 'various teams', 'Eli Lilly', 'healthcare clients', 'business development', 'GSK Biologicals', 'BAEF) scholar', 'risk committee', 'Investor Relations', 'Antje Witte', 'Corporate Communications', 'Laurent Schots', 'innovative medicines', 'severe diseases', 'press release', 'similar expressions', 'historical facts', 'operating margins', 'capital expenditures', 'unknown risks', 'Important factors', 'competitive conditions', 'acceptable terms', 'manufacturing issues', 'patent protection', 'human body', 'computer models', 'animal models', 'clinical trials', 'similar unpredictability', 'joint ventures', 'licensing collaborations', 'future performance', 'clinical results', 'industry results', 'Stefan Oschmann', 'forward-looking statements', 'current plans', 'expected timing', 'other products', 'existing products', 'differences disputes', 'UCB SA/NV', 'UCB Ventures', 'Euronext Brussels', 'tax laws', 'Board member', 'potential products', 'UCB.', 'Belgium', '12 December', 'CET', 'Directors', 'resignation', 'Chairman', 'role', 'wealth', '20 years', 'COO', 'Head', 'McKinsey', 'Europe', 'MBA', 'MSc', 'Management', 'ULB', 'governor', 'audit', 'May', 'email', 'discovery', 'solutions', 'lives', 'people', '40 countries', 'revenue', 'symbol', 'Twitter', 'UCB_news', 'limitation', 'words', 'estimates', 'beliefs', 'cash', 'legal', 'arbitration', 'practices', 'nature', 'guarantees', 'uncertainties', 'assumptions', 'achievements', 'impact', 'COVID-19', 'changes', 'inability', 'costs', 'research', 'prospects', 'pipeline', 'effects', 'investigations', 'safety', 'quality', 'disruptions', 'challenges', 'competition', 'biosimilars', 'regulations', 'administration', 'retention', 'employees', 'Movement', 'concept', 'efficacy', 'humans', 'complexity', 'length', 'past', 'subject', 'partnerships']",2022-12-12,2022-12-12,marketscreener.com
14669,EuroNext,NewsApi.org,https://www.prnewswire.com/news-releases/wolters-kluwer-announces-relaunch-of-kluwer-ip-law-301700408.html,Wolters Kluwer Announces Relaunch of Kluwer IP Law,The modern  easy-to-navigate design will allow legal professionals to customize the homepage view according to their needs  empowering them to maximize their productivity NEW YORK  Dec. 12  2022 /PRNewswire/ -- Wolters Kluwer Legal & Regulatory U.S. today annâ€¦,"The modern  easy-to-navigate design will allow legal professionals to customize the homepage view according to their needs  empowering them to maximize their productivityNEW YORK  Dec. 12  2022 /PRNewswire/ -- Wolters Kluwer Legal & Regulatory U.S. today announced it has relaunched Kluwer IP Law   the master resource for intellectual property rights and registration  to help users be more efficient and effective in their day-to-day work. With this redesign  users can save their favorite materials for future reference and will have instant access to its News Alert service.Wolters Kluwer Announces Relaunch of Kluwer IP LawKluwer IP Law is Wolters Kluwer's flagship service focused on all key IP law  providing legal professionals with quick answers and expert commentary from prominent practitioners and thought leaders. Kluwer IP Law also provides users with key EPC sources for European patent attorneys  such as Visser's Annotated European Patent Convention and the PCT Practice and Strategy work. Manual IP  also known as the Brown Book  which is housed within Kluwer IP Law  explains and compares the procedures and laws involved in filing applications for patents  trademarks  or designs in 237 jurisdictions to make important IP practice decisions.""Kluwer IP Law provides legal professionals with a combination of practical guidance  quick answers  and deep domain expertise all in one source "" said David Bartolone  Vice President and General Manager for the International Group within Wolters Kluwer Legal & Regulatory U.S. ""This redesign is our latest step as we continue to build expert solutions powered by high-quality content that directly meet the needs of our customers.""The user-centric redesign of Kluwer IP Law will enable IP professionals  such as patent and trademark attorneys and lawyers  to be more efficient and effective in their day-to-day tasks. The redesign includes:A completely new UX for the homepage  offering customization options for the desired viewA favorites feature allowing to easily retrieve saved materials and collaborate with colleaguesImproved research experienceTo learn more  visit: www.wolterskluwer.com/en/solutions/kluweriplawAbout Wolters Kluwer Legal & Regulatory U.S.Wolters Kluwer (WKL) is a global leader in professional information  software solutions  and services for the healthcare; tax and accounting; governance  risk  and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.Wolters Kluwer reported 2021 annual revenues of â‚¬4.8 billion. The group serves customers in over 180 countries  maintains operations in over 40 countries  and employs approximately 19 800 people worldwide. The company is headquartered in Alphen aan den Rijn  the Netherlands.Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).For more information  visit www.wolterskluwer.com   follow us on LinkedIn   Twitter   Facebook   and YouTube .MEDIA CONTACT:Linda GharibDirector  Brand & CommunicationsWolters Kluwer Legal & Regulatory U.S.Tel: +1 (646) 887-7962Email: [email protected]SOURCE Wolters Kluwer Legal & Regulatory U.S.",neutral,0.01,0.99,0.0,positive,0.98,0.01,0.0,True,English,"['Kluwer IP Law', 'Wolters Kluwer', 'Relaunch', 'Alphen aan den Rijn', 'Level 1 American Depositary Receipt', 'Annotated European Patent Convention', 'important IP practice decisions', 'intellectual property rights', 'key EPC sources', 'deep domain expertise', 'deep domain knowledge', 'Linda Gharib Director', 'key IP law', 'Kluwer IP Law', 'Regulatory U.S.', 'News Alert service', 'Wolters Kluwer shares', 'European patent attorneys', 'Wolters Kluwer Legal', 'PCT Practice', 'critical decisions', 'Manual IP', 'IP professionals', 'regulatory sectors', 'flagship service', 'legal professionals', 'NEW YORK', 'master resource', 'future reference', 'instant access', 'quick answers', 'expert commentary', 'prominent practitioners', 'thought leaders', 'Strategy work', 'Brown Book', 'David Bartolone', 'Vice President', 'General Manager', 'latest step', 'high-quality content', 'new UX', 'customization options', 'favorites feature', 'research experience', 'global leader', 'specialized technology', '2021 annual revenues', 'Euronext Amsterdam', 'Euronext 100 indices', 'ADR) program', 'counter market', 'MEDIA CONTACT', 'expert solutions', 'software solutions', 'day work', 'favorite materials', 'one source', 'International Group', 'day tasks', 'professional information', 'user-centric redesign', 'homepage view', 'needs', 'productivity', 'PRNewswire', 'registration', 'users', 'Relaunch', 'Visser', 'procedures', 'laws', 'applications', 'patents', 'trademarks', 'designs', '237 jurisdictions', 'combination', 'customers', 'lawyers', 'colleagues', 'wolterskluwer', 'WKL', 'services', 'healthcare', 'tax', 'accounting', 'governance', 'risk', 'compliance', '180 countries', 'operations', '40 countries', '19,800 people', 'company', 'Netherlands', 'AEX', 'ADRs', 'WTKWY', 'LinkedIn', 'Twitter', 'Facebook', 'YouTube', 'Brand', 'Communications', 'Email']",2022-12-12,2022-12-12,prnewswire.com
14670,EuroNext,NewsApi.org,https://www.streamingmedia.com/PressRelease/Broadpeak-Achieves-Video-Streaming-at-725-Gbps-With-New-BkS450-High-Performance-Software_54441.aspx,Broadpeak Achieves Video Streaming at 725 Gbps With New BkS450 High-Performance Software,Based on State-of-the-Art Commercial Off-the-Shelf Intel Xeon Processor Servers  Broadpeak's New Streamer Greatly Reduces Costs and Power Consumption,"Broadpeak Achieves Video Streaming at 725 Gbps With New BkS450 High-Performance SoftwareBased on State-of-the-Art Commercial Off-the-Shelf Intel Xeon Processor Servers  Broadpeak's New Streamer Greatly Reduces Costs and Power ConsumptionCesson-Sevigne  France( )BroadpeakÂ®  a leading provider of content delivery network (CDN) and video streaming solutions for content providers and pay-TV operators worldwide  today announced the launch of its new BkS450 high-performance video streaming software  which brings outstanding cost savings and energy efficiency to video streaming infrastructures. When running on a 3rd gen Intel Xeon Scalable processor  the BkS450 software enables video service providers to deliver low-latency 4K and 8K video streaming services  VR content  and other bandwidth-intensive offerings at a reduced cost while consuming significantly less power than traditional video servers.""Introducing the next-gen BkS450 software to our solutions family underscores our commitment to enabling greener video streaming while ensuring a superior quality of experience for consumers at a reasonable cost "" said Nivedita Nouvel  vice president of product marketing at Broadpeak. ""Working with Intel  we have achieved a giant leap forward in video streaming performance and energy efficiency  helping our customers deliver advanced video streaming services with increased agility  a smaller hardware footprint  and a reduced impact on the environment.""The BkS450 video streaming software offers a massive improvement in performance and sustainability  which is critical as video service providers look to address growing concerns about the energy impact of video streaming. Leveraging an ultra-efficient usage of hardware resources  the BkS450 delivers video services at 725 Gbps in HTTP on servers consuming 900 Watts  reducing the power required to stream 1 Gbps by a factor of 4 compared with previous-generation video streaming solutions. Broadpeak obtained this measurement using a sophisticated benchmark tool developed in collaboration with Intel  recreating a production environment.This collaboration demonstrates the power of software optimized with Intel Xeon CPUs. The two companies will continue to work together and push the performance-per-Watt envelope toward a more sustainable future for the rapidly growing media streaming market.In addition  Broadpeak's BkS450 video streamer features a high-density design that saves crucial space in data centers. Available as a container running on off-the-shelf hardware  the BkS450 eliminates the need for operators to use proprietary components  speeding up the time to market for new video streaming services while enhancing operators' flexibility  operational efficiency  and cost savings. Furthermore  the BkS450 video streamer is future-proof  natively supporting all of the latest HTTP protocols â€” as well as DASH and HLS low-latency streaming formats â€” to ensure a flawless video streaming experience.The new caching software engine built into the BkS450 will also extract maximum performance from more modest and cost-effective hardware configurations  including existing CDN deployments. This innovation unlocks CDN capacity across the board and better uses resources. This is only the first step  as Broadpeak plans to reach even higher numbers by continuously leveraging the new capabilities made available at the hardware level in its software.More information about Broadpeak solutions can be found at https://broadpeak.tv.# # #About BroadpeakÂ® (broadpeak.tv)BroadpeakÂ® designs and manufactures video delivery components for content providers and network service providers deploying IPTV  cable  OTT  and mobile services. Its portfolio of solutions and technologies powers the delivery of movies  television programming  and other video content over managed networks and the Internet for viewing on any type of device. The company's systems and services help operators increase market share and improve subscriber loyalty with superior quality of experience.Broadpeak supports all of its customers worldwide  from simple installations to large delivery systems reaching capacities of several million of simultaneous streams. The company is headquartered in Cesson-Sevigne  France.Broadpeak is listed on Euronext Growth Paris (code ISIN: FR001400AJZ7; ticker: ALBPK)All trademarks appearing herein are the property of their respective owners.",neutral,0.01,0.99,0.0,positive,0.95,0.04,0.0,True,English,"['New BkS450 High-Performance Software', 'Video Streaming', 'Broadpeak', '725 Gbps', '3rd gen Intel Xeon Scalable processor', 'new BkS450 high-performance video streaming software', 'Shelf Intel Xeon Processor Servers', 'The BkS450 video streaming software', 'new caching software engine', 'New BkS450 High-Performance Software', 'HLS low-latency streaming formats', '8K video streaming services', 'advanced video streaming services', 'new video streaming services', 'previous-generation video streaming solutions', 'growing media streaming market', 'flawless video streaming experience', 'Intel Xeon CPUs', 'greener video streaming', 'traditional video servers', 'next-gen BkS450 software', 'other bandwidth-intensive offerings', 'sophisticated benchmark tool', 'Euronext Growth Paris', 'video service providers', 'BkS450 video streamer', 'other video content', 'network service providers', 'video streaming performance', 'smaller hardware footprint', 'cost-effective hardware configurations', 'video delivery components', 'latest HTTP protocols', 'existing CDN deployments', 'content delivery network', 'outstanding cost savings', 'large delivery systems', 'New Streamer', 'video services', 'shelf hardware', 'new capabilities', 'streaming infrastructures', 'content providers', 'low-latency 4K', 'growing concerns', 'mobile services', 'proprietary components', 'VR content', 'hardware level', 'market share', 'reduced cost', 'reasonable cost', 'Art Commercial', 'leading provider', 'energy efficiency', 'superior quality', 'Nivedita Nouvel', 'vice president', 'product marketing', 'giant leap', 'reduced impact', 'massive improvement', 'energy impact', 'ultra-efficient usage', 'two companies', 'Watt envelope', 'sustainable future', 'high-density design', 'crucial space', 'data centers', 'operational efficiency', 'CDN capacity', 'first step', 'higher numbers', 'More information', 'television programming', 'subscriber loyalty', 'simple installations', 'simultaneous streams', 'respective owners', 'hardware resources', 'maximum performance', 'Power Consumption', 'pay-TV operators', 'less power', 'production environment', ""operators' flexibility"", 'Broadpeak solutions', 'Broadpeak Achieves', 'BroadpeakÂ®', '725 Gbps', 'State', 'Costs', 'Cesson-Sevigne', 'France', 'launch', 'family', 'commitment', 'consumers', 'customers', 'agility', 'sustainability', '900 Watts', '1 Gbps', 'factor', 'measurement', 'collaboration', 'addition', 'container', 'need', 'time', 'DASH', 'modest', 'innovation', 'board', 'IPTV', 'cable', 'OTT', 'portfolio', 'technologies', 'movies', 'networks', 'Internet', 'type', 'device', 'company', 'capacities', 'code', 'ticker', 'ALBPK', 'trademarks', 'property']",2022-12-12,2022-12-12,streamingmedia.com
14671,EuroNext,NewsApi.org,https://www.prnewswire.com/news-releases/south-korean-government-grants-a-new-patent-to-lleidanet-and-it-now-has-218-patents-worldwide-301700089.html,South Korean government grants a new patent to Lleida.net  and it now has 218 patents worldwide,MADRID  Dec. 12  2022 /PRNewswire/ -- Spanish listed company Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) has been granted a new 20-year patent by the South Korean government. The recognition  which refers to its EIDAS-certified sourcing method  is the fâ€¦,"MADRID  Dec. 12  2022 /PRNewswire/ -- Spanish listed company Lleida.net (BME: LLN) (EPA: ALLLN) (OTCQX: LLEIF) has been granted a new 20-year patent by the South Korean government.The recognition  which refers to its EIDAS-certified sourcing method  is the fourth recognition from the Seoul authorities and the 218th globally.With this patent  Lleida.net reinforces its position as the leading company in the registered electronic signature  notification  and contracting industry  also in terms of innovation.""South Korea is one of the world's leading markets in terms of adoption of new technology. Receiving one patent in South Korea is a milestone in itself  but to already have four makes it clear what our strength is in the East Asian markets "" explained Sisco Sapena  CEO and Founder of the company.The company has described the concession as 'the first patented method acting under the EIDAS umbrella  which requires identification by electronic signature of the signing parties to be indubitable in a court of law'.As Lleida.net told the market today  this patent has the potential to  directly and indirectly  generate three million euros in revenue over the next two decades.In the region  the company has received patents in powers such as China  Japan  and India or the Gulf Cooperation Council.Lleida.net's growth strategy in the electronic signature  notification  and contracting market in the countries where it is present and those it plans to be in the future includes a solid growth policy in intellectual property and R&D  as well as a reinforcement of its internationalization policy.More than 60 countries in the five continents have granted patents to the company  including the European Union  United States  China  Russia  India  Mexico  Japan  Colombia  Argentina  Peru  South Africa  Nigeria  Australia and New Zealand.Lleida.net is listed on the OTCQX index in New York  on Euronext Growth in Paris  and on BME Growth in Madrid.In the first nine months of 2022  the company's sales grew by 25% compared to last year's period. Between January and September of this year  cumulative sales reached â‚¬15.7 million.Likewise  its EBIDTA increased by 44% compared to the same period of the previous year.Learn more about Lleida.net IP strategy at https://investors.lleida.net/enSOURCE Lleida.net",neutral,0.0,1.0,0.0,neutral,0.01,0.97,0.02,True,English,"['South Korean government', 'new patent', 'Lleida.net', '218 patents', 'Lleida.net IP strategy', 'EIDAS-certified sourcing method', 'first patented method', 'three million euros', 'next two decades', 'Gulf Cooperation Council', 'first nine months', 'East Asian markets', 'South Korean government', 'solid growth policy', 'Spanish listed company', 'new 20-year patent', 'growth strategy', 'leading markets', 'internationalization policy', 'new technology', 'South Africa', 'New Zealand', 'New York', 'Euronext Growth', 'SOURCE Lleida', 'Seoul authorities', 'electronic signature', 'contracting industry', 'Sisco Sapena', 'EIDAS umbrella', 'signing parties', 'intellectual property', 'R&D', 'five continents', 'European Union', 'United States', 'one patent', 'BME Growth', 'last year', 'previous year', 'fourth recognition', 'contracting market', 'OTCQX index', 'cumulative sales', 'same period', 'leading company', 'MADRID', 'Dec.', 'PRNewswire', 'LLN', 'EPA', 'LLEIF', 'position', 'notification', 'terms', 'innovation', 'world', 'adoption', 'milestone', 'strength', 'CEO', 'Founder', 'concession', 'identification', 'court', 'law', 'potential', 'revenue', 'region', 'patents', 'powers', 'China', 'Japan', 'India', 'countries', 'future', 'reinforcement', 'More', 'Russia', 'Mexico', 'Colombia', 'Argentina', 'Peru', 'Nigeria', 'Australia', 'Paris', 'January', 'September', 'EBIDTA']",2022-12-12,2022-12-12,prnewswire.com
14672,EuroNext,Bing API,https://nz.finance.yahoo.com/news/argenx-appoints-ana-cespedes-board-210100776.html,argenx Appoints Ana Cespedes to Board of Directors,Amsterdam  the Netherlands â€“  (Euronext & Nasdaq: ARGX)  a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases  announced that during the extraordinary general meeting of shareholders held today at 12:00pm CET ,argenx SEDecember 12  2022Amsterdam  the Netherlands â€“ argenx SE (Euronext & Nasdaq: ARGX)  a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases  announced that during the extraordinary general meeting of shareholders held today at 12:00pm CET  Ana Cespedes was appointed as non-executive director to its Board of Directors.Ana Cespedes brings robust experience across a broad range of critical areas for commercialization and access  as well as for organizational effectiveness. The voting result and all documents relating to the shareholdersâ€™ meeting will be available on the argenx website at www.argenx.com/investors/shareholder-meetings.About argenxargenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP)  argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S.  Japan  and the EU. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information  visit www.argenx.com and follow us on LinkedIn  Twitter  and Instagram.For further information  please contact:Media:Kelsey Kirkkkirk@argenx.comInvestors:Beth DelGiaccobdelgiacco@argenx.com,neutral,0.03,0.97,0.0,negative,0.01,0.23,0.77,True,English,"['Ana Cespedes', 'argenx', 'Board', 'Directors', 'several earlier stage experimental medicines', 'multiple serious autoimmune diseases', 'novel antibody-based medicines', 'severe autoimmune diseases', 'leading academic researchers', 'neonatal Fc receptor', 'Immunology Innovation Program', 'extraordinary general meeting', 'global immunology company', 'immunology breakthroughs', 'The Company', 'Ana Cespedes', 'executive director', 'robust experience', 'broad range', 'critical areas', 'organizational effectiveness', 'voting result', 'shareholdersâ€™ meeting', 'world-class portfolio', 'FcRn) blocker', 'U.S.', 'therapeutic franchises', 'Kelsey Kirk', 'Beth DelGiacco', 'argenx SE', 'argenx website', 'Amsterdam', 'Netherlands', 'Euronext', 'Nasdaq', 'ARGX', 'lives', 'people', '12:00pm', 'Board', 'Directors', 'commercialization', 'access', 'documents', 'investors/shareholder-meetings', 'IIP', 'Japan', 'efgartigimod', 'information', 'LinkedIn', 'Twitter', 'Instagram', 'Media', 'bdelgiacco']",2022-12-12,2022-12-12,nz.finance.yahoo.com
14673,EuroNext,Bing API,https://uk.news.yahoo.com/ferrari-n-v-periodic-report-193200752.html,Ferrari N.v.: Periodic Report on the Buyback Program,(NYSE/EXM: RACE) (â€œFerrariâ€ or the â€œCompanyâ€) informs that the Company has purchased  under the Euro 200 million share buyback program announced on December 1  2022  as the second tranche of the multi-year share buyback program of approximately Euro 2 billion expected to be executed by 2026 in line with the disclosure made during the 2022 Capital Markets Day (the â€œSecond Trancheâ€) ,Ferrari N.V.Maranello (Italy)  December 12  2022 â€“ Ferrari N.V. (NYSE/EXM: RACE) (â€œFerrariâ€ or the â€œCompanyâ€) informs that the Company has purchased  under the Euro 200 million share buyback program announced on December 1  2022  as the second tranche of the multi-year share buyback program of approximately Euro 2 billion expected to be executed by 2026 in line with the disclosure made during the 2022 Capital Markets Day (the â€œSecond Trancheâ€)  the additional common shares - reported in aggregate form  on a daily basis - on the Euronext Milan (EXM) and on the New York Stock Exchange (NYSE) as follows:EXM NYSE Total Trading Number of common shares purchased Average price per share Consideration excluding fees Number of common shares purchased Average price per share Consideration excluding fees Consideration excluding fees Number of common shares purchased Average price per share Consideration excluding fees Date excluding fees excluding fees excluding fees (d/m/y) (â‚¬) (â‚¬) ($) ($) (â‚¬)* (â‚¬)* (â‚¬)* 02/12/2022 6 405 215.3180 1 379 111.79 - - - - 6 405 215.3180 1 379 111.79 05/12/2022 6 470 214.7257 1 389 275.28 - - - - 6 470 214.7257 1 389 275.28 06/12/2022 7 370 212.2501 1 564 283.24 7 565 220.0351 1 664 565.53 1 582 888.49 14 935 210.7246 3 147 171.73 07/12/2022 7 715 210.5572 1 624 448.80 5 329 220.3548 1 174 270.73 1 115 272.80 13 044 210.0369 2 739 721.60 08/12/2022 8 000 209.0239 1 672 191.20 - - - - 8 000 209.0239 1 672 191.20 09/12/2022 7 650 209.0428 1 599 177.42 - - - - 7 650 209.0428 1 599 177.42 43 610 211.6140 9 228 487.73 12 894 220.1672 2 838 836.26 2 698 161.28 56 504 211.0762 11 926 649.01 Total(*) translated at the European Central Bank EUR/USD exchange reference rate as of the date of each purchaseSince the announcement of such Second Tranche till December 9  2022  the total invested consideration has been:Euro 9 228 487.73 for No. 43 610 common shares purchased on the EXMUSD 2 838 836.26 (Euro 2 698 161.28*) for No. 12 894 common shares purchased on the NYSE.Story continuesOn December 2  2022  in the Ferrari Group employeesâ€™ granting share process  the Company assigned No. 11 218 common shares held in treasury. On the same day Ferrari purchased  in a â€œcross orderâ€ transaction executed on the EXM  No. 3 366 common shares in order to cover individual's taxable income as standard practice (Sell to Cover) at the average price of Euro 215.7000 per share.As of December 9  2022  the Company held in treasury No. 11 884 133 common shares equal to 4.62% of the total issued share capital including the common shares and the special voting shares  net of shares assigned under the Companyâ€™s equity incentive plan.Since July 1  2022 until December 9  2022  the Company has purchased a total of 830 241 own common shares on EXM and NYSE  including transactions for Sell to Cover  for a total consideration of Euro 162 652 328.72.A comprehensive overview of the transactions carried out under the buyback program  as well as the details of the above transactions  are available on Ferrariâ€™s corporate website under the Buyback Programs section ( https://www.ferrari.com/en-EN/corporate/buyback-programs ).Attachment,neutral,0.0,1.0,0.0,mixed,0.21,0.29,0.5,True,English,"['Ferrari N.v.', 'Periodic Report', 'Buyback Program', 'Ferrari Group employeesâ€™ granting share process', 'New York Stock Exchange', 'EUR/USD exchange reference rate', 'Ferrari N.V. Maranello', 'EXM NYSE Total Trading Number', '200 million share buyback program', 'multi-year share buyback program', 'Buyback Programs section', 'European Central Bank', 'equity incentive plan', 'special voting shares', '2022 Capital Markets Day', 'cross orderâ€ transaction', 'additional common shares', 'No. 43,610 common shares', 'No. 12,894 common shares', 'No. 11,218 common shares', 'No. 3,366 common shares', 'share capital', '884,133 common shares', 'same day', 'treasury No.', 'second tranche', 'aggregate form', 'daily basis', 'Euronext Milan', 'Average price', 'taxable income', 'standard practice', 'comprehensive overview', 'corporate website', 'total consideration', 'Italy', 'December', 'NYSE/EXM', 'RACE', 'Company', 'line', 'disclosure', 'fees', 'Date', 'purchase', 'announcement', 'Story', 'individual', 'July', 'transactions', 'Sell', 'Cover', 'details', 'buyback-programs', 'Attachment', '830,241']",2022-12-12,2022-12-12,uk.news.yahoo.com
14674,EuroNext,Bing API,https://www.msn.com/en-us/news/world/paris-wheat-higher-as-black-sea-risks-back-in-focus/ar-AA15cfWf,Paris wheat higher as Black Sea risks back in focus,Euronext wheat regained ground on Monday  tracking a similar rebound in Chicago  as a stoppage at Ukraine's Odesa port after Russian strikes on energy supply as well as the onset of winter weather shifted attention back to Black Sea supply risks.,"PARIS  Dec 12 (Reuters) - Euronext wheat regained ground on Monday  tracking a similar rebound in Chicago  as a stoppage at Ukraine's Odesa port after Russian strikes on energy supply as well as the onset of winter weather shifted attention back to Black Sea supply risks.News that Algeria will hold an import tender on Wednesday to buy wheat also supported Euronext  with the February shipment period potentially favoring European Union supplies if winter conditions hamper logistics in Russia and Ukraine  traders said.March wheat on Paris-based Euronext settled up 1.2% at 306.25 euros ($322.24) a tonne to move away from a nine-month low of 299.75 euros struck last week.Chicago wheat also rose to recover from last week's one-year low.The Ukrainian government said the port of Odesa suspended operations on Sunday after Russian strikes hit energy supply in the region  before activity resumed on Monday.""This highlights the logistical problems in this zone  whether it's power supply in the war or the challenge of moving grain in winter "" a dealer said.Russian grain exports fell to 550 000 tonnes last week from 1.0 million tonnes in the previous week due to storms in the Black Sea and the lower water level in the Azov sea  consultancy Sovecon said  citing port data.Wheat futures have fallen in recent weeks as increasing exports of a record Russian harvest and the continuation of a wartime shipping channel from Ukraine eased global supply concerns.Wintry weather in western Europe was causing less concern  with freezing temperatures not seen as severe enough to threaten wheat crops.Monday was the last trading session for December futures on Euronext. The contract settled at 304.25 euros  up 0.5% from Friday.February rapeseed settled 1.8% down at 555.25 euros a tonne  after earlier hitting a lowest front-month price since August last year at 552.75 euros.Oilseed markets including U.S. soybeans and Malaysian palm oil were cooled by worries over rising COVID-19 infections in China.($1 = 0.9504 euros) (Reporting by Gus Trompiz in Paris Editing by Mark Potter)",neutral,0.05,0.6,0.36,negative,0.0,0.01,0.99,True,English,"['Black Sea risks', 'Paris wheat', 'focus', 'Black Sea supply risks', 'European Union supplies', 'The Ukrainian government', 'lower water level', 'wartime shipping channel', 'lowest front-month price', 'U.S. soybeans', 'Malaysian palm oil', 'rising COVID-19 infections', 'global supply concerns', 'record Russian harvest', 'last trading session', 'February shipment period', 'Russian grain exports', 'Azov sea', 'energy supply', 'power supply', 'Russian strikes', 'last week', 'increasing exports', 'similar rebound', 'import tender', 'nine-month low', 'logistical problems', 'previous week', 'consultancy Sovecon', 'recent weeks', 'Wintry weather', 'western Europe', 'less concern', 'freezing temperatures', 'December futures', 'Oilseed markets', 'Gus Trompiz', 'Mark Potter', 'March wheat', 'Wheat futures', 'wheat crops', 'winter weather', 'winter conditions', 'port data', 'Paris-based Euronext', '1.0 million tonnes', 'Euronext wheat', 'Chicago wheat', 'Odesa port', '550,000 tonnes', 'Reuters', 'ground', 'Monday', 'stoppage', 'Ukraine', 'onset', 'attention', 'News', 'Algeria', 'Wednesday', 'logistics', 'traders', '306.25 euros', '299.75 euros', 'one-year', 'operations', 'Sunday', 'region', 'activity', 'zone', 'challenge', 'dealer', 'storms', 'continuation', 'contract', '304.25 euros', 'Friday', '555.25 euros', 'August', '552.75 euros', 'worries', 'China', '0.9504 euros']",2022-12-12,2022-12-12,msn.com
14675,EuroNext,Bing API,https://www.actusnews.com/fr/fermentalg/cp/2022/12/12/fermentalg-committed-to-the-food-needs-of-tomorrow-with-the-support-of-bpifrance,Fermentalg committed to the ' Food needs of Tomorrow ' with the support of Bpifrance,Fermentalg (Euronext - FALG)  the French microalgae expert  is accelerating the development of its 2nd product platform  dedicated to a natural and bioactive blue dye (BLUE ORIGINSÂ®) and alternative proteins (KALVEAâ„¢) ,"12/12/2022 - 17:40Libourne - December 6  2022 - Fermentalg (Euronext - FALG)  the French microalgae expert  is accelerating the development of its 2nd product platform  dedicated to a natural and bioactive blue dye (BLUE ORIGINSÂ®) and alternative proteins (KALVEAâ„¢)  with the support of Bpifrance as part of the ""Food needs of Tomorrow"" call for projects for a ""Sustainable and Health-Friendly Food"".Beyond the partnership with DDW  a subsidiary of the Givaudan Group  for the commercialization of a natural blue food colorant (already in industrial production)  Fermentalg pursues the deployment of its Galdieria platform for a wider valorization in the food and nutraceutical fields.Already at the origin of a natural alternative to chemical dyes in food  the innovative character and the maturity reached by the platform today allow Fermentalg to prepare the industrialization of new functional solutions with high added value addressing new market segments:- an antioxidant bioactive in nutraceuticals;- a superfood rich in antioxidants  vitamins and minerals for the animal nutrition market (petfood  aquafeed) or specialized for specific audiences  such as athletes or seniors.Microalgal fermentation for a new generation of ingredientsNutritional  health and wellness benefits are crucial issues in food. Today  they must also be addressed through solutions reducing impacts on biodiversity and climate  and favorable to the preservation of natural ecosystems.Through its bioindustrial innovations  Fermentalg is resolutely committed to an economic development approach that respects the environment  as the signatory countries of the COP-15[1] have committed to do by 2050. Among the priorities set for the current decade are the preservation of natural and fisheries resources  better traceability  the circular economy and the valorization of co-products  as well as preventive nutrition and the agroecological transition.To address these challenges  Bpifrance wishes to promote the development of healthier  more sustainable foodstuffs that meet consumer expectations  in particular by reducing or replacing additives and processing aids from petroleum-based chemistry. It also aims to develop new sources of plant proteins produced in our territories to contribute to the food sovereignty of our country.To support innovations targeting high-growth markets and responding to major societal issues  and in a logic of sovereignty to limit dependence on protein imports  Bpifrance has awarded Fermentalg a â‚¬4.4 million grant as part of the 4th Future Investment Program (PIA) of the ""France 2030"" plan.On this occasion  Philippe Lavielle  CEO of Fermentalg  declares:""The production of microalgal biomass by fermentation offers a very large field of applications for a more responsible  safer and more functional food. This development is possible with the tremendous commitment of all economic actors and we are very proud to put our expertise in marine biology at the service of this cause  which is essential for the sustainable health of our planet and future generations. Thanks to this support  we will be able to accelerate the development of applications from our second platform and thus continue to expand our product offering.""Next publication: 2022 sales January 19  2023 (after market close)About FermentalgAs an expert in research and bioindustrial exploitation of microalgae  Fermentalg's objective is to offer sustainable solutions and innovative products contributing to the development of healthy  natural and efficient products. Our business: the development  production and marketing of sustainable solutions and active ingredients from microalgae for nutrition  health and the environment. Nutritional lipids  alternative proteins  natural food colorings and innovative environmental solutions make up our company's current and future offer.Fermentalg shares are listed on Euronext Paris (FR0011271600 - FALG) and are eligible for the PEA-PME and the ""SRD long-only"". It is part of the GaÃ¯a index  designed for Socially Responsible Investment (SRI)  which groups together the SMEs with the best ratings in terms of environmental  social and governance (ESG) performance.For more information: www.fermentalg.comJournalists contact : Investor contact: ACTUS finance & communicationNawel NAAMANEphone : +33 (0)1 53 67 36 75nnaamane@actus.fr ACTUS finance & communicationAnne-Catherine BONJOURphone: +33 (0)1 53 67 36 93fermentalg@actus.fr[1] Post-2020 global biodiversity frameworkCOP-15  7 to 19 December 2022 (Montreal  Canada)",positive,0.66,0.34,0.0,positive,0.85,0.15,0.0,True,English,"['Food needs', 'Fermentalg', 'Tomorrow', 'support', 'Bpifrance', 'Post-2020 global biodiversity framework', '4th Future Investment Program', 'natural blue food colorant', 'high added value', 'GaÃ¯a index', 'Socially Responsible Investment', 'Nawel NAAMANE phone', 'Anne-Catherine BONJOUR phone', 'bioactive blue dye', 'major societal issues', 'new market segments', 'innovative environmental solutions', '2nd product platform', 'animal nutrition market', 'new functional solutions', 'natural food colorings', 'economic development approach', 'French microalgae expert', 'BLUE ORIGINSÂ®', 'future generations', 'future offer', 'antioxidant bioactive', 'new generation', 'crucial issues', 'new sources', 'responsible, safer', 'functional food', 'economic actors', 'product offering', 'innovative character', 'natural alternative', 'natural ecosystems', 'healthy, natural', 'alternative proteins', 'Food needs', 'Health-Friendly Food', 'Givaudan Group', 'Galdieria platform', 'nutraceutical fields', 'chemical dyes', 'specific audiences', 'wellness benefits', 'signatory countries', 'fisheries resources', 'circular economy', 'preventive nutrition', 'agroecological transition', 'consumer expectations', 'processing aids', 'petroleum-based chemistry', 'plant proteins', 'high-growth markets', 'protein imports', 'â‚¬4.4 million grant', 'France 2030"" plan', 'Philippe Lavielle', 'microalgal biomass', 'large field', 'tremendous commitment', 'marine biology', 'second platform', 'Next publication', 'bioindustrial exploitation', 'sustainable solutions', 'innovative products', 'Nutritional lipids', 'best ratings', 'ESG) performance', 'Journalists contact', 'Investor contact', 'sustainable foodstuffs', 'Nutritional, health', 'efficient products', 'ACTUS finance', 'wider valorization', 'Microalgal fermentation', 'bioindustrial innovations', 'current decade', 'food sovereignty', 'active ingredients', 'Euronext Paris', 'sustainable health', 'industrial production', 'Fermentalg shares', 'Libourne', 'December', 'FALG', 'KALVEAâ„¢', 'support', 'Bpifrance', 'part', 'Tomorrow', 'call', 'projects', 'DDW', 'subsidiary', 'commercialization', 'deployment', 'maturity', 'industrialization', 'nutraceuticals', 'superfood', 'antioxidants', 'vitamins', 'minerals', 'petfood', 'athletes', 'seniors', 'impacts', 'climate', 'preservation', 'COP', 'priorities', 'traceability', 'challenges', 'additives', 'territories', 'country', 'dependence', 'PIA', 'occasion', 'CEO', 'applications', 'expertise', 'service', 'cause', 'planet', '2022 sales', 'January', 'research', 'objective', 'business', 'marketing', 'company', 'PEA-PME', 'SRD', 'SRI', 'SMEs', 'terms', 'governance', 'information', 'communication', 'Montreal', 'Canada', '1']",2022-12-12,2022-12-12,actusnews.com
14676,EuroNext,Bing API,https://www.finanznachrichten.de/nachrichten-2022-12/57817166-fermentalg-industrial-production-and-first-order-for-the-new-natural-blue-food-colorant-650.htm,FERMENTALG: Industrial production and first order for the new natural blue food colorant,Fermentalg (Euronext - FALG)  the French microalgae expert  announces the launch of the production of the first industrial batches of its natural blue food colorant,"Libourne - December 1st  2022 - Fermentalg (Euronext - FALG)  the French microalgae expert  announces the launch of the production of the first industrial batches of its natural blue food colorant and a first order received from its partner DDW  a subsidiary of the Givaudan Group  as part of the pre-commercialization of this new natural ingredient resulting from the Blue OriginsÂ® program.This first open order of the 2nd Fermentalg product platform  for a maximum amount of 750 Kâ‚¬  will allow DDW/Givaudan to provide samples to worldwide leaders of food and beverage industries  especially in the beverage sector.As a reminder  the partnership between Fermentalg and DDW  a subsidiary of the Givaudan Group  was established in June 2020. The first phase of technological development and industrialization was completed in June 2022  after having achieved the technical milestones on schedule.Since then  Givaudan has started the commercialization phase of the product  under the name Galdieria Blue Extract. The competitive advantage of the product  the only natural blue food colorant stable in an acidic environment and resistant to heat treatment  opens up the sports drinks and confectionery segments  which are looking for alternatives to chemical colorants.In this pre-commercial phase  Fermentalg has planned up to three production campaigns with a leading German manufacturer  a number that will be adjusted according to the performance and needs of the sales teams. The first production campaign  carried out between early November and January 2023  represents a turnover of â‚¬250K. In addition  the regulatory process with the European Food Safety Authority (EFSA) and the US Food and Drug Administration (FDA) continues according to the announced schedule  and market authorization for this natural and sustainable alternative to synthetic dyes is expected in the second half of 2023.Next publication: 2022 sales January 19  2023 (after market close)About FermentalgAs an expert in research and bioindustrial exploitation of microalgae  Fermentalg's objective is to offer sustainable solutions and innovative products contributing to the development of healthy  natural and efficient products. Our business: the development  production and marketing of sustainable solutions and active ingredients from microalgae for nutrition  health and the environment. Nutritional lipids  alternative proteins  natural food colorings and innovative environmental solutions make up our company's current and future offer.Fermentalg shares are listed on Euronext Paris (FR0011271600 - FALG) and are eligible for the PEA-PME and the ""SRD long-only"". It is part of the GaÃ¯a index  designed for Socially Responsible Investment (SRI)  which groups together the SMEs with the best ratings in terms of environmental  social and governance (ESG) performance.For more information: www.fermentalg.comJournalists contact : Investor contact: ACTUS finance & communicationNawel NAAMANEphone: +33 (0)1 53 67 36 75nnaamane@actus.fr ACTUS finance & communicationAnne-Catherine BONJOURphone: +33 (0)1 53 67 36 93fermentalg@actus.fr------------------------This publication embed ""Actusnews SECURITY MASTER "".- SECURITY MASTER Key:m5ifaJlvamjHnJ1sY5yWbGdra2+VxmaZamaYlGJwY8jIbZ2VlGliacmbZnBom2Zo- Check this key: https://www.security-master-key.com.------------------------Â© Copyright Actusnews WireReceive by email the next press releases of the company by registering on www.actusnews.com  it's freeFull and original release in PDF format:https://www.actusnews.com/documents_communiques/ACTUS-0-77612-fermentalg_20221201_cp_industrial-production-and-first-order-bo_engl.pdf",neutral,0.01,0.99,0.0,neutral,0.02,0.97,0.0,True,English,"['new natural blue food colorant', 'Industrial production', 'first order', 'European Food Safety Authority', 'natural blue food colorant', '2nd Fermentalg product platform', 'Blue OriginsÂ® program', 'Galdieria Blue Extract', 'leading German manufacturer', 'GaÃ¯a index', 'Socially Responsible Investment', 'new natural ingredient', 'natural food colorings', 'first industrial batches', 'next press releases', 'first open order', 'three production campaigns', 'Anne-Catherine BONJOUR phone', 'Copyright Actusnews Wire', 'innovative environmental solutions', 'first production campaign', 'Actusnews SECURITY MASTER', 'SECURITY MASTER Key', 'French microalgae expert', 'first order', 'US Food', 'healthy, natural', 'first phase', 'innovative products', 'sustainable solutions', 'maximum amount', 'worldwide leaders', 'beverage industries', 'beverage sector', 'technical milestones', 'commercialization phase', 'competitive advantage', 'heat treatment', 'sports drinks', 'confectionery segments', 'chemical colorants', 'up to', 'early November', 'regulatory process', 'Drug Administration', 'sustainable alternative', 'synthetic dyes', 'second half', 'Next publication', 'bioindustrial exploitation', 'efficient products', 'active ingredients', 'Nutritional lipids', 'alternative proteins', 'future offer', 'best ratings', 'Journalists contact', 'Investor contact', 'Nawel NAAMANE', 'original release', 'PDF format', 'Givaudan Group', 'Fermentalg shares', 'acidic environment', 'sales teams', 'market authorization', 'Euronext Paris', 'ESG) performance', 'ACTUS finance', 'technological development', '2022 sales', 'Libourne', 'December', 'FALG', 'launch', 'partner', 'DDW', 'subsidiary', 'pre-commercialization', '750 K', 'samples', 'reminder', 'June', 'industrialization', 'schedule', 'name', 'alternatives', 'number', 'needs', 'January', 'turnover', 'addition', 'EFSA', 'FDA', 'research', 'objective', 'business', 'marketing', 'company', 'current', 'PEA-PME', 'SRD', 'SRI', 'SMEs', 'terms', 'governance', 'information', 'communication', 'VxmaZamaYlGJwY8jIbZ2VlGliacmbZnBom2Zo', 'email', 'Full', 'communiques', 'first-order', '1']",2022-12-05,2022-12-12,finanznachrichten.de
14677,EuroNext,Bing API,https://uk.finance.yahoo.com/news/2023-financial-communication-calendar-140000017.html,2023 financial communication calendar,Voltalia (Euronext Paris  ISIN code : FR0011995588)  an international player in renewable energies  releases its 2023 financial communication calendar Date Event January 25  2023 Q4 2022 Revenues  after market close March 23 ,Voltalia is an international player in the renewable energy sector. The Group produces and sells electricity generated from wind  solar  hydraulic  biomass and storage facilities that it owns and operates. Voltalia has generating capacity in operation and under construction of more than 2.4 GW and a portfolio of projects under development representing total capacity of 13.6 GW.Voltalia is also a service provider and supports its investor clients in renewable energy projects during all phases  from design to operation and maintenance.As a pioneer in the corporate market  Voltalia provides a global offer to private companies  ranging from the supply of green electricity and energy efficiency services to the local production of their own electricity.The Group has more than 1 450 employees and is present in 20 countries on 3 continents and is able to act worldwide on behalf of its clients.Voltalia is listed on the regulated market of Euronext Paris  compartment B (FR0011995588 â€“ VLTSA) and is part of the Enternext Tech 40 and CAC Mid & Small indices. The Group is also included in the GaÃ¯a-Index  an index for socially responsible midcaps.,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['2023 financial communication calendar', 'renewable energy sector', 'energy efficiency services', 'renewable energy projects', 'international player', 'The Group', 'hydraulic, biomass', 'storage facilities', 'generating capacity', 'total capacity', 'service provider', 'corporate market', 'global offer', 'private companies', 'local production', 'regulated market', 'Euronext Paris', 'Enternext Tech', 'CAC Mid', 'Small indices', 'GaÃ¯a-Index', 'responsible midcaps', 'investor clients', 'green electricity', 'Voltalia', 'operation', 'construction', '2.4 GW', 'portfolio', 'development', '13.6 GW', 'phases', 'design', 'maintenance', 'pioneer', 'supply', '1,450 employees', '20 countries', '3 continents', 'behalf', 'compartment', 'VLTSA']",2022-12-12,2022-12-12,uk.finance.yahoo.com
14678,EuroNext,Bing API,https://www.actusnews.com/fr/fermentalg/cp/2022/12/12/industrial-production-and-first-order-for-the-new-natural-blue-food-colorant,Industrial production and first order for the new natural blue food colorant,Fermentalg (Euronext - FALG)  the French microalgae expert  announces the launch of the production of the first industrial batches of its natural blue food colorant and a first order received from its partner DDW ,"12/12/2022 - 11:00Libourne - December 1st  2022 â€“ Fermentalg (Euronext - FALG)  the French microalgae expert  announces the launch of the production of the first industrial batches of its natural blue food colorant and a first order received from its partner DDW  a subsidiary of the Givaudan Group  as part of the pre-commercialization of this new natural ingredient resulting from the Blue OriginsÂ® program.This first open order of the 2nd Fermentalg product platform  for a maximum amount of 750 Kâ‚¬  will allow DDW/Givaudan to provide samples to worldwide leaders of food and beverage industries  especially in the beverage sector.As a reminder  the partnership between Fermentalg and DDW  a subsidiary of the Givaudan Group  was established in June 2020. The first phase of technological development and industrialization was completed in June 2022  after having achieved the technical milestones on schedule.Since then  Givaudan has started the commercialization phase of the product  under the name Galdieria Blue Extract. The competitive advantage of the product  the only natural blue food colorant stable in an acidic environment and resistant to heat treatment  opens up the sports drinks and confectionery segments  which are looking for alternatives to chemical colorants.In this pre-commercial phase  Fermentalg has planned up to three production campaigns with a leading German manufacturer  a number that will be adjusted according to the performance and needs of the sales teams. The first production campaign  carried out between early November and January 2023  represents a turnover of â‚¬250K. In addition  the regulatory process with the European Food Safety Authority (EFSA) and the US Food and Drug Administration (FDA) continues according to the announced schedule  and market authorization for this natural and sustainable alternative to synthetic dyes is expected in the second half of 2023.Next publication: 2022 sales January 19  2023 (after market close)About FermentalgAs an expert in research and bioindustrial exploitation of microalgae  Fermentalg's objective is to offer sustainable solutions and innovative products contributing to the development of healthy  natural and efficient products. Our business: the development  production and marketing of sustainable solutions and active ingredients from microalgae for nutrition  health and the environment. Nutritional lipids  alternative proteins  natural food colorings and innovative environmental solutions make up our company's current and future offer.Fermentalg shares are listed on Euronext Paris (FR0011271600 - FALG) and are eligible for the PEA-PME and the ""SRD long-only"". It is part of the GaÃ¯a index  designed for Socially Responsible Investment (SRI)  which groups together the SMEs with the best ratings in terms of environmental  social and governance (ESG) performance.For more information: www.fermentalg.com",neutral,0.01,0.99,0.0,neutral,0.03,0.97,0.0,True,English,"['new natural blue food colorant', 'Industrial production', 'first order', 'European Food Safety Authority', 'natural blue food colorant', '2nd Fermentalg product platform', 'Blue OriginsÂ® program', 'Galdieria Blue Extract', 'leading German manufacturer', 'GaÃ¯a index', 'Socially Responsible Investment', 'new natural ingredient', 'natural food colorings', 'first industrial batches', 'first open order', 'three production campaigns', 'innovative environmental solutions', 'first production campaign', 'French microalgae expert', 'first order', 'US Food', 'healthy, natural', 'first phase', 'innovative products', 'sustainable solutions', 'maximum amount', 'worldwide leaders', 'beverage industries', 'beverage sector', 'technical milestones', 'commercialization phase', 'competitive advantage', 'heat treatment', 'sports drinks', 'confectionery segments', 'chemical colorants', 'early November', 'regulatory process', 'Drug Administration', 'sustainable alternative', 'synthetic dyes', 'second half', 'Next publication', 'bioindustrial exploitation', 'efficient products', 'active ingredients', 'Nutritional lipids', 'alternative proteins', 'future offer', 'best ratings', 'Givaudan Group', 'Fermentalg shares', 'acidic environment', 'sales teams', 'market authorization', 'Euronext Paris', 'ESG) performance', 'technological development', '2022 sales', 'Libourne', 'December', 'FALG', 'launch', 'partner', 'DDW', 'subsidiary', 'pre-commercialization', '750 K', 'samples', 'reminder', 'June', 'industrialization', 'schedule', 'name', 'alternatives', 'number', 'needs', 'January', 'turnover', 'addition', 'EFSA', 'FDA', 'research', 'objective', 'business', 'marketing', 'company', 'current', 'PEA-PME', 'SRD', 'SRI', 'SMEs', 'terms', 'governance', 'information', '11:00']",2022-12-12,2022-12-12,actusnews.com
14679,EuroNext,Bing API,https://www.moneymarketing.co.uk/news/the-morning-briefing-all-things-investment-and-pensions-innovation/,The Morning Briefing: All things investment and pensions innovation,Good morning and welcome to your Morning Briefing for Monday 12 December 2022. To get this in your inbox every morning click here. Investment opportunitiesÂ  While many might want to write off 2022 as a bad year for investors there is always nuance in the narrative.,Good morning and welcome to your Morning Briefing for Monday 12 December 2022. To get this in your inbox every morning click here.Investment opportunitiesWhile many might want to write off 2022 as a bad year for investors there is always nuance in the narrative.This is the message from Dan Kemp  global chief investment officer  at Morningstar Investment Management.He said it was a poor year for those who have just started investing or those at retirement.But for the rest of us who save for the long term prices went lower in 2022 and that is always a better time to invest.Kemp talked about all this and more with our digital content manager Kimberly Dondo.Listen to the podcast here.Pension innovationPensions can have strange terms and arcane processes but on occasion you get innovation.For years some have been very excited about the prospect of collective defined contribution (CDC) schemes.Royal Mail is on course to provide the first.Amanda Newman Smith looks at the prospects for it to catch on.Quote Of The DayThe challenge of annual and lifetime allowance thresholds remains on the table. Itâ€™s the thing that seeâ€™s consultants  doctors  GPs  and surgeons reduce sessions in a bid to cut their exposure to long-term tax issues.â€“ Andrew Pow  director at Mazars  on the latest NHS pension scheme proposalsStat Attack The ONS has published a report showing how the cost of living and working arrangements shape daily life and events. It covers the period from 22 November to 4 December 2022. 92% Of adults reported the cost of living as an important issue when asked about the issues facing the UK today 80% Said the NHS was an other issue frequently reported  with the economy (77%)  and climate change and the environment (63%) Around 9 in 10 Adults reported their cost of living had increased compared with a year ago 74% A lower percentage reported an increase in their cost of living compared with one month ago 66% The most common actions reported by adults because of the rising cost of living were spending less on non-essentials 63% And using less fuel  such as gas or electricity  in their homes 1 in 5 Adults reported that they did not have any savings 7% Of adults reported that they had had either a direct debit  a standing order  or a bill that they were unable to pay in the past month 1 in 12 Adults reported that they had cancelled a financial product  such as a pension payment  motor vehicle breakdown cover or dental insurance  in the past month  because of increases in the cost of living 57% Of adults reported that they were worried (very or somewhat) about keeping warm in their home this winter Source: ONSOther newsThe FCA has fined Santander UK Plc (Santander) Â£107 793 300 after it found serious and persistent gaps in its anti-money laundering (AML) controls  affecting its Business Banking customers.Between 31 December 2012 and 18 October 2017  Santander failed to properly oversee and manage its AML systems  which significantly impacted the account oversight of more than 560 000 business customers.Santander had ineffective systems to adequately verify the information provided by customers about the business they would be doing.The firm also failed to properly monitor the money customers had told them would be going through their accounts compared with what actually was being deposited.BlackRock has launched a new ETF giving European clients targeted exposure to companies active in developing metaverse technologies.The iShares Metaverse UCITS ETF [MTAV] will track the STOXX Global Metaverse index.This index leverages patent data to identify market leaders  innovators  and specialists in the space. Companies are included based on the quality of their innovation activity through an assessment of the patents they file.The metaverse technology marketplace is developing at a rapid pace  with an expected value of $800m by 2025 and an expected market size of $4-5trn by 2030. Metaverse-themed global exchange traded products hit $2bn AUM globally in March 2022.The ETF is listed on Euronext  with a total expense ratio (TER) of 0.50%.From Elsewhere Next yearâ€™s unpleasant choices confronting the Fed (Financial Times) Royal Mail: When are the postal strikes and Christmas post dates? (BBC News) National Grid fires up two coal-fired plants amid UK icy weather (The Guardian)Did You See?For a chancellor who was brought into steady the ship Jeremy Hunt has now raised his flag over financial services.The flag says â€˜reformâ€™ and specifically the â€˜Edinburgh Reformsâ€™.On 9 December the government said it aims to make over 30 regulatory reforms to replace or modify retained European Union laws on financial services.These are intended to establish a smarter regulatory framework for the UK that  is agile  less costly and more responsive to emerging trends.,neutral,0.09,0.9,0.0,mixed,0.34,0.07,0.58,True,English,"['The Morning Briefing', 'things investment', 'pensions innovation', 'latest NHS pension scheme proposals', 'motor vehicle breakdown cover', 'global exchange traded products', 'global chief investment officer', 'iShares Metaverse UCITS ETF', 'Morningstar Investment Management', 'long term prices', 'digital content manager', 'collective defined contribution', 'Amanda Newman Smith', 'lifetime allowance thresholds', 'total expense ratio', 'Christmas post dates', 'two coal-fired plants', 'metaverse technology marketplace', 'European Union laws', 'smarter regulatory framework', 'Global Metaverse index', 'long-term tax issues', 'UK icy weather', 'Business Banking customers', 'Santander UK Plc', 'Investment opportunities', 'pension payment', 'Pension innovation', 'metaverse technologies', 'European clients', '30 regulatory reforms', 'new ETF', 'Morning Briefing', 'bad year', 'poor year', 'Kimberly Dondo', 'strange terms', 'arcane processes', 'CDC) schemes', 'Royal Mail', 'Andrew Pow', 'Stat Attack', 'working arrangements', 'daily life', 'important issue', 'other issue', 'climate change', 'lower percentage', 'common actions', 'less fuel', 'direct debit', 'standing order', 'past month', 'financial product', 'dental insurance', 'Other news', 'persistent gaps', 'anti-money laundering', 'AML) controls', 'AML systems', 'account oversight', 'ineffective systems', 'patent data', 'market leaders', 'rapid pace', 'expected value', 'market size', 'unpleasant choices', 'Financial Times', 'postal strikes', 'BBC News', 'National Grid', 'Jeremy Hunt', 'financial services', 'Edinburgh Reforms', 'emerging trends', '560,000 business customers', 'innovation activity', 'The ONS', 'The FCA', 'The Guardian', 'Dan Kemp', 'Monday 12 December', 'rising cost', '4 December', '31 December', '9 December', 'inbox', 'investors', 'nuance', 'narrative', 'message', 'retirement', 'rest', 'podcast', 'Pensions', 'occasion', 'years', 'prospect', 'course', 'Quote', 'challenge', 'annual', 'table', 'thing', 'consultants', 'doctors', 'GPs', 'surgeons', 'sessions', 'bid', 'exposure', 'director', 'Mazars', 'report', 'living', 'events', 'period', '22 November', 'adults', 'economy', 'environment', 'increase', 'non-essentials', 'gas', 'electricity', 'homes', 'savings', 'bill', 'Source', 'serious', '18 October', 'information', 'firm', 'accounts', 'BlackRock', 'companies', 'MTAV', 'innovators', 'specialists', 'space', 'quality', 'assessment', 'patents', 'March', 'Euronext', 'Elsewhere', 'Fed', 'chancellor', 'ship', 'flag', 'government']",2022-12-12,2022-12-12,moneymarketing.co.uk
14680,EuroNext,Bing API,https://www.joplinglobe.com/region/national_business/cramer-rosenthal-mcglynn-selects-linedata-adaptable-technology-and-streamlined-operations-empower-next-generation-of-growth/article_f1389944-64cb-520a-a41c-7dd46c0af000.html,Cramer Rosenthal Mcglynn Selects Linedata: Adaptable Technology and Streamlined Operations Empower Next Generation of Growth,Linedata  (Euronext Paris: LIN)  a global provider of asset management and credit technology data and services  announced today that Cramer Rosenthal McGlynn  LLC (â€œCRMâ€)  a US based value equity manager serving institutions and individuals ,Linedata  (Euronext Paris: LIN)  a global provider of asset management and credit technology data and services  announced today that Cramer Rosenthal McGlynn  LLC (â€œCRMâ€)  a US based value equity manager serving institutions and individuals ,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['Cramer Rosenthal Mcglynn', 'Adaptable Technology', 'Streamlined Operations', 'Next Generation', 'Linedata', 'Growth', 'US based value equity manager', 'credit technology data', 'Cramer Rosenthal McGlynn', 'Euronext Paris', 'global provider', 'asset management', 'Linedata', 'services', 'LLC', 'CRM', 'institutions', 'individuals']",2022-12-12,2022-12-12,joplinglobe.com
14681,EuroNext,Twitter API,Twitter,Euronext's FX volume remains in range-bound mode - FinanceFeeds https://t.co/kx0pKw21D4,nan,Euronext's FX volume remains in range-bound mode - FinanceFeeds https://t.co/kx0pKw21D4,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['FX volume', 'range-bound mode', 'Euronext', 'FinanceFeeds', 'FX volume', 'range-bound mode', 'Euronext', 'FinanceFeeds']",2022-12-12,2022-12-12,Unknown
14682,EuroNext,Twitter API,Twitter,"""The consequences of Brexit are there.""@euronext CEO StÃ©phane Boujnah comes on the show as the London Stock Exchaâ€¦ https://t.co/iQTeqmC6iM",nan,"""The consequences of Brexit are there.""@euronext CEO StÃ©phane Boujnah comes on the show as the London Stock Exchaâ€¦ https://t.co/iQTeqmC6iM",neutral,0.05,0.93,0.02,neutral,0.05,0.93,0.02,True,English,"['StÃ©phane Boujnah', 'London Stock Excha', 'consequences', 'Brexit', 'show', 'StÃ©phane Boujnah', 'London Stock Excha', 'consequences', 'Brexit', 'show']",2022-12-12,2022-12-12,Unknown
14683,EuroNext,Twitter API,Twitter,Euronext Launches Gender Equality Indices #Innovation via https://t.co/ypYmUnY8pA https://t.co/Ycjsv4ZzDQ,nan,Euronext Launches Gender Equality Indices #Innovation via https://t.co/ypYmUnY8pA https://t.co/Ycjsv4ZzDQ,neutral,0.02,0.98,0.0,neutral,0.02,0.98,0.0,True,English,"['Gender Equality Indices #Innovation', 'Euronext', 'Gender Equality Indices #Innovation', 'Euronext']",2022-12-12,2022-12-12,Unknown
14684,EuroNext,Twitter API,Twitter,#Cac40 CAC 40 6 637 60 | Euronext Live cours de bourse https://t.co/Iqh8wn15YL https://t.co/43yLwlwnIb,nan,#Cac40 CAC 40 6 637 60 | Euronext Live cours de bourse https://t.co/Iqh8wn15YL https://t.co/43yLwlwnIb,neutral,0.03,0.97,0.0,neutral,0.03,0.97,0.0,True,English,"['Euronext Live cours', 'Cac40', 'bourse', 'Euronext Live cours', 'Cac40', 'bourse']",2022-12-12,2022-12-12,Unknown
14685,EuroNext,Twitter API,Twitter,What is European stock market?Euronext  which is a pan-European  Dutch-domiciled and France-headquartered stock exâ€¦ https://t.co/xuMgPNJth5,nan,What is European stock market?Euronext  which is a pan-European  Dutch-domiciled and France-headquartered stock exâ€¦ https://t.co/xuMgPNJth5,neutral,0.04,0.95,0.01,neutral,0.04,0.95,0.01,True,English,"['European stock market', 'France-headquartered stock', 'pan-European, Dutch-domiciled', 'Euronext', 'European stock market', 'France-headquartered stock', 'pan-European, Dutch-domiciled', 'Euronext']",2022-12-12,2022-12-12,Unknown
14686,EuroNext,Twitter API,Twitter,At the right price i would buy $CME or $NAQ $DB1 (deutsche bÃ¶rse)  Euronext etc  without hesitation. (i thought mucâ€¦ https://t.co/EjjUjbhsYp,nan,At the right price i would buy $CME or $NAQ $DB1 (deutsche bÃ¶rse)  Euronext etc  without hesitation. (i thought mucâ€¦ https://t.co/EjjUjbhsYp,positive,0.95,0.04,0.01,positive,0.95,0.04,0.01,True,English,"['deutsche bÃ¶rse', 'right price', 'CME', 'Euronext', 'hesitation', 'EjjUjbhsYp', 'deutsche bÃ¶rse', 'right price', 'CME', 'Euronext', 'hesitation', 'EjjUjbhsYp']",2022-12-12,2022-12-12,Unknown
14687,EuroNext,Twitter API,Twitter,#Euronext announced the results of the quarterly review for the #PSIÂ® which will take place after markets close onâ€¦ https://t.co/lOJU6WCFCp,nan,#Euronext announced the results of the quarterly review for the #PSIÂ® which will take place after markets close onâ€¦ https://t.co/lOJU6WCFCp,neutral,0.1,0.88,0.02,neutral,0.1,0.88,0.02,True,English,"['quarterly review', 'results', 'place', 'markets', 'quarterly review', 'results', 'place', 'markets']",2022-12-12,2022-12-12,Unknown
14688,EuroNext,Twitter API,Twitter,Euronext Launches Gender Equality Indices #Innovation via https://t.co/pwflzXGpiN https://t.co/H4yonxf5xZ,nan,Euronext Launches Gender Equality Indices #Innovation via https://t.co/pwflzXGpiN https://t.co/H4yonxf5xZ,neutral,0.02,0.98,0.0,neutral,0.02,0.98,0.0,True,English,"['Gender Equality Indices #Innovation', 'Euronext', 'Gender Equality Indices #Innovation', 'Euronext']",2022-12-12,2022-12-12,Unknown
14689,EuroNext,Twitter API,Twitter,#dassault #StockMarket #euronext Daily Chart#forex #trading #investing #Finance https://t.co/Ut3inOpQbn,nan,#dassault #StockMarket #euronext Daily Chart#forex #trading #investing #Finance https://t.co/Ut3inOpQbn,neutral,0.04,0.87,0.09,neutral,0.04,0.87,0.09,True,English,"['StockMarket #euronext Daily Chart', 'dassault', 'Finance', 'StockMarket #euronext Daily Chart', 'dassault', 'Finance']",2022-12-12,2022-12-12,Unknown
14690,EuroNext,Twitter API,Twitter,Euronext completes acquisition of technology business from Nexi https://t.co/IWTJow0I42 via @finextra,nan,Euronext completes acquisition of technology business from Nexi https://t.co/IWTJow0I42 via @finextra,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['technology business', 'Euronext', 'acquisition', 'Nexi', 'co', 'IWTJow0I42', 'technology business', 'Euronext', 'acquisition', 'Nexi', 'co', 'IWTJow0I42']",2022-12-12,2022-12-12,Unknown
14691,EuroNext,Twitter API,Twitter,#Cac40 CAC 40 6 645 68 | Euronext Live cours de bourse https://t.co/Iqh8wn15YL https://t.co/EN9HH1JYWX,nan,#Cac40 CAC 40 6 645 68 | Euronext Live cours de bourse https://t.co/Iqh8wn15YL https://t.co/EN9HH1JYWX,neutral,0.06,0.93,0.0,neutral,0.06,0.93,0.0,True,English,"['Euronext Live cours', 'Cac40', 'bourse', 'EN9HH1JYWX', 'Euronext Live cours', 'Cac40', 'bourse', 'EN9HH1JYWX']",2022-12-12,2022-12-12,Unknown
14692,EuroNext,Twitter API,Twitter,@GweebarraG @Orsted @coilltenews @ESBGroup @anbordpleanala @CDP @corporateknight @swanireland @euronext_ieâ€¦ https://t.co/jac7fJf7ex,nan,@GweebarraG @Orsted @coilltenews @ESBGroup @anbordpleanala @CDP @corporateknight @swanireland @euronext_ieâ€¦ https://t.co/jac7fJf7ex,neutral,0.11,0.87,0.02,neutral,0.11,0.87,0.02,True,English,"['GweebarraG', 'ESBGroup', 'anbordpleanala', 'CDP', 'corporateknight', 'GweebarraG', 'ESBGroup', 'anbordpleanala', 'CDP', 'corporateknight']",2022-12-12,2022-12-12,Unknown
